1.631.750.51116222521316602431500581.120.631.753169501347731660240.020.530.513150000583150058P0YP0YP0YP0YP0Y2500000250000001606934744415823150058P3Y250000025000003150058250000025000004441582P15YP5Ytrue11000000001833908--12-312021FYfalseP5Y0001833908us-gaap:TreasuryStockCommonMember2021-01-012021-12-3100018339082021-06-232021-06-2300018339082021-06-230001833908alf:BridgeLoanWithRelatedPartyInvestorsMemberus-gaap:CommonStockMember2021-01-012021-12-310001833908alf:BridgeLoanWithRelatedPartyInvestorsMemberus-gaap:CommonStockMember2020-01-012020-12-310001833908us-gaap:PreferredStockMember2019-01-012019-12-310001833908alf:FoundersMember2018-04-042018-04-040001833908us-gaap:CommonStockMember2018-01-012018-12-310001833908us-gaap:CommonStockMember2020-01-012020-12-310001833908us-gaap:PreferredStockMember2021-01-012021-12-3100018339082021-05-312021-05-3100018339082021-05-012021-05-310001833908us-gaap:TreasuryStockCommonMember2021-12-310001833908us-gaap:RetainedEarningsMember2021-12-310001833908us-gaap:AdditionalPaidInCapitalMember2021-12-310001833908us-gaap:RetainedEarningsMember2020-12-310001833908us-gaap:AdditionalPaidInCapitalMember2020-12-310001833908us-gaap:RetainedEarningsMember2019-12-310001833908us-gaap:RetainedEarningsMember2018-12-310001833908us-gaap:CommonStockMember2021-12-310001833908us-gaap:PreferredStockMember2020-12-310001833908us-gaap:CommonStockMember2020-12-310001833908us-gaap:PreferredStockMember2019-12-310001833908us-gaap:CommonStockMember2019-12-310001833908us-gaap:PreferredStockMember2018-12-310001833908us-gaap:CommonStockMember2018-12-3100018339082018-01-012018-12-310001833908srt:MinimumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-12-310001833908srt:MaximumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-12-310001833908srt:MinimumMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-310001833908srt:MaximumMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-3100018339082020-01-012021-12-310001833908srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2021-01-012021-12-310001833908srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2021-01-012021-12-310001833908alf:TabletsMember2021-01-012021-12-310001833908us-gaap:FurnitureAndFixturesMember2021-12-310001833908alf:TabletsMember2021-12-310001833908us-gaap:FurnitureAndFixturesMember2020-12-310001833908alf:TabletsMember2020-12-310001833908us-gaap:FurnitureAndFixturesMember2019-12-310001833908us-gaap:SeniorNotesMember2020-01-012020-12-310001833908us-gaap:ConvertiblePreferredStockMember2019-01-012019-12-310001833908us-gaap:IPOMember2021-05-062021-05-060001833908us-gaap:OverAllotmentOptionMember2021-05-032021-05-030001833908srt:AffiliatedEntityMember2020-01-012020-12-310001833908us-gaap:ConvertiblePreferredStockMember2021-12-3100018339082021-05-060001833908us-gaap:ConvertiblePreferredStockMember2021-05-310001833908us-gaap:ConvertiblePreferredStockMember2020-12-310001833908us-gaap:ConvertiblePreferredStockMember2019-12-310001833908us-gaap:RetainedEarningsMember2021-01-012021-12-310001833908us-gaap:RetainedEarningsMember2020-01-012020-12-310001833908us-gaap:RetainedEarningsMember2019-01-012019-12-310001833908us-gaap:LineOfCreditMemberalf:RelatedPartyLenderMemberus-gaap:SubsequentEventMember2022-10-122022-10-120001833908alf:BelfastOfficeLeaseMember2019-07-010001833908us-gaap:PatentsMember2021-01-012021-12-310001833908us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-310001833908us-gaap:ComputerSoftwareIntangibleAssetMember2020-07-012020-07-010001833908alf:PatentAcquisitionCostsIntangibleAssetsMember2020-07-012020-07-010001833908us-gaap:PatentsMember2021-12-310001833908us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-310001833908us-gaap:PatentsMember2020-12-310001833908us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-310001833908us-gaap:PatentsMember2019-12-310001833908us-gaap:ComputerSoftwareIntangibleAssetMember2019-12-310001833908srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2019-01-012019-12-310001833908alf:BridgeLoanOneMember2021-12-310001833908us-gaap:CommonStockMember2020-01-012020-12-310001833908us-gaap:CommonStockMember2019-01-012019-12-310001833908srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-01-012020-12-310001833908us-gaap:CommonStockMember2021-05-012021-05-310001833908us-gaap:ConvertiblePreferredStockMember2021-05-012021-05-310001833908us-gaap:ConvertiblePreferredStockMember2020-01-012020-12-310001833908us-gaap:CommonStockMember2021-05-310001833908alf:EmployeeEquityStockIncentivePlanMember2021-12-310001833908us-gaap:OverAllotmentOptionMember2021-05-030001833908us-gaap:LineOfCreditMemberalf:RelatedPartyLenderMemberus-gaap:SubsequentEventMember2022-04-120001833908alf:UnderwriterSWarrantsMemberus-gaap:IPOMember2021-05-0300018339082021-05-030001833908srt:ScenarioPreviouslyReportedMember2018-12-310001833908srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2019-12-310001833908us-gaap:WarrantMember2021-01-012021-12-310001833908us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001833908us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001833908us-gaap:ConvertiblePreferredStockMember2020-01-012020-12-310001833908us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001833908us-gaap:ConvertiblePreferredStockMember2019-01-012019-12-310001833908us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001833908us-gaap:WarrantMember2021-01-012021-12-3100018339082021-06-3000018339082022-04-300001833908alf:BridgeLoanWithRelatedPartyInvestorsMember2021-01-012021-12-310001833908us-gaap:IPOMember2021-05-032021-05-030001833908srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-12-310001833908us-gaap:IPOMember2021-01-012021-12-310001833908us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001833908us-gaap:CommonStockMember2021-01-012021-12-310001833908alf:RelatedPartyNotesPayableTransactionMember2020-12-310001833908alf:RelatedPartyNotesPayableTransactionMember2019-12-310001833908alf:TabletFinancingMembersrt:AffiliatedEntityMember2020-01-012020-12-3100018339082021-05-032021-05-030001833908us-gaap:ConvertiblePreferredStockMember2018-01-012018-12-310001833908us-gaap:StateAndLocalJurisdictionMember2021-12-310001833908us-gaap:DomesticCountryMember2021-12-310001833908us-gaap:CommonStockMember2021-01-012021-12-310001833908us-gaap:SubsequentEventMember2022-03-012022-03-310001833908us-gaap:SubsequentEventMember2022-02-012022-02-280001833908alf:BelfastOfficeLeaseMember2019-07-012019-07-010001833908srt:ScenarioPreviouslyReportedMember2020-12-310001833908srt:ScenarioPreviouslyReportedMember2019-12-310001833908srt:ScenarioPreviouslyReportedMember2020-01-012020-12-3100018339082020-01-012020-12-310001833908srt:ScenarioPreviouslyReportedMember2019-01-012019-12-3100018339082019-01-012019-12-310001833908alf:PurchaseOfTabletDevicesMember2020-12-310001833908us-gaap:SubsequentEventMember2022-01-012022-03-310001833908us-gaap:LineOfCreditMemberalf:RelatedPartyLenderMemberus-gaap:SubsequentEventMember2022-04-122022-04-120001833908us-gaap:ConvertiblePreferredStockMember2018-12-310001833908alf:BridgeLoanTwoMemberalf:AffiliatedPersonsMember2021-01-012021-12-310001833908alf:BridgeLoanOneMembersrt:AffiliatedEntityMember2021-01-012021-12-3100018339082021-01-012021-06-300001833908us-gaap:SeniorNotesMembersrt:AffiliatedEntityMember2020-01-012020-12-310001833908alf:BridgeLoanTwoMembersrt:AffiliatedEntityMember2020-01-012020-12-310001833908alf:BridgeLoanOneMembersrt:AffiliatedEntityMember2020-01-012020-12-310001833908alf:BridgeLoanWithRelatedPartyInvestorsMember2020-01-012020-12-310001833908us-gaap:SeniorNotesMembersrt:AffiliatedEntityMember2019-01-012019-12-310001833908alf:RelatedPartyNotesPayableTransactionMember2019-01-012019-12-3100018339082021-01-012021-12-310001833908alf:BridgeLoanWithRelatedPartyInvestorsMember2020-12-3100018339082021-12-3100018339082020-12-3100018339082019-12-3100018339082018-12-31iso4217:USDxbrli:purexbrli:sharesalf:itemalf:employeealf:Miso4217:USDxbrli:shares

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from                  to

Commission file number 001-40294

Alfi, Inc.

(Exact name of registrant as specified in its charter)

Delaware

30-1107078

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

429 Lenox Avenue, Miami Beach, Florida

33139

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number including area code: (305395-4520

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

ALF

The Nasdaq Stock Market LLC

Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $4.57

ALFIW

The Nasdaq Stock Market LLC

Securities registered under Section 12(g) of the Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes      No  

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes      No  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

    

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No  

The aggregate market value of the voting common equity held by non-affiliates of the registrant as of June 30, 2021, was $118,809,433. As of April 30, 2022, there were 16,094,882 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.

Table of Contents

TABLE OF CONTENTS

    

    

Page

PART I

4

Item 1.

Business

4

Item 1A.

Risk Factors

12

Item 1B.

Unresolved Staff Comments

12

Item 2.

Properties

12

Item 3.

Legal Proceedings

12

Item 4.

Mine Safety Disclosures

14

PART II

15

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

15

Item 6.

[Reserved]

17

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

24

Item 8.

Financial Statements and Supplementary Data

24

Item 9.

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

53

Item 9A.

Controls and Procedures

53

Item 9B.

Other Information

54

Item 9C.

Disclosure Regarding Foreign Jurisdictions That Prevent Inspection

55

PART III

56

Item 10.

Directors, Executive Officers and Corporate Governance

56

Item 11.

Executive Compensation

62

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

70

Item 13.

Certain Relationships and Related Transactions, and Director Independence

72

Item 14.

Principal Accounting Fees and Services

76

PART IV

77

Item 15.

Exhibits, Financial Statement Schedules

77

Item 16.

Form 10-K Summary

80

Signatures

81

i

Table of Contents

USE OF MARKET AND INDUSTRY DATA

This Annual Report on Form 10-K includes market and industry data that we have obtained from third-party sources, including industry publications, as well as industry data prepared by our management on the basis of its knowledge of, and experience in, the industries in which we operate (including our management’s estimates and assumptions relating to such industries based on that knowledge). Management has developed its knowledge of such industries through its experience and participation in these industries. While our management believes the third-party sources referred to in this Annual Report on Form 10-K are reliable, neither we nor our management have independently verified any of the data from such sources referred to in this Annual Report on Form 10-K or ascertained the underlying economic assumptions relied upon by such sources. Furthermore, internally prepared and third-party market prospective information, in particular, are estimates only and there will usually be differences between the prospective and actual results, because events and circumstances frequently do not occur as expected, and those differences may be material. Also, references in this Annual Report on Form 10-K to any publications, reports, surveys or articles prepared by third parties should not be construed as depicting the complete findings of the entire publication, report, survey or article. The information in any such publication, report, survey or article is not incorporated by reference in this Annual Report on Form 10-K.

TRADEMARKS, SERVICE MARKS AND TRADE NAMES

We own or have rights to various trademarks, service marks and trade names that we use in connection with the operation of our business. This Annual Report on Form 10-K may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks and trade names or products in this Annual Report on Form 10-K is not intended to, and does not imply a relationship with, or endorsement or sponsorship, by us. Solely for convenience, the trademarks, service marks and trade names referred to in this Annual Report on Form 10-K may appear without the ®, TM or SM symbols, but the omission of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable owner of these trademarks, service marks and trade names.

OTHER PERTINENT INFORMATION

On March 1, 2021, we enacted a forward stock split on a 1.260023:1.000000 basis. Unless otherwise noted herein, all share and per share amounts reflected in this Annual Report on Form 10-K are presented post-split.

Unless the context otherwise indicates, when used in this Annual Report on Form 10-K, the terms “Alfi” “we,” “us,” “our,” the “Company” and similar terms refer to Alfi, Inc., a Delaware corporation and its wholly-owned subsidiary, Alfi (N.I.) Ltd.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. All statements included in this Annual Report on Form 10-K regarding our business and technology development, our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. Forward-looking statements contained in this Annual Report on Form 10-K include, but are not limited to, statements about:

Our expectations regarding the development of our technology and business model;
The evolution of technology affecting our products and services;
Our ability to innovate and make the right investment decisions for Alfi;
Our ability to retain key personnel and to grow and train our sales and support teams;

ii

Table of Contents

Our ability to attract and maintain customers;
Anticipated trends and growth rates in our business and in the markets in which we operate;
Our ability to anticipate market needs and successfully develop new and enhanced solutions to meet those needs;
Our ability to compete successfully in our intensively competitive industry;
Our future financial performance, including our expectations regarding our revenue, gross profit or gross margin, operating costs and expenses, ability to generate cash flow, and ability to achieve and maintain future profitability;
Our ability to continue as a going concern;
Our expectations regarding our liquidity position and our ability to raise sufficient additional capital through equity and debt financings to support our continued operations;
Our ability to appropriately manage our cash flows by extending payables, reducing overhead and scaling back our current business plan, if necessary;
Our beliefs regarding the possible effects of the COVID-19 pandemic, including on general economic conditions, public health and customer demand, as well as on our ability to roll-out our products and on our results of operations, liquidity, capital resources and general performance in the future;
Our ability to adequately protect our intellectual property; and
Our ability to comply with governmental regulations, legal requirements and industry standards relating to consumer privacy and data protection.

We caution you that the foregoing list may not contain all of the forward-looking statements made in this Annual Report on Form 10-K.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report on Form 10-K primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

iii

Table of Contents

PART I

ITEM 1.BUSINESS

Overview

We seek to provide solutions that bring transparency and accountability to the digital out of home (“DOOH”) advertising marketplace. Alfi uses artificial intelligence and big data analytics to measure and disseminate audience presence and audience demographics. Our computer vision technology is powered by proprietary artificial intelligence, to determine the relevant demographic and geospecific information of the audience in front of an Alfi-enabled device, such as a tablet or kiosk.  Alfi can then deliver in real-time, the advertisements to that particular viewer based on the viewer’s demographic profile and/or geolocation.  Alfi is designed to deliver the right marketing content, to the right person at the right time in a responsible and ethical manner.  By delivering the advertisements most relevant to the audience in front of the device, we connect our advertising customers to the viewers they seek to target.  The result is higher click through rates (“CTRs”), higher QR code scans and higher cost per thousand rates (“CPMs”).

Alfi seeks to solve the problems facing advertisers in the DOOH marketplace, as its proprietary technology is designed to measure the audience when an advertisement is displayed.  Our data rich reporting functionality is able to inform the advertiser exactly when someone viewed each ad, as well as the general demographic and geospecific characteristics of the viewing audience. Alfi can provide large and small businesses access to data-driven insights by expanding their advertising capabilities, by providing analytical sophistication and by delivering it all over multiple devices.  In addition to the traditional Content Management System model that delivers adverts on a scheduled loop, Alfi’s technology is able to first analyze the audience and determine the most relevant content to be displayed.

Alfi has created an enterprise grade, multimedia computer vision and machine learning platform, capable of generating powerful advertising recommendations and insights.  Multiple technologies work together with viewer privacy and data-rich reporting as our primary objectives.  Alfi is able to use a facial fingerprinting process to make demographic determinations.  As such, Alfi makes no attempt to identify the individual in front of the screen.  Brand owners do not need to know someone’s name or invade their privacy to gain a deeper understanding of the consumers who view their content.  By providing age, gender and geolocation information, we believe brand owners should have the pertinent data they need for meaningful insight.  From an analytics perspective, these data points are intended to provide meaningful reporting instead of arbitrary calculations based on estimates of ad engagement.

Alfi seeks to solve the problem of providing real time, accurate and rich reporting on customer demographics, usage, interactivity and engagement while never storing any personally identifiable information.  No viewer is ever required, or requested by us, to enter any information about themselves on any Alfi-enabled device.

Our initial focus is to place our Alfi-enabled devices in malls, airports rideshares and taxis.  We also have begun offering our software solution to other DOOH media operators as a Software as a Service (“SaaS”) product.

Currently, we intend to charge customers solely based on a CPM, or ads delivered, model.  As we continue to deploy Alfi in the marketplace, we expect to charge customers based on a combination of CPM and CTR, and we expect we will generate higher CPM rates than typical DOOH advertising platforms because we have the ability to only deliver ads to the customer’s desired demographic.  In addition, we also intend to provide the aggregated data to the brands so they can make more informed advertising decisions.

Advertising Industry Background

According to the Interactive Advertising Bureau Internet Advertising Revenue Report, the digital advertising (internet) marketplace grew to $189 billion in 2021. The DOOH marketplace is experiencing rapid growth due to, among other things, the rise in digitization and the declining demand for traditional billboards, paired with easy data integration. Additionally, we believe that the reduced cost of digital screens will also drive the market opportunity. Previously, advertisers could not effectively target viewers in out of home (“OOH”) and DOOH, having instead to rely on either static boards, or if placed on digital screens, their advertisements could only be played in an ongoing multi-ad loop for mass reach without viewer-based targeting.

In online advertising, advertisers have had access to behavioral and personal user data to know more about the viewer through the use of “cookies”.  The tracking cookie has been a key component to the growth of online advertising, built into nearly every website

4

Table of Contents

and online / mobile advertising medium. Cookies are designed to provide a system to capture personal data about customers, their browsing history, and their preferences and behaviors.  Depending on the sophistication and the data solicited, an advertiser could learn a great deal about their potential customers and target their ad messaging accordingly. The data derived has been used in targeting and retargeting ads, behavioral marketing tactics and display advertising strategies.  Cookies are the reason the ads a viewer was served as they browsed websites on their phone, tablet or computer would align with their interests and browsing history.

The data that cookies gathered was intrusive, and consumers have come to distrust cookies primarily because of their invasive nature and privacy concerns.  Smart technologies and apps have been developed to allow consumers to block cookies, and many consumers have done so. Globally, cookies are generally in the process of being phased out for online advertising and major search engines, forcing advertisers to rely more on contextual-based marketing rather than viewer-based targeting. This has forced advertisers to look for new ways to track consumer behavior without invading a consumer’s privacy, exposing the need for a new, targeted advertising technology that also prioritizes privacy compliance.

Historically, in the DOOH advertising marketplace, the best targeting an advertiser could utilize was the geolocation of their ad delivery on a screen (kiosk, video wall, digital billboard, etc.), day parting (time specific ad delivery), or an estimated forecast of the expected number of people that would be in that area based on typical consumer traffic for that time of year (such as a mall or an airport).  Advertisers would not get any information on the audience that might have actually seen their ad, for how long the ad was viewed, or the actual count of people in the area when the ad was displayed.  This resulted in wasted advertising dollars spent reaching the wrong audience (target market) or no audience at all – also known as unmeasurable and unverifiable impressions. This approach of unverified impressions meant a significant percentage of DOOH campaigns were executed to the wrong targets or no targets at all.

Internet advertising has faced another growing issue with online ad fraud. Digital advertising fraud occurs when an ad is displayed on either a fake website or to a ‘bot’ in an effort to inflate web traffic numbers, or served below the viewing area on the screen (but still charged as a delivered “impression.”)  Data and confidence in ad delivery is critically important to advertisers.  Savvy advertisers recognize that they need to make their decisions based on more comprehensive and accurate data to improve the efficiency of their advertising dollars.  Currently, advertisers cannot get that data in DOOH because it does not exist.

By providing artificial intelligence based, facial detection driven real time and post campaign reporting data, and delivering advertisements to the desired demographic, Alfi seeks to solve both problems facing advertisers in the DOOH and digital advertising marketplace without invading the privacy of the person viewing the ad.

Our Strategy

Alfi seeks to solve the problems facing advertisers in the DOOH marketplace, as its proprietary technology is able to determine when an advertisement was displayed, verify someone was in front of the screen, as well as report basic demographic and geolocation information. This actualized information is the data that advertisers seek to make strategy decisions. In addition to providing a new type of data to the DOOH marketplace, by telling advertisers actualized numbers as well as the demographic makeup of their campaign’s viewing audience, Alfi’s technology is able to provide confirmation to advertisers that they have reached their desired demographic and total number of purchased impressions. By delivering verified impressions, advertisers know their ad dollars were not wasted and their desired audience was reached, bringing digital accountability and audience transparency to the DOOH marketplace.

The main elements of our growth strategy are:

Increase distribution to increase revenue.  As we place more devices in areas where people live, work, and play outside the home, we will deliver more campaigns and derive more revenues.
Continue technological innovation.  The enhancements we continue to make to our software are designed to allow us to improve the viewer experience, sharpen our targeting by audience / viewer demographics and deliver better data to our advertiser-customers, while we continue to prioritize privacy compliance.
Diversify revenue streams.  As Alfi gathers more data, we intend to sell that data to advertisers, venues and municipalities that do not use the Alfi platform, which we believe will attract additional advertisers and generate advertising revenue. In addition, we intend to enter into joint venture agreements with retailers to provide Alfi-enabled devices at points of sale in their stores to enhance their customer’s experience and sell more product.

5

Table of Contents

License Alfi to other DOOH media operators.  Alfi is a robust, hosted software platform that we intend to make available by SaaS to other DOOH media network operators.
Pursue potential acquisitions.  We will seek to acquire additional technologies that we believe will expand Alfi’s software execution and capabilities, as well as companies with DOOH screen networks that will allow us to increase our screen footprint and market penetration.  Additionally, we will seek to acquire strategic “launch pads” that have legacy infrastructure and digital hardware, but lack true digital software and are incapable of being as intelligent, interactive, measured and targeted as Alfi enabled networks.

Our Products and Services

Alfi is an enterprise grade, multimedia state-of-the-art computer vision and machine learning platform, generating powerful advertising recommendations and insights.  Multiple technologies work together in Alfi with viewer privacy and data-rich reporting as our primary objectives. Alfi is able to use a facial fingerprinting process to make demographic determinations.  As such, Alfi makes no attempt to identify the individual in front of the screen.  Brand owners do not need to know a person’s name or invade their privacy to gain a deeper understanding of the consumers viewing their content.  By providing age, gender and geolocation information, we believe brand owners should have all of the data they need for meaningful interaction.  From an analytics perspective, these data points are intended to provide meaningful reporting instead of arbitrary calculations of ad engagement.

Alfi can be installed on most Linux or Android-based internet enabled devices enabled with a camera.  Our initial rollout of Alfi-owned devices started with tablets connected by cellular data service in taxis and rideshares.  The device rollout continues as we target airports and malls with kiosks.

We also will seek to license our software to other DOOH media operators on a subscription basis.  In addition to the subscription license fees, we will be able to capture additional data that should give us more detailed demographic information that we will be able to make available to advertisers.  We believe there are other uses for Alfi outside of advertising, and we will continue to explore and evaluate such uses so that we may endeavor to license the software for other uses.

Both our tablets and kiosks contain Alfi’s computer vision technology powered by proprietary artificial intelligence that determines the age, gender and geolocation of someone in front of the device.  Alfi can then deliver in real-time, curated advertisements to that particular viewer based on the viewer’s demographic and geolocation information.  Alfi is designed to deliver the right content, to the right person at the right time in a responsible and ethical manner.

Alfi gives large and small businesses access to data-driven insights by expanding their advertising capabilities, by providing analytical sophistication and by delivering it all over multiple devices.  If an advertiser wants to target a specific advert to a demographic, Alfi is able to deliver the content whenever a person fitting that demographic is in front of the device.

Marketing Strategy

We intend to market Alfi to advertisers and other DOOH and OOH media operators as the first facial detection-based ad technology offering verified impressions and true audience measurement based on “eyes on screens” (as opposed to measuring “exposed mobile devices” that are within a certain proximity of an OOH ad – which is currently the norm for measurement in the DOOH / OOH marketplace).

We provide Alfi-enabled tablets to independent ride share drivers and taxi fleets who install the tablets on the back of the passenger seat head rest in their vehicles. We intend to market Alfi tablets to the drivers as an additional source of income by earning monthly commissions based on their driving hours with passengers in front of our tablets.  We also intend to sell our kiosks into a variety of locations, including, airports, sports venues, shopping malls, hotels, hospitals, transit hubs and museums. We also will seek to enter into revenue sharing agreements with these place-based entities where we install our kiosks, video walls and digital boards, and to sell ads onto their screen network.

We intend to market Alfi to advertisers and ad agencies as the first artificial intelligence-based, demographic targeted digital out of home platform offering verified impressions. We will seek to sell advertising campaigns onto the Alfi tablet network in rideshare and taxi vehicles, and onto our kiosks through revenue share agreements with the place-based digital screen networks (airports, malls,

6

Table of Contents

transit hubs, etc.). By offering advertisers a verified audience / verified impressions capability, DOOH marketers will have the first out of home ad channels that confirm their campaign is being viewed by an actual person or people, in their targeted demographic, and provide data telling them when and where the ads were seen.  We believe that verified impressions will allow us (and our partners) to charge premium CPM rates compared with other DOOH and OOH media as well as realize additional revenue by charging for QR code activations, and paying for our data from true campaign measurement.

As mentioned above, we intend to market the Alfi tech stack, facial detection-based ad solution to other DOOH and OOH media operators. Our intended message is that media operators can license Alfi’s software to have it installed onto their screens, thus allowing them to charge more for advertising (because of the targeting capabilities), as well as giving them the access to Alfi’s audience measurement and data. We believe that these capabilities will allow place-based venues to take advantage of the Alfi audience information to sell more advertising, but also to identify the audience details of the people that in fact pass their screens each month and use that information to enhance their other business functions.

Our Technology

Graphic

Alfi’s technology is a set of independent granular services joined together to create a SaaS cloud-based platform. Coupled with our proprietary artificial intelligence and machine learning enabled devices are able to conduct an analysis of an audience in many different contexts.

Additionally, as a member or members of the audience remain in front the device, Alfi is able to monitor the level of engagement and dwell time of that audience, reporting these metrics back to the cloud for curation. This information is then aggregated and disseminated back to the relevant parties via rich reporting with drill-through capabilities.

Our Intellectual Property

We believe that our intellectual property rights are important to our business. We rely on a combination of patents, trademarks, service marks, copyrights, trade secrets, confidentiality procedures and contractual provisions to protect our proprietary technology and other intellectual property. We have registered, and applied for the registration of, U.S. and international trademarks, service marks, and domain names. Our domestically-applied for trademarks include, among others, the word mark ALFI, our stylized A and ALFI logos for various software and hardware related to our business.  We have registered the word mark ALFI, our stylized A and ALFI logos

7

Table of Contents

mark in a number of foreign countries. Additional domestic and foreign trademark applications are pending.  The trademarks that we currently use have not been registered in all of the countries outside of the U.S. in which we do business or may do business in the future and may never be registered in all of these countries.  We have been granted two patents and have additional patent applications pending in the U.S. and foreign countries related to certain aspects of our technology.  We have also registered our ownership of the internet domain name “www.getalfi.com” and other internet domain names. We have in the past protected, and expect to continue to protect, our proprietary rights. We cannot predict whether steps taken by us to protect our proprietary rights will be adequate to prevent misappropriation of these rights or the use by others of features based upon, or otherwise similar to, our concept, services, and products. Any actions or litigation undertaken to enforce our rights will likely be costly. In addition, we may face claims of misappropriation or infringement of third parties’ trademarks, patents or other intellectual property rights. Defending these claims may be costly and, if unsuccessful, may prevent us from continuing to use certain intellectual property rights or information in the future and may result in a judgment or monetary damages.

Privacy Regulation and Compliance

Multiple technologies work together in Alfi with viewer privacy and reporting objectives as our two goals.  Alfi uses a facial fingerprinting process to make demographic determinations. As such, Alfi makes no attempt to identify the individual in front of the screen.  Brand owners do not need to know someone’s name or invade their privacy to gain a deeper understanding of the consumers viewing their content.  By providing age, gender and geolocation information, we believe brand owners should have all of the data they need for meaningful interaction.  From an analytics perspective, these data points are intended to provide meaningful reporting instead of arbitrary calculations of ad engagement.

Alfi seeks to solve the problem of providing real time, accurate and rich reporting on customer demographics, usage, interactivity and engagement while never storing any personal identifiable information.  No viewer is ever required, or requested by us, to enter any information about themselves on any Alfi-enabled device.  Alfi is designed to be fully compliant with all privacy regulations, including the General Data Protection Regulation (“GDPR”) in Europe, the California Consumer Privacy Act and the Health Insurance Portability and Accountability Act.

The GDPR is a comprehensive data privacy law intended to protect fundamental rights and freedoms of natural persons related to their personal data.  The GDPR applies to the processing of personal data wholly or partly by automated means and to the processing other than by automated means of personal data which form part of a filing system or are intended to form part of a filing system. Personal data is defined as any information relating to an identified or identifiable natural person data subject; an identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person.  The legal requirements of the GDPR, however, do not apply if the personal data is not processed.  Alfi is specifically designed to comply with the most stringent privacy standard of the GDPR.  All of Alfi’s capture data systems anonymize incoming data, making the system incapable of identifying a specific person or processing any of their personal data.

Alfi’s data analysis and storage systems prevent violations and hacking through a complex system of protections and maintain privacy compliance as follows:

Alfi’s data systems convert a camera’s image of a person’s face into an anonymous vector map for analysis.
Alfi does not transmit images of the faces or connect any personally identifying information of the audience in front of the screen.
The Alfi matrix of conversions from camera image to the anonymous vector map occurs securely within the systems internal artificial intelligence network.
Alfi’s doesn’t collect or store any personal data, such as names, email addresses, or phone numbers of the viewing audience within its systems.

We continually monitor evolving privacy standards to make sure Alfi is compliant with the most stringent standards that could apply to our data.

8

Table of Contents

Competition

The digital video advertising market is intensely competitive, with many companies providing competing solutions. We believe rideshare and taxi- based advertising is a growing segment of the expanding DOOH and OOH marketplace.  In-car digital video ads playing on internet connected networks of tablets in the backseat is a popular media option in the rideshare based area. Alfi primarily competes with companies that have in-car tablet networks, and secondarily with companies providing rideshare advertising opportunities in general; through digital screens mounted on top of the cars and also messaging outside the car with vehicle wraps.  The competitive in-car tablet networks are operated by Octopus (recently purchased by T-Mobile), Curb Mobility (Taxi TV), Creative Mobile Technology (CMT), and Firefly Systems.  Each competitor has in-car digital tablets through which they sell advertising to the rideshare audience of passengers.

Alfi will also compete with online advertising publishers, online search engines, and social media platforms, such as Google (YouTube and DoubleClick), The Trade Desk and Facebook, for advertisers and ad networks.

Alfi’s SaaS product is a full stack ad tech solution utilizing artificial intelligence based, facial detection technology for content management, ad serving and audience measurement to DOOH media network operators such as airports, shopping malls, sports venues, transit hubs, etc. In this regard, we will compete with other software as service business such as Quividi (from France) and Ad Mobilize (from Miami Lakes, Florida).

Our competitors may establish or strengthen cooperative relationships with advertisers, or other parties, which will limit our ability to promote our solutions and generate revenue. For example, advertiser customers that adopt demand-side advertiser platforms disrupt our direct customer relationship with those customers. Competitors could also seek to gain market share by reducing the prices they charge to publishers or advertisers, introducing products and solutions that are similar to ours or introducing new technology tools for advertisers and digital media properties. Moreover, increased competition for video advertising inventory from digital media properties could result in an increase in the portion of advertiser revenue that we must pay to digital media property owners to acquire that advertising inventory.

Some large advertising agencies that represent advertising customers have their own relationships with digital media properties and can directly connect advertisers with digital media properties. Our business will suffer to the extent that our advertisers and digital media properties purchase and sell advertising inventory directly from one another or through other companies that act as intermediaries between advertisers and digital media properties. Other companies that offer analytics, mediation, ad exchange or other third-party solutions have or may become intermediaries between advertisers and digital media properties and thereby compete with us. Any of these developments would make it more difficult for us to sell our solutions and could result in increased pricing pressure, reduced profit margins, increased sales and marketing expenses or the loss of market share.

Our Team

We are a development stage company and currently have approximately 40 employees, including 33 full time employees. Of our employees, 13 are technical developers of Alfi and 10 are sales and marketing focused. We have been able to locate and engage highly qualified employees as needed and do not expect our growth efforts to be constrained by a lack of qualified personnel. None of our employees are represented by a union or parties to a collective bargaining agreement. We consider our relations with our employees and consultants to be good.

Organizational and Corporate Information

Alfi, Inc. is incorporated in Delaware. The Company’s timeline of events relative to its current formation began on April 4, 2018, when Lectrefy, Inc., a Florida corporation, was incorporated. On July 6, 2018, Lectrefy, Inc., a Delaware corporation, was incorporated. On July 11, 2018, Lectrefy, Inc., the Florida corporation, was merged into the newly created entity Lectrefy, Inc., the Delaware corporation. On July 25, 2018, Lectrefy, Inc., the Delaware corporation, became qualified to do business in Florida. On January 31, 2020, Lectrefy, Inc., the Delaware corporation, changed its name to Alfi, Inc.

Our mailing address is 429 Lenox Avenue, Miami Beach, Florida, 33139. Our telephone number is (305) 395-4520.

9

Table of Contents

Available Information

Our website, www.getALFI.com, provides access, without charge, to our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with the Securities and Exchange Commission (“SEC”). The information provided on our website is not part of this Annual Report on Form 10-K (this “Annual Report”) and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this Annual Report. The SEC also maintains a website at www.sec.gov that contains reports, proxy and information statements, and other information regarding our company that we file electronically with the SEC.

The references to our website, www.getALFI.com, in this Annual Report do not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this Annual Report.

10

Table of Contents

Implications of Being an Emerging Growth Company

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). For as long as we are an emerging growth company, unlike public companies that are not emerging growth companies under the JOBS Act, we will not be required to:

Provide an auditor’s attestation report on management’s assessment of the effectiveness of our system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002;
Provide more than two years of audited financial statements and related management’s discussion and analysis of financial condition and results of operations;
Comply with any new requirements adopted by the Public Company Accounting Oversight Board (the “PCAOB”) requiring mandatory audit firm rotation or a supplement to the auditor’s report in which the auditor would be required to provide additional information about the audit and the financial statements of the issuer;
Provide certain disclosure regarding executive compensation required of larger public companies or hold stockholder advisory votes on the executive compensation required by the Dodd-Frank Wall Street Reform and Consumer Protection Act; or
Obtain stockholder approval of any golden parachute payments not previously approved.

We will cease to be an emerging growth company upon the earliest of the:

Last day of the fiscal year in which we have $1.07 billion or more in total annual gross revenues;
Date on which we become a “large accelerated filer” (the fiscal year-end on which the total market value of our common equity securities held by non-affiliates is $700 million or more as of June 30);
Date on which we issue more than $1.0 billion of non-convertible debt over a three-year period; or
Last day of the fiscal year following the fifth anniversary of our initial public offering, which we completed on May 6, 2021 (“IPO”).

We have elected to take advantage of certain of the reduced disclosure obligations in this Annual Report and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”), for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

Recent Updates

Initial Public Offering

On May 3, 2021, our registration statement on Form S-1(File No. 333-251959) was declared effective by the SEC, and we completed its IPO on May 6, 2021. In connection with the IPO, we issued and sold 4,291,045 shares of our common stock, $0.0001 par value per share (the “Common Stock”), and warrants to purchase 4,291,045 shares of Common Stock (including 559,701 shares of Common Stock and warrants to purchase 559,701 shares of Common Stock pursuant to the full exercise of the underwriters' overallotment option), at the combined public offering price of $4.15, for aggregate gross proceeds of approximately $17.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The warrants were exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and have an exercise price of $4.57 per share.

11

Table of Contents

On May 3, 2021, pursuant to the underwriting agreement for the IPO, we issued to the underwriters warrants to purchase up to an aggregate of 186,567 shares of Common Stock. The warrants may be exercised beginning on May 3, 2022 until May 3, 2026. The initial exercise price of each warrant is $5.19 per share.

Warrants Exercises

As of December 31, 2021, holders of warrants issued in our IPO have exercised warrants to purchase 3,508,227 shares of Common Stock, providing us with $16,034,189 in additional funding. In connection therewith, we issued 3,508,227 shares of Common Stock.

As of December 31, 2021, there were outstanding warrants issued in our IPO to purchase 969,385 share of Common Stock.

Share Buy-Back

On June 23, 2021, we announced a $2.0 million buy-back of the Common Stock.  The buy-back was completed on July 9, 2021, with us acquiring 137,650 shares of Common Stock, for an aggregate price of $1,999,997, which are recorded as treasury stock.

ITEM 1A.RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 1B.UNRESOLVED STAFF COMMENTS

None.

ITEM 2.PROPERTIES

Our principal executive office is located at 429 Lenox Avenue, Miami Beach, Florida, where we lease approximately 404 square feet of general office space pursuant to a lease agreement which expires in August 2022.

Our research and development facilities are located at 1321 15th Street, Denver, Colorado, where we lease approximately 11,321 square feet pursuant to a lease agreement which expires in September 2022.

We lease approximately 3,188 square feet of space at 5th Floor, City Exchange Building 11-13 Gloucester Street Belfast, BT14GB, pursuant to a lease agreement which expires in December 2028 and may be earlier terminated at our option in December 2023. We previously used this space for research and development. We vacated this space in March 2022, and we are in negotiations with the landlord to terminate the lease early. Two employees who previously worked at this location now work remotely.

We lease approximately 413 square feet of warehouse space in Hialeah Gardens, Florida, pursuant to a month-to-month lease agreement.

Our rent expense totaled approximately $422,075 in 2021. We do not own any real property. We believe our current premises are sufficient for our needs at this time and that we can acquire suitable additional or alternative space as needed.

ITEM 3.LEGAL PROCEEDINGS

We are party to the legal proceedings described below. We are unable to provide any assurances as to the ultimate outcome of these proceedings and intend to vigorously defend these matters.

12

Table of Contents

Litigation

On December 2, 2021, the Company and certain of its present and former officers and directors were named as defendants in a putative class action lawsuit styled Steppacher v. Alfi, Inc., et al., Case No. 1:21-cv-24232, brought in the United States District Court for the Southern District of Florida. On December 15, 2021, the Company, certain of its present and former officers and directors, and the underwriters in the Company’s IPO were named as defendants in a second putative class action styled Kleinschmidt v. Alfi, Inc., et al., Case No. 1:21-cv-24338, also brought in the United States District Court for the Southern District of Florida. The complaints in both actions allege that the Company and other named defendants violated Sections 11 and 15 of the Securities Act of 1933, as amended (the “Securities Act”), with respect to allegedly false and misleading statements included in the registration statement and prospectus supplements issued in connection with the Company’s IPO (the “Offering Documents”) in May 2021, and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10b-5 promulgated thereunder, by allegedly making false and materially misleading statements and failing to disclose material adverse facts in the Company’s public filings with the SEC. Both complaints assert that the putative plaintiff class includes: (i) persons or entities, other than the defendants, who purchased or acquired the Common Stock or warrants to purchase the Common Stock pursuant and/or traceable to the Offering Documents; and (ii) persons or entities, other than the defendants, who purchased or acquired the Company’s securities between May 4, 2021, and November 15, 2021 (both dates inclusive). The plaintiffs seek unspecified compensatory damages, including interest, and costs and expenses, including attorney’s and expert fees. On February 3, 2022, the court consolidated the two actions under the caption Steppacher, Jr., et al. v. Alfi, Inc. et al., Case No. 21-cv-24232-KMW. Three putative stockholders (or groups of stockholders) moved to be appointed as lead plaintiff, and the court appointed Candido Rodriguez as lead plaintiff. The consolidated actions are now captioned Rodriguez, et al. v. Alfi, Inc., et al., Case No. 21-cv-24232-KMW. The Company intends to vigorously defend these actions.

On April 27, 2022, Ryan Dodgson filed a Verified Shareholder Derivative Complaint on behalf of the Company styled Ryan Dodgson, derivatively on behalf of Alfi, Inc., Plaintiff, v. Paul Pereira, Dennis McIntosh, Charles Pereira, Peter Bordes, John M. Cook, II, Justin Elkouri, Allison Ficken, Jim Lee, Richard Mowser, and Frank Smith, Defendants, and Alfi, Inc., Nominal Defendant, Case 1:22-cv-21318, in the United States District Court for the Southern District of Florida.  The complaint alleges, as to the defendants: (i) violations of Section 10(b) and Rule 10b-5 of the Exchange Act; (ii) violations of Section 20(a) of the Exchange Act; (iii) breach of fiduciary duties; (iv) unjust enrichment; (v) abuse of control; (vi) gross mismanagement; and (vii) waste of corporate assets, in connection with alleged improper corporate transactions, an alleged pattern and practice of abuse of control of the Company and allegedly deficient internal controls, among other things.  The complaint also seeks contribution under Section 11(f) of the Securities Act and Section 21D of the Exchange Act as to the defendants, and seeks contribution under Sections 10(b) and 21D of the Exchange Act as to defendants P. Pereira and McIntosh.  Plaintiff requests a declaration that the defendants have breached or aided and abetted the breach of their fiduciary duties to the Company, an award of damages to the Company, restitution, and an award of plaintiff’s costs and disbursements in the action, including reasonable attorneys’ and experts’ fees, costs and expenses, and alleged improvements to the Company’s corporate governance and internal procedures regarding compliance with laws.

Arbitration

On February 23, 2022, Fred Figueroa, a former Executive Assistant at the Company, filed a Demand for Arbitration against the Company with the American Arbitration Association (“AAA”), alleging overtime violations of the Fair Labor Standards Act, as amended, and breach of contract claims involving alleged termination without cause in violation of Mr. Figueroa’s employment agreement. In his Demand for Arbitration, Mr. Figueroa seeks damages in the amount of $81,000 for base salary and 5,000 shares of Common Stock in the amount of $16,650 pursuant to a stock option award from the Company, as well as attorneys’ fees and costs. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Figueroa’s employment agreement with the Company. The Company is in the process of responding to Mr. Figueroa’s claims. The Company is currently unable to estimate the costs and timing of the arbitration, including any potential damages, if Mr. Figueroa were to prevail on any of his claims.

On March 10, 2022, Charles Pereira, a former Chief Technology Officer of the Company, filed a Statement of Claim against the Company with the AAA, alleging various breaches of contract and torts with respect to his employment, his compensation, and the termination of his employment. In his Statement of Claim, Mr. Pereira seeks damages in an amount to be determined at the hearing, but not less than $10 million dollars, and certain declaratory relief and other money damages. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Pereira’s employment agreement with the Company. The Company is in the process of responding to Mr. Pereira’s claims. The Company is currently unable to estimate the costs and timing of the arbitration, including any potential damages, if Mr. Pereira were to prevail on any of his claims.

13

Table of Contents

Other Matters

As previously disclosed, on November 9, 2021, the Company received a letter from the staff of the SEC indicating that the Company, its affiliates and agents may possess documents and data relevant to an ongoing investigation being conducted by the staff of the SEC and notifying the Company that such documents and data should be reasonably preserved and retained until further notice. The materials to be preserved and retained include documents and data created on or after April 1, 2018 that: (i) were created, modified or accessed by certain named former and current officers and directors of the Company or any other officer or director of the Company; or (ii) relate or refer to the condominium or the sports tournament sponsorship identified in the Company’s Current Report on Form 8-K filed on November 1, 2021, or financial reporting and disclosure controls, policies or procedures. On March 8, 2022, the Company received a subpoena from the SEC relating to the investigation.  The Company intends to cooperate fully with the SEC in this matter.

The Company’s former Chief Executive Officer and former Chief Financial Officer have made claims that the Company indemnify and advance the legal fees and expenses incurred by them in connection with the previously announced independent internal investigation (“Investigation”) (see Note 12 to our consolidated financial statements included in this Annual Report) and the putative class action litigations and the SEC investigation, each referred to above. With respect to the advancement of fees and expenses incurred in connection with the Investigation prior to December 31, 2021, the amount of such fees and expenses that is subject to advancement is approximately $147,000. The former officers have also demanded advancement of fees and expenses of additional amounts of approximately $339,000 for the period from January 1, 2022 through March 31, 2022.  Additional amounts may be subject to claims for advancement and indemnification, but the Company is unable to estimate the amount of additional fees and expenses that may be subject to advancement or indemnification.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

14

Table of Contents

PART II

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

The Common Stock is listed on the Nasdaq Capital Market under the symbol “ALF.” The warrants to purchase Common Stock issued in our IPO are listed on The Nasdaq Capital Market under the symbol “ALFIW.”

Holders of Record

As of April 30, 2022, we had approximately 14 holders of record of the Common Stock.

Dividends

We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business, and therefore do not intend to pay cash dividends on the Common Stock for the foreseeable future. Any future determination related to our dividend policy will be made at the discretion of the Company’s Board of Directors (the “Board”) and will depend on, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects and other factors the Board may deem relevant.

Recent Sales of Unregistered Securities

On August 1, 2018, November 21, 2018, January 23, 2019 and April 18, 2019, the Company issued 1,000,000, 500,000, 500,000 and 500,000 shares, respectively, of the Company’s Series Seed Preferred Stock, $0.0001 par value per share (the “Series Seed Preferred Stock”), to an investor in exchange for $2,500,000 cash consideration. On May 3, 2021, 2,500,000 shares of Series Seed Preferred Stock were converted into 3,150,058 shares of Common Stock at a conversion ratio of 1:1.260023. The Series Seed Preferred Stock, and the shares of Common Stock issued upon conversion of the shares of Series Seed Preferred Stock, were issued in a transaction not involving a public offering, in reliance upon an exemption from registration under Section 4(a)(2) of the Securities Act. See Note 9 to our consolidated financial statements included in this Annual Report.

In connection with bridge loans entered into on December 30, 2020, March 22, 2021, and April 1, 2021, the Company issued to the lenders, who are all accredited investors, an aggregate of 1,732,532 shares of Common Stock. The shares of Common Stock were issued in a transaction not involving a public offering, in reliance upon an exemption from registration under Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder. See Note 9 to our consolidated financial statements included in this Annual Report.

On March 31, 2020 and May 13, 2021, the Company issued to an investor relations firm 31,501 and 150,000 shares, respectively, of Common Stock, pursuant to agreements with such firm. On May 13, 2021, the Company issued to a consultant 150,000 shares of Common Stock, pursuant to an agreement with such consultant. These shares of Common Stock were issued in a transaction not involving a public offering, in reliance upon an exemption from registration under Section 4(a)(2) of the Securities Act. See “Findings of the Investigation” in Note 12, and Note 9, to our consolidated financial statements included in this Annual Report.

On August 31, 2021, the Company issued to the organizer of a sports tournament 31,683 shares of Common Stock, pursuant to an agreement to sponsor such tournament. The shares of Common Stock were issued in a transaction not involving a public offering, in reliance upon an exemption from registration under Section 4(a)(2) of the Securities Act. The Company has since obtained, in connection with the Company’s termination of the sponsorship agreement, the return of the 31,683 shares of Common Stock. See “Findings of the Investigation” in Note 12 to our consolidated financial statements included in this Annual Report.

Prior to our IPO, from May 1, 2020 through March 15, 2021, the Company issued pursuant to the Alfi, Inc. 2018 Stock Incentive Plan (the “2018 Plan”) to employees, for services rendered or to be rendered, options to purchase an aggregate of 433,927 shares of Common Stock, at an average weighted exercise price of $1.52 per share, which vest over four years. The foregoing securities were issued in reliance upon an exemption from registration under Rule 701 promulgated under the Securities Act.

15

Table of Contents

Use of Proceeds From Registered Securities

On May 3, 2021, the SEC declared effective our registration statement on Form S-1 (333-251959), as amended, filed in connection with our IPO. Pursuant to the registration statement, we registered the offering and sale of: (i) 3,731,344 shares of Common Stock and warrants to purchase 3,731,344 shares of Common Stock, at a combined public offering price of $4.15; and (ii) an additional 559,701 shares of Common Stock and additional warrants to purchase 559,701 shares of Common Stock, at a combined public offering price of $4.15, pursuant to an over-allotment option granted to the underwriters in our IPO. Each warrant is exerciseable for one share of Common Stock at an exercise price of $4.57 per share. Kingswood Capital Markets, division of Benchmark Investments, Inc., served as the representative of the underwriters in our IPO.

On May 6, 2021, we completed our IPO selling 3,731,344 shares of Common Stock and warrants to purchase 3,731,344 shares of Common Stock at a combined public offering price of $4.15, for aggregate gross proceeds of approximately $15.5 million, prior to deducting underwriting discounts, commissions, and other offering expenses and excluding any exercise of the underwriters’ option to purchase any additional securities. On May 10, 2021, Kingswood Capital Markets exercised the over-allotment option for an aggregate of 559,701 shares of Common Stock, and warrants to purchase 559,701 shares of Common Stock, yielding gross proceeds to the Company of approximately $2.3 million, prior to deducting underwriting discounts, commissions, and other offering expenses.

Total gross proceeds to us from our IPO, including the over-allotment option, were approximately $17.8 million, prior to deducting underwriting discounts, commissions, and other offering expenses. The offering has terminated.

From the effective date of our registration statement on Form S-1 (333-251959), the Company has incurred underwriting discounts, commissions, and other offering expenses in connection with the IPO totaling approximately $2.1 million, resulting in net offering proceeds from the IPO to us of approximately $15.7 million. No payments for such expenses were made directly or indirectly to: (i) any of our officers or directors or their associates, (ii) any persons owning 10% or more of any class of our equity securities or (iii) any of our affiliates.

We have used the net proceeds of our IPO to pay: (i) approximately $6.3 million, including accrued and unpaid interest, owed under outstanding promissory notes and borrowings pursuant to bridge loan agreements with related party investors; (ii) approximately $4.5 million for capital expenditures; (iii) approximately $2.0 million to repurchase shares of Common Stock; and (iv) approximately $2.9 million for general corporate purposes, including working capital, business development, and sales and marketing activities. Repayments of related party debt payable included approximately $5.4 million owed to Lee Aerospace, Inc., a corporation controlled by James Lee, one of our Board members and a greater than 10% stockholder (“Lee Aerospace”), and a total of approximately $927,000 owed to Paul Pereira (our former Chief Executive Officer), Dennis McIntosh (our former Chief Financial Officer), Charles Pereira (our former Chief Technology Officer), Peter Bordes (our Interim CEO), Rachael Pereira (the wife of Paul Pereira) and three unaffiliated investors.

Except for the use of proceeds to repurchase shares of Common Stock, there has been no material change in the use of proceeds of our IPO from the use of proceeds described in the prospectus filed as part of our registration statement on Form S-1 (333-251959).

Issuer Purchases of Equity Securities

During the three months ended December 31, 2021, we did not repurchase any shares of the Common Stock.

Securities Authorized for Issuance Under Equity Compensation Plans

The following table sets forth certain information with respect to securities to be issued under our equity compensation plans as of December 31, 2021.

16

Table of Contents

Number of

 Securities Remaining

Available for

    

Number of 

Weighted

    

  Future Issuance 

Securities to be 

Average 

Under Equity 

Issued Upon

Exercise 

Compensation 

 Exercise of 

Price of 

Plans (Excluding 

Outstanding 

Outstanding 

Securities

Options, 

Options, 

 Reflected 

Plan Category

   

Warrants

  

Warrants

   

in Column (a))

Equity compensation plans approved by security holders (1)

455,474

$2.29

1,119,555

Equity compensation plans not approved by security holders (2)

186,567

$5.19

---

Total

642,041

$3.13

1,119,555

(1)Represents options to purchase shares of Common Stock issued pursuant to the Company’s 2018 Stock Incentive Plan.
(2)Represents warrants to purchase 186,567 shares of Common Stock issued to the representative of the underwriters in our IPO. The warrants have an exercise price of $5.19, are exercisable beginning on May 3, 2022 and expire on May 3, 2026.

ITEM 6.[RESERVED.]

ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context requires otherwise, references to the “Company,” “Alfi,” “we,” “us” and “our” refer to Alfi, Inc., a Delaware corporation and its wholly owned subsidiary, Alfi (N.I.) Ltd, formed in Belfast, Northern Ireland on September 18, 2018. Unless otherwise noted, the share and per share information in this Annual Report on Form 10-K (this “Annual Report”) reflect a forward stock split of the Common Stock privately held before the IPO at a percentage of 1.260023 effective on March 15, 2021.

Overview

Alfi is a Delaware corporation, incorporated in July 2018.

We seek to provide solutions that bring transparency and accountability to the digital out of home, or (“DOOH”) advertising marketplace. Alfi uses artificial intelligence and big data analytics to measure and disseminate audience presence and audience demographics. Our computer vision technology is powered by proprietary artificial intelligence, to determine the relevant demographic and geospecific information of the audience in front of an Alfi-enabled device, such as a tablet or kiosk. Alfi can then deliver in real-time, the advertisements to that particular viewer based on the viewer’s demographic profile and/or geolocation. Alfi is designed to deliver the right marketing content, to the right person at the right time in a responsible and ethical manner. By delivering the advertisements most relevant to the audience in front of the device, we connect our advertising customers to the viewers they seek to target. The result is higher click through rates (“CTRs”), higher QR code scans, and higher cost per thousand rates (“CPMs”).

Alfi seeks to solve the problems facing advertisers in the DOOH marketplace, as its proprietary technology is designed to measure the audience when an advertisement is displayed. Our data rich reporting functionality is able to inform the advertiser exactly when someone viewed each ad, as well as the general demographic and geospecific characteristics of the viewing audience.  Alfi can provide large and small businesses access to data-driven insights by expanding their advertising capabilities, by providing analytical sophistication and by delivering it all over multiple devices. In addition to the traditional Content Management System model that delivers adverts on a scheduled loop, Alfi’s technology is able to first analyze the audience and determine the most relevant content to be displayed.

Alfi has created an enterprise grade, multimedia computer vision and machine learning platform, capable of generating powerful advertising recommendations and insights. Multiple technologies work together with viewer privacy and data-rich reporting as our primary objectives. Alfi is able to use a facial fingerprinting process to make demographic determinations. As such, Alfi makes no attempt to identify the individual in front of the screen. Brand owners do not need to know someone’s name or invade their privacy to gain a deeper understanding of the consumers who view their content. By providing age, gender, and geolocation information, we believe brand owners should have the pertinent data they need for meaningful insight. From an analytics perspective, these data points are intended to provide meaningful reporting instead of arbitrary calculations based on estimates of ad engagement.

17

Table of Contents

Alfi seeks to solve the problem of providing real time, accurate and rich reporting on customer demographics, usage, interactivity, and engagement while never storing any personally identifiable information. No viewer is ever required, or requested by us, to enter any information about themselves on any Alfi-enabled device.

Our initial focus is to place our Alfi-enabled devices in malls, airports, rideshares and taxis. We also have begun offering our software solution to other DOOH media operators as a Software as a Service (“SaaS”) product.

Currently, we intend to charge customers solely based on a CPM, or ads delivered, model. As we continue to deploy Alfi in the marketplace, we expect to charge customers based on a combination of CPM and CTR, and we expect we will generate higher CPM rates than typical DOOH advertising platforms because we have the ability to only deliver ads to the customer’s desired demographic. In addition, we also intend to provide the aggregated data to the brands so they can make more informed advertising decisions.

With respect to Alfi-enabled tablets placed in rideshares or devices placed into service by Alfi, Alfi will recognize revenue on a CPM impression basis or a related basis for both the content and advertisements delivered. Alfi contracts (also called insertion orders) for both the advertiser and the content provider specify the amounts to be paid to Alfi for displaying the advertisement or content. Content and advertisements are provided to Alfi by companies desiring to deliver content for viewer engagement.

With respect to SaaS licenses, Alfi has entered into two license agreements with third parties to use Alfi-placed devices on customer property and share in advertising revenues. Under these agreements, the customer and Alfi work together to generate advertising revenue, and the devices have remote management access and data reporting that the Alfi platform provides. Alfi began to earn revenue from advertisers during the fourth quarter of 2021. Alfi will recognize the revenue from these contracts monthly, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update No. 2014‑09 (Topic 606) “Revenue from Contracts with Customers”.

Alfi believes that the aggregated data of viewer engagement has significant value for advertisers and content providers. Alfi intends to offer such data to third parties on a subscription basis and recognize revenue as the subscription payments are received depending on the nature of the contract. For subscriptions that are prepaid, revenue will be recognized as earned; with respect to subscriptions that are not prepaid, revenue will be recognized when the data is delivered to the subscriber.

As of the date of this Annual Report, Alfi has distributed approximately 7,600 devices (tablets and kiosks) at no cost to rideshare, mall, or airport owner(s) and has approximately 17,000 devices on hand. It is the viewers of the Alfi-enabled device, rather than the rideshare driver, mall, or airport owner that the Alfi-enabled device engages with and to whom Alfi delivers advertising and content. Alfi commenced selling advertising and content for those tablets placed into operation during the first quarter of 2022.

Recent Developments

Initial Public Offering

On May 3, 2021, the Company’s registration statement on Form S-1 (File No. 333-251959) was declared effective by the SEC and the Company completed its initial public offering (“IPO”) on May 6, 2021. In connection with the IPO, the Company issued and sold 4,291,045 shares of Common Stock and warrants to purchase 4,291,045 shares of Common Stock (including 559,701 shares of Common Stock and warrants to purchase 559,701 shares of Common Stock pursuant to the full exercise of the underwriters’ overallotment option), at the combined public offering price of $4.15 for aggregate gross proceeds of approximately $17.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Alfi. The warrants were exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and have an exercise price of $4.57 per share.

On May 3, 2021, pursuant to the underwriting agreement for the IPO, we issued to the underwriters warrants to purchase up to an aggregate of 186,567 shares of Common Stock (“Underwriter's Warrants”). The Underwriter's Warrants may be exercised beginning on May 3, 2022 until May 3, 2026. The initial exercise price of each Underwriter's Warrant is $5.19 per share.

18

Table of Contents

Warrants Exercised

Warrants to purchase 4,477,612 shares of Common Stock were issued in connection with the Company’s May 2021 IPO. As of December 31, 2021, warrant holders have exercised warrants to purchase 3,508,227 shares of Common Stock, providing Alfi with $16,034,541 in additional funding. As of December 31, 2021, there were warrants to purchase 969,385 shares of Common Stock outstanding.

Share Buy-Back

On June 23, 2021, Alfi announced a $2.0 million buy-back of its Common Stock. The buy-back was completed on July 9, 2021, with Alfi acquiring 137,650 shares of Common Stock, for an aggregate price of $1,999,997, which are recorded as treasury stock.

Changes in Management

As previously disclosed in the Company’s filings with the SEC on October 22, 2021, the Company’s Board of Directors (the “Board”) placed each of Paul Pereira, the Company’s then President and Chief Executive Officer, Dennis McIntosh, the Company’s then Chief Financial Officer and Treasurer, and Charles Pereira, the Company’s then Chief Technology Officer, on paid administrative leave and authorized an independent internal investigation  (the “Investigation”) into certain corporate transactions and other matters.

Also as previously disclosed, since placing the former executives on leave, the Board has appointed: (i) James Lee as Chairman of the Board, replacing Mr. P. Pereira in such role; (ii) new management personnel, including Peter Bordes as Interim Chief Executive Officer, Louis Almerini as Interim Chief Financial Officer and David Gardner as Chief Technology Officer; (iii) two new independent directors to the Board, Allen Capsuto and Patrick Dolan; and (iv) Mr. Capsuto as Chair of the Audit Committee of the Board (the “Audit Committee”) and Mr. Dolan as a member of the Compensation Committee (the “Compensation Committee”) and the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”). Furthermore, Mr. P. Pereira resigned as a director and from all positions he held with the Company, Mr. McIntosh resigned from all positions he held with the Company, and Mr. C. Pereira’s employment with the Company was terminated.

Findings of the Investigation

The Investigation was conducted by a special committee of the Board (the “Special Committee”) consisting of Mr. Capsuto, the Audit Committee Chair, who was appointed to the Special Committee on November 8, 2021. The Special Committee retained outside legal counsel to assist in conducting the Investigation, and such counsel retained additional advisors to provide forensic accounting services, computer forensics and e-discovery services and other legal services.

The Investigation found, among other things, that the Company’s former senior management caused the Company to enter into certain transactions and certain agreements that were not approved by the Board, some of which included the unauthorized issuance of shares of Common Stock, as follows:

The Company’s former senior management caused the Company to purchase a condominium in Miami Beach, Florida for a purchase price of approximately $1.1 million without the Board’s knowledge or approval. After the conclusion of the Investigation, the Company sold the condominium for a price of $1.1 million on April 15, 2022. Net proceeds after commissions and other expenses of the sale were approximately $990,000.
The Company’s former senior management caused the Company to enter into an agreement to sponsor a sports tournament for two years, for a $640,000 sponsorship fee, which the Company paid $320,000 in cash and $320,000 through the issuance of 31,683 shares of Common Stock, without the Board’s knowledge or approval. The Company has since obtained, in connection with the Company’s termination of the sponsorship agreement, the return of the 31,683 shares of Common Stock. In addition, of the $320,000 in cash paid by the Company, $295,000 was converted to a charitable contribution and the remaining $25,000 was retained by the tournament organizer.
The Company’s former senior management caused the Company to enter into agreements with three vendors: (i) an investor relations firm to provide investor relations and strategic consulting services and capital introductions; (ii) a consultant to provide financial and business advice; and (iii) a start-up call center to provide customer service, sales, and onboarding services.

19

Table of Contents

Pursuant to these agreements, cash payments totaling approximately $1,200,000 were made to these vendors and 300,000 shares of Common Stock were issued to them without the Board’s knowledge or approval.

These findings and other conduct by the Company’s former senior management were previously disclosed in the Company’s Current Report on Form 8-K filed on February 23, 2022.

The Investigation found the Company’s internal control over financial reporting to be deficient with respect to: (i) the disbursement process for third-party vendors; (ii) the review and approval process for significant vendor contracts; (iii) the use of Company credit cards by executives; (iv) the supervision and approval of travel and entertainment expenses incurred by executives; (v) the segregation of duties in connection with the payment and recording of invoices and related bank reconciliations; (vi) the lack of a sufficient accounting manual; and (vii) guidelines for the capitalization of fixed assets.

Credit and Security Agreement – Related Party

On April 12, 2022, the Company entered into a Credit and Security Agreement (the “Credit Agreement”) with a related party lender. Pursuant to the agreement, the Company may borrow up to $2,500,000 for up to one year. Through May 10, 2022, the lender has funded to the Company $1,000,000 under the Credit Agreement. Prior to the maturity date, the Company may borrow an additional $1.5 million under the Credit Agreement, in the lender’s sole discretion and subject to the Company requesting such additional funds from the lender in accordance with the Credit Agreement, the accuracy of the Company’s representations in the Credit Agreement and related documents, and that no default under the Credit Agreement has occurred and is continuing.

The line of credit note matures on the earlier of (i) the date upon which the Company consummates a debt or equity financing in an amount equal to or greater than $4,000,000 or (ii) April 12, 2023. Borrowings under the Credit Agreement are collateralized by a security interest in the Company’s assets. Interest on the unpaid principal amount accrues at an annual rate of 6% through October 12, 2022 and an annual rate of 9% thereafter, except that in event of default additional penalty interest at an annual rate of 3% will accrue on borrowings through October 12, 2022. In connection with the Credit Agreement, the Company issued a warrant to the lender pursuant to which the lender may purchase up to 1,250,000 shares of the Common Stock at a price of $1.51 per share. The warrant can be exercised commencing on the three-month anniversary of the Credit Agreement (i.e., on July 12, 2022) and expires on April 12, 2025.

Impact of COVID-19

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency caused by a new strain of the coronavirus and advised of the risks to the international community as the virus spread globally. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. The spread of COVID-19 coronavirus has caused public health officials to recommend precautions to mitigate the spread of the virus, especially as to travel and congregating in large numbers. In addition, certain states and municipalities have enacted quarantining regulations which severely limit the ability of people to move and travel.

COVID-19 has adversely affected the Company’s financial condition and results of operations. The impact of the COVID-19 outbreak on businesses and the economy in the United States is expected to continue to be significant. The extent to which the COVID-19 outbreak will continue to impact businesses and the economy is highly uncertain. Accordingly, the Company cannot predict the extent to which its financial condition and results of operation will be affected.

In addition, the Company is uncertain of the full effect the pandemic will have on it for the longer term since the scope and duration of the pandemic is unknown, and evolving factors such as the level and timing of the distribution of efficacious vaccines across the world and the extent of any resurgences of the virus or emergence of new variants of the virus, such as the Delta variant and the Omicron variant, will impact the stability of economic recovery and growth. The Company may experience long-term disruptions to its operations resulting from changes in government policy or guidance; quarantines of employees, customers and suppliers in areas affected by the pandemic; and closures of businesses or manufacturing facilities critical to its business.

20

Table of Contents

Results of Operations

Revenues

In general, Alfi earns revenue from rideshares or SaaS contracts with operating companies who maintain their own network and lease the Alfi platform.

Operating Expenses

Compensation and benefits expenses include compensation expenses related to our executive, finance, and administrative personnel (including salaries, commissions, bonuses, stock-based compensation, payroll taxes, and contract labor costs). Other general and administrative expenses include communications and technology costs, professional fees, selling and marketing fees, legal fees, and rent and occupancy expense.

Results of Operations for the Year Ended December 31, 2021 Compared with the Year Ended December 31, 2020

    

    

    

    

2021 vs. 2020

 

    

2021

    

2020

    

$Change

    

% Change

 

Revenues

$

26,465

$

$

26,465

 

N/A

Operating expenses

 

  

 

  

 

  

 

  

Compensation and benefits

 

6,030,179

 

950,641

 

5,079,538

 

534.3

%

Other general and administrative

 

11,031,739

 

1,838,708

 

9,193,031

 

500.0

%

Depreciation and amortization

 

1,150,782

 

716,558

 

434,224

 

60.6

%

Total operating expenses

 

18,212,700

 

3,505,907

 

14,706,793

 

419.5

%

Operating loss

 

(18,186,235)

 

(3,505,907)

 

(14,680,328)

 

418.7

%

Other income (expense)

 

  

 

  

 

  

 

  

Other income

 

160,671

 

198,704

 

(38,033)

 

(19.1)

%

Interest expense

 

(918,878)

 

(2,240,072)

 

1,321,194

 

(59.0)

%

Total other income (expense)

 

(758,207)

 

(2,041,368)

 

1,283,161

 

(62.9)

%

Net loss before provision for income taxes

 

(18,944,442)

 

(5,547,275)

 

(13,397,167)

 

241.5

%

Provision for income taxes

 

 

 

 

Net loss after provision for income taxes

$

(18,944,442)

$

(5,547,275)

$

(13,397,167)

 

241.5

%

Revenues

For the year ended December 31, 2021, net revenues were $26,465. Through September 30, 2021, the Company earned revenue from a single customer. During the three-month period ended December 31, 2021, the Company for the first time earned revenues from customers for advertising delivered through Alfi-owned devices.

For the year ended December 31, 2020, we had no net revenues. We were engaged in beta testing of our Alfi-enabled devices and had not yet begun charging advertisers for delivering advertisements.

Operating Expenses

For the years ended December 31, 2021 and December 31, 2020, total operating expenses were $18,212,700 and $3,505,907, respectively, an increase of $14,706,793. Compensation and benefits expense increased as independent contractors became full time employees effective March 1, 2021, and the Company added staff to support product distribution and its operation as a newly public company. Other general and administrative expenses increased due to higher costs related to the Company’s growth and launch of its technology platform and the Company’s May 2021 listing as a public company. The increase in other general and administrative

21

Table of Contents

expenses reflected higher investor relations, insurance, recruiting, legal and professional fees, and marketing costs incurred during the year ended December 31, 2021. Software development and patent acquisition costs totaling $307,728 were capitalized during the year ended December 31, 2020, resulting in a reduction in compensation and benefits and other general and administrative expenses of that amount. All software development and patent costs were expensed during the year ended December 31, 2021. Depreciation and amortization charges increased as the year ended December 31, 2021 included additional depreciation charges for tablets acquired during 2021.

Operating Loss

For the year ended December 31, 2021, the operating loss increased from $3,505,907 to $18,186,235, an increase of  $14,680,328 compared with the year ended December 31, 2020. The increase was primarily due to higher operating expenses related to the Company’s growth and launch of its technology platform and additional expenses incurred to operate as a public company subsequent to the Company’s May 2021 IPO.

Other Income (Expense)

Other income of $160,671 and $198,704 for the years ended December 31, 2021 and December 31, 2020, respectively, included realized and collected foreign tax credits of $152,278 and $195,040, respectively, associated with its wholly owned subsidiary Alfi (N.I.) Ltd. For the years ended December 31, 2021 and December 31, 2020, interest expense of $918,878 and $2,240,072 included the value of Common Stock issued to related parties who provided bridge financing prior to the Company’s May 2021 IPO.

Net Loss

For the year ended December 31, 2021, the net loss increased from $5,547,275 to $18,944,442, an increase of  $13,397,167  compared with the year ended December 31, 2020. The increase was primarily due to higher operating expenses related to the Company’s growth and launch of its technology platform and additional expenses incurred to operate as a public company subsequent to the Company’s May 2021 IPO.

Results of Operations for the Year Ended December 31, 2020 Compared with the Year Ended December 31, 2019

    

    

    

    

2020 vs. 2019

 

    

2020

    

2019

    

$Change

    

% Change

 

Revenues

$

$

$

 

N/A

Operating expenses

 

  

 

  

 

  

 

  

Compensation and benefits

 

950,641

 

540,516

 

410,125

 

75.9

%

Other general and administrative

 

1,838,708

 

1,125,351

 

713,357

 

63.4

%

Depreciation and amortization

 

716,558

 

22,166

 

694,392

 

N/M

Total operating expenses

 

3,505,907

 

1,688,033

 

1,817,874

 

107.7

%

Operating loss

 

(3,505,907)

 

(1,688,033)

 

(1,817,874)

 

107.7

%

Other income (expense)

 

  

 

  

 

  

 

  

Other income

 

198,704

 

97,379

 

101,325

 

104.1

%

Interest expense

 

(2,240,072)

 

(8,478)

 

(2,231,594)

 

N/M

Total other income (expense)

 

(2,041,368)

 

88,901

 

(2,130,269)

 

N/M

Net loss before provision for income taxes

 

(5,547,275)

 

(1,599,132)

 

(3,948,143)

 

246.9

%

Provision for income taxes

 

 

 

 

Net loss after provision for income taxes

$

(5,547,275)

$

(1,599,132)

$

(3,948,143)

 

246.9

%

22

Table of Contents

Revenues, net

For the years ended December 31, 2020 and December 31, 2019, we had no net revenues. We were engaged in beta testing of our Alfi-enabled devices and had not yet begun charging advertisers for delivering advertisements.

Operating Expenses

For the years ended December 31, 2020 and December 31, 2019, total operating expenses were $3,505,907 and $1,688,033, respectively, an increase of $1,817,874. Compensation and benefits expense increased as the Company added staff to support product development. The Company capitalized certain software development and patent acquisition costs incurred throughout 2019 and during the six-month period ended June 30, 2020, which reduced operating expenses for the years ended December 31, 2020 and December 31, 2019 by $501,685 and $307,728, respectively. It was determined that the application development phase for its software ended in June 2020, and all software development and patent acquisition costs incurred after June 30, 2020 were expensed. Depreciation and amortization charges increased, as the year ended December 31, 2020 included additional depreciation charges for tablets acquired during 2020.

Operating Loss

For the year ended December 31, 2020, the operating loss increased from $1,688,033 to $3,505,907, an increase of $1,817,874 compared with the year ended December 31, 2019. The increase was primarily due to higher operating expenses related to product development, as discussed above.

Other Income (Expense)

Other income of $198,704 and $97,379 for the years ended December 31, 2020 and December 31, 2019, respectively, included realized and collected foreign tax credits of $195,040 and $87,348, respectively, associated with its wholly owned subsidiary Alfi (N.I.) Ltd. Interest expense of $2,240,072 and $8,478 for the years ended December 31, 2020 and December 31, 2019, respectively, rose significantly in 2021 as the Company increased borrowings from related parties to finance ongoing product development. The year ended December 31, 2020 included the value of Common Stock issued to related parties who agreed to provide bridge financing prior to the Company’s May 2021 IPO.

Net Loss

For the year ended December 31, 2020, the net loss increased from $1,599,132 to $5,547,275, an increase of  $3,948,143  compared with the year ended December 31, 2019. The increase was primarily due to higher operating expenses related to the Company’s ongoing product development, as discussed above.

Liquidity and Capital Resources

As of the date of this Annual Report, the Company has not yet generated substantial revenue from customers and business activity has mainly consisted of cash outflows associated with its business development activities. These conditions indicate that there is substantial doubt about the Company’s ability to continue as a going concern within one year from the issuance date of the consolidated financial statements.

The Company’s primary source of operating funds since inception through April 2021 was cash proceeds from the private placements of preferred equity and debt securities. During 2021, the Company completed its IPO yielding net proceeds to the Company of approximately $15.7 million from the sale of Common Stock and warrants and approximately $16.0 million from the exercise of warrants. The capital raised included funding for working capital to launch and expand operations in accordance with its business model. On April 12, 2022, the Company entered into a Credit Agreement with a related party lender, pursuant to which it may borrow up to $2,500,000 for up to one year. Through May 10, 2022, the lender has funded to the Company $1,000,000 under the Credit Agreement.

The Company intends to raise additional capital through private placements of debt and equity securities, but there can be no assurance that these funds will be available on terms acceptable to the Company or will be sufficient to enable the Company to fully complete its development activities or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to

23

Table of Contents

develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There is no assurance that such a plan will be successful.

Off-Balance Sheet Arrangements

We did not have, during the period presented, and we do not currently have, any relationships with any organizations or financial partnerships, such as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Critical Accounting Policies and Significant Accounting Estimates

Our management’s discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements as well as the reported expenses during the reporting periods. Actual results may differ materially from these estimates.

We believe that the assumptions and estimates associated with the evaluation of revenue recognition criteria, including the determination of revenue recognition as net versus gross in our revenue arrangements, useful lives of long-lived assets and stock-based compensation expense have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results could differ materially from these estimates.

Our significant accounting policies are more fully described in our consolidated financial statements (Note 2) included in this Annual Report.

Recently Issued Accounting Standards

Our analysis of recently issued accounting standards are more fully described in our consolidated financial statements (Note 2) included in this Annual Report.

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

24

Table of Contents

TABLE OF CONTENTS FOR THE FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID 215)

    

26

Consolidated Balance Sheets as of December 31, 2021, 2020, and 2019

28

Consolidated Statements of Operations for the years ended December 31, 2021, 2020, and 2019

29

Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2021, 2020, and 2019

30

Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020, and 2019

31

Notes to Consolidated Financial Statements

32

25

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of Alfi, Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Alfi, Inc. and subsidiary (the "Company") as of December 31, 2021, 2020, and 2019, and the related consolidated statements of operations, changes in stockholders' equity (deficit) and cash flows for the years then ended, and the related notes (collectively referred to as the consolidated financial statements).  In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, 2020, and 2019, and the results of their operations and cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Restatement of the 2020 and 2019 Financial Statements

As discussed in Note 4 to the consolidated financial statements, the accompanying consolidated financial statements as of and for the years ended December 31, 2020 and 2019 have been restated to correct misstatements.

Substantial Doubt About the Company’s Ability to Continue as a Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the consolidated financial statements, the Company has not yet generated substantial revenue from customers and has experienced significant operating losses and negative operating cash flows. These factors raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits.  We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.  Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audits of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

26

Table of Contents

Capitalized software development costs

As described in Note 2 and Note 11 to financial statements, the Company capitalizes certain costs related to internally developed software. Management determines the amount of internal software development costs to be capitalized based on the amount of time spent by developers on projects in the application stage of development. The determination of the application development stage period, as well as the estimation of capitalizable costs, involves judgment.

We identified capitalized software development costs as a critical audit matter. Our principal considerations for this determination were the high degree of auditor judgment and subjectivity required in evaluating management’s determination of the activities and costs that qualify for capitalization and the relevant software development guidance to be applied under the applicable accounting standards.

The primary procedures we performed to address this critical audit matter included:

We obtained an understanding of the Company’s process for determining the activities and costs that qualify for capitalization and the relevant capitalized software development costs guidance to be applied under the applicable accounting standards.
We evaluated the Company’s determination of the application development stage period.
We tested the mathematical accuracy of the roll forward of capitalized software development costs and related amortization expense. We also tested the completeness and accuracy of applicable system-generated reports, including reconcilements of details to associated sub-ledgers.
For a sample of capitalized software development costs, we performed the following:
oInspected underlying documentation and assessed the eligibility of costs for capitalization,
oPerformed recalculations based on direct payroll related costs and invoices for work performed by third parties,
oInquired of project managers for significant projects to assess the nature of the costs and the employees devoted to capitalizable activities.

/s/ Frazier & Deeter, LLC

We have served as the Company’s auditor since 2021.

Tampa, Florida

May 16, 2022

27

Table of Contents

Alfi, Inc.

f/k/a Lectrefy, Inc.

Consolidated Balance Sheets

    

December 31, 

    

2021

    

2020

    

2019

Assets

 

  

 

  

 

  

Current assets:

 

  

 

  

 

  

Cash and cash equivalents

$

4,391,816

$

8,335

$

38,890

Accounts receivable

 

5,578

 

 

Prepaid expenses and other

 

926,170

 

793

 

3,651

Total current assets

 

5,323,564

 

9,128

 

42,541

Property and equipment, net

 

4,031,904

 

506,294

 

107,744

Intangible assets, net

 

712,247

 

888,271

 

668,556

Operating lease right-of-use asset, net

 

95,765

 

149,032

 

206,378

Assets held for sale and other assets

 

1,209,525

 

7,940

 

7,940

Total assets

$

11,373,005

$

1,560,665

$

1,033,159

Liabilities and Stockholders’ Equity (Deficit)

 

  

 

  

 

  

Current liabilities:

 

  

 

  

 

  

Accounts payable and accrued expenses

$

2,264,582

$

1,000,876

$

23,844

Debt payable, related parties

 

 

3,728,808

 

Lease liability

 

98,175

 

152,646

 

209,016

Interest payable, related parties

 

 

116,600

 

8,478

Total current liabilities

 

2,362,757

 

4,998,930

 

241,338

Long-term debt, net (related parties)

 

 

 

759,090

Total liabilities

 

2,362,757

 

4,998,930

 

1,000,428

Stockholders' Equity (Deficit)

 

  

 

  

 

  

Series Seed convertible preferred stock, $0.0001 par value,

 

  

 

  

 

  

2,500,000 shares authorized, -0-, 2,500,000, and 2,500,000

 

  

 

  

 

  

shares issued and outstanding at December 31, 2021,

 

  

 

  

 

  

2020, and 2019, respectively

 

 

2,500,000

 

2,500,000

Common stock, $0.0001 par value, 80,000,000 shares

 

  

 

  

 

  

authorized, 16,069,347, 4,441,582 and 3,150,058 shares

 

  

 

  

 

  

issued and outstanding at December 31, 2021,

 

  

 

  

 

  

2020, and 2019, respectively

 

1,620

 

444

 

315

Additional paid-in capital

 

37,967,926

 

2,076,150

 

Accumulated deficit

 

(26,959,301)

 

(8,014,859)

 

(2,467,584)

Common stock held in treasury at cost, $0.0001 par

 

  

 

  

 

  

137,650, -0-, and -0- shares, respectively

 

(1,999,997)

 

 

Total stockholders' equity (deficit)

 

9,010,248

 

(3,438,265)

 

32,731

Total liabilities and stockholders' equity (deficit)

$

11,373,005

$

1,560,665

$

1,033,159

See accompanying notes to the consolidated financial statements

28

Table of Contents

Alfi, Inc.

f/k/a Lectrefy, Inc.

Consolidated Statements of Operations

    

2021

    

2020

    

2019

Revenues

$

26,465

$

$

Operating expenses

 

  

 

  

 

  

Compensation and benefits

 

6,030,179

 

950,641

 

540,516

Other general and administrative

 

11,031,739

 

1,838,708

 

1,125,351

Depreciation and amortization

 

1,150,782

 

716,558

 

22,166

Total operating expenses

 

18,212,700

 

3,505,907

 

1,688,033

Operating loss

 

(18,186,235)

 

(3,505,907)

 

(1,688,033)

Other income (expense)

 

  

 

  

 

  

Other income

 

160,671

 

198,704

 

97,379

Interest expense

 

(918,878)

 

(2,240,072)

 

(8,478)

Total other income (expense)

 

(758,207)

 

(2,041,368)

 

88,901

Net loss before provision for income taxes

 

(18,944,442)

 

(5,547,275)

 

(1,599,132)

Provision for income taxes

 

 

 

Net loss

$

(18,944,442)

$

(5,547,275)

$

(1,599,132)

Loss per share, basic and diluted

$

(1.63)

$

(1.75)

$

(0.51)

Weighted average shares outstanding, basic and diluted

 

11,622,251

 

3,166,024

 

3,150,058

See accompanying notes to the consolidated financial statements

29

Table of Contents

Alfi Inc.

f/k/a Lectrefy, Inc.

Consolidated Statement of Changes to Stockholders’ Equity (Deficit)

    

    

    

    

    

    

    

    

Total

Series Seed Convertible

Additional

Common

Stockholders'

Preferred Stock

Common Stock

Paid-In

Accumulated

Stock Held

Equity

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

in Treasury

    

(Deficit)

As of January 1, 2019

 

1,500,000

$

1,500,000

 

3,150,058

$

315

$

$

(868,452)

$

$

631,863

Issuance of convertible preferred stock

 

1,000,000

 

1,000,000

 

 

 

 

 

 

1,000,000

Net loss

 

 

 

 

 

 

(1,599,132)

 

 

(1,599,132)

As of December 31, 2019

 

2,500,000

 

2,500,000

 

3,150,058

 

315

 

 

(2,467,584)

 

 

32,731

Shares issued for services

 

 

 

31,501

 

3

 

24,997

 

 

 

25,000

Shares issued with debt

 

 

 

1,260,023

 

126

 

1,999,874

 

 

 

2,000,000

Share based compensation

 

 

 

 

 

51,279

 

 

 

51,279

Net loss

 

 

 

 

 

 

(5,547,275)

 

 

(5,547,275)

As of December 31, 2020

 

2,500,000

 

2,500,000

 

4,441,582

 

444

 

2,076,150

 

(8,014,859)

 

 

(3,438,265)

Shares issued with debt

 

 

 

472,510

 

48

 

749,952

 

 

 

750,000

Conversion of convertible preferred stock to common

 

(2,500,000)

 

(2,500,000)

 

3,150,058

 

315

 

2,499,685

 

 

 

Shares issued for cash

 

 

 

4,291,045

 

429

 

10,993,471

 

 

 

10,993,899

Warrants issued for cash

4,738,750

4,738,750

Exercise of warrants

 

 

 

3,508,227

 

352

 

16,034,189

 

 

 

16,034,541

Shares issued for services

 

 

 

331,683

 

30

 

476,150

 

 

 

476,180

Share based compensation

 

 

 

 

 

384,495

 

 

 

384,495

Options exercised

 

 

 

11,892

 

2

 

15,085

 

 

 

15,087

Treasury shares purchased

 

 

 

(137,650)

 

 

 

 

(1,999,997)

 

(1,999,997)

Net loss

 

 

 

 

 

 

(18,944,442)

 

 

(18,944,442)

As of December 31, 2021

 

$

 

16,069,347

$

1,620

$

37,967,926

$

(26,959,301)

$

(1,999,997)

$

9,010,248

See accompanying notes to the consolidated financial statements

30

Table of Contents

Alfi, Inc.

f/k/a Lectrefy, Inc.

Consolidated Statements of Cash Flows

    

2021

    

2020

    

2019

Cash flows from operating activities

 

  

 

  

 

  

Net loss

$

(18,944,442)

$

(5,547,275)

$

(1,599,132)

Adjustments to reconcile net loss to net cash used in operating activities:

 

  

 

  

 

  

Depreciation and amortization

 

1,150,782

 

716,558

 

22,166

Shares issued with debt

 

750,000

 

2,000,000

 

Share based compensation

 

384,495

 

51,279

 

Share based payments for services

 

476,180

 

25,000

 

Amortization of operating lease right-of-use asset

 

53,267

 

57,346

 

30,214

Changes in assets and liabilities:

 

  

 

  

 

  

Accounts receivable

 

(5,578)

 

 

Prepaid expenses and other assets

 

(925,377)

 

2,858

 

99,418

Other assets

 

(98,149)

 

 

3,726

Accounts payable

 

1,263,705

 

977,032

 

13,310

Lease liability

 

(54,472)

 

(56,370)

 

(27,576)

Interest payable, related parties

 

(116,599)

 

108,122

 

8,478

Net cash used in operations

 

(16,066,188)

 

(1,665,450)

 

(1,449,396)

Investing activities

 

  

 

  

 

  

Capital expenditures

 

(4,500,365)

 

(1,027,096)

 

(59,455)

Purchase of condominium

(1,103,437)

Acquisition of intangible assets

 

 

(307,728)

 

(501,685)

Net cash used in investing activities

 

(5,603,802)

 

(1,334,824)

 

(561,140)

Financing activities

 

  

 

  

 

  

Proceeds from related party debt payable

 

2,548,346

 

2,969,719

 

759,090

Proceeds from issuance of convertible preferred stock

 

 

 

1,000,000

Proceeds from issuance of common stock, net

 

15,732,649

 

 

Proceeds from exercise of warrants

 

16,034,541

 

 

Proceeds from exercise of options

 

15,085

 

 

Repayments of related party debt payable

 

(6,277,154)

 

 

Purchase of treasury shares

 

(1,999,997)

 

 

Net cash provided by financing activities

 

26,053,470

 

2,969,719

 

1,759,090

Net change in cash and cash equivalents

 

4,383,480

 

(30,555)

 

(251,446)

Cash and cash equivalents at the beginning of the period

 

8,335

 

38,890

 

290,336

Cash and cash equivalents at the end of the period

$

4,391,816

$

8,335

$

38,890

Supplemental disclosure of cash flow information

 

  

 

  

 

  

Cash paid for interest

$

285,478

$

$

Cash paid for income tax

$

$

$

Supplemental disclosure of non-cash investing and financing activities

 

  

 

  

 

  

Conversion of convertible preferred stock to common

$

2,500,000

$

$

Adoption of ASC 842 lease asset and liability recorded

$

$

$

236,592

See accompanying notes to the consolidated financial statements

31

Table of Contents

ALFI, INC. AND SUBSIDIARY

f/k/a LECTREFY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 BUSINESS DESCRIPTION BACKGROUND

Alfi, Inc. is a C-corporation incorporated in Delaware that operates in the technology sector; specifically, Software as a Service (“SaaS”) in the Digital Out Of Home (“DOOH”) Smart Advertising segment. This segment includes artificial intelligence, machine & deep learning, edge computing, Big Data, telecommunications, and the Internet of Things (IoT). Alfi, Inc. includes its wholly owned subsidiary Alfi (N.I.) Ltd, the results of which are presented on a consolidated basis in the financial statements. Alfi (N.I.) Ltd is a registered business in Belfast, Ireland. Collectively, the consolidated entity is referred to as the “Company” or “Alfi” throughout the consolidated financial statements.

The Company's timeline of events relative to its current formation above began on April 4, 2018, when Lectrefy, Inc., a Florida corporation, was incorporated. On July 6, 2018, Lectrefy, Inc., a Delaware corporation, was incorporated. On July 11, 2018, Lectrefy, Inc., the Florida corporation, was merged into the newly created entity Lectrefy, Inc., the Delaware corporation. On July 25, 2018, Lectrefy, Inc., the Delaware corporation, became qualified to do business in Florida. On January 31, 2020, Lectrefy, Inc., the Delaware corporation, changed its name to Alfi, Inc.

On September 18, 2018, Lectrefy, (N.I.) Ltd was organized in Belfast, Ireland. On February 4, 2020, Lectrefy, (N.I.) Ltd’s name was changed to Alfi (N.I.) Ltd. On February 13, 2020, Lectrefy Inc., the Delaware corporation, registered its name change to Alfi, Inc. in the State of Florida.

Alfi seeks to provide solutions that bring transparency and accountability to the DOOH advertising marketplace. Alfi uses artificial intelligence and big data analytics to measure and disseminate audience presence and audience demographics. The Company’s computer vision technology is powered by proprietary artificial intelligence, to determine the relevant demographic and geospecific information of the audience in front of an Alfi-enabled device, such as a tablet or kiosk. Alfi can then deliver in real-time, the advertisements to that particular viewer based on the viewer’s demographic profile and/or geolocation. Alfi is designed to deliver the right marketing content, to the right person at the right time in a responsible and ethical manner. By delivering the advertisements most relevant to the audience in front of the device, Alfi connects its advertising customers to the viewers they seek to target.

The Company’s initial focus is to place Alfi-enabled devices in malls, airports, rideshares and taxis. In addition, the Company has begun offering its software solution to other DOOH media operators as a SaaS product.

The Company’s primary activities since inception have been research and development, managing collaborations, and raising capital. As of December 31, 2021, the Company had approximately 27,000 tablets included in the Company’s balance sheet in property and equipment, net of accumulated depreciation.

NOTE 2 SIGNIFICANT ACCOUNTING POLICIES

Consolidation

The consolidated financial statements include the accounts of Alfi, Inc. and its wholly owned subsidiary, Alfi (N.I.) Ltd. Collectively, these entities make up the consolidated financial statements during the periods presented in this Annual Report. All significant intercompany balances and transactions are eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

32

Table of Contents

Revenue Recognition

Under Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 (Topic 606) “Revenue from Contracts with Customers” (“Topic 606”), revenue from contracts with customers is measured based on the consideration specified in the contract with the customer.

With respect to Alfi-enabled tablets placed in rideshares or devices placed into service by Alfi, Alfi will recognize revenue on a cost per thousand (“CPM”) basis or a related basis for both the content and advertisements delivered. Alfi contracts (also called insertion orders) for both the advertiser and the content provider specify the amounts to be paid to Alfi for displaying the advertisement or content. Content and advertisements are provided to Alfi by companies desiring to deliver content for viewer engagement.

With respect to SaaS licenses, Alfi has entered into two license agreements with third parties to use Alfi-placed devices on customer property and share in advertising revenues. Under these agreements, the customer and Alfi work together to generate advertising revenue, and the devices have remote management access and data reporting that the Alfi platform provides. Alfi began to earn revenue from advertisers during the fourth quarter of 2021. Alfi will recognize the revenue from these contracts monthly, in accordance with Topic 606.

Through December 31, 2021, the Company has distributed and activated into operations approximately 7,600 devices (tablets and kiosks) at no cost to rideshare, mall, or airport owner(s). It is the viewers of the Alfi-enabled device, rather than the rideshare, mall or airport owner, that the Alfi-enabled device engages with and to whom the Company delivers advertising and content.

The Company recognizes revenue when earned from rideshare sources, advertisers, and content providers. Each contract for placing a device in service with rideshare, mall, or airport owners generally does not trigger a payment from such party to the Company. With respect to a kiosk in a mall or airport, the Company may be paid a separate service fee to maintain the device, but the Company does not anticipate that to be a material source of revenue. The Company’s contract with a device host may provide that the Company pays a revenue sharing amount, or fee, based on the revenue the Company derives from that device. The Company will expense that fee in other general and administrative expenses. Removing a tablet from the vehicle or returning it to the Company would automatically cancel the opportunity for a rideshare to receive commissions. Thus, the Company does not anticipate that a rideshare would seek to return a tablet. Kiosks, because of their high cost, may either be returned to the Company or purchased by the facility owner at the end of the contract.

Accounts Receivable

The Company records accounts receivable at its net realizable value.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less from the purchase date to be cash equivalents.

Property and Equipment

Property and equipment includes tablets recorded at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over estimated useful lives of three years.

Property and equipment also includes office equipment recorded at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which for office equipment is three to five years.

Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.

33

Table of Contents

Intangible Assets

The Company’s intangible assets include capitalized software development and patent acquisition costs associated with creation of its technology. The Company places intangible assets into service upon the date in which they are available for use. Intangible assets are amortized over a 5 year useful life for capitalized software development costs and a 15 year useful life for patent acquisition costs. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, then an impairment charge is recognized for the amount by which the carrying value of the asset exceeds the estimated fair value of the asset. As of December 31, 2021, 2020, and 2019, the Company believes that no revision of the remaining useful lives or write-down of long-lived assets is required.

Prepaid Expenses and Other Assets

The Company records premiums paid up front for insurance and retainers paid to professional services firms as prepaid expenses.

Assets Held for Sale and Other Assets

Assets held for sale and other assets include a condominium purchased in August 2021 and sold in April 2022. The purchase and sale prices were approximately $1.1 million.

Fair Value of Financial Instruments

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. Fair values approximate carrying values for cash, accounts payable, notes payable, fixed assets, and amortizable intangible assets.

Net Loss Per Share

The Company computes basic net loss per share by dividing net loss per share available to Common Stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into Common Stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share for the years ended December 31, 2021, 2020, and 2019, excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of Common Stock during the period.

Potentially dilutive securities excluded from the computation of basic net loss per share are as follows:

December 31, 

December 31, 

December 31, 

    

2021

    

2020

    

2019

Convertible Series (“Seed”) Preferred stock

 

 

3,150,058

 

3,150,058

Warrants

 

969,385

 

 

Employee stock options

 

455,474

 

236,259

 

59,064

Total potentially dilutive securities

 

1,424,859

 

3,386,317

 

3,209,122

34

Table of Contents

Common Stock

The Company issued 3,150,058 shares of Common Stock on April 4, 2018 to the Company's founders. At December 31, 2020, outstanding shares of Common Stock totaled 4,441,582. During the year ended December 31, 2021, the Company issued 4,291,045 shares of Common Stock for cash in a its initial public offering, which was completed on May 6, 2021 (“IPO”), 3,508,227 shares of Common Stock upon exercise of warrants issued in connection with the IPO, and 3,150,058 shares of Common Stock from conversion of all outstanding shares of the Company's Series Seed Preferred Stock, $0.0001 par value per share (the "Series Seed Preferred Stock"), to shares of Common Stock. During the year ended December 31, 2021, the Company repurchased 137,650 shares of its Common Stock for $1,999,997. The Company paid no dividends on Common Stock issued during the years ended December 31, 2021, 2020, and 2019, respectively. The Company accounts for Common Stock issued with debt, issued for services, and issued as share based compensation at fair value.

Convertible Instruments

During the years ended December 31, 2021, 2020, and 2019, the Company did not record or issue convertible notes with beneficial conversion features and did not record debt discounts related to beneficial conversion features. During 2020 and 2019, the Company issued Series Seed Preferred Stock which is convertible into Common Stock on a 1:1.260023 basis at the option of the holder, and is classified as stockholders’ equity on the balance sheet at December 31, 2020, and December 31, 2019. When converted into Common Stock by Series Seed Preferred Stock holders, its fair value approximates the existing carrying (book) value of the Series Seed Preferred Stock as stated.

U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional.

The Company has determined that the embedded conversion options should not be bifurcated from their host instruments and the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments (the beneficial conversion feature) based upon the differences between the fair value of the underlying Common Stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

Thus, no embedded derivatives were identified on the conversion option of the Series Seed Preferred Stock at December 31, 2020, and 2019. In May 2021, 2,500,000 shares of Series Seed Preferred Stock converted into 3,150,058 shares of Common Stock. There were no outstanding shares of Series Seed Preferred Stock on December 31, 2021.

Common Stock Purchase Warrants

The Company accounts for warrants to purchase its Common Stock in accordance with ASC 815. Proceeds from the issuance of warrants indexed to the Company’s own stock are equity classified.

Stock based compensation

The Company maintains a stock equity incentive plan, the Alfi, Inc. 2018 Stock Incentive Plan (the “2018 Plan”), under which it may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants. The Company measures compensation expense for stock-based grants at fair value. Compensation expense is recognized over the vesting period relevant to the award.

35

Table of Contents

Income Taxes

Deferred income tax assets and liabilities are determined based on the estimated future tax effects of net operating loss and credit carryforwards and temporary differences between the tax basis of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records an estimated valuation allowance on its deferred income tax assets if it is more likely than not that these deferred income tax assets will be realized. The Company carries a 100% valuation allowance against deferred tax assets as of December 31, 2021, 2020, and 2019. The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of December 31, 2021, 2020, and 2019, the Company has not recorded any unrecognized tax benefits. The Company’s policy is to classify assessments, if any, for tax-related interest as interest expense and penalties as general and administrative expenses in the statements of operations. The Company did not recognize any such penalties or interest during the periods presented under this Annual Report.

Recent Accounting Pronouncements

There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

Forward Stock Split

On March 1, 2021, the Company enacted a forward stock split on a 1.260023:1.000000 basis. Share amounts reflected in this Annual Report are presented post-split, unless otherwise noted.

NOTE 3 GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS

As of the date of this Annual Report, the Company has not yet generated substantial revenue from customers and business activity has mainly consisted of cash outflows associated with its business development activities. These conditions indicate that there is substantial doubt about the Company’s ability to continue as a going concern within one year from the issuance date of the consolidated financial statements.

The Company’s primary source of operating funds since inception through April 2021 was cash proceeds from the private placements of preferred equity and debt securities. During 2021, the Company completed its IPO yielding net proceeds to the Company of approximately $15.7 million from the sale of Common Stock and warrants and approximately $16.0 million from the exercise of warrants. The capital raised included funding for working capital to launch and expand operations in accordance with its business model.

The Company intends to raise additional capital through private placements of debt and equity securities, but there can be no assurance that these funds will be available on terms acceptable to the Company or will be sufficient to enable the Company to fully complete its development activities or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There is no assurance that such a plan will be successful.

Accordingly, the accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not necessarily represent realizable or settlement values. The consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.

36

Table of Contents

NOTE 4 RESTATEMENTS OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Prior Period Restatements

On March 11, 2022, the Audit Committee (the “Audit Committee”) of the Company’s Board of Directors (the “Board”) and the Company’s management concluded that the Company’s previously issued audited financial statements for the years ended December 31, 2019 and 2020, included in the Company’s Registration Statement on Form S-1 (File No. 333-251959), and the Company’s previously issued interim financial statements included in the Company’s Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2021 and June 30, 2021 (collectively, the “Prior Period Financial Statements”), should no longer be relied upon as a result of the accounting errors described below and should be restated. Similarly, any previously furnished or filed reports, press releases, earnings releases, investor presentations or other communications describing the Prior Period Financial Statements and related financial information should not be relied upon.

In connection with the Company’s evaluation of the issues and findings identified in the Company’s previously disclosed internal independent investigation (the “Investigation”), the Company reviewed the Prior Period Financial Statements and identified the following accounting errors:

(a)The Company incorrectly capitalized certain general and administrative expenses incurred during the years ended December 31, 2018, 2019, and 2020, and incorrectly included those costs in intangible assets in its balance sheets as of December 31, 2019 and 2020, March 31, 2021, and June 30, 2021.
(b)The Company overstated the carrying value of tablets by incorrectly reporting them at cost with no allowance for depreciation, resulting in an overstatement of other assets (complimentary devices), net, in its balance sheets as of December 31, 2019 and 2020, March 31, 2021, and June 30, 2021.
(c)The Company overstated total assets and total liabilities as of December 31, 2020, by incorrectly recording a note receivable (related parties) and a liability included in current portion of long-term debt (related parties). This note receivable represents a bridge loan provided to the Company by certain related parties that was executed in December 2020 but not fully funded until April 2021.
(d)The Company did not recognize and report on its balance sheets as of December 31, 2019 and 2020, March 31, 2021, and June 30, 2021, an office lease in accordance with FASB Accounting Standards Update No. 2018-11, Leases (Topic 842).

The accompanying financial statements have been restated to correct the accounting errors and conform to current period presentation.

37

Table of Contents

Impact of the Restatements

The impact of the restatement on the consolidated balance sheet as of December 31, 2020 is presented below:

As of December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Assets

 

  

 

  

 

  

Current assets:

 

  

 

  

 

  

Cash and cash equivalents

$

8,335

$

$

8,335

Note receivable (related parties)

 

1,830,000

 

(1,830,000)

 

Prepaid expenses and other

 

793

 

 

793

Total current assets

 

1,839,128

 

(1,830,000)

 

9,128

Property and equipment, net

 

117,474

 

388,820

 

506,294

Intangible assets, net

 

4,384,188

 

(3,495,917)

 

888,271

Other assets (complimentary devices), net

 

1,104,000

 

(1,104,000)

 

Operating lease right-of-use asset, net

 

 

149,032

 

149,032

Other assets

 

7,940

 

 

7,940

Total assets

$

7,452,730

$

(5,892,065)

$

1,560,665

Liabilities

 

  

 

  

 

  

Current liabilities:

 

  

 

  

 

  

Accounts payable

$

516,705

$

484,171

$

1,000,876

Debt payable, related parties

 

5,558,808

 

(1,830,000)

 

3,728,808

Derivative liability

 

229,712

 

(229,712)

 

Lease liability

 

 

152,646

 

152,646

Interest payable, related parties

 

116,600

 

 

116,600

Total current liabilities

 

6,421,825

 

(1,422,895)

 

4,998,930

Total liabilities

 

6,421,825

 

(1,422,895)

 

4,998,930

Stockholders' Equity (deficit)

 

  

 

  

 

  

Series Seed convertible preferred stock, $0.0001 par value, 2,500,000 shares authorized, issued, and outstanding

 

2,500,000

 

 

2,500,000

Common stock, $0.0001 par value, 15,000,000 shares authorized, 4,441,582 shares issued and outstanding

 

444

 

 

444

Additional paid-in capital

 

2,024,871

 

51,279

 

2,076,150

Accumulated deficit

 

(3,494,410)

 

(4,520,449)

 

(8,014,859)

Total stockholders' equity (deficit)

 

1,030,905

 

(4,469,170)

 

(3,438,265)

Total liabilities and stockholders' equity (deficit)

$

7,452,730

$

(5,892,065)

$

1,560,665

38

Table of Contents

The impact of the restatement on the consolidated balance sheet as of December 31, 2019 is presented below:

As of December 31, 2019

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Assets

 

  

 

  

 

  

Current assets:

 

  

 

  

 

  

Cash and cash equivalents

$

38,890

$

$

38,890

Prepaid expenses and other

 

3,651

 

 

3,651

Total current assets

 

42,541

 

 

42,541

Property and equipment, net

 

107,744

 

 

107,744

Intangible assets, net

 

3,198,051

 

(2,529,495)

 

668,556

Operating lease right-of-use asset, net

 

 

206,378

 

206,378

Other assets

 

7,940

 

 

7,940

Total assets

$

3,356,276

$

(2,323,117)

$

1,033,159

Liabilities and Stockholders’ Equity (Deficit)

 

  

 

  

 

  

Current liabilities:

 

  

 

  

 

  

Accounts payable

$

23,844

$

$

23,844

Lease liability

 

 

209,016

 

209,016

Interest payable, related parties

 

8,478

 

 

8,478

Total current liabilities

 

32,322

 

209,016

 

241,338

Long-term debt, net (related parties)

 

759,090

 

 

759,090

Total liabilities

 

791,412

 

209,016

 

1,000,428

Stockholders' Equity

 

  

 

  

 

  

Series Seed convertible preferred stock, $0.0001 par value, 2,500,000 shares authorized, issued, and outstanding

 

2,500,000

 

 

2,500,000

Common stock, $0.0001 par value, 15,000,000 shares authorized, 3,150,058 shares issued and outstanding

 

315

 

 

315

Accumulated surplus (deficit)

 

64,549

 

(2,532,133)

 

(2,467,584)

Total stockholders' equity

 

2,564,864

 

(2,532,133)

 

32,731

Total liabilities and stockholders' equity

$

3,356,276

$

(2,323,117)

$

1,033,159

39

Table of Contents

The impact of the restatement on the consolidated statement of operations for the year ended December 31, 2020 is presented below:

For the Year Ended December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Revenues

$

$

$

Cost of sales, net

 

331,110

 

(331,110)

 

  

Gross margin

 

(331,110)

 

331,110

 

Operating expenses

 

  

 

  

 

  

Compensation and benefits

 

 

950,641

 

950,641

Other general and administrative

 

2,850,531

 

(1,011,823)

 

1,838,708

Depreciation and amortization

 

464,236

 

252,322

 

716,558

Total operating expenses

 

3,314,767

 

191,140

 

3,505,907

Operating loss

 

 

(3,505,907)

 

(3,505,907)

Other income (expense)

 

  

 

  

 

  

Other income

 

195,040

 

3,664

 

198,704

Interest expense

 

(108,122)

 

(2,131,950)

 

(2,240,072)

Total other income (expense)

 

86,918

 

(2,128,286)

 

(2,041,368)

Net loss before provision for income taxes

 

(3,558,959)

 

(1,988,316)

 

(5,547,275)

Provision for income taxes

 

 

 

Net loss after provision for income taxes

$

(3,558,959)

$

(1,988,316)

$

(5,547,275)

Loss per share, basic and diluted

$

(1.12)

$

(0.63)

$

(1.75)

Weighted average shares outstanding, basic and diluted

 

3,169,501

 

(3,477)

 

3,166,024

40

Table of Contents

The impact of the restatement on the consolidated statement of operations for the year ended December 31, 2019 is presented below:

    

For the Year Ended December 31, 2019

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Revenues

$

$

$

Cost of sales, net

 

 

 

Gross margin

 

 

 

Operating expenses

 

  

 

  

 

  

Compensation and benefits

 

 

540,516

 

540,516

Other general and administrative

 

 

1,125,351

 

1,125,351

Depreciation and amortization

 

22,166

 

 

22,166

Total operating expenses

 

22,166

 

1,665,867

 

1,688,033

Operating loss

 

 

(1,688,033)

 

(1,688,033)

Other income (expense)

 

  

 

  

 

  

Other income

 

97,379

 

 

97,379

Interest expense

 

(8,478)

 

 

(8,478)

Total other income

 

88,901

 

 

88,901

Net income (loss) before provision for income taxes

 

66,735

 

(1,665,867)

 

(1,599,132)

Provision for income taxes

 

 

 

Net income (loss) after provision for income taxes

$

66,735

$

(1,665,867)

$

(1,599,132)

Loss per share, basic and diluted

$

0.02

$

(0.53)

$

(0.51)

Weighted average shares outstanding,

 

  

 

  

 

  

basic and diluted

 

3,150,000

 

58

 

3,150,058

41

Table of Contents

The impact of the restatement on the consolidated statement of cash flows for the year ended December 31, 2020 is presented below:

    

For the Year Ended December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Operating activities

 

  

 

  

 

  

Net loss

$

(3,558,959)

$

(1,988,316)

$

(5,547,275)

Adjustments to reconcile net loss to net cash used

 

  

 

  

 

  

in operating activities:

 

  

 

  

 

  

Depreciation and amortization

 

464,236

 

252,322

 

716,558

Stock issued in lieu of cash payments for expenses

 

2,254,712

 

(178,433)

 

2,076,279

Amortization of operating lease right-of-use asset

 

 

57,346

 

57,346

Changes in assets and liabilities:

 

  

 

  

 

  

Other assets (complimentary devices)

 

(1,104,000)

 

1,104,000

 

Note receivable (related parties)

 

(1,830,000)

 

1,830,000

 

Prepaid expenses and other assets

 

2,858

 

 

2,858

Accounts payable

 

492,861

 

484,171

 

977,032

Lease liability

 

 

(56,370)

 

(56,370)

Interest payable, related parties

 

108,122

 

 

108,122

Net cash used in operations

 

(3,170,170)

 

1,504,720

 

(1,665,450)

Investing activities

 

  

 

  

 

  

Capital expenditures

 

(23,584)

 

(1,003,512)

 

(1,027,096)

Acquisition of intangible assets

 

(1,636,519)

 

1,328,791

 

(307,728)

Net cash used in investing activities

 

(1,660,103)

 

325,279

 

(1,334,824)

Financing activities

 

  

 

  

 

  

Proceeds from related party debt payable

 

4,799,718

 

(1,830,000)

 

2,969,719

Net cash provided by financing activities

 

4,799,718

 

(1,830,000)

 

2,969,719

Net change in cash and cash equivalents

 

(30,555)

 

 

(30,555)

Cash and cash equivalents at the beginning of the period

 

38,890

 

 

38,890

Cash and cash equivalents at the end of the period

$

8,335

$

$

8,335

42

Table of Contents

The impact of the restatement on the consolidated statement of cash flows for the year ended December 31, 2019 is presented below:

    

For the Year Ended December 31, 2019

    

As Previously

Restatement

    

Reported

    

Adjustments

    

As Restated

Operating activities

 

  

 

  

 

  

Net income (loss)

$

66,735

$

(1,665,867)

$

(1,599,132)

Adjustments to reconcile net loss to net cash used

 

  

 

  

 

  

in operating activities:

 

  

 

  

 

  

Depreciation and amortization

 

22,166

 

 

22,166

Amortization of operating lease right-of-use asset

 

 

30,214

 

30,214

Changes in assets and liabilities:

 

  

 

  

 

  

Prepaid expenses and other assets

 

96,068

 

3,350

 

99,418

Other assets

 

 

3,726

 

3,726

Accounts payable

 

13,311

 

(1)

 

13,310

Lease liability

 

 

(27,576)

 

(27,576)

Interest payable, related parties

 

8,478

 

 

8,478

Net cash used in operations

 

206,758

 

(1,656,154)

 

(1,449,396)

Investing activities

 

  

 

  

 

  

Capital expenditures

 

(52,380)

 

(7,075)

 

(59,455)

Acquisition of intangible assets

 

(2,164,914)

 

1,663,229

 

(501,685)

Net cash used in investing activities

 

(2,217,294)

 

1,656,154

 

(561,140)

Financing activities

 

  

 

  

 

  

Proceeds from related party debt payable

 

759,090

 

 

759,090

Proceeds from issuance of convertible preferred stock

 

1,000,000

 

 

1,000,000

Net cash provided by financing activities

 

1,759,090

 

 

1,759,090

Net change in cash and cash equivalents

 

(251,446)

 

 

(251,446)

Cash and cash equivalents at the beginning of the period

 

290,336

 

 

290,336

Cash and cash equivalents at the end of the period

$

38,890

$

$

38,890

Supplemental disclosure of cash flow information

 

  

 

  

 

  

Adoption of ASC 842 lease

 

  

 

  

 

  

asset and liability recorded

$

$

236,592

$

236,592

NOTE 5 FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company also follows a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable based on an entity’s own assumptions, as there is little, if any, related market activity (e.g., cash flow modeling inputs based on assumptions).

The risk-free interest rate is the United States Treasury rate on the measurement date having a term equal to the remaining contractual life of the instrument. The volatility is a measure of the amount by which the comparable companies’ share price has fluctuated or is expected to fluctuate. Since the Common Stock was not publicly traded prior to the IPO, an average of the historical volatility of comparative companies was used.

43

Table of Contents

Level 3 financial assets and liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of fair value. The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods.

An increase or decrease in volatility or interest free rate, in isolation, can significantly increase or decrease the fair value of financial assets and liabilities. Changes in the values of the assets and liabilities are recorded as a component of other income (expense) on the accompanying consolidated statement of operations.

Non-financial assets that are measured on a non-recurring basis include our intellectual property and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.

NOTE 6 DEBT PAYABLE – RELATED PARTIES

During 2019 and 2020, the Company entered into six promissory note agreements with a related party pursuant to which the Company could borrow up to $2,500,000 at an annual interest rate of 5%. Borrowings pursuant to those agreements were $759,091 at December 31, 2019. During the year ended December 31, 2020, the Company borrowed an additional $1,740,909.

During the year ended December 31, 2020, a related party provided financing of approximately $950,000 for the Company’s purchase of 7,600 tablets. Payment terms associated with the approximately 7,600 tablet devices purchased by the related party on behalf of the Company required a fixed repayment of $125 per device, due to related party by Alfi upon the closing of the IPO. There was no stated interest rate or additional repayment terms.

On December 30, 2020, the Company entered into a $2,000,000 bridge loan agreement with a related party. As of December 31, 2020, $251,654 had been funded on the bridge loan. The terms of the bridge loan included repayment of principal on or before June 30, 2021, and an annual interest rate of 18%. In addition to repayment of principal and interest under the bridge loan, the Company issued to the related party 1,260,023 shares of Common Stock. Management valued this issuance of shares at $2,000,000 and recorded that amount in interest expense.

During the year ended December 31, 2020, the Company received a cash advance of $27,154 from related parties. The cash advances carried no specified repayment term, interest rate, or security interest.

During the year ended December 31, 2021, the Company entered into bridge loans totaling $800,000 with related party investors. Terms of the bridge loans with the related parties included repayment of principal on or before June 30, 2021, and an annual interest rate of 18%. In addition to repayment of principal and interest under the bridge loans, the Company issued 472,510 shares of Common Stock. Management valued these issuances of shares at $750,000 and recorded that amount in interest expense.

44

Table of Contents

A summary of borrowings from related parties follows.

    

    

    

    

Interest

    

Lender

    

Loan Payable

    

Rate

    

Accrual

Balance at January 1, 2019

$

 

  

 

$

Note borrowings

Affiliated entity

 

759,091

 

5%

8,358

Balance at December 31, 2019

$

759,091

 

  

 

$

8,358

Interest on prior borrowings

 

 

  

 

38,059

Note borrowings

Affiliated entity

 

1,740,909

 

5%

66,576

Tablet financing

Affiliated entity

 

950,000

 

N/A

 

Bridge loan

Affiliated entity

 

251,654

 

18%

3,138

Bridge loan

Affiliated entity

 

27,154

 

0%

Balance at December 31, 2020

$

3,728,808

 

  

 

$

116,130

Interest on prior borrowings

 

 

  

 

60,256

Bridge loans

Affiliated entities

 

1,748,346

 

18%

83,399

Bridge loans

Affiliated persons

 

800,000

 

18%

25,693

Repayments

 

(6,277,154)

 

  

 

(285,478)

Balance at December 31, 2021

$

 

  

 

$

All borrowings from related parties were paid in full upon completion of the Company’s IPO in May 2021.

NOTE 7 INCOME TAXES

The Company utilizes the liability method of accounting for income taxes as set forth in FASB ASC Topic 740, “Income Taxes”. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using tax rates expected to be in effect during the years in which the basis difference reverses. The Company accounts for interest and penalties on income taxes as income tax expense. A valuation allowances is recorded when it is more likely than not that a tax benefit will not be realized. In determining the need for valuation allowances the Company considers projected future taxable income and the availability of tax planning strategies.

The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. As of December 31, 2021, 2020, and 2019, the Company has not recorded any uncertain tax positions and, therefore, has not incurred any interest or penalties. The Company files Federal and state tax returns in as a C-corporation. The Company is not currently under examination by any Federal or state authority. All tax returns filed since the Company’s inception in 2018 are subject to examination by taxing authorities.

A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows for the years ended December 31, 2021, 2020, and 2019:

    

2021

    

2020

    

2019

Statutory rate

 

21.0%

21.0%

21.0%

Effect of:

 

  

 

  

 

  

State taxes, net of federal benefit

 

5.0%

5.0%

5.0%

Change in valuation allowance

 

(26.0)%

(26.0)%

(26.0)%

Effective tax rate

 

0.0%

0.0%

0.0%

The Company’s financial statements contain certain deferred tax assets which have arisen primarily as a result of losses incurred that are considered start-up costs for tax purposes, as well as net deferred income tax assets resulting from other temporary differences related to certain reserves and differences between book and tax depreciation and amortization. The Company assesses the realizability of deferred tax assets based on the available evidence, including a history of taxable income and estimates of future taxable income. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of deferred tax assets will not be realized. Due to the history of losses incurred by the Company, management believes it is not more likely than not that all of the deferred tax assets can be realized. Accordingly, the Company established and recorded a full valuation allowance

45

Table of Contents

on its net deferred tax assets of approximately $6.1 million, $1.6 million, and $0.8 million as of December 31, 2021, 2020 and 2019, respectively.

Deferred tax assets and liabilities consist of the following at December 31, 2021, 2020, and 2019:

    

December 31, 

    

2021

    

2020

    

2019

Deferred tax assets

 

  

 

  

 

  

Federal and state net operating loss carry forwards

$

6,087,010

$

1,612,569

$

812,857

Total gross deferred tax assets

 

6,087,010

 

1,612,569

 

812,857

Valuation Allowance

 

(6,087,010)

 

(1,612,569)

 

(812,857)

Net deferred tax assets

$

$

$

As of December 31, 2021, the Company had $23.4 million of U.S. Federal net operating loss carryforwards available to reduce future taxable income, of which $23.4 million will be carried forward indefinitely for U.S. Federal tax purposes and $-0- will expire beginning in 2035 to 2037. The Company also has $23.5 million of U.S. state net operating loss carryforwards of which $23.5 million will be carried forward indefinitely and $-0- will expire beginning in 2035 to 2037.

During the years ended December 31, 2021, December 31, 2020, and December 31, 2019, the Company realized foreign tax credits associated with its wholly owned subsidiary Alfi (N.I.) Ltd of $152,278, $195,040, and $87,348. These amounts were recorded as other income in the consolidated statement of operations.

NOTE 8 COMMITMENTS AND CONTINGENCIES

Operating leases

During the years ended December 31, 2021, 2020, and 2019, the Company had office leases in Miami, FL, Denver, CO, and Belfast, Northern Ireland. Rent expense under those leases was $422,075, $93,962, and $134,034 during the years ended December 31, 2021, 2020, and 2019, respectively.

The Belfast office lease is an operating lease that commenced on July 1, 2019 and has a ten-year term with an option to terminate the lease after five years. The Company vacated this office in March 2022 and is in negotiations to terminate the lease early. In accordance with ASC 842, upon lease inception the Company recorded an operating lease right-of-use (“ROU”) asset of $236,592 and lease liability of $236,592 for this lease. Operating lease ROU assets and lease liabilities at commencement date were determined based on the present value of minimum lease payments over the lease term of five years. Future minimum payments due under the Belfast office lease are $62,438 in 2022 and $62,438 in 2023.

Concentration of Credit Risk

Generally, the Company’s cash balances, which are deposited in non-interest-bearing accounts may exceed FDIC insurance limits from time to time. The financial stability of these institutions is periodically reviewed by senior management. At December 31, 2021, 2020, and 2019, cash balances in excess of FDIC requirements were $4,141,816, $-0-, and $-0-, respectively. The Company incurred no losses from cash balances in excess of FDIC requirements.

Litigation, Claims, and Assessments

The Company may be involved in legal proceedings, claims and assessments. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance.

On December 2, 2021, the Company and certain of its present and former officers and directors were named as defendants in a putative class action lawsuit styled Steppacher v. Alfi, Inc., et al., Case No. 1:21-cv-24232, brought in the United States District Court for the Southern District of Florida. On December 15, 2021, the Company, certain of its present and former officers and directors, and the underwriters in the Company’s IPO were named as defendants in a second putative class action styled Kleinschmidt v. Alfi, Inc., et al., Case No. 1:21-cv-24338, also brought in the United States District Court for the Southern District of Florida. The complaints in both

46

Table of Contents

actions allege that the Company and other named defendants violated Sections 11 and 15 of the Securities Act of 1933, as amended, with respect to allegedly false and misleading statements included in the registration statement and prospectus supplements issued in connection with the Company’s IPO (the “Offering Documents”) in May 2021, and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, by allegedly making false and materially misleading statements and failing to disclose material adverse facts in the Company’s public filings with the SEC. Both complaints assert that the putative plaintiff class includes: (i) persons or entities, other than the defendants, who purchased or acquired the Common Stock or warrants to purchase the Common Stock pursuant and/or traceable to the Offering Documents; and (ii) persons or entities, other than the defendants, who purchased or acquired the Company’s securities between May 4, 2021, and November 15, 2021 (both dates inclusive). The plaintiffs seek unspecified compensatory damages, including interest, and costs and expenses, including attorney’s and expert fees. On February 3, 2022, the court consolidated the two actions under the caption Steppacher, Jr., et al. v. Alfi, Inc. et al., Case No. 21-cv-24232-KMW. Three putative stockholders (or groups of stockholders) moved to be appointed as lead plaintiff, and the court appointed Candido Rodriguez as lead plaintiff. The consolidated actions are now captioned Rodriguez, et al. v. Alfi, Inc., et al., Case No. 21-cv-24232-KMW. The Company intends to vigorously defend these actions and is currently unable to estimate the costs and timing of the resolution of this matter.

During February and March 2022, two former employees filed breach of contract claims against the Company. The Company is currently unable to estimate the costs and timing of arbitration of these claims.

Other Matters

As previously disclosed, on November 9, 2021, the Company received a letter from the staff of the SEC indicating that the Company, its affiliates and agents may possess documents and data relevant to an ongoing investigation being conducted by the staff of the SEC and notifying the Company that such documents and data should be reasonably preserved and retained until further notice. The materials to be preserved and retained include documents and data created on or after April 1, 2018 that: (i) were created, modified or accessed by certain named former and current officers and directors of the Company or any other officer or director of the Company; or (ii) relate or refer to the condominium or the sports tournament sponsorship identified in the Company's Current Report on Form 8-K filed on November 1, 2021, or financial reporting and disclosure controls, policies or procedures. On March 8, 2022, the Company received a subpoena from the SEC relating to the investigation. The Company intends to cooperate fully with the SEC in this matter. The Company is currently unable to estimate the costs and timing of the resolution of this matter.

The Company’s former Chief Executive Officer and former Chief Financial Officer have made claims that the Company indemnify and advance the legal fees and expenses incurred by them in connection with the Investigation and the putative class action litigations and the SEC investigation, each referred to above. With respect to the advancement of fees and expenses incurred in connection with the Investigation prior to December 31, 2021, the amount of such fees and expenses that is subject to advancement is approximately $147,000. The former officers have also demanded advancement of fees and expenses of additional amounts of approximately $339,000 for the period from January 1, 2022 through March 31, 2022.  Additional amounts may be subject to claims for advancement and indemnification, but the Company is unable to estimate the amount of additional fees and expenses that may be subject to advancement or indemnification.

NOTE 9 STOCKHOLDERS’ EQUITY (DEFICIT)

Common shares issued before the IPO were recorded at estimated fair value. In May 2021, the Company completed its IPO of its Common Stock, creating liquidity and a visible fair market value for its stock. The Common Stock is listed on the Nasdaq Capital Market under the symbol “ALF”.

In 2018, the Company created the Series Seed Preferred Stock and 2,500,000 shares of Series Seed Preferred Stock were authorized. During 2018 and 2019, 2,500,000 shares of Series Seed Preferred Stock was issued to an investor in exchange for $2,500,000 cash consideration. Shares of Series Seed Preferred Stock converted to Common Stock at a ratio of 1:1.260023 at any time at the option of the holder. Holders of Series Seed Preferred Stock had preferential liquidation rights in the event of the Company’s dissolution. Shares of Series Seed Preferred stock bore no interest or dividend payments to its holders. The Series Seed Preferred Stock had a buyout feature if not converted into Common Stock by the holder. Series Seed Preferred Stock could be bought out by the Company if full return of principal is made to investor ($2,500,000), plus an additional 1x return of capital to the holder ($2,500,000). On December 31, 2020, 2,500,000 Series Seed Preferred Stock shares were issued and outstanding. In May 2021, 2,500,000 shares of Series Seed Preferred

47

Table of Contents

Stock were converted into 3,150,058 shares of Common Stock at a conversion ratio of 1:1.260023. During the year ended December 31, 2021, no preferred stock was issued by the Company, and no shares of preferred stock were outstanding as of December 31, 2021.

Dividends

Holders of preferred stock are not entitled to dividend payment but do have liquidation preference in the event of dissolution of the Company. Holders of Common Stock are not entitled to dividend payments but would receive such payments in the event dividend payments were made to stockholders. There was no dividend payment made on any class of stock (Common Stock or preferred stock) during the years ended December 31, 2021, 2020, and 2019.

Common Stock

The Company is authorized to issue 80,000,000 shares of Common Stock, par value $0.0001. In 2018, 3,150,058 shares of Common Stock were issued to the three management members who are the Company’s founders, at par. In March 2021, a 1.260023 to 1 forward stock split was effected. Common Stock share numbers contained herein in this Annual Report are presented on a post-split basis unless specifically noted otherwise.

During the year ended December 31, 2020, the Company issued 31,501 shares of Common Stock to an unaffiliated third party in exchange for services associated with investment relations and fundraising, and to support the development of revenue producing contracts. Management valued this issuance of shares at $25,000 and recorded that amount in other general and administrative expense.

During the year ended December 31, 2020, the Company issued 1,260,023 shares of Common Stock to related party investors in exchange for bridge loan funding necessary to procure ongoing business operations. Management valued this issuance of shares at $2,000,000 and recorded that amount in interest expense.

During the year ended December 31, 2021, the Company arranged two bridge loans with related party investors. The Company issued 472,510 shares of Common Stock, in exchange for bridge loan funding necessary to procure ongoing business operations. Management valued these issuances of shares at $750,000 and recorded that amount in interest expense.

During the year ended December 31, 2021, the Company also issued 300,000 shares of Common Stock in connection with certain vendor contracts. Management valued this issuance of shares at $476,180 and recorded that amount in other general and administrative expense.

Initial Public Offering

On May 3, 2021, the Company’s registration statement on Form S-1 (File No. 333-251959) was declared effective by the SEC and the Company completed its IPO on May 6, 2021. In connection with the IPO, the Company issued and sold 4,291,045 shares of Common Stock and warrants to purchase 4,291,045 shares of Common Stock (including 559,701 shares of Common Stock and warrants to purchase 559,701 shares of Common Stock pursuant to the full exercise of the underwriters’ overallotment option), at the combined public offering price of $4.15 for aggregate gross proceeds of approximately $17.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Alfi. Net IPO proceeds of approximately $15.7 million were allocated $11.0 million to Common Stock and $4.7 million to warrants. The warrants were exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and have an exercise price of $4.57 per share.

On May 3, 2021, pursuant to the underwriting agreement for the IPO, we issued to the underwriters warrants to purchase up to an aggregate of 186,567 shares of Common Stock (“Underwriter's Warrants”). The Underwriter's Warrants may be exercised beginning on May 3, 2022 until May 3, 2026. The initial exercise price of each Underwriter's Warrant is $5.19 per share.

Warrants Issued and Exercised

Warrants to purchase 4,477,612 shares of Common Stock were issued in connection with the Company’s May 2021 IPO. As of December 31, 2021, warrant holders have exercised warrants to purchase 3,508,227 shares of Common Stock, providing Alfi with $16,034,189 in additional funding. As of December 31, 2021, there were warrants to purchase 969,385 shares of Common Stock outstanding.

48

Table of Contents

Activity related to warrants was as follows:

Balance at January 1, 2021

    

Issued

 

4,477,612

Exercised

 

(3,508,227)

Balance at December 31, 2021

 

969,385

Share Buy-Back

On June 23, 2021, Alfi announced a $2.0 million buy-back of its Common Stock. The buy-back was completed on July 9, 2021, with Alfi acquiring 137,650 shares of Common Stock, for an aggregate price of $1,999,997, which are recorded as treasury stock.

Employee Equity (Stock) Incentive Plan

The Company has stock equity incentive plan, the 2018 Plan, in which, at its sole discretion, it may award employees of the Company Common Stock or Common Stock options, among other awards as an incentive for performance (the “Plan”). Total shares of Common Stock reserved under the plan for employee grants is not to exceed 1,575,029 shares.

Stock compensation expense recorded for options for the years ended December 31, 2021, 2020, and 2019 was  $384,495, $51,279, and $ -0-, respectively. Unrecognized costs related to non-vested options at December 31, 2021, 2020, and 2019 was $322,238, $706,733, and $ -0-, respectively, and will be recognized over remaining vesting periods which terminate on or before June 2025.

The following table summarizes stock option activity for the years ended December 31, 2019, 2020, and 2021.

Weighted-Average 

Weighted-Average 

Remaining Contractual

Total Options

    

Exercise Price

    

 Life (Years)

Outstanding at December 31, 2018

 

59,064

$

0.80

 

9.8

Granted

 

 

 

Exercised

 

 

 

Canceled

 

 

 

Outstanding at December 31, 2019

 

59,064

$

0.80

 

8.8

Vested and exercisable at December 31, 2019

 

38,713

$

0.80

 

8.8

Vested and unvested at December 31, 2019

 

59,064

$

0.80

 

8.8

Outstanding at December 31, 2019

 

59,064

$

0.80

 

8.8

Granted

 

177,195

$

1.22

 

9.4

Exercised

 

 

 

Canceled

 

 

 

Outstanding at December 31, 2020

 

236,259

$

1.12

 

9.0

Vested and exercisable at December 31, 2020

 

116,576

$

0.96

 

8.7

Vested and unvested at December 31, 2020

 

236,259

$

1.12

 

9.0

Outstanding at December 31, 2020

 

236,259

$

1.12

 

9.0

Granted

 

449,168

$

2.74

 

9.4

Exercised

 

(11,892)

$

0.80

 

7.3

Canceled

 

(218,061)

$

2.03

 

8.6

Outstanding at December 31, 2021

 

455,474

$

2.29

 

9.1

Vested and exercisable at December 31, 2021

 

293,519

$

2.31

 

9.0

Vested and unvested at December 31, 2021

 

455,474

$

2.29

 

9.1

Stock option and warrant valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from an index of historical stock prices for comparable entities. For warrants and stock options issued to non- employees, the Company accounts for the expected life

49

Table of Contents

based on the contractual life of the warrants and stock options. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options.

Options granted during 2020 had exercise prices of $1.00 and $2.00 and were valued at $0.73 and $1.45 per share. Options granted during 2021 had exercise prices of $2.00 and $3.33 and were valued at $1.45 and $2.42 per share. The assumptions used in the Black-Scholes option pricing model to determine the fair value of options granted during the years ended December 31, 2021 and 2020 were as follows:

Expected volatility

    

65%

Dividend yield

 

0%

Risk-free interest rate

 

2.00%

Expected term in years

 

10

NOTE 10 PROPERTY AND EQUIPMENT

Property and equipment, net of accumulated depreciation, consists of the following:

December 31, 

    

2021

    

2020

    

2019

Tablets

$

5,314,005

$

972,050

$

Office furniture and fixtures

 

349,672

 

191,261

 

136,215

Property and equipment, gross

 

5,663,677

 

1,163,311

 

136,215

Less accumulated depreciation

 

(1,631,773)

 

(657,017)

 

(28,471)

Property and equipment, net

$

4,031,904

$

506,294

$

107,744

Depreciation expense for the years ended December 31, 2021, 2020, and 2019 was $974,758, $628,546, and $25,450, respectively.

Property and equipment includes approximately 27,000 Lenovo tablet hardware devices including approximately 7,600 tablets placed with rideshare and other businesses. Tablets are provided to rideshare and other businesses at no charge, but remain the property of the Company and must be returned to the Company upon termination of the rideshare or other use agreement. The Company may pay a revenue share or commission to such third party for the placement of the Alfi-enabled device.

NOTE 11 INTANGIBLE ASSETS – INTELLECTUAL PROPERTY

Intellectual Property – Software Development and Patent Acquisition Costs

The Company’s intellectual property includes capitalized software development and patent acquisition costs associated with creation of its technology (see Note 1). During the period between the Company’s formation in 2018 through June 2020, the Company created and developed the proprietary software that is the basis of its ability to deliver targeted digital advertising. The Company considers this software to be internal-use software, as it is used exclusively by the Company on devices it controls to deliver the advertising services it is engaged to provide. The Company determined that the application development phase for this software began in May 2018 and ended in June 2020, and its first release of production software was activated in a tablet in July 2020.

On July 1, 2020 forward, the Company commenced depreciation of these intangible assets. The Company estimated a 5-year useful life for capitalized software development costs and a 15-year useful life for patent acquisition costs. Management selected a 5-year useful life for software development costs as an expectation of the length of time the Company expects its technology product set to produce future cash flows assuming that there are no significant software or version upgrades. All software development costs incurred beyond June 30, 2020 are being expensed.

50

Table of Contents

Intangible assets, net of accumulated amortization, consists of the following:

December 31, 

    

2021

    

2020

    

2019

Capitalized software

$

832,045

$

832,045

$

592,863

Patents

 

144,239

 

144,239

 

75,693

Intangible assets, gross

 

976,284

 

976,284

 

668,556

Less accumulated amortization

 

(264,037)

 

(88,013)

 

Intangible assets, net

$

712,247

$

888,271

$

668,556

Amortization expense for the years ended December 31, 2021, 2020, and 2019 was $176,024, $88,013, and $-0-, respectively.

Future amortization of intangible assets as of December 31, 2021, is as follows:

2022

    

$

176,025

2023

 

176,025

2024

 

176,025

2025

 

92,820

2026

 

9,616

Thereafter

 

81,736

$

712,247

NOTE 12 CHANGES IN MANAGEMENT

Replacement of Executive Officers, Board Members, and Independent Accountants

As previously disclosed in the Company’s filings with the SEC on October 22, 2021, the Board placed each of Paul Pereira, the Company’s then President and Chief Executive Officer, Dennis McIntosh, the Company’s then Chief Financial Officer and Treasurer, and Charles Pereira, the Company’s then Chief Technology Officer, on paid administrative leave and authorized an Investigation into certain corporate transactions and other matters.

Also as previously disclosed, since placing the former executives on leave, the Board has appointed: (i) James Lee as Chairman of the Board, replacing Mr. P. Pereira in such role; (ii) new management personnel, including Peter Bordes as Interim Chief Executive Officer, Louis Almerini as Interim Chief Financial Officer and David Gardner as Chief Technology Officer; (iii) two new independent directors to the Board, Allen Capsuto and Patrick Dolan; and (iv) Mr. Capsuto as Chair of the Audit Committee and Mr. Dolan as a member of the Compensation Committee and the Nominating and Corporate Governance Committee. Furthermore, Mr. P. Pereira resigned as a director and from all positions he held with the Company, Mr. McIntosh resigned from all positions he held with the Company, and Mr. C. Pereira’s employment with the Company was terminated.

Findings of the Investigation

The Investigation was conducted by a special committee of the Board (the “Special Committee”) consisting of Mr. Capsuto, the Audit Committee Chair, who was appointed to the Special Committee on November 8, 2021. The Special Committee retained outside legal counsel to assist in conducting the Investigation, and such counsel retained additional advisors to provide forensic accounting services, computer forensics and e-discovery services and other legal services.

51

Table of Contents

The Investigation found, among other things, that the Company’s former senior management caused the Company to enter into certain transactions and certain agreements that were not approved by the Board, some of which included the unauthorized issuance of shares of Common Stock, as follows:

The Company’s former senior management caused the Company to purchase a condominium in Miami Beach, Florida for a purchase price of approximately $1.1 million without the Board’s knowledge or approval. After the conclusion of the Investigation, the Company sold the condominium for a price of $1.1 million on April 15, 2022. Net proceeds after commissions and other expenses of the sale were approximately $990,000.
The Company’s former senior management caused the Company to enter into an agreement to sponsor a sports tournament for two years, for a $640,000 sponsorship fee, which the Company paid $320,000 in cash and $320,000 through the issuance of 31,683 shares of Common Stock, without the Board’s knowledge or approval. The Company has since obtained, in connection with the Company’s termination of the sponsorship agreement, the return of the 31,683 shares of Common Stock. In addition, of the $320,000 in cash paid by the Company, $295,000 was converted to a charitable contribution and the remaining $25,000 was retained by the tournament organizer.
The Company’s former senior management caused the Company to enter into agreements with three vendors: (i) an investor relations firm to provide investor relations and strategic consulting services and capital introductions; (ii) a consultant to provide financial and business advice; and (iii) a start-up call center to provide customer service, sales, and onboarding services. Pursuant to these agreements, cash payments totaling approximately $1,200,000 were made to these vendors and 300,000 shares of Common Stock were issued to them without the Board’s knowledge or approval.

These findings and other conduct by the Company’s former senior management were previously disclosed in the Company’s Current Report on Form 8-K filed on February 23, 2022.

The Investigation found the Company’s internal control over financial reporting to be deficient with respect to: (i) the disbursement process for third-party vendors; (ii) the review and approval process for significant vendor contracts; (iii) the use of Company credit cards by executives; (iv) the supervision and approval of travel and entertainment expenses incurred by executives; (v) the segregation of duties in connection with the payment and recording of invoices and related bank reconciliations; (vi) the lack of a sufficient accounting manual; and (vii) guidelines for the capitalization of fixed assets.

NOTE 13 SUBSEQUENT EVENTS

Credit and Security Agreement – Related Party

On April 12, 2022, the Company entered into a Credit and Security Agreement (the “Credit Agreement”) with a related party lender. Pursuant to the agreement, the Company may borrow up to $2,500,000 for up to one year. Through May 10, 2022, the lender has funded to the Company $1,000,000 under the Credit Agreement. Prior to the maturity date, the Company may borrow an additional $1.5 million under the Credit Agreement, in the lender’s sole discretion and subject to the Company requesting such additional funds from the lender in accordance with the Credit Agreement, the accuracy of the Company’s representations in the Credit Agreement and related documents, and that no default under the Credit Agreement has occurred and is continuing.

The line of credit note matures on the earlier of (i) the date upon which the Company consummates a debt or equity financing in an amount equal to or greater than $4,000,000 or (ii) April 12, 2023. Borrowings under the Credit Agreement are collateralized by a security interest in the Company’s assets. Interest on the unpaid principal amount accrues an annual rate of 6% through October 12, 2022 and an annual rate of 9% thereafter, except that in event of default additional penalty interest at an annual rate of 3% will accrue on borrowings through October 12, 2022. In connection with the Credit Agreement, the Company issued a warrant to the lender pursuant to which the lender may purchase up to 1,250,000 shares of the Common Stock at a price of $1.51 per share. The warrant can be exercised commencing on the three-month anniversary of the Credit Agreement (i.e., on July 12, 2022) and expires on April 12, 2025.

52

Table of Contents

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Disclosure regarding our changes in accountants was provided in our: (i) Current Report on Form 8-K filed with the SEC on November 1, 2021, and amended by Amendment No. 1 thereto, filed with the SEC on November 2, 2021; and (ii) Current Report on Form 8-K filed with the SEC on December 30, 2021.

ITEM 9A.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

Our Interim Chief Executive Officer and Interim Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) as of December 31, 2021, the end of our fiscal year. In designing and evaluating the Company’s disclosure controls and procedures, management recognizes that disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives, and the Company necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

Our management, with the participation of our Interim Chief Executive Officer and Interim Chief Financial Officer, who serve as our principal executive officer and principal financial and accounting officer, respectively, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2021. Based on such evaluation, our Interim Chief Executive Officer and Interim Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of December 31, 2021. See Note 4 to the consolidated financial statements included elsewhere in this Annual Report relating to the Company’s restatement of Prior Period Financial Statements.

In light of the conclusion that our internal disclosure controls are ineffective as of December 31, 2021, we have applied procedures and processes as necessary to ensure the reliability of our financial reporting in regard to this Annual Report. Accordingly, the Company believes, based on its knowledge, that: (i) this Annual Report does not contain any untrue statement of a material fact or omit a material fact; and (ii) the financial statements, and other financial information included in this Annual Report, fairly present in all material respects our financial condition, results of operations and cash flows as of and for the periods presented in this Annual Report.

Internal Control Over Financial Reporting

Management’s Report on Internal Control Over Financial Reporting

This Annual Report does not include a report of management’s assessment regarding internal control over financial reporting due to a transition period established by rules of the SEC for newly public companies.

As noted in Note 4 to the consolidated financial statements included in this Annual Report, the Company concluded that the Prior Period Financial Statements should no longer be relied upon and should be restated. As such, management believes a material weakness exists in its internal controls over financial reporting as of December 31, 2021. The Company does not have a sufficient complement of personnel commensurate with the accounting and reporting requirements of a public company. The material weaknesses identified relate to inadequate controls that address segregation of certain accounting duties and reconciliation and analysis of certain key accounts. We have concluded that these material weaknesses arose because, as a pre-revenue private company recently formed, we did not have the necessary personnel to design effective components of internal control, including risk assessment control activities information/communication and monitoring to satisfy the accounting and financial reporting requirements of a public company.

53

Table of Contents

Remediation Efforts to Address Material Weaknesses

Management will seek to remediate the material weaknesses described above through hiring additional qualified accounting and financial reporting personnel, and designing and implementing financial reporting systems, processes, policies and internal controls.

Attestation Report of Independent Registered Public Accounting Firm

We are a "non-accelerated filer” as defined by Rule 12b-2 of the Exchange Act, and as such, we are not required to provide an attestation report on the Company’s internal control over financial reporting.

Changes in Internal Control Over Financial Reporting

Except as disclosed in Note 4 to the consolidated financial statements included elsewhere in this Annual Report, there have been no changes in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.OTHER INFORMATION

On May 13, 2022, upon approval and recommendation of the Compensation Committee, the Board approved the following director compensation:

For Board service during the second and third quarters of 2021, each of Peter Bordes, Frank Smith and Allison Ficken shall receive: (i) a restricted stock award of 5,000 shares of Common Stock, to be issued pursuant to the 2018 Plan on the Specified Grant Date (defined below), which shall be fully vested upon such date; and (ii) $6,000 in cash per quarter.
For Board service during the fourth quarter of 2021 and the first quarter of 2022, each of Peter Bordes, Allen Capsuto, Patrick Dolan, James Lee, Frank Smith and Allison Ficken shall receive: (i) $10,000 in cash for each such quarter (with such amounts for Messrs. Capsuto and Dolan for 2021 prorated proportionately to reflect their appointment as directors on November 1, 2022); and (ii) a restricted stock award of 25,000 shares of Common Stock, to be issued pursuant to the 2018 Plan on the Specified Grant Date, which shall be fully vested on such date.
Commencing with the second quarter of 2022, each non-employee director shall receive for Board service $10,000 in cash per quarter.
Commencing with the first quarter of 2022, each committee chair shall receive for committee service additional cash compensation as follows: Audit Committee Chair ($10,000 per quarter), Compensation Committee Chair ($2,500 per quarter), and Nominating and Corporate Governance Committee Chair ($2,500 per quarter).
Also commencing with the first quarter of 2022, each non-employee director shall receive a $500 meeting fee in cash for each Board or committee meeting attended.
Commencing the fourth quarter of 2022, each non-employee director shall receive a restricted stock award of 6,250 shares of Common Stock per quarter, to be issued pursuant to the 2018 Plan, which shall be fully vested on the date of grant.

The Company may defer the payment of any cash compensation to be paid to the directors for the fourth quarter 2021 and the first, second and third quarters of 2022 in the discretion of the Compensation Committee, based on the recommendation of our Chief Executive Officer and Chief Financial Officer; provided that such payments shall be made no later than December 31, 2022.

Also on May 13, 2022, upon approval and recommendation of the Compensation Committee, the Board approved a restricted stock award to Ronald Spears, our Chief Revenue Officer, of 25,000 shares of Common Stock to be issued pursuant to the 2018 Plan on the Specified Grant Date, which shall vest on the six-month anniversary of such date. For our compensation arrangements with Mr. Spears, see Part III, Item 11. “Executive Compensation” in this Annual Report.

54

Table of Contents

“Specified Grant Date” means the second business day following the first date on which the Company has filed this Annual Report, the Company’s Quarterly Reports for each of the quarters ended September 30, 2021 and March 31, 2022, and amendments to each of the Company’s Quarterly Reports for each of the quarters ended March 31, 2021 and June 30, 2021.

ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION

Not applicable.

55

Table of Contents

PART III

ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information About Executive Officers and Directors

The following table sets forth certain information with respect to our executive officers and directors.

Name

    

Age

    

Position

Peter Bordes

 

59

 

Interim Chief Executive Officer and Director

Louis Almerini

 

63

 

Interim Chief Financial Officer

David M. Gardner

 

47

 

Chief Technology Officer

John M. Cook, II

 

52

 

Chief Business Development Officer

Ronald Spears

 

49

 

Chief Revenue Officer

James Lee

 

63

 

Chairman of the Board

Allen Capsuto(1)

 

69

 

Director

Patrick Dolan(2)(3

 

59

 

Director

Allison Ficken(1)(2)(3)

 

61

 

Director

Frank Smith(1)(2)(3)

 

56

 

Director

(1)Member of the Audit Committee
(2)Member of the Nominating and Corporate Governance Committee
(3)Member of the Compensation Committee

Directors serve a term until our next annual meeting of stockholders. The terms of our current directors will expire at our next annual meeting of stockholders. Executive officers serve at the discretion of the Board, subject to any applicable employment or consulting agreement. See Part III, Item 11. “Executive Compensation” in this Annual Report for more information.

Executive Officers

Peter Bordes. Mr. Bordes has served as the Company’s Interim Chief Executive Officer since October 22, 2021 and as a director since March 2021. From February 2021 to the present, Mr. Bordes has been employed as the Executive Chairman and Chief Executive Officer of Trajectory Alpha Acquisition Corp. (NYSE:TCOA.U), a SPAC, or blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or companies. From May 15, 2019 to October 31, 2020, Mr. Bordes was Chief Executive Officer of Kubient, Inc. (Nasdaq:KBNT), a cloud advertising platform with artificial intelligence ad fraud prevention, that he led from a private company through an initial public offering, and he has served on Kubient’s Board of Directors since May 15, 2019. From January 2011 to June 2019, Mr. Bordes acted as the Founder and Chief Executive Officer of OneQube, Inc., a digital Audience Management Platform, which enables its customers to develop, manage and market to custom digital audiences. Mr. Bordes continue to serve as Chairman of the Board of OneQube, Inc. From June 2004 to August 2011, Mr. Bordes was a Co-Founder and Chief Executive Officer of MediaTrust, a real-time performance marketing advertising exchange for direct response marketing. From November 2018 to June 2019, Mr. Bordes acted as the Chairman and Co-Founder of MainBloq, a cloud-based modular Full Stack Execution Management platform for trading digital currencies and investing in digital assets. From January 2017 to June 2019, Mr. Bordes worked as the Co-Founder and Director of TruVest a sustainable affordable housing, real estate investment, development and technology company. Mr. Bordes’ current board service includes seats on the Board of Directors of Beasley Broadcast Group (Nasdaq: BBGI), Brooklyn School of Music, New England College, Fraud.net, Hoo.be, Ocearch and RevTrax. Mr. Bordes holds a Bachelor of Arts from New England College. We believe Mr. Bordes vast experience with technology companies and in helping guide them through multiple stages of growth, as well as his experience as a public company director, qualifies him to serve on the Board.

56

Table of Contents

Louis A. Almerini. Mr. Almerini has served as the Company’s Interim Chief Financial Officer since November 8, 2021. Mr. Almerini has been the Managing Member of Louis Almerini CPA, LLC, which provides outsourced CFO, FINOP, accounting and related consulting services to clients directly or under contract as an independent contractor with CFO Partners, since 2016. In this capacity, Mr. Almerini has served as Chief Financial Officer or Chief Compliance Officer for several registered broker-dealers, investment advisers and other companies. From 2011 to 2016, Mr. Almerini served as Managing Director, Finance at PineBridge Investments, a registered investment adviser. From 1980 to early 2011, Mr. Almerini served in various senior finance roles with Kellogg Capital Markets (Chief Financial Officer), Merrill Lynch (First Vice President), Morgan Stanley (Principal) and PwC (Manager). Mr. Almerini is a Certified Public Accountant (New York), a Registered Principal (Series 27 FINOP) with FINRA, and graduated magna cum laude from Georgetown University.

John M. Cook, II. Mr. Cook has served as the Company’s Chief Business Development Officer since October 2020. Prior to that, Mr. Cook served as the Company’s Chief Financial Officer from April 2018 until October 2020. Mr. Cook is a Wall Street veteran with over 24 years of experience and expertise in Investment Banking, Capital Markets, and Commercial banking both domestic and abroad. From July 2005 to March 2018, Mr. Cook served as Senior Portfolio Manager for a Private Family Office with a primary investment focus on U.S. Capital Markets. Prior to that, Mr. Cook served as an Investment Banker and Financial Consultant gaining vast experience in the Investment Banking and Capital Markets space with respect to publicly traded companies. Mr. Cook attended Five Towns College.

David M. Gardner. Mr. Gardner served as the Company’s Chief Technology Officer since October 27, 2021 and as the Company’s Vice President of Technology from October 4, 2021 through October 27, 2021. From April 2019 through September 2021, Mr. Gardner served as a Director-level Architect at Lenovo Group Limited, a multinational technology company specializing in designing, manufacturing and marketing consumer electronics, personal computers, software, business solutions and related services. At Lenovo, Mr. Gardner had global responsibility for Lenovo’s Digital Transformation Office, including leading efforts to design, deploy and modernize global sales and marketing architecture and processes, and he provided architecture oversight with the Enterprise Architecture Team and data system architecture, modeling and governance processes support. From May 2015 to April 2019, Mr. Gardner served as a Senior Director, Client Partner and Global Architect at The Sogeti Group, the Technology and Engineering Services Division of Capgemini. Sogeti is an information technology consulting company specializing in local professional services. At Sogeti, Mr. Gardner oversaw the activities of the digital transformation and software development and cloud practices, handled both technical and business client relationships, and was responsible for building and growing various accounts.

Ronald Spears. Mr. Spears has served as the Company’s Chief Revenue Officer since March 6, 2021. Mr. Spears has led sales and operations teams for nearly 20 years, building and managing large and emerging, high-growth advertising technology sales organizations. Prior to joining the Company, Mr. Spears was Senior Vice President, Head of US Sales, for Firefly, a Google Ventures backed ad tech start-up specializing in targeted digital advertising through a mobile network of 4,000 GPS-enabled and Internet connected Hi-Res Smart Screens atop rideshare vehicles in the top 8 US markets. Mr. Spears was promoted to lead the national sales organization after having successfully become the leading regional revenue producer in 2019. Mr. Spears has also held roles at Modern Luxury Media, the largest publisher of luxury lifestyle magazines and websites in the US; Vector Media, OOH and Digital Out-of-Home leader and the largest Transit advertising network in the US; and Tribune Publishing, a leader in print, online, mobile, and social news gathering. Mr. Spears earned his Bachelor of Journalism, Advertising from the University of Missouri, Columbia.

Directors

Allen Capsuto. Mr. Capsuto has served as a director of the Company since November 1, 2021. Mr. Capsuto has served as a Managing Director of Everest Group International, LLC, which provides stakeholder services in the areas of Professional Advisory, Mergers and Acquisitions, since 2015. He is also the founder and principal of Capsuto Consulting LLC, which provides consulting services for high net worth individuals. From 2002 to 2007, Mr. Capsuto served as Executive Vice President and CFO of Magnatrax Corporation, a provider of custom-engineered metal building systems for the North American nonresidential construction market. He has served on the Board of Directors of QualServ Corporation (Chairman), Champion Homes (Audit Chair), CCLM Holdings (Chairman), Euramax (Compensation Committee), Magnatrx China JV-steel company, EquipMD (Chairman) and as the sole Trustee of the Magnatrax Shareholders Liquidity Trust. Mr. Capsuto received his BS in Computer Science and Math from the University of Illinois - Chicago and his MBA from Roosevelt University. We believe that Mr. Capsuto’s financial expertise qualifies him to serve on the Board.

57

Table of Contents

Patrick Dolan. Mr. Dolan has served as a director of the Company since November 1, 2021. Mr. Dolan is the former President and COO of the Interactive Advertising Bureau (“IAB”), an advertising business organization that develops industry standards, conducts research and provides legal support for the online advertising industry. Mr. Dolan was with IAB for 13 years, from 2007 through January 2021. During this time, he founded its Data Council and Data Center of Excellence, co-founded its Video and Mobile Centers of Excellence and was a founding executive board member of the IAB Tech Lab. He helped expand the Digital Content NewFronts and establish the IAB Podcast Upfront’s and IAB’s Digital Sales Certification Program. Currently, Mr. Dolan is providing advising and consulting services. Mr. Dolan received his BA in economics from the University of Virginia and his MBA from Virginia Commonwealth University. We believe Mr. Dolan’s experience in the digital media industry, and his understanding of the relevant trade association environment, qualifies him to serve on the Board

Allison Ficken. Allison Ficken has served as a director of the Company since November 2020. Ms. Ficken has been a partner at the law firm of Dovin Ficken LLC since January 2015. Ms. Ficken practices primarily in the areas of commercial arbitration, securities litigation/arbitration, and business litigation. Ms. Ficken earned her Bachelor of Science from Wake Forest University with honors. Ms. Ficken earned her Juris Doctor, with honors, from the University of Georgia School of Law. We believe Ms. Ficken’s knowledge of securities laws and business experience qualifies her to serve on the Board.

James Lee. James Lee has served as Chairman of the Board since October 22, 2021 and a director of the Company since July 2018. Mr. Lee has been the founder, President and Chief Executive Officer of Lee Aerospace, Inc., a transparency manufacturer for the aerospace industry since 1987. Mr. Lee has diversified Lee Aerospace to include the manufacturing of full-fuselage builds, and complex composite parts, details, and assemblies. In addition, Lee Aerospace has expanded its position in the market through strategic investments and partnerships both inside and outside the aviation industry. With a passion for aviation at an early age, Mr. Lee graduated from Spartan School of Aeronautics. In addition, as a multi-engine instrument pilot, he has accumulated over 5,000 hours. We believe Mr. Lee’s experience growing and running a company qualifies him to serve on the Board.

Frank Smith. Frank Smith has served as a director of the Company since November 2020. Mr. Smith is an attorney and has run his own law firm FMS Lawyer PL since 2010. Mr. Smith’s areas of practice include civil, administrative, and criminal litigation, as well as legal services related to contracts, corporate governance, compliance, insurance, employment and human resources issues, real estate, financing, mergers and acquisitions and the creation and protection of intellectual property. With over 27 years of legal experience, Mr. Smith has served as an attorney in Florida where he has helped clients resolve multi-year intra-family corporate governance disputes, successfully win millions of dollars for clients in breach of contract disputes, as well as general corporate counseling for his clients. Mr. Smith earned his Bachelor of Arts from Franklin and Marshall College. Mr. Smith earned his Juris Doctor from Hofstra University School of Law. We believe Mr. Smith’s experience in providing a broad range of legal services to businesses qualifies him to serve on the Board.

Involvement in Certain Legal Proceedings

On September 3, 2002, the SEC issued a release (SEC Admin Release 34-46447) in reference to Mr. Cook. On December 12, 2001, the SEC filed a complaint in the United States District Court for the Southern District of Florida, Case No. 01-7874, alleging, among other things, that Mr. Cook violated the registration, antifraud, and broker-dealer registration provisions of the federal securities laws by selling unregistered securities and by offering and selling the securities in exchange for sales commissions without the knowledge or approval of the registered broker-dealers which he was associated with and by continuing to offer and sell the securities when he was no longer associated with the registered broker-dealer. On March 28, 2002, a final judgment was entered permanently enjoining Mr. Cook from violating Sections 5(a), 5(c), and 17(a) of the Securities Act and Sections 10(b) and 15(a) of the Exchange Act and Rule 10b-5 thereunder. Mr. Cook consented to the entry of the final judgment without admitting or denying the allegations contained in the SEC’s complaint. In addition, on July 2, 2003, Mr. Cook was barred from association with any NASD member firm in any capacity for violating certain NASD procedural and conduct rules by failing to appear at an on-the–record interview scheduled by the NASD. This decision became final on July 30, 2003.

Family Relationships

There are no family relationships among any of our executive officers or directors.

58

Table of Contents

Committees of the Board

The Board has established an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. The Compensation Committee and Nominating and Corporate Governance Committee began service on January 1, 2021. The composition and responsibilities of each committee of the Board directors are described below. Members serve on these committees until their resignation or until otherwise determined by the Board. The Board may establish other committees as it deems necessary or appropriate from time to time.

Although each committee is directly responsible for evaluating certain enumerated risks and overseeing the management of such risks, the entire Board is generally responsible for and is regularly informed through committee reports about such risks and any corresponding remediation efforts designed to mitigate such risks. This enables the Board and its committees to coordinate the risk oversight role.

Audit Committee. The Company has a separately designated Audit Committee which was established in accordance with Section 3(e)(58)(A) of the Exchange Act. The members of the Audit Committee are Mr. Capsuto, Ms. Ficken and Mr. Smith, each of whom is “independent” as independence for Audit Committee members is defined in the applicable rules of Nasdaq and the rules of the SEC. The Board has designated Mr. Capsuto as Chairman of the Audit Committee and has determined that Mr. Capsuto is an “audit committee financial expert” as defined by Item 407 of Regulation S-K of the Exchange Act.

The Audit Committee’s main function is to oversee the Company’s accounting and financial reporting processes, internal systems of control, independent registered public accounting firm relationships and the audits of the Company’s financial statements. The Audit Committee’s responsibilities include, among other things:

Approve and retain the independent auditors to conduct the annual audit of the Company’s financial statements;
Review the proposed scope and results of the audit;
Review accounting and financial controls with the independent auditors and the Company’s financial and accounting staff;
Review and approve transactions between the Company and the Company’s director, officer and affiliates;
Recognize and prevent prohibited non-audit services;
Establish procedures for complaints received by us regarding accounting matters; and
Oversee internal audit functions, if any.

All audit and non-audit services, other than de minimis non-audit services, to be provided to us by the Company’s independent registered public accounting firm must be approved in advance by the Audit Committee.

The Audit Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq and which is available on our website at www.getALFI.com.

Compensation Committee. The members of the Compensation Committee are Mr. Dolan, Mr. Smith, and Ms. Ficken, who chairs the Compensation Committee. The primary purpose of the Compensation Committee is to discharge the responsibilities of the Board in overseeing our compensation policies, plans and programs and to review and determine the compensation to be paid to our executive officers, directors and other senior management, as appropriate. Specific responsibilities of the Compensation Committee include, among other things:

Review and determine the compensation arrangements for management;
Establish and review general compensation policies with the objective to attract and retain superior talent, to reward individual performance and to achieve our financial goals;

59

Table of Contents

Administer our stock incentive and purchase plans;
Oversee the evaluation of the Board and management; and
Review the independence of any compensation advisers engaged by the Compensation Committee.

Each member of the Compensation Committee is a non-employee director, as defined in Rule 16b-3 promulgated under the Exchange Act and an outside director, as defined pursuant to Section 162(m) of the Internal Revenue Code of 1986, as amended, or the “Code.”

With respect to director compensation, the Compensation Committee is responsible for reviewing the compensation paid to members of the Board and recommending modifications to Board compensation that the Compensation Committee determines are appropriate and advisable to the Board for its approval from time to time. In this regard, the Compensation Committee may request that management report to the Compensation Committee periodically on the status of the Board’s compensation in relation to other similarly situated companies.

The Compensation Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq and which is available on our website at www.getALFI.com.

Nominating and Corporate Governance Committee. The members of the Nominating and Corporate Governance Committee are Mr. Dolan, Ms. Ficken and Mr. Smith, who chairs the committee. The Nominating and Corporate Governance Committee’s responsibilities include, among other things:

Identifying and evaluating candidates to serve on the Board, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, and nominees to fill Board vacancies;
Considering and making recommendations to the Board regarding the composition and chairmanship of the committees of the Board;
Developing and recommending to the Board’s corporate governance principles, codes of conduct and compliance mechanisms; and
Overseeing periodic evaluations of the Board’s performance, including committees of the Board.

The Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq and which is available on our website at www.getALFI.com.

Director Nomination Process

With respect to our director nomination process, the Nominating and Corporate Governance Committee reviews the composition and size of the Board and evaluates its expertise and independence; determines the qualifications, qualities, skills, expertise and other criteria for service as a Board member; establishes criteria for qualifications as independent directors, consistent with applicable laws and listing standards; and reviews Board candidates recommended by stockholders in compliance with all director nomination procedures for stockholders. The Nominating and Corporate Governance Committee makes a recommendation to the full Board as to any person it believes should be nominated by the Board to serve as a director, and the Board determines the nominees after considering the recommendation of the Nominating and Corporate Governance Committee.

The Nominating and Corporate Governance Committee and the Board will evaluate candidates for election to the Board based on a variety of factors, including their financial literacy, business acumen and experience, independence, skills and willingness, ability and availability for service, all in the context of our needs and the needs of the Board. This may include consideration of factors such as: (i) whether the potential nominee has leadership, strategic or policy-setting experience; (ii) whether the potential nominee has experience and expertise that is relevant to our business, including any specialized business experience, technical expertise or industry expertise, and whether the potential nominee has knowledge regarding issues affecting us; (iii) the ability or willingness of the potential nominee to devote sufficient time to the Board’s activities and to enhance his or her understanding of our business; (iv) the professional experience, education, skill and other qualities or attributes of the potential nominee that together contribute to the functioning of the Board.

60

Table of Contents

The Nominating and Corporate Governance Committee has not adopted a formal policy with regard to the consideration of diversity in identifying director nominees. In determining whether to recommend a director nominee, the Nominating and Corporate Governance Committee consider diversity, with a view toward the role and needs of the Board as a whole. The Nominating and Corporate Governance Committee generally view diversity expansively to include, without limitation, concepts such as race, gender, national origin, differences of viewpoint and perspective, professional experience, education, skill and other qualities or attributes that together contribute to the functioning of the Board.

The Nominating and Corporate Governance Committee will consider nominees to the Board recommended by stockholders of record who have given timely written notice to our Corporate Secretary in accordance with Section 2.12 of our By-laws. To be timely, a proposing stockholder’s notice for:

an annual meeting of stockholders must be delivered to our Corporate Secretary at our principal executive offices not later than the close of business on the 90th day, nor earlier than the close of business on the 120th day, in advance of the anniversary of the previous year’s annual meeting if such meeting is to be held on a day not more than 30 days in advance of, or not later than 60 days after, the anniversary of the previous year’s annual meeting, and for any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year, not earlier than the close of business on the 120th day prior to the annual meeting and not later than the close of business on the later of: (i) the 90th day prior to the annual meeting and (ii) the close of business on the tenth day following the first date of public disclosure of the date of such meeting; and
a special meeting of stockholders, called by us for the purpose of electing one or more directors to the Board, must be delivered to our Corporate Secretary at our the principal executive offices not earlier than the close of business on the 120th day prior to such special meeting and not later than the close of business on the later of: (i) the 90th day prior to such special meeting; or (ii) the tenth day following the date of the first public disclosure of the date of the special meeting and of the nominees proposed by the Board to be elected at such meeting.

The proposing stockholder’s notice to our Corporate Secretary must set forth the information required by Section 2.12 of our By-laws, including, among other things: (i) with respect to the director nominee, his or her name, age, business address, residence address, principal occupation or employment; a statement of the shares of capital stock of the Company which are owned of record and beneficially by such nominee; all information relating to the nominee as would be required to be disclosed in a proxy statement; a written questionnaire with respect to background and qualifications; his or her consent to be considered as a director nominee; and certain other representations and agreements; and (ii) with respect to the proposing stockholder, the name and address of the proposing stockholder as they appear on the Company’s books and of the beneficial owner, if any, on whose behalf the nomination is made, a statement of the shares of capital stock of the Company which are owned of record and beneficially by the proposing stockholder and owned by the beneficial owner, if any, on whose behalf the nomination is made; a description of any agreement or understanding regarding the nomination; and certain other representations and agreements.

There are no differences in the manner in which the Nominating and Corporate Governance Committee evaluates director candidates it identifies and candidates who are recommended for nomination for membership on the Board by a stockholder.

Delinquent Section 16(a) Reports

Based solely upon a review of Forms 3, Forms 4, and Forms 5 furnished to us pursuant to Rule 16a-3 under the Exchange Act, we believe that all such forms required to be filed pursuant to Section 16(a) of the Exchange Act since our IPO were timely filed, as necessary, by the officers, directors, and security holders required to file such forms, except that: (i) Mr. Spears did not file his Form 3 with respect to becoming an executive officer of the Company; (ii) Mr. Gardner did not file his Form 3 following his appointment as executive officer of the Company in October 2021; and (iii) James Lee and Lee Aerospace did not file timely a Form 4 with respect to the issuance of the warrant to purchase 1,250,000 shares of Common Stock issued to Lee Aerospace in connection with the Credit Agreement.

61

Table of Contents

Code of Business Conduct and Ethics

The Company has adopted a written Code of Business Conduct and Ethics that applies to the Company’s directors, officers and employees, including the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the Code of Business Conduct and Ethics is posted on the Corporate Governance section of the Company’s website, www.getALFI.com.

ITEM 11.EXECUTIVE COMPENSATION

As an emerging growth company under the JOBS Act, we have opted to comply with the executive compensation disclosure rules applicable to “smaller reporting companies” as such term is defined in the rules promulgated under the Securities Act, which permit us to limit reporting of executive compensation to: (i) all individuals serving as our principal executive officer during 2021; (ii) our two other most highly compensated executive officers serving as executive officers at the end of 2021; and (iii) up to two additional individuals for whom disclosure would have been provided under clause (ii) but for the fact that the individual was not serving as our executive officer at the end of 2021.

Summary Compensation Table

    

    

    

    

    

    

Non-Equity

    

    

Stock

Option

Incentive Plan

All Other

Name and Principal Position

    

Year

    

Salary

    

Bonus

    

Awards

    

Awards(1)

    

Compensation

    

Compensation

    

Total

Peter Bordes(2)

 

2021

$

50,000

 

 

 

 

$

28,000

(3)

$

78,000

Interim Chief Executive

 

2020

 

 

 

 

 

 

 

Paul Antonio Pereira(4)

 

2021

$

278,000

 

 

 

 

 

$

278,000

Former President and Chief Executive Officer

 

2020

$

168,000

 

 

 

 

 

$

168,000

John M. Cook, II

 

2021

$

215,500

 

 

 

 

 

$

215,500

Chief Business Development Officer

 

2020

$

168,000

 

 

 

 

 

$

168,000

Ronald Spears(5)

 

2021

 

 

 

$

91,422

(6)

$

135,000

(7)

$

226,422

Chief Revenue Officer

 

2020

 

 

 

 

 

 

 

Dennis McIntosh(8)

 

2021

$

234,434

 

 

 

 

 

$

234,434

Former Chief Financial Officer

 

2020

 

 

 

$

57,139

(9)

 

$

57,139

(1)For the valuation assumptions underlying the awards, see Note 9 to our consolidated financial statements included in this Annual Report.
(2)Mr. Bordes commenced serving as our Interim Chief Executive Officer on October 22, 2022.
(3)Represents director compensation earned by or paid to Mr. Bordes in 2021.
(4)Mr. Pereira served as our President and Chief Executive Officer until October 22, 2022, when the Board placed him on paid administrative leave.
(5)Mr. Spears commenced serving as our Chief Revenue Officer on March 6, 2021.
(6)Represents an option to purchase 63,001 shares of Common Stock, granted on March 15, 2021, at an exercise price of $2.00 per share, which vested as to 15,751 shares on March 1, 2022, and vests as to 1,313 shares per month for each of the following 36 months, and expires March 15, 2031.
(7)Represents $45,000 in consulting fees paid under Mr. Spears’s consulting agreement with us and $90,000 which we have accrued, but not yet paid, in respect of his services to us since the expiration of his consulting agreement and through December 31, 2021. Such accrual has been calculated based upon the amount of the monthly consulting fee set forth in his consulting agreement. See “- Narrative to Summary Compensation Table – Employment, Consulting and Resignation Agreements – Ronald Spears.”
(8)Mr. McIntosh served as our Chief Financial Officer until October 22, 2022, when the Board placed him on paid administrative leave.
(9)Represents an option to purchase 39,376 shares of Common Stock, granted on October 1, 2020, at an exercise price of $2.00 per share, which vested as to 9,844 shares on October 1, 2021, and vests as to 821 shares per month for each of the following 36 months, and expires October 1, 2030. The option terminated on May 3, 2022 pursuant to its terms due to Mr. McIntosh terminating his employment with us on February 2, 2022.

62

Table of Contents

Narrative to Summary Compensation Table

Executive Compensation Considerations

The Compensation Committee reviews financial information and other metrics relative to the compensation of executive management. The Compensation Committee also considers management’s recommendations for compensation levels of our named executive officers. The totality of the information reviewed by the Compensation Committee is considered when establishing current executive salary levels, and similar analysis is expected to be considered when reviewing and establishing future salaries and long-term incentives. Our compensation policies and practices are designed to ensure that they do not foster risk taking above the level of risk associated with our business model. Our compensation programs are aimed at enabling us to attract and retain executive talent and rewarding those executives commensurate with their ability and performance. Our compensation program for 2021 and 2020 consisted primarily of base salary. Salary guidelines are established by comparing the responsibilities of the individual’s position in relation to similar positions in other companies of similar size in our industry.

Employment, Consulting and Resignation Agreements

Peter Bordes. Mr. Bordes has served as our Interim Chief Executive Officer since October 22, 2021. For his service in this capacity, we pay Mr. Bordes an annual salary of $300,000. We have not entered into an employment agreement with Mr. Bordes. Mr. Bordes is also eligible for equity awards.

John M. Cook, II. On February 10, 2021, we entered into an employment agreement with Mr. Cook to continue in his current role for a three-year period. Mr. Cook receives a base pay of $225,000. Mr. Cook is eligible for discretionary bonuses at the Board’s discretion with a target amount equal to 30% of base salary. Mr. Cook is also eligible for equity awards and to participate in our other benefit plans. In the event that more than 50% of the Common Stock is acquired by a third party, any unvested options shall vest immediately.

63

Table of Contents

In the event Mr. Cook terminates his employment for Good Reason (as defined below), he will be entitled to six months of his then existing annual base salary. If Mr. Cook remains in compliance with the noncompete obligations under his employment agreement and has actively sought other employment and has been unable to find alternative employment, we will pay an additional six months of severance. To the extent we desire to terminate Mr. Cook without Cause (as defined below), we would be obligated to pay base salary for the balance of the term of his employment agreement.

Mr. Cook’s employment agreement includes confidentiality, non-competition, non-solicitation and non-disparagement covenants. The confidentiality covenants apply during the term of the employment agreement and at all times thereafter. The non-competition covenant applies during the term of the employment agreement and for six months following termination of employment. The non-solicitation covenant applies during the term of the employment agreement and for two years following termination of employment. The non-disparagement covenant is mutual and applies at all times during employment and thereafter. Mr. Cook’s employment agreement does not prohibit us from waiving a breach of a restrictive covenant.

For purposes of Mr. Cook’s employment agreement:

“Cause” is defined (as determined by us) as: (i) the breach by the executive of any fiduciary duty to the Company; (ii) the breach by the executive of any provision of the employment agreement, provided that if such failure is capable of cure in the determination of the Company, the executive is given written notice of any such failure, which notice shall specify in reasonable detail the nature of the failure to substantially perform, and employee fails to remedy the same within ten (10) days of receipt of such notice; (iii) the commission of an act constituting a felony in the jurisdiction in which committed; (iv) the commission of a criminal act of moral turpitude (whether or not a felony); (v) the commission of an act of embezzlement, misappropriation of money, fraud, theft, or bribery (whether or not a felony); (vi) illegal or controlled substance abuse or insobriety by the executive; (G) material negligence or dereliction by such person in the performance of his duties or failure to perform the executive’s duties, provided that if such failure is capable of cure in the determination of the Company, such person is given written notice of any such failure, which notice shall specify in reasonable detail the nature of the failure to substantially perform, and the executive fails to remedy the same within ten (10) days of receipt of such notice; (vii) the executive’s refusal or failure to carry out a lawful directive of the Company or any member of the Board or any of their respective designees, which directive is consistent with the scope and nature of the executive’s responsibilities; (viii) any conduct, action or behavior by such person that is, or is reasonably expected to be, materially damaging to the Company, whether to the business interests, finance or reputation. If on the date of termination facts and circumstances exist that would have justified a termination for Cause, even if such facts and circumstances are discovered after such termination, such termination shall be deemed to have been for Cause.
“Good Reason” means, material breach by the Company of its obligations under the employment agreement. In order for the executive to resign for Good Reason: (i) the Company must be notified by employee in writing within thirty (30) days of the event constituting such material breach; (ii) the event must remain uncorrected by the Company for thirty (30) days following such notice (the “Company Notice Period”); and (iii) if the Company fails to cure the same during the Company Notice Period. Notwithstanding the foregoing, a change of control as defined in the Company’s stock incentive plan shall constitute Good Reason.

Ronald Spears. On March 15, 2021, we entered into a consulting agreement with Mr. Spears for a term of 90 days. The consulting agreement provides Mr. Spears with a monthly fee of $15,000. The consulting agreement also provides Mr. Spears a 7% fee based on revenue generated from paid advertisement placed as a result of Mr. Spears’ effort and a 1% override fee on all call-center revenue invoiced and collected during the 90-day term. The consulting agreement provides that at the end of the 90-day term, Mr. Spears and management would discuss the potential continuation of the working relationship and the manner in which any such continuation would occur. While Mr. Spears has continued to serve as our Chief Revenue Officer since the expiration of the term of his consulting agreement, discussions regarding his compensation for such continued service are on-going and the terms of such compensation have not yet been finalized. On May 13, 2022, the Board approved, upon approval and recommendation of the Compensation Committee, a restricted stock award to Mr. Spears of 25,000 shares of Common Stock, to be issued pursuant to the 2018 Plan on the Specified Grant Date, which shall vest on the six month anniversary of the date of grant.

64

Table of Contents

Mr. Spears’ consulting agreement includes confidentiality and non-solicitation covenants. The confidentiality covenants apply during the term of the consulting agreement and at all times thereafter. The non-solicitation covenant applies during the term of the consulting agreement and for twelve months following termination or expiration of the consulting agreement. Mr. Spears’ consulting agreement does not prohibit us from waiving a breach of a restrictive covenant.

Paul Antonio Pereira and Dennis McIntosh. On October 22, 2021, the Board placed Paul Pereira, who was then serving as our Chief Executive Officer and President, and Dennis McIntosh, who was then serving as our Chief Financial Officer, on paid administrative leave.

On February 2, 2022, (i) Mr. Pereira resigned his position as a director of the Company and all other positions he held with the Company, and its subsidiaries and affiliates, effective as of February 2, 2022; and (ii) Mr. McIntosh resigned all positions he held with the Company, and its subsidiaries and affiliates, effective February 2, 2022. Each of Mr. Pereira and Mr. McIntosh agreed that his resignation constitutes termination by him of his employment with the Company.

In connection with his resignation, each of Mr. Pereira and Mr. McIntosh entered into a letter agreement with us pursuant to which he and we agreed that the following will constitute all of our obligations due to him in connection with his employment, or under his employment agreement, with us: (i) we paid to him his accrued but unpaid base salary through February 2, 2022; (ii) we will reimburse him for his monthly COBRA premium for a period of 18 months after February 2, 2022; and (iii) we will comply with (or continue to comply with) our existing obligations to him for indemnification, advancement, exculpation and hold harmless rights pursuant to our By-Laws, any applicable law and/or Section 6 of his employment agreement. We also entered into a limited release of claims with each of Mr. Pereira and Mr. McIntosh pursuant to which they released us and related parties from all claims which they have or may have against us or such parties under their employment agreements and/or for any other compensation or financial remuneration due to them in their capacities as employees of the Company.

Prior to Mr. Pereira’s and Mr. McIntosh’s resignation, each was employed by us under an employment agreement entered into on February 10, 2021. Under the applicable employments agreement, Mr. Pereira and Mr. McIntosh received annual base salary of $300,000 and $225,000, respectively, and were eligible for discretionary bonuses at the Board’s discretion with a target amount equal to 30% of base salary. Each was also eligible for stock awards and to participate in our other benefit plans. In the event that more than 50% of the Common Stock is acquired by a third party, any unvested options would vest immediately. The employment agreements with Mr. Pereira and Mr. McIntosh include the same confidentiality, non-competition, non-solicitation and non-disparagement covenants as are included in Mr. Cook’s employment agreement.

2018 Stock Incentive Plan

Under our 2018 Stock Incentive Plan, we may issue to eligible persons awards of Common Stock, non-qualified stock options, incentive stock options, stock appreciation rights, dividend equivalent rights, restricted stock and restricted stock units. The purposes of the 2018 Plan are to attract and retain the best available personnel, to provide additional incentive to employees, directors and consultants and to promote the success of our business.

Eligibility. Our employees, directors and consultants are eligible to receive awards under the 2018 Plan. However, only employees are eligible to receive awards of incentive stock options.

Administration. The 2018 Plan provides generally that it will be administered by the Board or a committee designated by the Board. The Party administering the 2018 Plan is referred to as the “administrator.” Under the charter of the Compensation Committee, it has the authority to administer our incentive compensation plans and equity-based plans. The Board has designated the Compensation Committee as the administrator of the 2018 Plan.

The administrator has the authority under the 2018 Plan, in its discretion and subject to the express terms of the 2018 Plan:

to select the employees, directors and consultants to whom awards may be granted from time to time;
to determine whether and to what extent awards are granted;
to approve forms of award agreements for use;

65

Table of Contents

to determine the terms and conditions of any award;
to establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable non-U.S. jurisdictions and to afford grantees favorable treatment under such rules or laws;
to amend the terms of any outstanding award granted under the 2018 Plan;
to construe and interpret the terms of the 2018 Plan and awards; and
to take such other action, not inconsistent with the terms of the 2018 Plan, as the administrator deems appropriate.

Shares Available for Awards. The maximum number of shares of Common Stock which may be issued pursuant to awards granted under the 2018 Plan is 1,575,029, subject to certain adjustments. As of December 31, 2021, there were outstanding under the 2018 Plan options to purchase 143,367 shares of Common Stock, with weighted average exercise price of $2.14 per share. As of December 31, 2021, 853,562 shares of Common Stock remain available for awards under the 2018 Plan. Shares issued under the 2018 Plan may be authorized but unissued, or reacquired shares of Common Stock.

If an award of shares under the 2018 Plan is forfeited, canceled or expired, whether voluntarily or involuntarily, any shares subject to such award will become or again be available for new grants under the 2018 Plan. Any award of shares that have actually been issued under the 2018 Plan and returned will not be available for future issuance under the 2018 Plan, except that if the if unvested shares are forfeited or repurchased by us, then such shares shall become available for future grant under the 2018 Plan. To the extent not prohibited by the listing requirements of Nasdaq and applicable law, any shares covered by an award which are surrendered (i) in payment of the award exercise or purchase price or (ii) in satisfaction of tax withholding obligations incident to the exercise of an award, shall be deemed not to have been issued for purposes of determining the maximum number of shares which may be issued pursuant to all awards under the 2018 Plan, unless otherwise determined by the administrator.

Award Limitations. The maximum term of each award shall be no more than ten (10) years from the date of grant; provided, that the maximum term of incentive stock options that are granted to holders of more than 10% of the Company’s voting securities shall be five years from the date of grant or such shorter time as provided in the award agreement.

The aggregate fair market value, determined at the time of the grant, of shares of the Common Stock with respect to incentive stock options that become exercisable for the first time by an optionee during any calendar year under all of our stock plans, may not exceed $100,000. The options or portions of options that exceed this limit are treated as nonstatutory stock options. Incentive stock options that are granted to holders of more than 10% of the Company’s voting securities are subject to certain additional restrictions, including a five-year maximum term and a minimum exercise price of 110% of fair market value.

The maximum number of shares with respect to which options and stock appreciation rights may be granted to any optionee in any calendar year shall be six hundred and twenty-five thousand (625,000) shares. In connection with a optionee’s commencement of continuous service, an optionee may be granted options and stock appreciation rights for up to an additional six hundred and twenty-five thousand (625,000) shares, with these limitations to be adjusted proportionately in connection with any change in the Company’s capitalization. To the extent required by Section 162(m) of the Code or the regulations thereunder, in applying the foregoing limitations with respect to a optionee, if any option or stock appreciation right is canceled, the canceled option or stock appreciation right shall continue to count against the maximum number of shares with respect to which options and stock appreciation rights may be granted to the grantee.

66

Table of Contents

Awards. The 2018 Plan provides for the awards of: (i) shares of Common Stock; (ii) options, including both incentive stock options, which can result in potentially favorable tax treatment to the optionee, and non-qualified stock options; (iii) stock appreciation rights, which entitle the grantee to shares or cash compensation, as established by the administration, measured by the appreciation in value of the Common Stock; (iv) restricted stock, which is an award of shares of Common Stock, for such consideration, if any, and subject to such restrictions on transfer, rights of first refusal, repurchase provisions, and forfeiture provisions, and other terms and conditions as established by the administrator; (v) restricted stock units, which is an award which may be earned in whole or in part upon the passage of time or the attainment of performance criteria established by the administrator and which may be settled for cash, shares or other securities, or a combination thereof, as established by the administrator; and (vi) dividend equivalent rights, which are rights entitling the grantee to compensation measured by dividends paid on the Common Stock. All awards under the 2018 Plan will be set forth in award agreements, which will detail the terms and conditions of the awards.

Subject to the terms of the 2018 Plan, the administrator shall determine the provisions, terms, and conditions of each award including, the vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, shares, or other consideration) upon settlement of the award, payment contingencies, and satisfaction of any performance criteria. The performance criteria established by the administrator may be based on any one of, or combination of, increase in share price, earnings per share, total stockholder return, return on equity, return on assets, return on investment, net operating income, cash flow, revenue, economic value added, personal management objectives, or other measure of performance selected by the administrator. Partial achievement of the specified criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the award agreement.

Award Exercise or Purchase Price and Consideration. The exercise or purchase price for an incentive stock option award granted to an employee will be not less than the fair market value per share on the date of the grant; if the employee owns shares representing more than 10% of the voting power of all classes of stock of the Company, the exercise or purchase price will be not less than 110% of the fair market value per share on the date of the grant. In the case of non-qualified stock options and awards intended to qualify as performance-based compensation, or the sale of shares, the per share exercise or purchase price shall be not less than the fair market value per share on the date of the grant. In the case of other awards under the 2018 Plan, the exercise or purchase price will be determined by the administrator. In the case of awards in settlement, assumption or substitution for outstanding awards or obligations to grant future awards in connection with an acquisition by the Company, the exercise or purchase price for the award will be determined in accordance with the relevant instrument evidence the agreement to issue that award.

The consideration to be paid for shares to be issued upon exercise or purchase of an award, including the method of payment, shall be determined by the administrator. The administrator is authorized to accept as consideration: (i) cash; (ii) check; (iii) delivery of the optionee’s promissory note with such provisions as the administrator determines is appropriate; (iv) surrender of shares or delivery of a properly executed form of attestation of ownership of shares which have a fair market value on the date of surrender or attestation equal to the aggregate exercise price of the shares as to which said award shall be exercised; (v) with respect to options, if the exercise occurs on or after the registration date, payment through a broker-dealer sale and remittance procedure pursuant to which the optionee (A) shall provide written instructions to a Company-designated brokerage firm to effect the immediate sale of some or all of the purchased shares and remit to us sufficient funds to cover the aggregate exercise price payable for the purchased shares and (B) shall provide written directives to us to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale transaction; (vi) with respect to options, payment through a “net exercise” such that, without the payment of any funds, the optionee may exercise the option and receive the net number of shares equal to (A) the number of shares as to which the option is being exercised, multiplied by (B) a fraction, the numerator of which is the fair market value per share (on such date as is determined by the administrator) less the exercise price per share, and the denominator of which is such fair market value per share; or (vii) any combination of the foregoing methods of payment.

The administrator may at any time or from time to time grant awards which do not permit all of the foregoing forms of consideration to be used in payment for the shares or which otherwise restrict one or more forms of consideration.

67

Table of Contents

Adjustments. Subject to any required action by our stockholders, (i) the number of shares covered by each outstanding award, (ii) the number of shares which have been authorized for issuance under the 2018 Plan but as to which no awards have yet been granted or which have been returned to the 2018 Plan, (iii) the exercise or purchase price of each such outstanding award, (iv) the maximum number of shares with respect to which options and stock appreciation rights may be granted to any optionee in any calendar year, and (v) any other terms that the administrator determines require adjustment, will be proportionately adjusted for:

any change in the number of issued shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of shares, or similar transaction affecting the shares;
any other change in the number of issued shares effected without receipt of consideration by us; or
as the administrator may determine, any other transaction with respect to the Common Stock including a corporate merger, consolidation, acquisition of property or stock, separation, reorganization, liquidation or any similar transaction.

In the event of any distribution of cash or other assets to stockholders other than a normal cash dividend, the Compensation Committee may make adjustments in connection with the events described in (i)-(iii) above or substitute, exchange or grant awards with respect to the shares of a parent or subsidiary of the Company.

In determining such adjustments to be made, the administrator may take into account appropriate factors such as applicable law, potential taxes or accounting consequences and potential unintended benefits, and in light of such factors make adjustments that are not uniform or proportionate among outstanding awards, modify vesting dates, defer the delivery of stock certificates or make other equitable adjustments. The administrator may prohibit the exercise of awards during certain time periods. Adjustments, and any interpretations or determinations thereof, are made by the administrator and such determinations are final.

Termination of Continuous Service. In the event of termination of a grantee’s continuous service for any reason other than disability or death, the grantee may, during the post-termination exercise period (defined below) but no later than the expiration date set forth in the award agreement, exercise the portion of the award that was vested at the date of termination or such other portion of the award as the administrator may determine. An award agreement may provide that, if terminated for cause, the grantee’s right to exercise the award terminates concurrently with the termination of the grantee’s continuous service. To the extent that the grantee’s award was unvested at termination, or if the grantee does not exercise the vested portion within a post-termination exercise period, the award will terminate. Under the 2018 Plan, “post-termination exercise period” means the earlier conclusion of either: (i) the term of the option stated in the award agreement; or (ii) the period specified in the award agreement of not less than thirty (30) days commencing on the date of termination of the optionee’s continuous service (other than termination by the Company for cause), or such longer period as may be applicable upon death or disability.

Corporate Transactions and Change in Control. All outstanding awards under the 2018 Plan will terminate, effective upon the consummation of a corporate transaction such as a merger, reverse merger, acquisition, consolidation, or sale or disposition of all or substantially all of our assets, except to the extent they are assumed in connection with such a corporate transaction.

The administrator may provide for the full or partial automatic vesting and exercisability of outstanding unvested awards and the release from restrictions on transfer and repurchase or forfeiture rights of such awards in connection with such a corporate transaction or a change in control of us. The administrator may also condition any such award vesting and exercisability or release from limitations upon the subsequent termination of the continuous service of the grantee within a specified period after such corporation transaction or a change in control of us.

Any incentive stock option accelerated in connection with such a corporation transaction or change in control will remain exercisable as an incentive stock option under the Code only to the extent it does not exceed the $100,000 limitation of Section 422(d) of the Code.

Amendment, Suspension and Termination. The Board may at any time amend, suspend or terminate the 2018 Plan. To the extent necessary to comply with applicable laws or rules of any applicable stock exchange, we shall obtain stockholder approval of any amendment in such a manner and to such a degree as required. During any suspension or after termination, no award may be granted, but no rights under awards already granted will be adversely affected by suspension or termination.

The administrator has the authority, in its discretion, to amend the terms of any outstanding award granted under the 2018 Plan, provided that any amendment that would adversely affect the optionee’s rights under an outstanding award shall not be made without the optionee’s written consent, and provided that an amendment or modification that may cause an incentive stock option to become a non-qualified stock option shall not be treated as adversely affecting the rights of the optionee.

68

Table of Contents

Outstanding Equity Awards at 2021 Fiscal Year End

The following table provides information with respect to holdings of unvested options held by our named executive officers at December 31, 2021. Our named executive officers did not hold any unvested stock awards at December 31, 2021.

Option Awards

    

Number of Securities

    

Number of Securities

    

    

 Underlying Unexercised

 Underlying Unexercised

Name

  

 Option (#) Exercisable

  

 Option (#) Unexercisable

  

Option Exercise Price

  

Option Expiration Date

Peter Bordes
Interim Chief Executive Officer

 

 

 

 

Paul Antonio Pereira
Former President and Chief Executive Officer

 

 

 

 

John M. Cook, II
Chief Business Development Officer

 

 

 

 

Ronald Spears
Chief Revenue Officer

 

63,001

(1)

$

2.00

 

3/15/3031

Dennis McIntosh
Former Chief Financial Officer

 

11,486

(2)

27,890

$

2.00

 

10/1/2030

(1)Represents an option which vested as to 15,751 shares on March 15, 2022 and vests as to 1,313 shares per month for each of the following 36 months.
(2)Represents an option which vests as to 821 shares per month. The option terminated on May 3, 2022 pursuant to its terms due to Mr. McIntosh terminating his employment with us on February 2, 2022.

Director Compensation

The following table shows the compensation earned by directors during the year ended December 31, 2021:

    

    

    

    

    

Change in 

    

    

Pension Value 

and 

Fees 

Non-Equity 

Nonqualified 

Earned or 

Incentive 

Deferred 

Paid in 

Stock 

Option 

Plan 

Compensation 

All Other 

Name(1)

Cash

Awards

Awards

Compensation

Earnings

Compensation

Total

Allen Capsuto

$

106,667

(2)

$

106,667

Patrick Dolan

$

6,667

$

6,667

Allison Ficken

$

22,000

$

22,000

James Lee

$

10,000

$

10,000

Frank Smith

$

22,000

$

22,000

Richard Mowser(3)

$

9,000

$

9,000

(1)Compensation earned by or paid to Mr. Bordes for his service as a director is reported in the Other Compensation column of the Summary Compensation Table above. No compensation was earned or paid to Mr. Paul Pereira for his service as a director in 2021, and he resigned from the Board on February 2, 2022.
(2)Includes $100,000 paid to Mr. Capsuto for his service on, and in his capacity as a member of, the Special Committee, which compensation was approved by the Board, upon approval and recommendation of the Compensation Committee, on December 29, 2021.
(3)Mr. Mowser resigned from the Board on October 27, 2021.

On May 13, 2022, upon approval and recommendation of the Compensation Committee, the Board approved the following director compensation:

69

Table of Contents

For Board service during the second and third quarters of 2021, each of Messrs. Bordes and Smith and Ms. Ficken shall receive: (i) a restricted stock award of 5,000 shares of Common Stock, to be issued pursuant to the 2018 Plan on the Specified Grant Date, which shall be fully vested upon such date; and (ii) $6,000 in cash per quarter.
For Board service during the fourth quarter of 2021 and the first quarter of 2022, each of Messrs. Bordes, Capsuto, Dolan, Lee and Smith and Ms. Ficken shall receive: (i) $10,000 in cash for each such quarter (with such amounts for Messrs. Capsuto and Dolan for 2021 prorated proportionately to reflect their appointment as directors on November 1, 2022); and (ii) a restricted stock award of 25,000 shares of Common Stock, to be issued pursuant to the 2018 Plan on the Specified Grant Date, which shall be fully vested on such date.
Commencing with the second quarter of 2022, each non-employee director shall receive for Board service $10,000 in cash per quarter.
Commencing with the first quarter of 2022, each committee chair shall receive for committee service additional cash compensation as follows: Audit Committee Chair ($10,000 per quarter), Compensation Committee Chair ($2,500 per quarter), and Nominating and Corporate Governance Committee Chair ($2,500 per quarter).
Also commencing with the first quarter of 2022, each non-employee director shall receive a $500 meeting fee in cash for each Board or committee meeting attended.
Commencing the fourth quarter of 2022, each non-employee director shall receive a restricted stock award of 6,250 shares of Common Stock per quarter, to be issued pursuant to the 2018 Plan, which shall be fully vested on the date of grant.

The Company may defer the payment of any cash compensation to be paid to the directors for the fourth quarter 2021 and the first, second and third quarters of 2022 in the discretion of the Compensation Committee, based on the recommendation of our Chief Executive Officer and Chief Financial Officer; provided that such payments shall be made no later than December 31, 2022.

Compensation Committee Interlocks and Insider Participation

Not applicable to smaller reporting companies.

Compensation Committee Report

Not applicable to smaller reporting companies.

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Beneficial Ownership of Common Stock

The following table furnishes information, as of April 30, 2022, as to shares of Common Stock beneficially owned by: (i) each person or entity known to us to be the beneficial owner of more than 5% of the Common Stock; (ii) each of our directors and our named executive officers identified in Part III, Item 11, “Executive Compensation – Summary Compensation Table” in this Annual Report; and (iii) our directors and executive officers as a group.

70

Table of Contents

We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting of securities, or to dispose or direct the disposition of securities. A security holder is also deemed to be, as of any date, the beneficial owner of all securities that such security holder has the right to acquire within 60 days after such date through: (i) the exercise of any option or warrant; (ii) the conversion of a security; (iii) the power to revoke a trust, discretionary account or similar arrangement; or (iv) the automatic termination of a trust, discretionary account or similar arrangement. Except as disclosed in the footnotes to this table and subject to applicable community property laws, we believe that each person identified in the table has sole voting and investment power over all of the shares shown opposite such person’s name.

As of April 30, 2022, there were 16,094,882 shares of Common Stock outstanding.

    

Number of 

    

Shares of 

Common 

Percent of 

Stock 

Outstanding 

Beneficially 

Common 

Name of Beneficial Owner (1)

Owned

Stock

Executive Officers and Directors:

  

  

Peter Bordes

31,501

(2)

*

Louis Almerini

John M. Cook, II

1,417,526

8.8

%  

Ronald Spears

19,690

(3)

*

Allen Capsuto

 

 

 

Patrick Dolan

 

 

 

Allison Ficken

 

 

 

James Lee

 

5,597,079

(4)

32.3

%

Frank Smith

 

 

 

All Executive Officers and Directors as a Group (10 persons)

 

7,065,796

 

40.7

%  

Other 5% Stockholders

 

  

 

  

 

Lee Aerospace, Inc.

 

5,597,079

(4)

32.3

%

Other Named Executive Officers:

 

  

  

  

 

Paul Antonio Pereira

 

1,764,032

(5)

11.0

%

Dennis McIntosh

 

63,002

(6)

*

 

*

Less than one percent.

(1)The address for each of our directors and executive officers is c/o Alfi, Inc., 429 Lenox Avenue, Miami Beach, Florida 33139.
(2)Represents shares of Common Stock held by Trajectory Capital, LLC, over which Mr. Bordes has voting and dispositive power.
(3)Represents shares Mr.Spears has the right to acquire within 60 days after April 30, 2022 pursuant to an option with an exercise price of $2.00 per share which expires on March 15, 2031.
(4)Includes 4,347,079 shares of Common Stock and a warrant to purchase 1,250,000 shares of Common Stock, which is exerciseable from July 12, 2022 through April 12, 2025, at an exercise price of $1.51 per share. The shares of Common Stock and the warrant are held of record by Lee Aerospace, 9323 E. 34th St., Wichita, Kansas 67226. Mr. Lee is the founder, president and chairman of Lee Aerospace. Mr. Lee disclaims beneficial ownership of these shares.
(5)Includes 63,001 shares which are owned directly by Mr. Pereira’s spouse. The information for Mr. Pereira is based on the Schedule 13D filed by Mr. Pereira on May 7, 2021. Mr. Pereira has sole voting and dispositive power with respect to 1,701,031 shares of Common Stock. Mr. Pereira may be deemed to have shared voting and/or dispositive power with respect to 63,001 shares of Common Stock owned directly by his spouse. Mr. Pereira expressly disclaims beneficial ownership of the shares of Common Stock directly owned by his spouse by virtue of his inability to exercise voting or investment power over such shares.
(6)Based on ownership information as of April 30, 2022 provided by the Company’s transfer agent.

71

Table of Contents

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Policies and Procedures for Related Party Transactions

Prior to our IPO, the Board reviewed and approved transactions with directors, officers and holders of 5% or more of our voting securities and their affiliates, each a related party. Pursuant to this unwritten policy, the material facts as to the related party’s relationship or interest in the transaction were disclosed to the Board prior to its consideration of such transaction, and the transaction was not considered approved by the Board unless a majority of the directors who were not interested in the transaction approved the transaction. Further, if our stockholders were entitled to vote on a transaction with a related party, then the material facts of the related party’s relationship or interest in the transaction would be disclosed to the stockholders, who must approve the transaction in good faith.

In connection with our IPO, we adopted a written related party transactions policy, which became effective on the date on which the registration statement relating to our IPO was declared effective by the SEC. Pursuant to this policy, the Audit Committee has the primary responsibility for reviewing and approving or disapproving “related person transactions,” which are transactions in which (i) the Company was, is or will be a participant; (ii) the aggregate amount involved exceeds or may be expected to exceed $120,000; and (iii) a related person had, has or will have a direct or indirect material interest. For purposes of this policy, a related person is defined as a director, executive officer, nominee for director, or greater than 5% beneficial owner of the Common Stock, in each case since the beginning of the most recently completed year, and their immediate family members.

If a related person proposes to enter into a related person transaction, the related person must report the proposed related person transaction to our General Counsel or Chief Financial Officer. The policy calls for the facts and circumstance of the proposed related person transaction to be referred to the Audit Committee Chair to assess whether the proposed transaction requires approval under related person transaction policies and procedures. The policy also provides that if our Chief Financial Officer or Chief Executive Officer determines that a proposed transaction requires approval, the proposed transaction will be submitted for consideration and approval: (i) to the Board if the related person transaction is directly related or integral to a transaction for which Board approval will be obtained; (ii) to the Audit Committee for all other related person transactions for consideration at its next committee meeting; or (iii) in those instances in which the Audit Committee Chair, in consultation with our Chief Executive Officer, determines that it is not practicable or desirable for the Company to wait until the next Audit Committee meeting, to the Audit Committee Chair.

A related person transaction reviewed under the policy will be considered approved or ratified if it is authorized by the Board, the Audit Committee, or the Audit Committee Chair, as applicable, after full disclosure of the related person’s interest in the transaction. As appropriate for the circumstances, the Audit Committee will review and consider:

the related person’s interest in the related person transaction;
the approximate dollar value of the amount involved in the related person transaction, particularly as it relates to the related person;
whether the transaction was undertaken in the ordinary course of our business;
the impact on a director’s independence in the event the related person is a director, an immediate family member of a director or an entity in which a director is a partner, stockholder, or executive officer;
whether the terms of the transaction are no less favorable to us than terms that could have been reached with an unrelated third party;
the availability of other sources to us for comparable products or services; and
the purpose of, and the potential benefits to us of, the transaction.

No director shall participate in any review, consideration, or approval of any related person transaction with respect to which such member or any of his or her immediate family members is the related person.

72

Table of Contents

In the event our Chief Executive Officer, Chief Financial Officer, General Counsel or Chair of the Nominating and Governance Committee becomes aware of a related person transaction that has not been previously approved or previously ratified: (i) if the transaction is pending or ongoing, it will be submitted to the Audit Committee or Audit Committee Chair promptly, and the Audit Committee or Audit Committee Chair shall consider all of the relevant facts and circumstances available to the Audit Committee or the Audit Committee Chair. Based on the conclusions reached, the Audit Committee or the Audit Committee Chair shall evaluate all options, including, but not limited to, the ratification, amendment or termination of the related person transaction; and (ii) if the transaction is completed, the Audit Committee or Audit Committee Chair shall evaluate the transaction, taking into account the same factors described above, to determine if any changes to the transaction, including, but not limited to, rescission of the transaction, are appropriate, and shall request that the Audit Committee Chair evaluate our controls and procedures to ascertain the reason the transaction was not submitted to the Audit Committee or Audit Committee Chair for prior approval and whether any changes to these procedures are recommended.

The Audit Committee has determined that the types of related person transactions described below are deemed pre-approved by the Audit Committee:

Any employment or employment contract by us of an executive officer of the Company if: (i) the related compensation is required to be reported in our proxy statement; and (ii) the executive officer is not an immediate family member of another executive officer or director of the Company, the related compensation would be reported in the Company’s proxy statement if the executive officer was a “named executive officer”, and the Compensation Committee or the Board approved the compensation.
Any compensation paid to a director if the compensation is required to be reported in our proxy statement and is approved by the Compensation Committee.
Any transaction with another company at which a related person’s only relationship is as an employee (other than an officer), director or beneficial owner of less than 10% of that company’s shares, if the aggregate amount involved does not exceed the greater of $1,000,000, or 2% of that company’s total annual revenues.
Any charitable contribution, grant or endowment by us to a charitable organization, foundation or university at which a related person’s only relationship is as an employee (other than an executive officer) or a director, which has been approved pursuant to our Charitable Contribution Policy, if any, if the aggregate amount involved does not exceed the greater of $1,000,000, or 2% of that charitable organization’s total annual receipts.
Any transaction where the related person’s interest arises solely from the ownership of the Common Stock and all holders of the Common Stock received the same benefit on a pro rata basis.
Any transaction involving a related person where the rates or charges involved are determined by competitive bids.
Any transaction with a related person involving services as a bank depository of funds, transfer agent, registrar, trustee under a trust indenture, or similar services.
Indemnification and advancement of expenses to any related person made pursuant to the Company’s Charter or By-laws or pursuant to any agreement.

Related Party Transactions

Other than the compensation agreements and other arrangements described under Part II., Item 11. “Executive Compensation” and the transactions described below, since January 1, 2021, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, the lesser of (i) $120,000 or (ii) 1% of the average of our total assets for the last two completed fiscal years, and in which any director, executive officer, holder of 5% or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest.

73

Table of Contents

Credit and Security Agreement. On April 12, 2022, we entered into a Credit Agreement with Lee Aerospace, a corporation controlled by James Lee, one of our Board members and a stockholder, as lender. Pursuant to the Credit Agreement, the lender has made available to us until the maturity date a non-revolving line of credit, up to an aggregate principal amount of $2,500,000, on the terms and conditions set forth in the Credit Agreement. Through May 10, 2022, the lender has funded to the Company $1,000,000 under the Credit Agreement. Prior to the maturity date, we may borrow an additional $1.5 million under the Credit Agreement, in the lender’s sole discretion and subject to us requesting such additional funds from the lender in accordance with the Credit Agreement, the accuracy of our representations in the Credit Agreement and related documents, and that no default under the Credit Agreement has occurred and is continuing.

The entire outstanding principal amount borrowed under the Credit Agreement, together with all accrued and unpaid interest on such borrowings outstanding from time to time, is due and payable on the earlier of: (i) the date upon which we consummate a debt or equity financing in an amount equal to or greater than $4,000,000 or (ii) April 12, 2023. Interest on the unpaid principal amount borrowed under the Credit Agreement accrues at an annual rate of 6% through October 12, 2022, and at an annual rate of 9% thereafter; provided, however, that upon the occurrence of an event of default, additional interest at an annual rate of 3% will accrue on all borrowings through October 12, 2022. All or part of the outstanding principal amount borrowed under the Credit Agreement may be prepaid at any time without penalty or premium, provided that such prepayments must be accompanied by the payment of all interest accrued on the amount so prepaid through the date of prepayment. The principal amount so prepaid may not be reborrowed under the terms of the Credit Agreement.

All of our obligations under the Credit Agreement and all related documents are secured by a first lien on substantially all of our assets. In connection with and as contemplated by the Credit Agreement, we also executed a Non-Revolving Line of Credit Note, a Patent Security Agreement and a Trademark Security Agreement in favor of the lender, each containing customary terms and conditions for a transaction of the size and type contemplated by the Credit Agreement.

In addition, in connection with the Credit Agreement and as a required condition thereof, on April 12, 2022 we issued to the lender a warrant to purchase up to 1,250,000 shares of the Common Stock at any time, or from time to time, on or after July 12, 2022 and prior to April 12, 2025, at an exercise price of $1.51 per share of Common Stock. The warrant may be exercised for cash or on a cashless basis, and the exercise price of the warrant is subject to anti-dilution adjustments for stock splits, stock dividends and similar corporate actions, but not for other dilutive equity issuances. The warrant also provides for certain “piggy back” registration rights to the lender if, at any time prior to the six-month anniversary of the expiration date, we determine to register on a new registration statement any shares of Common Stock for resale for the account of selling stockholders, subject to certain exceptions.

Secured Notes. During the year ended December 31, 2021 and immediately prior to our IPO, we had outstanding promissory notes to Lee Aerospace, a corporation controlled by James Lee, one of our Board members and a stockholder. The notes had an aggregate principal amount of $2.5 million and bore interest at the rate of 5.0% per year. The notes matured upon the closing of our IPO. The notes were secured by a pledge of shares by Paul Pereira, our former Chief Executive Officer, and John M. Cook II, our Chief Business Development Officer, and one note was also secured by a pledge of all of our intellectual property. On May 7, 2021, we used the net proceeds from our IPO to repay the amount outstanding on these notes which, including accrued interest, was approximately $2.66 million.

Tablets. Pursuant to a Letter Agreement dated March 19, 2020, Lee Aerospace advanced on the Company’s behalf 7,600 tablets from Lenovo Group Limited on which the Company could install Alfi software. Under the Letter Agreement, the Company had the right to acquire those tablets from Lee Aerospace at any time, or from time to time, upon payment of a purchase price of $125 per tablet. As of December 31, 2020, we completed the purchase of all 7,600 tables.

Bridge Loans. On December 30, 2020, we entered into a bridge loan agreement with Lee Aerospace (with respect to $1,700,000), Paul Pereira (with respect to $250,000), our former Chief Executive Officer, and Dennis McIntosh (with respect to $50,000), our former Chief Financial Officer, in an amount not to exceed an aggregate of $2,000,000 and an amount not less than $1,000,000; provided that any advances in excess of $1,000,000 would be at the discretion of the lenders. On March 22, 2021, we entered into a second bridge loan agreement to provide for an additional $250,000 with Lee Aerospace (with respect to $100,000), Paul Pereira (with respect to $100,000), our former Chief Executive Officer, and Rachael Pereira (with respect to $50,000), the wife of our former Chief Executive Officer. On April 1, 2021, we entered into a third bridge loan agreement to provide for an additional $500,000 with Lee Aerospace (with respect to $100,000), Paul Pereira (with respect to $100,000), our former Chief Executive Officer, Dennis McIntosh (with respect to $50,000), our former Chief Financial Officer, Charles Pereira (with respect to $50,000), our former Chief

74

Table of Contents

Technology Officer, Peter Bordes (with respect to $50,000), a director, Rachael Pereira (with respect to $50,000), the wife of our former Chief Executive Officer, and three unaffiliated investors (with respect to $100,000). Amounts were to be advanced as requested by us, subject to the satisfaction of customary conditions. Amounts outstanding under the bridge loans bore interest at the rate of 18.0% per year. The notes matured upon the closing of our IPO. In addition, the lenders received, on a pro rata basis, shares of Common Stock for each $2.00 advanced by the lenders (the “Lender Shares”). On May 7, 2021, we used net proceeds from our IPO to repay the amount outstanding on the bridge loans which, including accrued interest, was approximately $2.93 million. In addition, the lenders received an aggregate of 1,732,533 shares of Common Stock as follows: Lee Aerospace (1,197,021 shares), Paul Pereira (283,505 shares), Dennis McIntosh (63,002 shares), Rachel Pereira (63,001 shares), Charles Pereira (31,502 shares), Peter Bordes (31,501 shares), and three unrelated investors (63,001 shares).

The Lender Shares were subject to a one-year lock-up restriction following completion of our IPO. Thereafter, subject to Rule 144, the lenders may sell up to 25% of their shares at one-time and thereafter such shares may only be sold if the selling price is at least 110% of the price per share in our IPO and the number of shares sold in such sale, combined with any other sales by such lender, during a 30-day period, represents no more than 10% of the most recent 25-day average trading volume of the Company’s shares.

For a period of 36 months from the date such Lender Shares are issued to a lender, we have the right to acquire, with the lender’s consent and after compliance with securities laws, the Lender Shares at a purchase price of $4.00 per share.

In addition, the bridge loan agreements limit the ability of any lender to vote their shares if such shares, combined with other voting shares held by the lender would cause the lender to be able to vote more than 50% of the outstanding voting shares of the Company.

Director Independence

Applicable Nasdaq rules require a majority of a listed company’s board of directors to be comprised of independent directors within one (1) year of listing. In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent, and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act.

The Board has undertaken a review of the independence of each director. Based on information provided by each director concerning his or her background, employment and affiliations, the Board has determined that each of Allen Capsuto, Patrick Dolan, Allison Ficken and Frank Smith (four of the six of our directors) are independent, and do not have relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is “independent” as that term is defined under the listing standards of Nasdaq. In making such determination, the Board considered the relationships that each such non-employee director has with us and all other facts and circumstances that the Board deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each non-employee director.

75

Table of Contents

ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES

The following is a summary of the fees billed to us by Frazier & Deeter, LLC (“Frazier”) for professional accounting services rendered for the years ended December 31, 2021, 2020 and 2019. Frazier has served as our independent registered public accounting firm since December 27, 2021 and has been engaged to audit our consolidated financial statements for the years ended December 31, 2021, 2020 and 2019, included elsewhere in this Annual Report.

Fee Category

    

Fiscal 2021

    

Fiscal 2020

    

Fiscal 2019

Audit Fees(1)

$

135,000

$

125,000

$

100,000

Audit-related Fees(2)

 

50,000

 

 

Tax Fees

 

 

 

All Other Fees

 

 

 

Total Fees

$

185,000

$

125,000

$

100,000

(1)Audit fees consist of fees billed for services rendered for the audit of our financial statements and review of our financial statements included in our Quarterly Reports on Form 10–Q.
(2)Audit-related fees consist of fees billed for services rendered relating to restatement of Prior Period Financial Statements.

All audit and non-audit services, other than de minimis non-audit services, to be provided to us by our independent registered public accounting firm must be approved in advance by the Audit Committee.

76

Table of Contents

PART IV

ITEM 15.EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)1. Financial Statements

Included in Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report.

2. Financial Statement Schedules

Financial statement schedules are omitted because they are not required, are not material, are not applicable, or the required information is shown in the financial statements or notes thereto.

3. Exhibits

An “Exhibit Index” has been filed as part of this Annual Report beginning on the following page and is incorporated herein by reference.

The agreements included as exhibits to this Annual Report are included to provide information regarding the terms of these agreements and are not intended to provide any other factual or disclosure information about the Company or its subsidiaries, our business or the other parties to these agreements. These agreements may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:

should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
may apply standards of materiality in a way that is different from what may be viewed as material to our investors; and
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time, and should not be relied upon by investors.

77

Table of Contents

Exhibit Number

    

Description

    

Reference

3.1

Restated Certificate of Incorporation of Alfi, Inc., dated January 31, 2020

Incorporated by reference to Exhibit 3.1 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

3.2

Third Amended and Restated Certificate of Incorporation, effective May 3, 2021

Filed herewith.

3.3

Bylaws of Lectrefy, Inc.

Incorporated by reference to Exhibit 3.3 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

3.4

Amended and Restated By-laws

Filed herewith.

4.1

Form of Common Stock Certificate

Incorporated by reference to Exhibit 4.1 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

4.2

Form of Warrant Agent Agreement (including form of Series A Warrant) between Alfi, Inc. and VStock Transfer, LLC

Incorporated by reference to Exhibit 4.2 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

4.3

Form of Representative’s Warrant

Incorporated by reference to Exhibit 1.2 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

4.4

Warrant, dated April 12, 2022, issued by Alfi, Inc. to Lee Aerospace, Inc.

Incorporated by reference to Exhibit 99.3 to Alfi, Inc.’s Current Report on Form 8-K filed on April 18, 2022 (Commission File No. 001-40294).

4.5

Description of Registrant’s Securities

Filed herewith.

10.1*

Alfi, Inc. 2018 Stock Incentive Plan

Incorporated by reference to Exhibit 10.1 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.2

Agreement and Plan of Merger, dated July 11, 2018, between Lectrefy Inc., a Florida corporation, and Lectrefy Inc., a Delaware corporation

Incorporated by reference to Exhibit 10.2 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.3

Series Seed Stock Investment Agreement, dated August 1, 2018, among Lectrefy Inc., the Purchasers and the Key Holders

Incorporated by reference to Exhibit 10.3 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.4

Amendment No. 1 to Series Seed Stock Investment Agreement, dated October 31, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Incorporated by reference to Exhibit 10.4 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.5*

Executive Employment Agreement, dated February 10, 2021, between Alfi, Inc. and Paul Pereira

Incorporated by reference to Exhibit 10.5 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.6*

Executive Employment Agreement, dated February 10, 2021, between Alfi, Inc. and John Cook, III

Incorporated by reference to Exhibit 10.6 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.7*

Executive Employment Agreement, dated February 10, 2021, between Alfi, Inc. and Charles Pereira

Incorporated by reference to Exhibit 10.7 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.8*

Executive Employment Agreement, dated February 10, 2021, between Alfi, Inc. and Dennis McIntosh

Incorporated by reference to Exhibit 10.8 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.9

Promissory Note, dated January 15, 2019, between Lectrefy Inc. and Lee Aerospace, Inc.

Incorporated by reference to Exhibit 10.9 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.10

Security Agreement, dated January 15, 2020, between Lectrefy Inc. and Lee Aerospace, Inc.

Incorporated by reference to Exhibit 10.10 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.11

Bridge Loan Agreement, dated December 30, 2020, among Alfi, Inc., Lee Aerospace, Inc., Paul Antonio Pereira and Dennis McIntosh

Incorporated by reference to Exhibit 10.11 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

78

Table of Contents

10.12

Letter Agreement Related to Purchase of Lenovo Tablets, dated March 19, 2020, between Alfi, Inc. and Lee Aerospace, Inc.

Incorporated by reference to Exhibit 10.12 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.13

Bridge Loan Agreement, dated March 22, 2021, among Alfi, Inc., Lee Aerospace, Inc., Paul Antonio Pereira and Rachael Pereira

Incorporated by reference to Exhibit 10.13 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.14

Bridge Loan Agreement, dated April 1, 2021, among Alfi, Inc., Lee Aerospace, Inc., Paul Antonio Pereira, Peter Bordes, Dennis McIntosh, Rachael Pereira, Charles Pereira and FLBT, LLC

Incorporated by reference to Exhibit 10.14 to Alfi, Inc.’s Registration Statement on Form S-1, as amended (No. 333-251959).

10.15

Letter of Understanding, dated November 8, 2021, between Alfi, Inc. and CFO Financial Partners, LLC

Incorporated by reference to Exhibit 99.1 to Alfi, Inc.’s Current Report on Form 8-K filed on November 15, 2021 (Commission File No. 001-40294).

10.16*

Resignation Agreement, dated February 2, 2022, between Alfi, Inc. and Paul Pereira

Filed herewith.

10.17*

Limited Release of Claims, dated as of February 2, 2022, between Alfi, Inc. and Paul Pereira

Filed herewith.

10.18*

Resignation Agreement, dated February 2, 2022, between Alfi, Inc. and Dennis McIntosh

Filed herewith.

10.19*

Limited Release of Claims, dated as of February 2, 2022, between Alfi, Inc. and Dennis McIntosh

Filed herewith.

10.20

Credit and Security Agreement, dated April 12, 2022, between Alfi, Inc. and Lee Aerospace, Inc.

Incorporated by reference to Exhibit 99.1 to Alfi, Inc.’s Current Report on Form 8-K filed on April 18, 2022 (Commission File No. 001-40294).

10.21

Non-Revolving Line of Credit Note, dated April 12, 2022, made by Alfi, Inc. in favor of Lee Aerospace, Inc.

Incorporated by reference to Exhibit 99.2 to Alfi, Inc.’s Current Report on Form 8-K filed on April 18, 2022 (Commission File No. 001-40294).

10.22

Patent Security Agreement, dated April 12, 2022, made by Alfi, Inc. in favor of Lee Aerospace, Inc.

Incorporated by reference to Exhibit 99.4 to Alfi, Inc.’s Current Report on Form 8-K filed on April 18, 2022 (Commission File No. 001-40294).

10.23

Trademark Security Agreement, dated April 12, 2022, made by Alfi, Inc. in favor of Lee Aerospace, Inc.

Incorporated by reference to Exhibit 99.5 to Alfi, Inc.’s Current Report on Form 8-K filed on April 18, 2022 (Commission File No. 001-40294).

10.24*

Consulting Agreement, dated as of March 15, 2021, between Alfi, Inc. and Ronald Spears

Incorporated by reference to Exhibit 10.1 to Alfi, Inc.’s Current Report on Form 8-K filed on May 10, 2021 (Commission File No. 001-40294).

10.25*

Form of Incentive Stock Option Award Agreement (under the Alfi, Inc. 2018 Stock Incentive Plan)

Filed herewith.

10.26*

Stock Option Award Agreement, dated March 15, 2021, between Alfi, Inc. and Ronald Spears.

Filed herewith.

10.27

Promissory Note, dated August 8, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Filed herewith.

10.28

First Amended and Restated Promissory Note, dated September 20, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Filed herewith.

10.29

Promissory Note, dated October 25, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Filed herewith.

10.30

Promissory Note, dated November 12, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Filed herewith.

10.31

Promissory Note, dated November 26, 2019, between Lectrefy, Inc. and Lee Aerospace, Inc.

Filed herewith.

16.1

Letter from Friedman LLP, dated November 2, 2021

Incorporated by reference to Exhibit 16.1 to Alfi, Inc.’s Current Report on Form 8-K filed on November 2, 2021 (Commission File No. 001-40294).

21.1

Subsidiary of the Registrant

Filed herewith.

23.1

Consent of Frazier & Deeter LLC

Filed herewith.

31.1

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed herewith.

31.2

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed herewith.

79

Table of Contents

32.1

Certification of Principal Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Furnished herewith.

101.INS

Inline XBRL Instance Document

The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).

*Identifies a management contract or compensatory plan or arrangement.

ITEM 16.FORM 10-K SUMMARY

None.

80

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in Miami Beach, Florida, on May 16, 2022.

ALFI, INC.

By:

/s/ Peter Bordes

Peter Bordes

Interim Chief Executive Officer

(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

/s/ Peter Bordes

    

Interim Chief Executive Officer

    

May 16, 2022

Peter Bordes

(Principal Executive Officer) and Director

/s/ Louis Almerini

Interim Chief Financial Officer

May 16, 2022

Louis Almerini

(Principal Financial and Accounting Officer)

/s/ James Lee

Chairman of the Board

May 16, 2022

James Lee

/s/ Allen Capsuto

Director

May 16, 2022

Allen Capsuto

/s/ Patrick Dolan

Director

May 16, 2022

Patrick Dolan

/s/ Allison Ficken

Director

May 16, 2022

Allison Ficken

/s/ Frank Smith

Director

May 16, 2022

Frank Smith

81

Exhibit 3.2

Delaware

Page 1

The First State

I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF

DELAWARE, DO HEREBY CERTIFY THE ATTACHED ARE TRUE AND CORRECT

COPIES OF ALL DOCUMENTS FILED FROM AND INCLUDING THE RESTATED

CERTIFICATE OR A MERGER WITH A RESTATED CERTIFICATE ATTACHED

OF “ALFI, INC.” AS RECEIVED AND FILED IN THIS OFFICE.

THE FOLLOWING DOCUMENTS HAVE BEEN CERTIFIED:

RESTATED CERTIFICATE, FILED THE THIRD DAY OF MAY, A.D. 2021, AT 12:08

O`CLOCK P.M.

Graphic

Graphic

6964750 8100X

Authentication: 203103116

SR# 20221320278

Date: 04-05-22

You may verify this certificate online at corp.delaware.gov/authver.shtml


State of Delaware

Secretary of State

Division of Corporations

THIRD AMENDED AND RESTATED

Delivered 12:08 PM 05/03/2021

CERTIFICATE OF INCORPORATION

FILED 12:08 PM 05/03/2021

OF

SR 20211557482 - File Number 6964750

ALFI, INC.

Alfi, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows:

1.The name of the Corporation is Alfi, Inc. The date of the filing of Lectrefy Inc.’s original Certificate of Incorporation with the Secretary of State of the State of Delaware was July 6, 2018 (the “Original Certificate”).

2.The date of the filing of its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware was January 31, 2020 (the “Restated Certificate”) and changed its name to Alfi, Inc.

3.This Third Amended and Restated Certificate of Incorporation (the “Certificate”) amends and restates the Restated Certificate of Incorporation (the “Third Amended and Restated Certificate”), and was duly adopted in accordance with the provisions of Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware (the “DGCL”).

4.The text of the Third Amended and Restated Certificate is hereby amended and restated in its entirety to provide as herein set forth in full.

ARTICLE I

NAME OF THE CORPORATION

The name of the corporation is Alfi, Inc. (the “Corporation”).

ARTICLE II

REGISTERED AGENT

The address of the Corporation’s registered office in the State of Delaware is c/o Telos Legal Corp., 1300 South View Drive, #J-35 in the City of Dover, County of Kent, 19904. The name of its registered agent at such address is Telos Legal Corp.

ARTICLE III

BUSINESS PURPOSE

The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”).

ARTICLE IV

CAPITAL STOCK

Section 4.01. Authorized Classes of Stock. The total number of shares of stock of all classes of capital stock that the Corporation is authorized to issue is Eighty Eight Million (88,000,000), of which Eighty Million (80,000,000) shares shall be shares of common stock having a par value of $0.0001 per share (“Common Stock”) and Eight Million (8,000,000) shares shall be shares of preferred stock having a par value of $0.0001 per share (“Preferred Stock”).

Section 4.02. Common Stock. Except as otherwise required by law, as provided in this Certificate of Incorporation, and as otherwise provided in the resolution or resolutions, if any, adopted by the board of directors of the Corporation (the “Board of Directors”) with respect to any series of the Preferred Stock, the holders of the Common Stock shall exclusively possess all voting power. Each holder of shares of Common Stock shall be entitled to one vote for each share held by him. Subject to the rights of holders of any series of outstanding Preferred Stock,


Section 4.03. Preferred Stock. The Board of Directors is hereby authorized to provide, out of the unissued shares of Preferred Stock, for one or more series of Preferred Stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional, or other special rights, if any, and any qualifications, limitations, or restrictions thereof, of the shares of such series, as shall be stated in the resolution or resolutions providing for the issuance of such series adopted by the Board of Directors. The authority of the Board with respect to each series of Preferred Stock shall include, but not be limited to, determination of the following:

(a)the designation of the series;

(b)the number of shares of the series;

(c)the dividend rate or rates on the shares of that series, whether dividends will be cumulative, and if so, from which date or dates, and the relative rights of priority, if any, of payment of dividends on shares of that series;

(d)whether the series will have voting rights in addition to the voting rights provided by law, and, if so, the terms of such voting rights;

(e)whether the series will have conversion privileges, and, if so, the terms and conditions of such conversion, including provision for adjustment of the conversion rate in such events as the Board of Directors shall determine;

(f)whether or not the shares of that series shall be redeemable, in whole or in part, at the option of the Corporation or the holder thereof, and if made subject to such redemption, the terms and conditions of such redemption, including the date or dates upon or after which they shall be redeemable, and the amount per share payable in case of redemptions, which amount may vary under different conditions and at different redemption rates;

(g)the terms and amount of any sinking fund provided for the purchase or redemption of the shares of such series;

(h)the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution, or winding up of the Corporation, and the relative rights of priority, if any, of payment of shares of that series;

(i)the restrictions, if any, on the issue or reissue of any additional Preferred Stock; and

(j)any other relative rights, preferences, and limitations of that series.

ARTICLE V

BOARD OF DIRECTORS

Section 5.01. General Powers. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.

Section 5.02. Number of Directors; Term of Office. Subject to any rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the number of directors of the Corporation which shall constitute the entire Board of Directors shall as fixed from time to time solely by resolution of a majority of the total number of directors that the Corporation would have if there were no vacancies/in accordance with the by-laws of the Corporation (the “By-Laws”). The Directors shall serve a term until the next annual meeting of the stockholders. At each annual meeting of stockholders, Directors elected to succeed those Directors whose terms expire shall be elected for a term of office to expire at the next annual meeting of stockholders. Notwithstanding the foregoing, the Directors elected to each class shall hold office until their successors are duly elected and qualified or until their earlier resignation, death or removal.

Notwithstanding the foregoing, whenever, pursuant to the provisions of Article IV of this Certificate, the holders of any one or more series of Preferred Stock shall have the right, voting separately as a series or together with holders of other such series, to elect Directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other features of such directorships shall be governed by the terms of this Certificate and any certificate of designations applicable to such series.


Notwithstanding anything herein to the contrary, the affirmative vote of not less than two thirds (2/3) of the outstanding shares of capital stock entitled to vote thereon, and the affirmative vote of not less than two thirds (2/3) of the outstanding shares of each class entitled to vote thereon as a class, shall be required to amend or repeal any provision of this Article V, Section 5.02.

Section 5.03. Newly Created Directorships and Vacancies. Except as otherwise required by law and subject to any rights of the holders of any series of Preferred Stock to elect directors under specified circumstances, any newly created directorships resulting from an increase in the authorized number of directors and any vacancies occurring in the Board of Directors, may be filled solely by the affirmative votes of a majority of the remaining members of the Board of Directors, although less than a quorum, or by a sole remaining director. A director so elected shall be elected to hold office until the earlier of the expiration of the term of office of the director whom he or she has replaced, a successor is duly elected and qualified, or the earlier of such director’s death, resignation, or removal.

Section 5.04. Written Ballot. Unless and except to the extent that the By-Laws shall so require, the election of directors of the Corporation need not be by written ballot.

ARTICLE VI

LIMITATION OF LIABILITY; INDEMNIFICATION

Section 6.01. Limitation of Liability. To the fullest extent permitted by the DGCL as it presently exists or may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or to its stockholders for monetary damages for any breach of fiduciary duty as a director. No amendment to, modification of, or repeal of this Section 6.01 shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.

Section 6.02. Indemnification. The corporation may indemnify to the fullest extent permitted by law as it presently exists or may hereafter be amended any person made or threatened to be made a party to an action or proceeding, whether criminal, civil, administrative, or investigative, by reason of the fact that he, his testator, or intestate is or was a director of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as a director at the request of the Corporation or any predecessor to the Corporation. Any amendment, repeal, or modification of this Section 6.02 shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.

Notwithstanding anything herein to the contrary, the affirmative vote of not less than two thirds (2/3) of the outstanding shares of capital stock entitled to vote thereon, and the affirmative vote of not less than two thirds (2/3) of the outstanding shares of each class entitled to vote thereon as a class, shall be required to amend or repeal any provision of this Article VI.

ARTICLE VII

STOCKHOLDER ACTION

Section 7.01. Stockholder Consent Prohibition. Subject to the rights of the holders of any series of Preferred Stock, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of the stockholders of the Corporation and may not be effected by any consent by such stockholders.

Section 7.02. Special Meetings of Stockholders. Except as otherwise required by law and subject to the rights of the holders of any series of Preferred Stock, special meetings of the stockholders of the Corporation shall be called only by: (i) the Board of Directors acting pursuant to a resolution approved by the affirmative vote of a majority of the Directors then in office; or (ii) the Secretary of the Corporation, following receipt of one or more written demands to call a special meeting of the stockholders from stockholders of record who own, in the aggregate, at least 25% of the voting power of the outstanding shares of the Corporation then entitled to vote on the matter or matters to be brought before the proposed special meeting that complies with the procedures for calling a special meeting of the stockholders as may be set forth in the By-Laws.


ARTICLE VIII

BY-LAWS

Section 8.01. Board of Directors. In furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized and empowered to adopt, amend, alter, or repeal the By-Laws without any action on the part of the stockholders.

Section 8.02. Stockholders. The stockholders shall also have the power to adopt, amend, alter, or repeal the By-Laws; provided that, in addition to any affirmative vote of the holders of any particular class or series of capital stock of the Corporation required by applicable law or this Certificate of Incorporation, such adoption, amendment, alteration, or repeal shall be approved by the affirmative vote of the holders of at least two thirds (2/3) of the voting power of the shares of the then outstanding voting stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class.

ARTICLE IX

FORUM

Section 9.1 Forum. Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers or employees arising pursuant to any provision of the DGCL or this Amended and Restated Certificate or the Bylaws, or (iv) any action asserting a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction. This exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act, the Securities Act of 1933, as amended (the “Securities Act”), or any other claim for which the federal courts have exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act, the Securities Act, or any other claim for which the federal courts have exclusive jurisdiction.

Section 9.2 Consent to Jurisdiction. If any action the subject matter of which is within the scope of Section 9.1 is filed in a court other than a court located within the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce Section 9.1 (an “FSC Enforcement Action”) and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such stockholder’s counsel in the Foreign Action as agent for such stockholder.

Section 9.3 Severability. If any provision or provisions of this Article IX shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article IX (including, without limitation, each portion of any sentence of this Article IX containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise


acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article IX.

ARTICLE X

AMENDMENTS

The Corporation reserves the right to amend, alter, or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by the laws of the State of Delaware, and all rights conferred herein are granted subject to this reservation; provided however, that notwithstanding any other provision of this Certificate of Incorporation or applicable law that might permit a lesser vote or no vote and in addition to any affirmative vote of the holders of any particular class or series of capital stock of the Corporation required by applicable law or this Certificate of Incorporation, the affirmative vote of the holders of a majority of the voting power of the shares of the then outstanding voting stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend, alter, repeal, or adopt any provisions inconsistent with this Article X of this Certificate of Incorporation.

[Signature Page to Follow]


THIS CERTIFICATE OF INCORPORATION is executed as of this 24th day of March, 2021.

ALFI, INC.

By: /s/ Paul Pereira

Name: Paul Pereira

Title: Chief Executive Officer


Exhibit 3.4

AMENDED AND RESTATED

BY-LAWS

OF

ALFI, INC.

ARTICLE I

OFFICES

Section 1.01 Registered Office. The registered office of Alfi, Inc. (the “Corporation”) will be fixed in the Certificate of Incorporation of the Corporation (the “Certificate of Incorporation”).

Section 1.02 Other Offices. The Corporation may have other offices, both within and without the State of Delaware, as the board of directors of the Corporation (the “Board of Directors”) from time to time shall determine or the business of the Corporation may require.

ARTICLE II

MEETINGS OF THE STOCKHOLDERS

Section 2.01 Place of Meetings. All meetings of the stockholders shall be held at such place, if any, either within or without the State of Delaware, or by means of remote communication, as shall be designated from time to time by resolution of the Board of Directors and stated in the notice of meeting.

Section 2.02 Annual Meeting. The annual meeting of the stockholders for the election of directors and for the transaction of such other business as may properly come before the meeting in accordance with these by-laws shall be held at such date, time, and place, if any, as shall be determined by the Board of Directors and stated in the notice of the meeting.

Section 2.03 Special Meetings.

(a) Purpose. Special meetings of stockholders for any purpose or purposes shall be called only:

(i)by the Board of Directors acting pursuant to a resolution approved by the affirmative vote of a majority of the Directors then in office; or

(ii)by the Secretary (as defined in Section 4.01), following receipt of one or more written demands to call a special meeting of the stockholders in accordance with, and subject to, this Section 2.03 from stockholders of record satisfying the ownership requirements as set forth in the Certificate of Incorporation.

(b) Notice. A request to the Secretary shall be delivered to him or her at the Corporation’s principal executive offices and signed by each stockholder, or a duly authorized agent of such stockholder, requesting the special meeting and shall set forth:

(i)a brief description of each matter of business desired to be brought before the special meeting;
(ii)the reasons for conducting such business at the special meeting;
(iii)the text of any proposal or business to be considered at the special meeting (including the text of any resolutions proposed to be considered and in the event that such business includes a proposal to amend these by-laws, the language of the proposed amendment); and
(iv)the information required in Section 2.12(b) of these by-laws (for stockholder nomination demands) or Section 2.12(c) of these by-laws (for all other stockholder proposal demands), as applicable.

(c) Business. Business transacted at a special meeting requested by stockholders shall be limited to the matters described in the special meeting request; provided, however, that nothing herein shall prohibit the Board of Directors from submitting matters to the stockholders at any special meeting requested by stockholders.

(d) Time and Date. A special meeting requested by stockholders shall be held at such date and time as may be fixed by the Board of

Directors; provided, however, that the date of any such special meeting shall be not more than 90 days after the request to call the special meeting is received by the Secretary. Notwithstanding the foregoing, a special meeting requested by stockholders shall not be held if:

(i)the Board of Directors has called or calls for an annual or special meeting of the stockholders to be held within 90 days after the Secretary receives the request for the special meeting and the Board of Directors determines in good faith that the business of such meeting includes (among any other matters properly brought before the meeting) the business specified in the request;

(ii)the stated business to be brought before the special meeting is not a proper subject for stockholder action under applicable law;

(iii)an identical or substantially similar item (a “Similar Item”) was presented at any meeting of stockholders held within 90 days prior to the receipt by the Secretary of the request for the special meeting (and, for purposes of this Section 2.03(d)(iii), the election of directors shall be deemed a Similar Item with respect to all items of business involving the election or removal of directors); or


(iv)the special meeting request was made in a manner that involved a violation of Regulation 14A under the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder (the “Exchange Act”).

(e) Revocation. A stockholder may revoke a request for a special meeting at any time by written revocation delivered to the Secretary at the Corporation’s principal executive offices, and if, following such revocation, there are unrevoked requests from stockholders holding in the aggregate less than the requisite number of shares entitling the stockholders to request the calling of a special meeting, the Board of Directors, in its discretion, may cancel the special meeting.

Section 2.04 Adjournments. Any meeting of the stockholders, annual or special, may be adjourned from time to time to reconvene at the same or some other place, if any, and notice need not be given of any such adjourned meeting if the time, place, if any, thereof and the means of remote communication, if any, are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than 30 days, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date is fixed for stockholders entitled to vote at the adjourned meeting, the Board of Directors shall fix a new record date for notice of the adjourned meeting and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at the adjourned meeting as of the record date fixed for notice of the adjourned meeting.

Section 2.05 Notice of Meetings. Notice of the place (if any), date, hour, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for stockholders entitled to notice of the meeting), and means of remote communication, if any, of every meeting of stockholders shall be given by the Corporation not less than ten days nor more than 60 days before the meeting (unless a different time is specified by law) to every stockholder entitled to vote at the meeting as of the record date for determining the stockholders entitled to notice of the meeting. Notices of special meetings shall also specify the purpose or purposes for which the meeting has been called. Notices of meetings to stockholders may be given by mailing the same, addressed to the stockholder entitled thereto, at such stockholder’s mailing address as it appears on the records of the corporation and such notice shall be deemed to be given when deposited in the U.S. mail, postage prepaid. Without limiting the manner by which notices of meetings otherwise may be given effectively to stockholders, any such notice may be given by electronic transmission in accordance with applicable law. Notice of any meeting need not be given to any stockholder who shall, either before or after the meeting, submit a waiver of notice or who shall attend such meeting, except when the stockholder attends for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder so waiving notice of the meeting shall be bound by the proceedings of the meeting in all respects as if due notice thereof had been given.

Section 2.06 List of Stockholders. The Corporation shall prepare a complete list of the stockholders entitled to vote at any meeting of stockholders (provided, however, if the record date for determining the stockholders entitled to vote is less than ten days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date), arranged in alphabetical order, and showing the address of each stockholder and the number of shares of capital stock of the Corporation registered in the name of each stockholder at least ten days before any meeting of the stockholders. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten days before the meeting: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list was provided with the notice of the meeting; or (b) during ordinary business hours, at the principal place of business of the Corporation. If the meeting is to be held at a place, the list shall also be produced and kept at the time and place of the meeting the whole time thereof and may be inspected by any stockholder who is present. If the meeting is held solely by means of remote communication, the list shall also be open for inspection by any stockholder during the whole time of the meeting as provided by applicable law. Except as provided by applicable law, the stock ledger of the Corporation shall be the only evidence as to who are the stockholders entitled to examine the stock ledger and the list of stockholders or to vote in person or by proxy at any meeting of stockholders.

Section 2.07 Quorum. Unless otherwise required by law, the Certificate of Incorporation or these by-laws, at each meeting of the stockholders, a majority in voting power of the shares of the Corporation entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the chair of the meeting or the stockholders entitled to vote at the meeting, present in person or represented by proxy, shall have power, by the affirmative vote of a majority in voting power thereof, to adjourn the meeting from time to time, in the manner provided in Section 2.04, until a quorum shall be present or represented. A quorum, once established, shall not be broken by the subsequent withdrawal of enough votes to leave less than a quorum. At any such adjourned meeting at which there is a quorum, any business may be transacted that might have been transacted at the meeting originally called.

Section 2.08 Organization. The Board of Directors may adopt by resolution such rules and regulations for the conduct of the meeting of the stockholders as it shall deem appropriate. At every meeting of the stockholders, the Chair of the Board, or in his or her absence or inability to act, the Chief Executive Officer (as defined in Section 4.01), or, in his or her absence or inability to act, the officer or director whom the Board of Directors shall appoint, shall act as chair of, and preside at, the meeting. The Secretary or, in his or her absence or inability to act, the person whom the chair of the meeting shall appoint secretary of the meeting, shall act as secretary of the meeting and keep the minutes thereof. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chair of any meeting of the stockholders shall have the right and authority to prescribe such rules, regulations, and procedures and to do all such acts as, in


the judgment of such chair, are appropriate for the proper conduct of the meeting. Such rules, regulations, or procedures, whether adopted by the Board of Directors or prescribed by the chair of the meeting, may include, without limitation, the following:

(a)the establishment of an agenda or order of business for the meeting;

(b)the determination of when the polls shall open and close for any given matter to be voted on at the meeting;

(c)rules and procedures for maintaining order at the meeting and the safety of those present;

(d)limitations on attendance at or participation in the meeting to stockholders of record of the corporation, their duly authorized and

constituted proxies, or such other persons as the chair of the meeting shall determine;

(e)restrictions on entry to the meeting after the time fixed for the commencement thereof; and

(f)limitations on the time allotted to questions or comments by participants.

Section 2.09 Voting; Proxies.

(a) General. Unless otherwise required by law or provided in the Certificate of Incorporation, each stockholder shall be entitled to one vote, in person or by proxy, for each share of capital stock held by such stockholder.

(b)Election of Directors. Unless otherwise required by the Certificate of Incorporation, the election of directors shall be by written ballot. If authorized by the Board of Directors, such requirement of a written ballot shall be satisfied by a ballot submitted by electronic transmission, provided that any such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder or proxy holder. Unless otherwise required by law, the Certificate of Incorporation, or these by-laws, the election of directors shall be decided by a majority of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election; provided, however, that, if the Secretary determines that the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes of the shares represented in person or by proxy at any meeting of stockholders held to elect directors and entitled to vote on such election of directors. For purposes of this Section 2.09(b), a majority of the votes cast means that the number of shares voted “for” a nominee must exceed the votes cast “against” such nominee’s election. If a nominee for director who is not an incumbent director does not receive a majority of the votes cast, the nominee shall not be elected. The Nominating and Corporate Governance Committee has established procedures under which a director standing for reelection in an uncontested election must tender a resignation conditioned on the incumbent director’s failure to receive a majority of the votes cast. If an incumbent director who is standing for re-election does not receive a majority of the votes cast, the Nominating and Corporate Governance Committee will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will act on the committee’s recommendation and publicly disclose its decision and the rationale behind it within 90 days from the date of the certification of the election results. The director who fails to receive a majority vote will not participate in the committee’s recommendation or the Board of Directors’ decision.

(c)Other Matters. Unless otherwise required by law, the Certificate of Incorporation, or these by-laws, any matter, other than the election of directors, brought before any meeting of stockholders shall be decided by the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the matter.

(d)Proxies. Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. Such authorization may be a document executed by the stockholder or his or her authorized officer, director, employee, or agent. To the extent permitted by law, a stockholder may authorize another person or persons to act for him or her as proxy by transmitting or authorizing the transmission of an electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization, or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that the electronic transmission either sets forth or is submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder. A copy, facsimile transmission, or other reliable reproduction (including any electronic transmission) of the proxy authorized by this Section 2.09(d) may be substituted for or used in lieu of the original document for any and all purposes for which the original document could be used, provided that such copy, facsimile transmission, or other reproduction shall be a complete reproduction of the entire original document. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy that is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary a revocation of the proxy or a new proxy bearing a later date.

Section 2.10 Inspectors at Meetings of Stockholders. In advance of any meeting of the stockholders, the Board of Directors shall, appoint one or more inspectors, who may be employees of the Corporation, to act at the meeting or any adjournment thereof and make a written report thereof. The Board of Directors may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is


able to act at a meeting, the person presiding at the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her ability. The inspector or inspectors may appoint or retain other persons or entities to assist the inspector or inspectors in the performance of their duties. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders, the inspector or inspectors may consider such information as is permitted by applicable law. No person who is a candidate for office at an election may serve as an inspector at such election. When executing the duties of inspector, the inspector or inspectors shall:

(a) ascertain the number of shares outstanding and the voting power of each;

(b)determine the shares represented at the meeting and the validity of proxies and ballots;

(c)count all votes and ballots;

(d)determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors; and

(e)certify their determination of the number of shares represented at the meeting and their count of all votes and ballots.

Section 2.11 Fixing the Record Date.

(a)In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than 60 nor less than ten days before the date of such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the determination of stockholders entitled to notice of or to vote at the adjourned meeting.

(b)In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion, or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.

Section 2.12 Advance Notice of Stockholder Nominations and Proposals.

(a) Annual Meetings. At a meeting of the stockholders, only such nominations of persons for the election of directors and such other business shall be conducted as shall have been properly brought before the meeting. Except for nominations that are included in the Corporation’s annual meeting proxy statement pursuant to Section 2.13, to be properly brought before an annual meeting, nominations or such other business must be:

(i)specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors or any committee thereof;

(ii)otherwise properly brought before the meeting by or at the direction of the Board of Directors or any committee thereof; or

(iii)otherwise properly brought before an annual meeting by a stockholder who is a stockholder of record of the Corporation at the time such notice of meeting is delivered, who is entitled to vote at the meeting, and who complies with the notice procedures set forth in this Section 2.12.

In addition, any proposal of business (other than the nomination of persons for election to the Board of Directors) must be a proper matter for stockholder action. For business (including, but not limited to, director nominations) to be properly brought before an annual meeting by a stockholder pursuant to Section 2.12(a)(iii), the stockholder or stockholders of record intending to propose the business (the “Proposing Stockholder”) must have given timely notice thereof pursuant to this Section 2.12(a), in writing to the Secretary even if such matter is already the subject of any notice to the stockholders or Public Disclosure from the Board of Directors. To be timely, a Proposing Stockholder’s notice for an annual meeting must be delivered to the Secretary at the principal executive offices of the Corporation: (x) not later than the close of business on the 90th day, nor earlier than the close of business on the 120th day, in advance of the anniversary of the previous year’s annual meeting if such meeting is to be held on a day which is not more than 30 days in advance of the anniversary of the previous year’s annual meeting or not later than 60 days after the anniversary of the previous year’s annual meeting; and (y) with respect to any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year, not earlier than the close of business on the 120th day prior to the annual meeting and not later than the close of business on the later of: (1) the 90th day prior to the annual meeting and (2) the close of business on the tenth day following the first date of Public Disclosure of the date of such meeting. In no event shall the Public Disclosure of an adjournment or postponement of an annual meeting commence a new notice time period (or extend any notice time period). For the purposes of this Section 2.12 and Section 2.13, “Public Disclosure” shall mean a disclosure made in a press release reported by the Dow Jones News Services, The Associated Press, or a


comparable national news service or in a document filed by the Corporation with the Securities and Exchange Commission (“SEC”) pursuant to Section 13, 14, or 15(d) of the Exchange Act.

(b) Stockholder Nominations. For the nomination of any person or persons for election to the Board of Directors pursuant to Section 2.12(a)(iii) or Section 2.12(d), a Proposing Stockholder’s notice to the Secretary shall set forth or include:

(i) the name, age, business address, and residence address of each nominee proposed in such notice;

(ii) the principal occupation or employment of each such nominee;

(iii) the class and number of shares of capital stock of the Corporation which are owned of record and beneficially by each such nominee (if any);

(iv) such other information concerning each such nominee as would be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved) or that is otherwise required to be disclosed, under Section 14(a) of the Exchange Act;

(v) a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire shall be provided by the Secretary upon written request) and a written statement and agreement executed by each such nominee acknowledging that such person:

(A)consents to being named in the Company’s proxy statement as a nominee and to serving as a director if elected,

(B)intends to serve as a director for the full term for which such person is standing for election, and

(C)makes the following representations: (1) that the director nominee has read and agrees to adhere to the Corporation’s Corporate Governance Guidelines, Ethics Code, Related Party Transactions Policy, and any other of the Corporation’s policies or guidelines applicable to directors, including with regard to securities trading, (2) that the director nominee is not and will not become a party to any agreement, arrangement, or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the Corporation or any Voting Commitment that could limit or interfere with such person’s ability to comply, if elected as a director of the Corporation, with such person’s fiduciary duties under applicable law, and (3) that the director nominee is not and will not become a party to any agreement, arrangement, or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement, or indemnification (“Compensation Arrangement”) that has not been disclosed to the Corporation in connection with such person’s nomination for director or service as a director; and

(vi) as to the Proposing Stockholder:

(A) the name and address of the Proposing Stockholder as they appear on the Corporation’s books and of the

beneficial owner, if any, on whose behalf the nomination is being made,

(B)the class and number of shares of the Corporation which are owned by the Proposing Stockholder (beneficially and of record) and owned by the beneficial owner, if any, on whose behalf the nomination is being made, as of the date of the Proposing Stockholder’s notice, and a representation that the Proposing Stockholder will notify the Corporation in writing of the class and number of such shares owned of record and beneficially as of the record date for the meeting within five business days after the record date for such meeting,

(C)a description of any agreement, arrangement, or understanding with respect to such nomination between or among the Proposing Stockholder or the beneficial owner, if any, on whose behalf the nomination is being made and any of their affiliates or associates, and any others (including their names) acting in concert with any of the foregoing, and a representation that the Proposing Stockholder will notify the Corporation in writing of any such agreement, arrangement, or understanding in effect as of the record date for the meeting within five business days after the record date for such meeting,

(D)a description of any agreement, arrangement, or understanding (including any derivative or short positions, profit interests, options, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the Proposing Stockholder’s notice by, or on behalf of, the Proposing Stockholder or the beneficial owner, if any, on whose behalf the nomination is being made and any of their affiliates or associates, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of such person or any of their affiliates or associates with respect to shares of stock of the Corporation, and a representation that the Proposing Stockholder will notify the Corporation in writing of any such agreement, arrangement, or understanding in effect as of the record date for the meeting within five business days after the record date for such meeting,

(E)a representation that the Proposing Stockholder is a holder of record of shares of the Corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice, and

(F)a representation whether the Proposing Stockholder intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation’s


outstanding capital stock required to approve the nomination and/or otherwise to solicit proxies from stockholders in support of the nomination.

The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or that could be material to a reasonable stockholder’s understanding of the independence, or lack thereof, of such nominee. Any such update or supplement shall be delivered to the Secretary at the Corporation’s principal executive offices no later than five business days after the request by the Corporation for subsequent information has been delivered to the Proposing Stockholder.

(c) Other Stockholder Proposals. For all business other than director nominations, a Proposing Stockholder’s notice to the Secretary shall set forth as to each matter the Proposing Stockholder proposes to bring before the annual meeting:

(i)a brief description of the business desired to be brought before the annual meeting;

(ii)the reasons for conducting such business at the annual meeting;

(iii)the text of any proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend these by-laws, the language of the proposed amendment);

(iv)any substantial interest (within the meaning of Item 5 of Schedule 14A under the Exchange Act) in such business of such stockholder and the beneficial owner (within the meaning of Section 13(d) of the Exchange Act), if any, on whose behalf the business is being proposed;

(v)any other information relating to such stockholder and beneficial owner, if any, on whose behalf the proposal is being made, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for the proposal and pursuant to and in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder;

(vi)a description of all agreements, arrangements, or understandings between or among such stockholder, the beneficial

owner, if any, on whose behalf the proposal is being made, any of their affiliates or associates, and any other person or persons (including their names) in connection with the proposal of such business and any material interest of such stockholder, beneficial owner, or any of their affiliates or associates, in such business, including any anticipated benefit therefrom to such stockholder, beneficial owner, or their affiliates or associates; and

(vii)the information required by Section 2.12(b)(vi) above.

(d) Special Meetings of Stockholders. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the Corporation’s notice of meeting. Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders called by the Board of Directors at which directors are to be elected pursuant to the Corporation’s notice of meeting:

(i)by or at the direction of the Board of Directors or any committee thereof; or

(ii)provided that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of the Corporation who is a stockholder of record at the time the notice provided for in this Section 2.12(d) is delivered to the Secretary, who is entitled to vote at the meeting, and upon such election and who complies with the notice procedures set forth in this Section 2.12.

In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such position(s) as specified in the Corporation’s notice of meeting, if such stockholder delivers a stockholder’s notice that complies with the requirements of Section 2.12(b) to the Secretary at the principal executive offices of the Corporation not earlier than the close of business on the 120th day prior to such special meeting and not later than the close of business on the later of: (x) the 90th day prior to such special meeting; or (y) the tenth (10th) day following the date of the first Public Disclosure of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. In no event shall the Public Disclosure of an adjournment or postponement of a special meeting commence a new time period (or extend any notice time period).

(e) Effect of Noncompliance. Only such persons who are nominated in accordance with the procedures set forth in this Section 2.12 or Section 2.13 shall be eligible to be elected at any meeting of stockholders of the Corporation to serve as directors and only such other business shall be conducted at a meeting as shall be brought before the meeting in accordance with the procedures set forth in this Section 2.12 or Section 2.13, as applicable. If any proposed nomination was not made or proposed in compliance with this Section 2.12 or Section 2.13, as applicable, or other business was not made or proposed in compliance with this Section 2.12, then except as otherwise required by law, the chair of the meeting shall have the power and duty to declare that such nomination shall be disregarded or that such proposed other business shall not be transacted. Notwithstanding anything in these by-laws to the contrary, unless otherwise required by law, if a Proposing Stockholder intending to propose business or make nominations at an annual meeting or propose a nomination at a special meeting pursuant to this Section 2.12 does not provide the information required under this Section 2.12 to the Corporation, including the updated information required by Section 2.12(b)(vi)(B), Section 2.12(b)(vi)(C), and Section 2.12(b)(vi)(D) within five business days after the record date for such meeting or the Proposing


Stockholder (or a qualified representative of the Proposing Stockholder) does not appear at the meeting to present the proposed business or nominations, such business or nominations shall not be considered, notwithstanding that proxies in respect of such business or nominations may have been received by the Corporation.

(f) Rule 14a-8. This Section 2.12 and Section 2.13 shall not apply to a proposal proposed to be made by a stockholder if the stockholder has notified the Corporation of the stockholder’s intention to present the proposal at an annual or special meeting only pursuant to and in compliance with Rule 14a-8 under the Exchange Act and such proposal has been included in a proxy statement that has been prepared by the Corporation to solicit proxies for such meeting.

Section 2.13 Proxy Access.

(a) Inclusion of Proxy Access Stockholder Nominee in Proxy Statement. Subject to the provisions of this Section 2.13, the Corporation shall include in its proxy statement (including its form of proxy and ballot) for an annual meeting of stockholders the name of any stockholder nominee for election to the Board of Directors submitted pursuant to this Section 2.13 (each a “Proxy Access Stockholder Nominee”) provided:

(i)timely written notice of such Proxy Access Stockholder Nominee satisfying this Section 2.13 (“Proxy Access Notice”) is delivered to the Corporation by or on behalf of a stockholder or stockholders that, at the time the Proxy Access Notice is delivered, satisfy the ownership and other requirements of this Section 2.13 (such stockholder or stockholders, and any person on whose behalf they are acting, the “Eligible Stockholder”);

(ii)the Eligible Stockholder expressly elects in writing at the time of providing the Proxy Access Notice to have its Proxy Access Stockholder Nominee included in the Corporation’s proxy statement pursuant to this Section 2.13; and

(iii)the Eligible Stockholder and the Proxy Access Stockholder Nominee otherwise satisfy the requirements of this Section 2.13.

(b) Timely Notice. To be timely, the Proxy Access Notice must be delivered to the Secretary at the principal executive offices of the Corporation, not later than 120 days nor more than 150 days prior to the first anniversary of the date (as stated in the Corporation’s proxy materials) that the Corporation’s definitive proxy statement was first sent to stockholders in connection with the preceding year’s annual meeting of stockholders/of the preceding year’s annual meeting; provided, however, that in the event that the date of the annual meeting is advanced by more than 30 days or delayed by more than 60 days from the anniversary of the preceding year’s annual meeting, or if no annual meeting was held in the preceding year, the Proxy Access Notice must be so delivered not earlier than the close of business on the 150th day prior to such annual meeting and not later than the close of business on the later of: (i) the 120th day prior to such annual meeting; or (ii) the 10th day following the day on which Public Disclosure of the date of such annual meeting is first made by the Corporation. In no event shall the public announcement of an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of the Proxy Access Notice.

(c) Information to be Included in Proxy Statement. In addition to including the name of the Proxy Access Stockholder Nominee in the Corporation’s proxy statement for the annual meeting, the Corporation shall also include (collectively, the “Required Information”):

(i)the information concerning the Proxy Access Stockholder Nominee and the Eligible Stockholder that is required to be disclosed in the Corporation’s proxy statement pursuant to the Exchange Act, and the rules and regulations promulgated thereunder; and

(ii)if the Eligible Stockholder so elects, a written statement of the Eligible Stockholder (or in the case of a group, a written statement of the group), not to exceed 500 words, in support of its Proxy Access Stockholder Nominee, which must be provided at the same time as the Proxy Access Notice for inclusion in the Corporation’s proxy statement for the annual meeting (a “Statement”). Notwithstanding anything to the contrary contained in this Section 2.13, the Corporation may omit from its proxy materials any information or Statement that it, in good faith, believes is untrue in any material respect (or omits a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading) or would violate any applicable law, rule, regulation, or listing standard. Additionally, nothing in this Section 2.13 shall limit the Corporation’s ability to solicit against and include in its proxy statement its own statements relating to any Proxy Access Stockholder Nominee.

(d) Proxy Access Stockholder Nominee Limits. The number of Proxy Access Stockholder Nominees (including Proxy Access Stockholder Nominees that were submitted by an Eligible Stockholder for inclusion in the Corporation’s proxy statement pursuant to this Section 2.13 but either are subsequently withdrawn or that the Board of Directors decides to nominate (a “Board Nominee”)) appearing in the Corporation’s proxy statement with respect to a meeting of stockholders shall not exceed the greater of: (x) two; or (y) 20% of the number of directors in office as of the last day on which notice of a nomination may be delivered pursuant to this Section 2.13 (the “Final Proxy Access Nomination Date”) or, if such amount is not a whole number, the closest whole number below 20% (the “Permitted Number”); provided, however, that:

(i)in the event that one or more vacancies for any reason occurs on the Board of Directors at any time after the Final Proxy Access Nomination Date and before the date of the applicable annual meeting of stockholders and the Board of Directors resolves to reduce the size


of the Board of Directors in connection therewith, the Permitted Number shall be calculated based on the number of directors in office as so reduced;

(ii)any Proxy Access Stockholder Nominee who is included in the Corporation’s proxy statement for a particular meeting of

stockholders but either: (A) withdraws from or becomes ineligible or unavailable for election at the meeting, or (B) does not receive a number of votes cast in favor of his or her election at least equal to 25% of the shares present in person or represented by proxy at the annual meeting and entitled to vote on the Proxy Access Stockholder Nominee’s election, shall be ineligible to be included in the Corporation’s proxy statement as a Proxy Access Stockholder Nominee pursuant to this Section 2.13 for the next two annual meetings of stockholders following the meeting for which the Proxy Access Stockholder Nominee has been nominated for election; and

(iii)any director in office as of the nomination deadline who was included in the Corporation’s proxy statement as a Proxy Access Stockholder Nominee for any of the two preceding annual meetings and whom the Board of Directors decides to nominate for election to the Board of Directors also will be counted against the Permitted Number.

In the event that the number of Proxy Access Stockholder Nominees submitted by Eligible Stockholders pursuant to this Section 2.13 exceeds the Permitted Number, each Eligible Stockholder shall select one Proxy Access Stockholder Nominee for inclusion in the Corporation’s proxy statement until the Permitted Number is reached, going in order of the amount (from greatest to least) of voting power of the Corporation’s capital stock entitled to vote on the election of directors as disclosed in the Proxy Access Notice. If the Permitted Number is not reached after each Eligible Stockholder has selected one Proxy Access Stockholder Nominee, this selection process shall continue as many times as necessary, following the same order each time, until the Permitted Number is reached.

(e) Eligibility of Nominating Stockholder; Stockholder Groups. An Eligible Stockholder must have owned (as defined below) continuously for at least three years a number of shares that represents 3% or more of the outstanding shares of the Corporation entitled to vote in the election of directors (the “Required Shares”) as of both the date the Proxy Access Notice is delivered to or received by the Corporation in accordance with this Section 2.13 and the record date for determining stockholders entitled to vote at the meeting and must intend to continue to own the Required Shares for at least one year following the date of the annual meeting/deliver a statement regarding the Eligible Stockholder’s intent with respect to continued ownership of the Required Shares for at least one year following the annual meeting. For purposes of satisfying the ownership requirement under this Section 2.13, the voting power represented by the shares of the Corporation’s capital stock owned by one or more stockholders, or by the person or persons who own shares of the Corporation’s capital stock and on whose behalf any stockholder is acting, may be aggregated, provided that:

(i)the number of stockholders and other persons whose ownership of shares is aggregated for such purpose shall not exceed 20; and

(ii)each stockholder or other person whose shares are aggregated shall have held such shares continuously for at least three years.

Whenever an Eligible Stockholder consists of a group of stockholders and/or other persons, any and all requirements and obligations for an Eligible Stockholder set forth in this Section 2.13 must be satisfied by and as to each such stockholder or other person, except that shares may be aggregated to meet the Required Shares as provided in this Section 2.13(e). With respect to any one particular annual meeting, no stockholder or other person may be a member of more than one group of persons constituting an Eligible Stockholder under this Section 2.13.

(f) Funds. A group of two or more funds shall be treated as one stockholder or person for this Section 2.13 provided that the other terms and conditions in this Section 2.13 are met (including Section 2.13(h)(v)(A)) and the funds are:

(i)under common management and investment control;

(ii)under common management and funded primarily by the same employer (or by a group of related employers that are under common control); or

(iii)a “group of investment companies,” as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended.

(g) Ownership. For purposes of this Section 2.13, an Eligible Stockholder shall be deemed to “own” only those outstanding shares of the Corporation’s capital stock as to which the person possesses both:

(i)the full voting and investment rights pertaining to the shares; and

(ii)the full economic interest in (including the opportunity for profit and risk of loss on) such shares; provided that the number of shares calculated in accordance with clauses (i) and (ii) shall not include any shares:

(A)sold by such person or any of its affiliates in any transaction that has not been settled or closed,

(B)borrowed by such person or any of its affiliates for any purposes or purchased by such person or any of its affiliates pursuant to an agreement to resell, or

(C)subject to any option, warrant, forward contract, swap, contract of sale, other derivative, or similar agreement entered into by such person or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of the Corporation’s capital stock, in any such case which instrument or


agreement has, or is intended to have, the purpose or effect of: (1) reducing in any manner, to any extent or at any time in the future, such person’s or affiliates’ full right to vote or direct the voting of any such shares; and/or (2) hedging, offsetting, or altering to any degree gain or loss arising from the full economic ownership of such shares by such person or affiliate.

An Eligible Stockholder “owns” shares held in the name of a nominee or other intermediary so long as the Eligible Stockholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Stockholder’s ownership of shares shall be deemed to continue during any period in which the Eligible Stockholder has delegated any voting power by means of a proxy, power of attorney, or other instrument or arrangement that is revocable at any time by the person. An Eligible Stockholder’s ownership of shares shall be deemed to continue during any period in which the Eligible Stockholder has loaned such shares, provided that the Eligible Stockholder has the power to recall such loaned shares on five business days’ notice and recalls such loaned shares not more than five business days after being notified that any of its Proxy Access Stockholder Nominees will be included in the Corporation’s proxy statement. The terms “owned,” “owning,” and other variations of the word “own” shall have correlative meanings. For purposes of this Section 2.13, the term “affiliate” shall have the meaning ascribed thereto in the regulations promulgated under the Exchange Act.

(h) Nomination Notice and Other Eligible Stockholder Deliverables. An Eligible Stockholder must provide with its Proxy Access Notice the following information in writing to the Secretary:

(i) one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or have been held during the requisite three-year holding period) verifying that, as of a date within seven calendar days prior to the date the Proxy Access Notice is delivered to or received by the Corporation, the Eligible Stockholder owns, and has owned continuously for the preceding three years, the Required Shares, and the Eligible Stockholder’s agreement to provide:

(A)within five business days after the record date for the meeting, written statements from the record holder and intermediaries verifying the Eligible Stockholder’s continuous ownership of the Required Shares through the record date, and

(B)immediate notice if the Eligible Stockholder ceases to own any of the Required Shares prior to the date of the applicable annual meeting of stockholders;

(ii) the Eligible Stockholder’s representation and agreement that the Eligible Stockholder (including each member of any group of stockholders that together is an Eligible Stockholder under this Section 2.13):

(A)intends to continue to satisfy the eligibility requirements described in this Section 2.13 through the date of the annual meeting, including a statement that the Eligible Stockholder intends to continue to own the Required Shares for at least one year following the date of the annual meeting/regarding the Eligible Stockholder’s intent with respect to continued ownership of the Required Shares for at least one year following the annual meeting,

(B)acquired the Required Shares in the ordinary course of business and not with the intent to change or influence control of the Corporation, and does not presently have such intent,

(C)has not nominated and will not nominate for election to the Board of Directors at the meeting any person other than the Proxy Access Stockholder Nominee(s) being nominated pursuant to this Section 2.13,

(D)has not engaged and will not engage in, and has not and will not be, a “participant” in another person’s “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a director at the meeting other than its Proxy Access Stockholder Nominee(s) or a Board Nominee,

(E)will not distribute to any stockholder any form of proxy for the meeting other than the form distributed by the Corporation,

(F)has provided and will provide facts, statements, and other information in all communications with the Corporation and its stockholders that are or will be true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading,

(G)agrees to assume all liability stemming from any legal or regulatory violation arising out of the Eligible Stockholder’s communications with the Corporation’s stockholders or out of the information that the Eligible Stockholder provides to the Corporation,

(H)agrees to indemnify and hold harmless the Corporation and each of its directors, officers, and employees individually against any liability, loss, or damages in connection with any threatened or pending action, suit, or proceeding, whether legal, administrative, or investigative, against the Corporation or any of its directors, officers, or employees arising out of any nomination submitted by the Eligible Stockholder pursuant to this Section 2.13,

(I)will file with the SEC any solicitation or other communication with the Corporation’s stockholders relating to the meeting at which the Proxy Access Stockholder Nominee will be nominated, regardless of whether any such filing is required under Section 14


of the Exchange Act and the rules and regulations promulgated thereunder or whether any exemption from filing is available for such solicitation or other communication under Section 14 of the Exchange Act and the rules and regulations promulgated thereunder, and

(J)will comply with all other applicable laws, rules, regulations, and listing standards with respect to any solicitation in connection with the meeting;

(iii) the written consent of each Proxy Access Stockholder Nominee to be named in the Corporation’s proxy statement, and form of proxy and ballot and, as a nominee and, if elected, to serve as a director;

(iv) a copy of the Schedule 14N (or any successor form) that has been filed with the SEC as required by Rule 14a-18 under the Exchange Act;

(v) in the case of a nomination by a group of stockholders that together is an Eligible Stockholder:

(A)documentation satisfactory to the Corporation demonstrating that a group of funds qualifies pursuant to the criteria set forth in Section 2.13(f) to be treated as one stockholder or person for purposes of this Section 2.13, and

(B)the designation by all group members of one group member that is authorized to act on behalf of all members of the nominating stockholder group with respect to the nomination and matters related thereto, including withdrawal of the nomination; and

(vi) if desired, a Statement.

(i) Stockholder Nominee Agreement. Each Proxy Access Stockholder Nominee must:

(i) provide within five business days of the Corporation’s request an executed agreement, in a form deemed satisfactory to the Corporation, providing the following representations:

(A) the Proxy Access Stockholder Nominee has read and agrees to adhere to the Corporation’s Corporate Governance Guidelines, Ethics Code, Related Party Transactions Policy and any other of the Corporation’s policies or guidelines applicable to directors, including with regard to securities trading,

(B)the Proxy Access Stockholder Nominee is not and will not become a party to: (1) any Voting Commitment that has not been disclosed to the Corporation; or (2) any Voting Commitment that could limit or interfere with such person’s ability to comply, if elected as a director of the Corporation, with such person’s fiduciary duties under applicable law, and

(C)the Proxy Access Stockholder Nominee is not and will not become a party to any Compensation Arrangement in connection with such person’s nomination for director or service as a director that has not been disclosed to the Corporation;

(ii)complete, sign, and submit all questionnaires required of the Corporation’s Board of Directors within five business days of receipt of each such questionnaire from the Corporation; and

(iii)provide within five business days of the Corporation’s request such additional information as the Corporation determines may be necessary to permit the Board of Directors to determine whether such Proxy Access Stockholder Nominee meets the requirements of this Section 2.13 or the Corporation’s requirements with regard to director qualifications and policies and guidelines applicable to directors, including whether:

(A)such Proxy Access Stockholder Nominee is independent under the independence requirements, including the committee independence requirements, set forth in the listing standards of the stock exchange on which shares of the Corporation’s capital stock are listed, any applicable rules of the SEC, and any publicly disclosed standards used by the Board of Directors in determining and disclosing the independence of the directors (the “Independence Standards”),

(B)such Proxy Access Stockholder Nominee has any direct or indirect relationship with the Corporation that has not been deemed categorically immaterial pursuant to the Corporation’s Corporate Governance Guidelines, and

(C)such Proxy Access Stockholder Nominee is not and has not been subject to: (1) any event specified in Item 401(f) of Regulation S-K under the Securities Act of 1933, as amended (the “Securities Act”), or (2) any order of the type specified in Rule 506(d) of Regulation D under the Securities Act.

(j) Eligible Stockholder/Proxy Access Stockholder Nominee Undertaking. In the event that any information or communications provided by the Eligible Stockholder or Proxy Access Stockholder Nominee to the Corporation or its stockholders ceases to be true and correct in any respect or omits a fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading, each Eligible Stockholder or Proxy Access Stockholder Nominee, as the case may be, shall promptly notify the Secretary of any such inaccuracy or omission in such previously provided information and of the information that is required to make such information or communication true and correct. Notwithstanding the foregoing, the provision of any such notification pursuant to the preceding sentence shall not be deemed to cure any defect or limit the Corporation’s right to omit a Proxy Access Stockholder Nominee from its proxy materials as provided in this Section 2.13.

(k) Exceptions Permitting Exclusion of Proxy Access Stockholder Nominee. The Corporation shall not be required to include pursuant to this Section 2.13 a Proxy Access Stockholder Nominee in its proxy statement (or, if the proxy statement has already been filed, to allow the nomination of a Proxy


Access Stockholder Nominee, notwithstanding that proxies in respect of such vote may have been received by the Corporation):

(i)if the Eligible Stockholder who has nominated such Proxy Access Stockholder Nominee has nominated for election to the Board of Directors at the meeting any person other than pursuant to this Section 2.13, or has or is engaged in, or has been or is a “participant” in another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a director at the meeting other than its Proxy Access Stockholder Nominee(s) or a Board Nominee;

(ii)if the Corporation has received a notice (whether or not subsequently withdrawn) that a stockholder intends to nominate any candidate for election to the Board of Directors pursuant to the advance notice requirements in Section 2.12 of these by-laws;

(iii)who is not independent under the Independence Standards;

(iv)whose election as a member of the Board of Directors would violate or cause the Corporation to be in violation of these by-laws, the Corporation’s Certificate of Incorporation, Corporate Governance Guidelines, Ethics Code, or other document setting forth qualifications for directors, the listing standards of the stock exchange on which shares of the Corporation’s capital stock is listed, or any applicable state or federal law, rule, or regulation;

(v)if the Proxy Access Stockholder Nominee is or becomes a party to any undisclosed Voting Commitment;

(vi)if the Proxy Access Stockholder Nominee is or becomes a party to any undisclosed Compensation Arrangement;

(vii)who is or has been, within the past three years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914;

(viii)who is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been convicted in such a criminal proceeding within the past ten years;

(ix)who is subject to any order of the type specified in Rule 506(d) of Regulation D under the Securities Act; or

(x)if such Proxy Access Stockholder Nominee or the applicable Eligible Stockholder shall have provided information to the Corporation in respect of such nomination that was untrue in any material respect or omitted to state a material fact necessary in order to make the statement made, in light of the circumstances under which they were made, not misleading or shall have breached its or their agreements, representations, undertakings, or obligations pursuant to this Section 2.13.

(l) Invalidity. Notwithstanding anything to the contrary set forth herein, the Board of Directors or the person presiding at the meeting shall be entitled to declare a nomination by an Eligible Stockholder to be invalid, and such nomination shall be disregarded notwithstanding that proxies in respect of such vote may have been received by the Corporation; and the Corporation shall not be required to include in its proxy statement any successor or replacement nominee proposed by the applicable Eligible Stockholder or any other Eligible Stockholder if:

(i)the Proxy Access Stockholder Nominee and/or the applicable Eligible Stockholder shall have breached its or their agreements, representations, undertakings, or obligations pursuant to this Section 2.13, as determined by the Board of Directors or the person presiding at the meeting; or

(ii)the Eligible Stockholder (or a qualified representative thereof) does not appear at the meeting to present any nomination

pursuant to this Section 2.13.

No Action by Stockholder Consent in Lieu of a Meeting. Any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of the stockholders of Corporation and may not be effected by any consent by such stockholders.

ARTICLE III

BOARD OF DIRECTORS

Section 3.01 General Powers. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. The Board of Directors may adopt such rules and procedures, not inconsistent with the Certificate of Incorporation, these by-laws, or applicable law, as it may deem proper for the conduct of its meetings and the management of the Corporation.

Section 3.02 Number; Term of Office. The Board of Directors shall consist of not less than one (1) and not more than eleven (11) directors as fixed from time to time solely by resolution of a majority of the total number of directors that the Corporation would have if there were no vacancies. Each director shall hold office until a successor is duly elected and qualified or until the director’s earlier death, resignation, disqualification, or removal.

Section 3.03 Newly Created Directorships and Vacancies. Any newly created directorships resulting from an increase in the authorized number of directors and any vacancies occurring in the Board of Directors, may be filled by the affirmative votes of a majority of the remaining members of the Board of Directors, although less than a quorum, or by a sole remaining director. A director so elected shall be elected to hold office until the earlier of the expiration of the term of office of the director whom he or she has replaced, a successor is duly elected and qualified, or the earlier of such director’s death, resignation, or removal.


Section 3.04 Resignation. Any director may resign at any time by notice given in writing or by electronic transmission to the Corporation. Such resignation shall take effect at the date of receipt of such notice by the Corporation or at such later effective date or upon the happening of an event or events as is therein specified. A resignation that is conditioned on a director failing to receive a specified vote for reelection as a director may provide that it is irrevocable. A verbal resignation shall not be deemed effective until confirmed by the director in writing or by electronic transmission to the Corporation.

Section 3.05 Removal. Except as prohibited by applicable law or the Certificate of Incorporation, the stockholders holding a majority of the shares then entitled to vote at an election of directors may remove any director from office with or without cause.

Section 3.06 Fees and Expenses. Directors shall receive such reasonable fees for their services on the Board of Directors and any committee thereof and such reimbursement of their actual and reasonable expenses as may be fixed or determined by the Board of Directors.

Section 3.07 Regular Meetings. Regular meetings of the Board of Directors may be held without notice at such times and at such places as may be determined from time to time by the Board of Directors.

Section 3.08 Special Meetings. Special meetings of the Board of Directors may be held at such times and at such places as may be determined by the Chair of the Board or the Chief Executive Officer on at least 24 hours’ notice to each director given by one of the means specified in Section 3.11 hereof other than by mail or on at least three days’ notice if given by mail. Special meetings shall be called by the Chair of the Board or the Chief Executive Officer in like manner and on like notice on the written request of any two or more directors. The notice need not state the purposes of the special meeting and, unless indicated in the notice thereof, any and all business may be transacted at a special meeting.

Section 3.09 Telephone Meetings. Board of Directors or Board of Directors committee meetings may be held by means of telephone conference or other communications equipment by means of which all persons participating in the meeting can hear each other and be heard. Participation by a director in a meeting pursuant to this Section 3.09 shall constitute presence in person at such meeting.

Section 3.10 Adjourned Meetings. A majority of the directors present at any meeting of the Board of Directors, including an adjourned meeting, whether or not a quorum is present, may adjourn and reconvene such meeting to another time and place. At least 24 hours’ notice of any adjourned meeting of the Board of Directors shall be given to each director whether or not present at the time of the adjournment, if such notice shall be given by one of the means specified in Section 3.11 hereof other than by mail, or at least three days’ notice if by mail. Any business may be transacted at an adjourned meeting that might have been transacted at the meeting as originally called.

Section 3.11 Notices. Subject to Section 3.08, Section 3.10, and Section 3.12 hereof, whenever notice is required to be given to any director by applicable law, the Certificate of Incorporation, or these by-laws, such notice shall be deemed given effectively if given in person or by telephone, mail addressed to such director at such director’s address as it appears on the records of the Corporation, facsimile, e-mail, or by other means of electronic transmission.

Section 3.12 Waiver of Notice. Whenever notice to directors is required by applicable law, the Certificate of Incorporation, or these by-laws, a waiver thereof, in writing signed by, or by electronic transmission by, the director entitled to the notice, whether before or after such notice is required, shall be deemed equivalent to notice. Attendance by a director at a meeting shall constitute a waiver of notice of such meeting except when the director attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business on the ground that the meeting was not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special Board of Directors or committee meeting need be specified in any waiver of notice.

Section 3.13 Organization. At each regular or special meeting of the Board of Directors, the Chair of the Board or, in his or her absence, the lead independent director or, in his or her absence, another director or officer selected by the Board of Directors shall preside. The Secretary shall act as secretary at each meeting of the Board of Directors. If the Secretary is absent from any meeting of the Board of Directors, an assistant secretary of the Corporation shall perform the duties of secretary at such meeting; and in the absence from any such meeting of the Secretary and all assistant secretaries of the Corporation, the person presiding at the meeting may appoint any person to act as secretary of the meeting.

Section 3.14 Quorum of Directors. Except as otherwise provided by these by-laws, the Certificate of Incorporation, or required by applicable law, the presence of a majority of the total number of directors on the Board of Directors shall be necessary and sufficient to constitute a quorum for the transaction of business at any meeting of the Board of Directors.

Section 3.15 Action by Majority Vote. Except as otherwise provided by these by-laws, the Certificate of Incorporation, or required by applicable law, the vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors.

Section 3.16 Directors’ Action Without Meeting. Unless otherwise restricted by the Certificate of Incorporation or these by-laws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting if all directors or members of such committee, as the case may be, consent thereto in writing or by electronic transmission.

Section 3.17 Chair of the Board. The Board of Directors shall annually elect one of its members to be its chair (the “Chair of the Board”) and shall fill any vacancy in the position of Chair of the Board at such time and in such manner as the Board of Directors shall determine. Except as otherwise provided in these by-laws, the Chair of the Board shall preside at all meetings of the Board of Directors and of stockholders. The Chair of the Board shall perform such other duties and services as shall be assigned to or required of the Chair of the Board by the Board of Directors.


Section 3.18 Committees of the Board of Directors. The Board of Directors may designate one or more committees, each committee to consist of one or more of the directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. If a member of a committee shall be absent from any meeting, or disqualified from voting, the remaining member or members present at the meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent permitted by applicable law, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation and may authorize the seal of the Corporation to be affixed to all papers that may require it to the extent so authorized by the Board of Directors. Unless the Board of Directors provides otherwise, at all meetings of such committee, a majority of the then authorized members of the committee shall constitute a quorum for the transaction of business, and the vote of a majority of the members of the committee present at any meeting at which there is a quorum shall be the act of the committee. Each committee shall keep regular minutes of its meetings. Unless the Board of Directors provides otherwise, each committee designated by the Board of Directors may make, alter and repeal rules and procedures for the conduct of its business. In the absence of such rules and procedures each committee shall conduct its business in the same manner as the Board of Directors conducts its business pursuant to this Article III.

ARTICLE IV

OFFICERS

Section 4.01 Positions and Election. The officers of the Corporation shall be chosen by the Board of Directors and shall include a chief executive officer (the “Chief Executive Officer”), a president (the “President”), a chief financial officer (the “Chief Financial Officer”), a treasurer (the “Treasurer”), and a secretary (the “Secretary”). The Board of Directors, in its discretion, may also elect one or more vice presidents, assistant treasurers, assistant secretaries, and other officers in accordance with these by-laws. Any two or more offices may be held by the same person.

Section 4.02 Term. Each officer of the Corporation shall hold office until such officer’s successor is elected and qualified or until such officer’s earlier death, resignation, or removal. Any officer elected or appointed by the Board of Directors may be removed by the Board of Directors at any time with or without cause by the majority vote of the members of the Board of Directors then in office. The removal of an officer shall be without prejudice to his or her contract rights, if any. The election or appointment of an officer shall not of itself create contract rights. Any officer of the Corporation may resign at any time by giving notice of his or her resignation in writing, or by electronic transmission, to the President or the Secretary. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, immediately upon its receipt. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective. Should any vacancy occur among the officers, the position shall be filled for the unexpired portion of the term by appointment made by the Board of Directors.

Section 4.03 Chief Executive Officer. The Chief Executive Officer shall, subject to the provisions of these by-laws and the control of the Board of Directors, have general supervision, direction, and control over the business of the Corporation and over its officers. The Chief Executive Officer shall perform all duties incident to the office of the Chief Executive Officer, and any other duties as may be from time to time assigned to the Chief Executive Officer by the Board of Directors, in each case subject to the control of the Board of Directors.

Section 4.04 President. The President shall report and be responsible to the Chief Executive Officer. The President shall have such powers and perform such duties as from time to time may be assigned or delegated to the President by the Board of Directors or the Chief Executive Officer or that are incident to the office of president.

Section 4.05 Vice Presidents. Each vice president of the Corporation shall have such powers and perform such duties as may be assigned to him or her from time to time by the Board of Directors, the Chief Executive Officer, or the President, or that are incident to the office of vice president.

Section 4.06 Secretary. The Secretary shall attend all sessions of the Board of Directors and all meetings of the stockholders and record all votes and the minutes of all proceedings in a book to be kept for that purpose, and shall perform like duties for committees of the Board of Directors when required. He or she shall give, or cause to be given, notice of all meetings of the stockholders and meetings of the Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors, the Chair of the Board, or the Chief Executive Officer. The Secretary shall keep in safe custody the seal of the Corporation and have authority to affix the seal to all documents requiring it and attest to the same.

Section 4.07 Chief Financial Officer. The Chief Financial Officer shall be the principal financial and accounting officer of the Corporation and shall have such powers and perform such duties as may be assigned by the Board of Directors, the Chair of the Board, or the Chief Executive Officer.

Section 4.08 Treasurer. The treasurer of the Corporation shall have the custody of the Corporation’s funds and securities, except as otherwise provided by the Board of Directors, and shall keep full and accurate accounts of receipts and disbursements in records belonging to the Corporation and shall deposit all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. The treasurer shall disburse the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall render to the Chief Executive Officer and the President and the directors, at the regular meetings of the Board of Directors,


or whenever they may require it, an account of all his or her transactions as treasurer and of the financial condition of the Corporation.

Section 4.09 Other Officers. Such other officers as the Board of Directors may choose shall perform such duties and have such powers as from time to time may be assigned to them by the Board of Directors. The Board of Directors may delegate to any other officer of the Corporation the power to choose such other officers and to prescribe their respective duties and powers.

Section 4.10 Duties of Officers May Be Delegated. In case any officer is absent, or for any other reason that the Board of Directors may deem sufficient, the Chief Executive Officer or the President or the Board of Directors may delegate for the time being the powers or duties of such officer to any other officer or to any director.

ARTICLE V

INDEMNIFICATION

Section 5.01 Indemnification. The Corporation shall indemnify and hold harmless to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person who was or is made or is threatened to be made a party or is otherwise involved in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative (a “Proceeding”), by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, enterprise, or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys’ fees) actually and reasonably incurred by such person. Notwithstanding the preceding sentence, the Corporation shall be required to indemnify a person in connection with a Proceeding (or part thereof) commenced by such person only if the commencement of such Proceeding (or part thereof) by the person was authorized in the specific case by the Board of Directors.

Section 5.02 Advancement of Expenses. The Corporation shall pay the expenses (including attorneys’ fees) actually and reasonably incurred by a director or officer of the Corporation in defending any Proceeding in advance of its final disposition, upon receipt of an undertaking by or on behalf of such person to repay all amounts advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such person is not entitled to be indemnified for such expenses under this Section 5.02 or otherwise. Payment of such expenses actually and reasonably incurred by such person, may be made by the Corporation, subject to such terms and conditions as the general counsel of the Corporation in his or her discretion deems appropriate.

Section 5.03 Non-Exclusivity of Rights. The rights conferred on any person by this Article V will not be exclusive of any other right which such person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation, these by-laws, agreement, vote of stockholders or disinterested directors, or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding office. The Corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees, or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL.

Section 5.04 Other Indemnification. The Corporation’s obligation, if any, to indemnify any person who was or is serving at its request as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, enterprise, or nonprofit entity shall be reduced by any amount such person may collect as indemnification from such other corporation, partnership, joint venture, trust, enterprise, or nonprofit entity.

Section 5.05 Insurance. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee, or agent of the Corporation, or is or was serving at the request of Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, enterprise, or nonprofit entity against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under the provisions of the DGCL.

Section 5.06 Repeal, Amendment, or Modification. Any amendment, repeal, or modification of this Article V shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.

ARTICLE VI

STOCK CERTIFICATES AND THEIR TRANSFER

Section 6.01 Certificates Representing Shares. The shares of stock of the Corporation shall be represented by certificates; provided that the Board of Directors may provide by resolution or resolutions that some or all of any class or series shall be uncertificated shares that may be evidenced by a book-entry system maintained by the registrar of such stock. If shares are represented by certificates, such certificates shall be in the form, other than bearer form, approved by the Board of Directors. The certificates representing shares of stock shall be signed by, or in the name of, the Corporation by any two authorized officers of the Corporation. Any or all such signatures may be facsimiles. In case any officer, transfer agent, or registrar who has signed such a certificate ceases to be an officer, transfer agent, or registrar before such certificate has been issued, it may nevertheless be issued by the Corporation with the same effect as if the signatory were still such at the date of its issue.

Section 6.02 Transfers of Stock. Stock of the Corporation shall be transferable in the manner prescribed by law and in these by-laws. Transfers of stock shall be made on the books administered by or on behalf of the


Corporation only by the direction of the registered holder thereof or such person’s attorney, lawfully constituted in writing, and, in the case of certificated shares, upon the surrender to the Company or its transfer agent or other designated agent of the certificate thereof, which shall be cancelled before a new certificate or uncertificated shares shall be issued.

Section 6.03 Transfer Agents and Registrars. The Board of Directors may appoint, or authorize any officer or officers to appoint, one or more transfer agents and one or more registrars.

Section 6.04 Lost, Stolen, or Destroyed Certificates. The Board of Directors or the Secretary may direct a new certificate or uncertificated shares to be issued in place of any certificate theretofore issued by the Corporation alleged to have been lost, stolen, or destroyed upon the making of an affidavit of that fact by the owner of the allegedly lost, stolen, or destroyed certificate. When authorizing such issue of a new certificate or uncertificated shares, the Board of Directors or the Secretary may, in its discretion and as a condition precedent to the issuance thereof, require the owner of the lost, stolen, or destroyed certificate, or the owner’s legal representative to give the Corporation a bond sufficient to indemnify it against any claim that may be made against the Corporation with respect to the certificate alleged to have been lost, stolen, or destroyed or the issuance of such new certificate or uncertificated shares.

ARTICLE VII

GENERAL PROVISIONS

Section 7.01 Seal. The seal of the Corporation shall be in such form as shall be approved by the Board of Directors. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise, as may be prescribed by law or custom or by the Board of Directors.

Section 7.02 Fiscal Year. The fiscal year of the Corporation shall be the calendar year.

Section 7.03 Checks, Notes, Drafts, Etc. All checks, notes, drafts, or other orders for the payment of money of the Corporation shall be signed, endorsed, or accepted in the name of the Corporation by such officer, officers, person, or persons as from time to time may be designated by the Board of Directors or by an officer or officers authorized by the Board of Directors to make such designation.

Section 7.04 Conflict with Applicable Law or Certificate of Incorporation. These by-laws are adopted subject to any applicable law and the Certificate of Incorporation. Whenever these by-laws may conflict with any applicable law or the Certificate of Incorporation, such conflict shall be resolved in favor of such law or the Certificate of Incorporation.

Section 7.05 Books and Records. Any records administered by or on behalf of the Corporation in the regular course of its business, including its stock ledger, books of account, and minute books, may be maintained on any information storage device, method, or one or more electronic networks or databases (including one or more distributed electronic networks or databases); provided that the records so kept can be converted into clearly legible paper form within a reasonable time, and, with respect to the stock ledger, the records so kept comply with Section 224 of the DGCL. The Corporation shall so convert any records so kept upon the request of any person entitled to inspect such records pursuant to applicable law.

Section 7.06 Forum for Adjudication of Disputes.

(a) Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for:

(i)any derivative action or proceeding brought on behalf of the Corporation;

(ii)any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee, or agent of the Corporation to the Corporation or the Corporation’s stockholders;

(v)any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, the Certificate of Incorporation, or these by-laws; or

(vi)any action asserting a claim governed by the internal affairs doctrine;

in each case, subject to said court having personal jurisdiction over the indispensable parties named as defendants therein. If any action the subject matter of which is within the scope of this Section 7.06 is filed in a court other than a court located within the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder shall be deemed to have consented to: (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce this Section 7.06 (an “Enforcement Action”); and (ii) having service of process made upon such stockholder in any such Enforcement Action by

service upon such stockholder’s counsel in the Foreign Action as agent for such stockholder. Any person or entity purchasing or

otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 7.06(a).

(b) Unless the Corporation consents in writing to the selection of an alternative forum, the federal district courts of the United States of America located in the Southern District of Florida shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 7.06(b).

ARTICLE VIII

AMENDMENTS


These by-laws may be adopted, amended, or repealed by the stockholders entitled to vote; provided, however, that the Corporation may, in its Certificate of Incorporation, confer the power to adopt, amend, or repeal these by-laws upon the Board of Directors; and, provided further, that any proposal by a stockholder to amend these by-laws will be subject to the provisions of Article II of these by-laws except as otherwise required by law. The fact that such power has been so conferred upon the Board of Directors will not divest the stockholders of the power, nor limit their power to adopt, amend, or repeal by-laws.


Exhibit 4.5

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

Alfi, Inc. (“Alfi”, the “Corporation” or “we”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.0001 per share (the “common stock”).

Authorized Capital Stock

Our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0001 per share, and 8,000,000 shares of preferred stock, par value $0.0001 per share, all of which shares of preferred stock are undesignated.

Common Stock

Holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders, including the election of directors. Such holders are not entitled to vote cumulatively for the election of directors. Holders of a majority of the shares of common stock may elect all of the directors standing for election. Subject to preferences that may be applicable to any outstanding preferred stock, common stockholders are entitled to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally available for that purpose. In the event of our liquidation, dissolution or winding up, the common stockholders are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. Common stockholders have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock.

We have never declared or paid any cash dividends on our capital stock. We currently expect to retain future earnings, if any, to finance the growth and development of our business and do not anticipate paying any cash dividends in the foreseeable future.

Preferred Stock

Under our Third Amended and Restated Certificate of Incorporation (our “Charter”), our board of directors is authorized, without action by the stockholders, to designate and issue preferred stock in one or more series and to designate the powers, preferences and rights of each series, which may be greater than the rights of the common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of holders of the common stock until our board of directors determines the specific rights of the holders of such preferred stock. However, the effects might include, among other things:

·

impairing dividend rights of the common stock;

·

diluting the voting power of the common stock;

·

impairing the liquidation rights of the common stock; and

·

delaying or preventing a change in control of us without further action by the stockholders.

Common Stock Purchase Warrants Issued in Our Initial Public Offering

In connection with our initial public offering completed on May 6, 2021, we issued and sold 4,291,045 shares of common stock and warrants to purchase 4,291,045 shares of common stock (including 559,701 shares of common stock and warrants to purchase 559,701 shares of common stock pursuant to full exercise of the underwriters’ overallotment option). The following is a summary of certain terms and provisions of the common stock purchase warrants we issued and sold in our initial public offering.


Exercisability. The warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the shares of common stock underlying the warrants under the Securities Act of 1933, as amended (the “Securities Act”), is effective and available for the issuance of such shares, or an exemption from registration under the Securities Act is available for the issuance of such shares, by payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares of common stock underlying the warrants under the Securities Act is not effective or available and an exemption from registration under the Securities Act is not available for the issuance of such shares, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according to the formula set forth in the warrant. No fractional shares of common stock will be issued in connection with the exercise of a warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up or down, as applicable, to the next whole share.

Exercise Limitation. A holder does not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own more than 4.99% of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the terms of the warrants, except that upon notice from the holder to us, the holder may waive such limitation up to a percentage, not in excess of 9.99% of the number of shares of the common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants.

Exercise Price. The exercise price per whole share of common stock purchasable upon exercise of the warrants is $4.57 per share. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting the common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.

Transferability. Subject to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.

Warrant Agent. The warrants were issued in registered form under a warrant agency agreement between VStock Transfer, LLC, as warrant agent, and us. Upon closing of our initial public offering, our warrants were represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company (“DTC”), and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

Fundamental Transactions. In the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization or reclassification of the common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of the outstanding common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by the outstanding common stock, the holders of the warrants are entitled to receive upon exercise of the warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior to such fundamental transaction.

Rights as a Stockholder. Except as otherwise provided in the warrants or by virtue of such holder’s ownership of shares of the common stock, the holder of a warrant does not have the rights or privileges of a holder of the common stock, including any voting rights, until the holder exercises the warrant.

Governing Law. The warrants and the warrant agency agreement are governed by New York law.

Anti-Takeover Effects of our Charter and Bylaws and Delaware Law

Our Charter and Amended and Restated By-laws (our “Bylaws”) include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts. These provisions include the items described below.

2


Filling Newly Created Directorship and Vacancies

Any newly created directorships resulting from an increase in the authorized number of directors and any vacancies occurring in our board of directors, may be filled by the affirmative votes of a majority of the remaining members of our board, although less than a quorum, or by a sole remaining director. A director so elected shall be elected to hold office until the earlier of the expiration of the term of office of the director whom he or she has replaced, a successor is duly elected and qualified, or the earlier of such director’s death, resignation, or removal. The treatment of vacancies has the effect of making it more difficult for stockholders to change the composition of our board.

No Written Consent of Stockholders

Our Charter provides that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our Bylaws or removal of directors by our stockholders without holding a meeting of stockholders.

Special Meetings of Stockholders

Except as otherwise required by law and subject to the rights of the holders of any series of preferred stock, special meetings of the stockholders of the Corporation shall be called only by: (i) our board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office; or (ii) the Secretary of the Corporation, following receipt of one or more written demands to call a special meeting of the stockholders from stockholders of record who own, in the aggregate, at least 25% of the voting power of the outstanding shares of the Corporation then entitled to vote on the matter or matters to be brought before the proposed special meeting that complies with the procedures for calling a special meeting of the stockholders as forth in our Byaws. Pursuant to our Bylaws, the business transacted at a special meeting requested by stockholders shall be limited to the matters described in the special meeting request; provided, however, that nothing in our Bylaws prohibits our board of directors from submitting matters to the stockholders at any special meeting requested by stockholders.

Advance Notice Requirements

Our Bylaws include advance notice procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our Bylaws specify the requirements as to form and content of all stockholders’ notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting.

Amendment to Charter and Bylaws

Any amendment of our Charter must first be approved by a majority of our board of directors, and if required by law or our Charter, must thereafter be approved by a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to the number of directors, their terms of office, limitation of liability and indemnification must be approved by not less than two-thirds of the outstanding shares entitled to vote on the amendment, and not less than two-thirds of the outstanding shares of each class entitled to vote thereon as a class.

Our Charter and Bylaws expressly authorize and empower our board of directors to adopt, amend, alter, or repeal our Bylaws without any action on the part of the stockholders. The stockholders also may adopt, amend, alter or repeal our Bylaws; provided that, in addition to any affirmative vote of the holders of any particular class or series of capital stock of the Corporation required by applicable law or our Charter, such adoption, amendment, alteration or repeal must be approved by the affirmative vote of the holders of at least two-thirds of the voting power of the shares

3


of the then outstanding voting stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class.

Undesignated Preferred Stock

Our Charter provides for authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our Charter grants our board of directors’ broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.

Choice of Forum

Our Bylaws provide that, unless we consent in writing to the selection of an alternative form, the Court of Chancery of the State of Delaware (or, if the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) will be the sole and exclusive forum for state law claims for: (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees or agents to us or our stockholders; (iii) any action asserting a claim against us, or any current or former director, officer, or other employee or stockholder, arising out of or pursuant to any provision of the General Corporation Law of the State of Delaware or our Charter or Bylaws; and (iv) any action asserting a claim against us or any current or former director or officer or other employee governed by the internal affairs doctrine; provided, however, that this choice of forum provision does not apply to any causes of action arising under the Securities Act or the Exchange Act. Our Bylaws further provide that, unless we consent in writing to an alternative forum, the United States District Court for the Southern District of Florida will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. Our Bylaws also provides that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and to have consented to this choice of forum provision. We recognize that the forum selection clause in our Bylaws may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the State of Florida, as applicable. Additionally, the forum selection clause in our Bylaws may limit our stockholders’ ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware or the United States District Court for the Southern District of Florida may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203 (“Section 203”) of the Delaware General Corporation Law (“DGCL”). In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner.

Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:

·

before the stockholder became interested, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

4


·

upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or

·

at or after the time the stockholder became interested, the business combination was approved by our board of directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.

Section 203 defines a business combination to include:

·

any merger or consolidation involving the corporation and the interested stockholder;

·

any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;

·

subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

·

subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and

·

the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.

Limitation of Liability and Indemnification

As permitted by the DGCL, provisions in our Charter and Bylaws limit or eliminate the personal liability of our directors.  Thus, directors will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director.

In addition, our Charter and Bylaws provide that we may (i) indemnify our directors and officers to the fullest extent permitted by applicable law, subject to limited exceptions, including an exception for indemnification in connection with a proceeding initiated by such persons authorized in the specific case by the board of directors; and (ii) advance expenses, including attorney’s fees, actually incurred by a director or officer in connection with legal proceedings, subject to certain terms and conditions.

We may also maintain general liability insurance that covers our directors, officers, employees and agents against any liability for claims in any such capacity, whether or not we would have the power to indemnify such persons against such liability under the DGCL.

These provisions may discourage stockholders from bringing a lawsuit against our directors or officers for breach of their fiduciary duty. These provisions may also discourage stockholders from bringing a derivative lawsuit against our directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to indemnification provisions, a stockholder’s investment may be adversely affected.

Nasdaq Capital Market Listing

5


The common stock is listed on The Nasdaq Capital Market under the symbol “ALF.” The common stock purchase warrants issued in connection with our initial public offering in May 2021 are listed on the Nasdaq Capital Market under the symbol “ALFIW.”

Transfer Agent and Registrar

The transfer agent and registrar for the common stock and the Warrant Agent is VStock Transfer, LLC. The transfer agent’s address is 18 Lafayette Place, Woodmere, NY 11598, and its telephone number is (212) 828-8436.

6


Exhibit 10.16

ALFI, INC.

429 Lenox Avenue

Suite 547

Miami Beach, Florida 33139

February 2, 2022

Mr. Paul Pereira

1521 Alton Road, #287

Miami Beach, FL 33139

Re:

Resignation of all positions with Alfi, Inc. (the “Company”) and its subsidiaries and affiliates.

Mr. Pereira:

This letter agreement (this “Letter Agreement”) will confirm the understanding and agreement between the Company and Paul Pereira (“You,” and collectively with the Company, the “Parties”) with respect to the subject matter hereof.

1.

Resignation. You hereby resign your position as a director of the Company and all other positions you hold with the Company, and its subsidiaries and affiliates, effective as of the date of this Letter Agreement written above (the “Effective Date”). You acknowledge and agree that your resignation as a director is not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. You acknowledge that the Company provided to You the disclosures the Company is making in connection with your resignation as a director in response to Item 5.02 of Form 8-K and you agree with such statements.

2.

Employment.

a.

You hereby agree that your resignation constitutes termination by You of your employment with the Company, effective as of the Effective Date, and the Company agrees to such termination date.

b.

You and the Company acknowledge and agree that the following will constitute all of the obligations of the Company, or its subsidiaries or affiliates, due to You in connection with your employment with the Company or the termination of such employment, or under the provisions of the Employment Agreement (as defined in Section 2(d) below): (i) the Company will pay to You, within thirty days following the Effective Date, any accrued but unpaid Base Salary (as defined in the Employment Agreement) through the Effective Date; (ii) if You timely and properly elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), and subject to You not revoking your release of any Age Discrimination in Employment Act claims set forth in the Release (as defined in Section 3 below), then the Company will reimburse You for your monthly COBRA


Mr. Paul Pereira

February 2, 2022

Page 2

premium for a period of 18 months after the Effective Date; and (iii) the Company will comply with (or continue to comply with, as the case may be) its existing obligations to You for indemnification, advancement, exculpation and hold harmless rights pursuant to the Amended and Restated By-Laws of the Company in the form attached as Exhibit 3.4 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission (the “By-Laws”), any applicable law, and/or Section 6 of the Employment Agreement. The Parties further agree that this provision is in furtherance of the By-Laws, applicable law, applicable insurance coverage, and Section 6 of the Employment Agreement, and shall not be deemed to be exclusive or diminish or abrogate any of Your rights thereunder. You acknowledge and agree that Your obligations under the Employment Agreement which survive the termination of your employment with the Company remain in full force and effect.

c.

You acknowledge and agree that the Employment Agreement, the By-Laws, this Letter Agreement and the Release are the only agreements You have with the Company, or its subsidiaries or affiliates, regarding your employment with the Company or your service as a director of the Company.

d.

For purposes of this Letter Agreement, “Employment Agreement” means the Executive Employment Agreement, dated February 10, 2021, between the Company and You, in the form attached as Exhibit 10.5 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission.

3.

Release. In connection with, and contemporaneously with, your execution and delivery of this Letter Agreement, You will execute and deliver to the Company the Limited Release of Claims attached hereto as Exhibit A (the “Release”).

Please indicate your agreement with the foregoing provisions by signing below and returning a copy of this Letter Agreement and the Release to the Company.

Sincerely,

ALFI, INC.

By:

/s/ Peter Bordes

Name: Peter Bordes

Title: Interim Chief Executive Officer

AGREED, ACKNOWLEDGED AND ACCEPTED:

/s/ Paul Pereira 2/2/2022

PAUL PEREIRA


Exhibit 10.17

LIMITED RELEASE OF CLAIMS

This Limited Release of Claims (hereinafter, this “Release”) is made and entered into as of February 2, 2022 (the “Effective Date”), by and between Paul Pereira (“Pereira”) and Alfi, Inc. (the “Company”) (collectively, the “Parties”).

W I T N E S S E T H:

WHEREAS, Pereira and the Company have entered into that certain letter agreement, dated as of the date hereof, regarding Pereira’s resignation from the Company and the termination of his employment (the “Letter Agreement”);

WHEREAS, Pereira and the Company have entered into that certain Executive Employment Agreement, dated February 10, 2021, in the form attached as Exhibit 10.5 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) (the “Employment Agreement”), filed with the Securities and Exchange Commission; and

WHEREAS, this Release shall not be deemed in any manner as an admission, finding, or indication for any purposes whatsoever, that either Party, or any of the Company’s officials, officers, employees, and/or other agents acted contrary to the law or violated the rights of Pereira or any other person at any time.

Now, therefore, in exchange for good and valuable consideration, the sufficiency and receipt of which is hereby acknowledged, the Parties agree as follows:

1.

CONSIDERATION

a.In compromise and settlement of all of Pereira’s claims against Releasees (as defined and limited in Paragraph 2 of this Release and related sub-parts), the Company has entered into and undertaken its obligations under the Letter Agreement, including, without limitation: (i) to pay to Pereira, within thirty days following the Effective Date, any accrued but unpaid Base Salary (as defined in the Employment Agreement) through the Effective Date; (ii) to reimburse Pereira for the amount of his premiums for continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 for a period of 18 months as set forth in, and accordance with, the terms of the Letter Agreement (the total amount of such reimbursements, the “Final Compensation Payment”); and (iii) to comply with (or continue to comply with, as the case may be) the Company’s  existing obligations to Pereira for indemnification, advancement, exculpation and hold harmless rights pursuant to the Amended and Restated By-Laws of the Company in the form attached as Exhibit 3.4 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission, applicable law and/or Section 6 of the Employment Agreement (collectively, the “Company’s Indemnification Obligations”).

b.Pereira accepts full and complete responsibility for any federal, state, and/or local taxes that may be required by law to be paid with respect to the Final Compensation Payment.


Pereira acknowledges that no representation has been made to him under this Release or at any other time regarding or relating to the tax status of the Final Compensation Payment and that he is not relying in any way upon the Company or Releasees in this regard.

2.LIMITED WAIVER AND LIMITED RELEASE OF CLAIMS

a.In exchange for the foregoing consideration described in Paragraph 1 of this Release, the sufficiency of which is hereby acknowledged, and except as set forth herein in Paragraphs 2c. and 2d. of this Release, Pereira, for himself, his spouse, assigns, heirs, executors, administrators, and any other agents or representatives, hereby fully and finally releases and discharges the Company, its direct and indirect parents, subsidiaries and/or related entities, and all of their respective present or former employees, attorneys, outside investigators, officers, directors, agents, representatives, and each of them (collectively, “Releasees”), from any and all claims, demands, actions, causes of action, suits, damages, losses, costs, expenses, and attorneys’ fees of any kind and every character whatsoever, whether known or unknown, which he has or may have, or may later claim to have had, against one or more of Releasees pursuant to or under the Employment Agreement and/or for any other compensation or financial remuneration due to Pereira in his capacity as an employee of the Company, or any of its subsidiaries or affiliates (collectively, the “Compensation Claims”).

b.Without in any way limiting the foregoing, the Compensation Claims  waived and released by Pereira include any possible or alleged claims under the Civil Rights Act of 1866, 42 U.S.C. § 1981; the Civil Rights Act of 1991, Pub. L. No. 102-166, 105 stat. 1071 (1991); the Civil Rights Act of 1871, 42 U.S.C. § 1983; Executive Order 11246; the Equal Pay Act of 1963, 29 U.S.C. § 206; the anti-retaliation provisions of the Fair Labor Standards Act of 1938 (FLSA), 29 U.S.C. § 201, et seq.; Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e, et seq.; the Age Discrimination in Employment Act (ADEA), 29 U.S.C. § 621, et seq.; the Americans with Disabilities Act of 1990 (ADA), 42 U.S.C. § 12101, et seq.; the Americans with Disabilities Act Amendments Act of 2008 (ADAAA), Pub. L. No. 110-325; the Family and Medical Leave Act (FMLA), 29 U.S.C. § 2601, et seq.; the Fair Credit Reporting Act (FCRA), 15 U.S.C. § 1681, et seq.; the Genetic Information Nondiscrimination Act of 2008 (GINA), 42 U.S.C. § 2000ff et seq.; and under any other federal, state (including claims under the jurisdiction of the Florida Commission on Human Relations), local, constitutional, or common law, statute, ordinance, resolution, charter, or regulation; any and all claims arising out of any alleged tort, including, but not limited to, claims of willful, intentional, or negligent infliction of emotional harm and/or distress, negligent retention, whistleblower retaliation, tortious breach or interference with business or contractual relations, defamation, fraud, or any other unlawful behavior; any and all claims for monetary recovery, including past or future lost wages, pension accruals, employee benefits, liquidated, compensatory and/or punitive damages, and/or attorneys’ fees and expenses; and any and all claims of whatsoever nature asserted or which could be asserted by Pereira in any lawsuit, claim, complaint, grievance, appeal, or charge against any of the Releasees for or on account of any Compensation Claim existing or occurring up to and including the date on which this Release is signed by Pereira, except as otherwise provided herein.

c.Pereira hereby acknowledges, understands, and agrees that the release set forth in Paragraph 2 of this Release is absolute with regard to the Compensation Claims.  The Parties agree

-2-


and acknowledge that the release set forth in Paragraph 2 of this Release does not apply to any matter relating to: (i) the Company’s Indemnification Obligations; (ii) any alleged breach by the Company of this Release or the Letter Agreement; (iii) any vested benefits; or (iv) to any other claim which cannot be released by private agreement, including, but not limited to, the validity of this Release under the Age Discrimination in Employment Act (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”). Pereira further acknowledges, understands, and agrees that said release operates as a waiver of his right to recover in any such administrative proceeding as well as his right to recover in any action brought on Pereira’s behalf by any other party, including, but not limited to, the EEOC, or any comparable federal, state, or local agency as to the Compensation Claims arising from events from the beginning of time through the effective date of this Release.

d.For the avoidance of doubt, the execution of this Release is limited solely to the Compensation Claims and nothing herein is intended to waive, release, restrict, limit or otherwise curtail Pereira’s rights as a shareholder or to otherwise affect Pereira’s equity interest in the Company.

e.Except as set forth in this Release or the Letter Agreement, including without limitation preservation of the Company’s Indemnification Obligations, Pereira acknowledges and agrees that he is not entitled to any further payment or compensation, of whatever kind, from the Company, whether under the Employment Agreement or otherwise.

f.Pereira certifies that he has the intention of releasing all Compensation Claims recited herein in exchange for the consideration described in Paragraph 1 of this Release.  Pereira acknowledges, understands, and agrees that the consideration described in Paragraph 1 of this Release includes consideration over and above anything of value to which he is already entitled.

3.ADEA AND OWBPA ACKNOWLEDGMENTS

a.Pursuant to the ADEA, for the release of any federal age claims Pereira has or may have against any of the Releasees, Pereira acknowledges and understands that he has been afforded a reasonable period of time, up to twenty-one (21) calendar days, in which to consider the terms and conditions of this Release. Pereira further acknowledges and agrees, by his signature, that he has taken as much of the consideration period as needed or wanted to consider this Release before signing.  Pereira further acknowledges that he has had the opportunity to consult with his attorneys, accountants, tax advisors, and/or spouse regarding whether to execute this Release and to release any claim that may or may not exist. Pereira further acknowledges that no representations have been made to him by the Company or by any of the other Releasees concerning the terms or effects of this Release other than those contained herein.

b.Pereira further acknowledges that he may revoke his release of any ADEA claims as set forth in this Release within seven (7) calendar days after he signs it.  Pereira further acknowledges that, to be effective, his revocation must be in writing and returned to Edward J. Hardin, c/o Smith, Gambrell & Russell, LLP, 1105 W. Peachtree St. NE, Suite 1000, Atlanta, Georgia 30309.  Pereira further acknowledges that, if by mail, the revocation must be: (i) postmarked within the 7-day period; (ii) properly addressed; (iii) postage prepaid; and (iv) sent by

-3-


certified mail, return receipt requested.  Pereira further agrees that if he exercises his right to revoke, in addition to providing the required written notice within the 7-day revocation period, he or his counsel will provide additional notice of such revocation by calling Edward J. Hardin at (404) 815-3553 within the 7-day revocation period and advising him of such revocation decision by telephone or through voicemail.

Pereira acknowledges and agrees that in the event he revokes his release of any ADEA claims as set forth in this Release, Pereira shall not be entitled to, and the Company shall have no obligation to pay, the Final Compensation Payment.

For the avoidance of doubt, the Parties acknowledge and agree that, following Pereira’s execution of this Release, he may not and shall not revoke any terms or provisions of the Letter Agreement or the release of any claims set forth in this Release, except for the release of any ADEA claims, which may only be revoked in accordance with Section 3b. of this Release.

4.COVENANT NOT TO SUE

Except as to those claims identified in Paragraphs 2c. and 2d. of this Release, Pereira agrees and covenants not to institute any action, administrative proceeding, charge, complaint, grievance, appeal, or suit against any Releasee with any state, federal, or local court or agency or other tribunal or forum for any Compensation Claim arising from events occurring prior to the execution of this Release.

5.

REMEDIES FOR BREACH

In the event of a breach of any material term of this Release, the non-breaching party shall have available to it all remedies and damages under law.

6.

MISCELLANEOUS

a.The Parties acknowledge, understand, and agree that this Release may not be modified or canceled in any manner, except as otherwise provided herein or in writing signed by both Parties.

c.No provision of this Release is inferred or shall be interpreted or applied so as to preclude any party to this Release from complying with any federal, state, or local law, rule, or regulation.

d.Each provision of this Release shall be considered separable, distinct and severable from the other and remaining provisions, and any breach, invalidity or unenforceability of any provision shall not impair the operation, validity or enforceability of those provisions that are valid, and to the extent allowed by law, such invalid or otherwise unenforceable provision may be modified by a court of competent jurisdiction so as to render it enforceable.

e.The Parties acknowledge, understand, and agree that this Release shall be interpreted, enforced, and governed by and under the laws of the State of Florida except that the

-4-


preservation of the Company’s Indemnification Obligations shall be interpreted, enforced, and governed by Delaware law.

PEREIRA HAS READ AND CONSIDERED THE TERMS AND CONDITIONS CONTAINED IN THIS RELEASE.  PEREIRA FULLY UNDERSTANDS THAT HIS RIGHT TO RECEIVE THE BENEFITS DESCRIBED HEREIN IS SUBJECT TO THE TERMS AND CONDITIONS SET FORTH IN THIS RELEASE OF CLAIMS, AND THAT HE WOULD NOT RECEIVE SUCH BENEFITS BUT FOR HIS EXECUTION OF THIS RELEASE AND THE LETTER AGREEMENT.  PEREIRA ALSO FULLY UNDERSTANDS THAT BY EXECUTION OF THIS RELEASE, HE WILL BE WAIVING HIS RIGHTS UNDER FEDERAL, STATE, AND LOCAL LAW TO BRING ANY CLAIMS THAT HE HAS OR MIGHT HAVE AGAINST ANY ONE OR MORE RELEASEES (EXCEPT AS OTHERWISE PROVIDED HEREIN). PEREIRA ACKNOWLEDGES, UNDERSTANDS, AND AGREES THAT HE HAS BEEN AFFORDED REASONABLE TIME TO CONSIDER THIS RELEASE, THAT HE HAS BEEN ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTING THIS RELEASE, AND THAT HE HAS ALSO HAD AN OPPORTUNITY TO DISCUSS THIS RELEASE WITH HIS ACCOUNTANT AND TAX ADVISOR.

The Parties knowingly and voluntarily execute this Release as of the date set forth below.

ACCEPTED AND AGREED BY: Paul Pereira

Signature:

/s/ Paul Pereira

Date:

2/2/2022

ACCEPTED AND AGREED BY: Alfi, Inc.

Printed Name:

Peter Bordes

Title:

Interim CEO

Signature:

/s/ Peter Bordes

Date:

February 3, 2022

-5-


Exhibit 10.18

ALFI, INC.

429 Lenox Avenue

Suite 547

Miami Beach, Florida 33139

February 2, 2022

Mr. Dennis McIntosh

185 Smith Road

Box 1956

Wilmington, VT 05363

Re:

Resignation of all positions with Alfi, Inc. (the “Company”) and its subsidiaries and affiliates.

Mr. McIntosh:

This letter agreement (this “Letter Agreement”) will confirm the understanding and agreement between the Company and Dennis McIntosh (“You,” and collectively with the Company, the “Parties”) with respect to the subject matter hereof.

1.

Resignation. You hereby resign your position as an officer of the Company and all other positions you hold with the Company, and its subsidiaries and affiliates, effective as of the date of this Letter Agreement written above (the “Effective Date”).

2.

Employment.

a.

You hereby agree that your resignation constitutes termination by You of your employment with the Company, effective as of the Effective Date, and the Company agrees to such termination date.

b.

You and the Company acknowledge and agree that the following will constitute all of the obligations of the C­ompany, or its subsidiaries or affiliates, due to You in connection with your employment with the Company or the termination of such employment, or under the provisions of the Employment Agreement (as defined in Section 2(d) below): (i) the Company will pay to You, within thirty days following the Effective Date, any accrued but unpaid Base Salary (as defined in the Employment Agreement) through the Effective Date; (ii) if You timely and properly elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), and subject to You not revoking your release of any Age Discrimination in Employment Act claims set forth in the Release (as defined in Section 3 below), then the Company will reimburse You for your monthly COBRA premium for a period of 18 months after the Effective Date; and (iii) the Company will comply with (or continue to comply with, as the case may be) its existing obligations to You for indemnification, advancement, exculpation and hold harmless rights pursuant to the Amended and Restated By-Laws of the Company in the form attached


Mr. Dennis McIntosh

February 2, 2022

Page 2

as Exhibit 3.4 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission (the “By-Laws”), any applicable law, and/or Section 6 of the Employment Agreement. The Parties further agree that this provision is in furtherance of the By-Laws, applicable law, applicable insurance coverage, and Section 6 of the Employment Agreement, and shall not be deemed to be exclusive or diminish or abrogate any of Your rights thereunder. You acknowledge and agree that Your obligations under the Employment Agreement which survive the termination of your employment with the Company remain in full force and effect.

c.

You acknowledge and agree that the Employment Agreement, the By-Laws, this Letter Agreement and the Release are the only agreements You have with the Company, or its subsidiaries or affiliates, regarding your employment with the Company or your service as a director of the Company.

d.

For purposes of this Letter Agreement, “Employment Agreement” means the Executive Employment Agreement, dated February 10, 2021, between the Company and You, in the form attached as Exhibit 10.8 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission.

3.

Release. In connection with, and contemporaneously with, your execution and delivery of this Letter Agreement, You will execute and deliver to the Company the Limited Release of Claims attached hereto as Exhibit A (the “Release”).

Please indicate your agreement with the foregoing provisions by signing below and returning a copy of this Letter Agreement and the Release to the Company.

Sincerely,

ALFI, INC.

By:

/s/ Peter Bordes

Name: Peter Bordes

Title: Interim Chief Executive Officer

AGREED, ACKNOWLEDGED AND ACCEPTED:

/s/ Dennis McIntosh 2/2/2022

DENNIS MCINTOSH


Exhibit 10.19

LIMITED RELEASE OF CLAIMS

This Limited Release of Claims (hereinafter, this “Release”) is made and entered into as of February 2, 2022 (the “Effective Date”), by and between Dennis McIntosh (“McIntosh”) and Alfi, Inc. (the “Company”) (collectively, the “Parties”).

W I T N E S S E T H:

WHEREAS, and the Company have entered into that certain letter agreement, dated as of the date hereof, regarding resignation from the Company and the termination of his employment (the “Letter Agreement”);

WHEREAS, McIntosh and the Company have entered into that certain Executive Employment Agreement, dated February 10, 2021, in the form attached as Exhibit 10.8 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) (the “Employment Agreement”), filed with the Securities and Exchange Commission; and

WHEREAS, this Release shall not be deemed in any manner as an admission, finding, or indication for any purposes whatsoever, that either Party, or any of the Company’s officials, officers, employees, and/or other agents acted contrary to the law or violated the rights of McIntosh or any other person at any time.

Now, therefore, in exchange for good and valuable consideration, the sufficiency and receipt of which is hereby acknowledged, the Parties agree as follows:

1.

CONSIDERATION

a.In compromise and settlement of all of McIntosh’s claims against Releasees (as defined and limited in Paragraph 2 of this Release and related sub-parts), the Company has entered into and undertaken its obligations under the Letter Agreement, including, without limitation: (i) to pay to, within thirty days following the Effective Date, any accrued but unpaid Base Salary (as defined in the Employment Agreement) through the Effective Date; (ii) to reimburse McIntosh for the amount of his premiums for continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 for a period of 18 months as set forth in, and accordance with, the terms of the Letter Agreement (the total amount of such reimbursements, the “Final Compensation Payment”); and (iii) to comply with (or continue to comply with, as the case may be) the Company’s  existing obligations to McIntosh for indemnification, advancement, exculpation and hold harmless rights pursuant to the Amended and Restated By-Laws of the Company in the form attached as Exhibit 3.4 to the Company’s Registration Statement on Form S-1 (Registration No. 333-251959) filed with the Securities and Exchange Commission, applicable law and/or Section 6 of the Employment Agreement (collectively, the “Company’s Indemnification Obligations”).

b.McIntosh accepts full and complete responsibility for any federal, state, and/or local taxes that may be required by law to be paid with respect to the Final Compensation Payment. McIntosh acknowledges that no representation has been made to him under this Release or at any


other time regarding or relating to the tax status of the Final Compensation Payment and that he is not relying in any way upon the Company or Releasees in this regard.

2.LIMITED WAIVER AND LIMITED RELEASE OF CLAIMS

a.In exchange for the foregoing consideration described in Paragraph 1 of this Release, the sufficiency of which is hereby acknowledged, and except as set forth herein in Paragraphs 2c. and 2d. of this Release, McIntosh, for himself, his spouse, assigns, heirs, executors, administrators, and any other agents or representatives, hereby fully and finally releases and discharges the Company, its direct and indirect parents, subsidiaries and/or related entities, and all of their respective present or former employees, attorneys, outside investigators, officers, directors, agents, representatives, and each of them (collectively, “Releasees”), from any and all claims, demands, actions, causes of action, suits, damages, losses, costs, expenses, and attorneys’ fees of any kind and every character whatsoever, whether known or unknown, which he has or may have, or may later claim to have had, against one or more of Releasees pursuant to or under the Employment Agreement and/or for any other compensation or financial remuneration due to McIntosh in his capacity as an employee of the Company, or any of its subsidiaries or affiliates (collectively, the “Compensation Claims”).

b.Without in any way limiting the foregoing, the Compensation Claims  waived and released by McIntosh include any possible or alleged claims under the Civil Rights Act of 1866, 42 U.S.C. § 1981; the Civil Rights Act of 1991, Pub. L. No. 102-166, 105 stat. 1071 (1991); the Civil Rights Act of 1871, 42 U.S.C. § 1983; Executive Order 11246; the Equal Pay Act of 1963, 29 U.S.C. § 206; the anti-retaliation provisions of the Fair Labor Standards Act of 1938 (FLSA), 29 U.S.C. § 201, et seq.; Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e, et seq.; the Age Discrimination in Employment Act (ADEA), 29 U.S.C. § 621, et seq.; the Americans with Disabilities Act of 1990 (ADA), 42 U.S.C. § 12101, et seq.; the Americans with Disabilities Act Amendments Act of 2008 (ADAAA), Pub. L. No. 110-325; the Family and Medical Leave Act (FMLA), 29 U.S.C. § 2601, et seq.; the Fair Credit Reporting Act (FCRA), 15 U.S.C. § 1681, et seq.; the Genetic Information Nondiscrimination Act of 2008 (GINA), 42 U.S.C. § 2000ff et seq.; and under any other federal, state (including claims under the jurisdiction of the Florida Commission on Human Relations), local, constitutional, or common law, statute, ordinance, resolution, charter, or regulation; any and all claims arising out of any alleged tort, including, but not limited to, claims of willful, intentional, or negligent infliction of emotional harm and/or distress, negligent retention, whistleblower retaliation, tortious breach or interference with business or contractual relations, defamation, fraud, or any other unlawful behavior; any and all claims for monetary recovery, including past or future lost wages, pension accruals, employee benefits, liquidated, compensatory and/or punitive damages, and/or attorneys’ fees and expenses; and any and all claims of whatsoever nature asserted or which could be asserted by McIntosh in any lawsuit, claim, complaint, grievance, appeal, or charge against any of the Releasees for or on account of any Compensation Claim existing or occurring up to and including the date on which this Release is signed by McIntosh, except as otherwise provided herein.

c.McIntosh hereby acknowledges, understands, and agrees that the release set forth in Paragraph 2 of this Release is absolute with regard to the Compensation Claims.  The Parties agree and acknowledge that the release set forth in Paragraph 2 of this Release does not apply to

-2-


any matter relating to: (i) the Company’s Indemnification Obligations; (ii) any alleged breach by the Company of this Release or the Letter Agreement; (iii) any vested benefits; or (iv) to any other claim which cannot be released by private agreement, including, but not limited to, the validity of this Release under the Age Discrimination in Employment Act (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”). McIntosh further acknowledges, understands, and agrees that said release operates as a waiver of his right to recover in any such administrative proceeding as well as his right to recover in any action brought on McIntosh’s behalf by any other party, including, but not limited to, the EEOC, or any comparable federal, state, or local agency as to the Compensation Claims arising from events from the beginning of time through the effective date of this Release.

d.For the avoidance of doubt, the execution of this Release is limited solely to the Compensation Claims and nothing herein is intended to waive, release, restrict, limit or otherwise curtail McIntosh’s rights as a shareholder or to otherwise affect McIntosh’s equity interest in the Company.

e.Except as set forth in this Release or the Letter Agreement, including without limitation preservation of the Company’s Indemnification Obligations, McIntosh acknowledges and agrees that he is not entitled to any further payment or compensation, of whatever kind, from the Company, whether under the Employment Agreement or otherwise.

f. McIntosh certifies that he has the intention of releasing all Compensation Claims recited herein in exchange for the consideration described in Paragraph 1 of this Release.  McIntosh acknowledges, understands, and agrees that the consideration described in Paragraph 1 of this Release includes consideration over and above anything of value to which he is already entitled.

3.ADEA AND OWBPA ACKNOWLEDGMENTS

a.Pursuant to the ADEA, for the release of any federal age claims McIntosh has or may have against any of the Releasees, McIntosh acknowledges and understands that he has been afforded a reasonable period of time, up to twenty-one (21) calendar days, in which to consider the terms and conditions of this Release. McIntosh further acknowledges and agrees, by his signature, that he has taken as much of the consideration period as needed or wanted to consider this Release before signing.  McIntosh further acknowledges that he has had the opportunity to consult with his attorneys, accountants, tax advisors, and/or spouse regarding whether to execute this Release and to release any claim that may or may not exist. McIntosh further acknowledges that no representations have been made to him by the Company or by any of the other Releasees concerning the terms or effects of this Release other than those contained herein.

b.McIntosh further acknowledges that he may revoke his release of any ADEA claims as set forth in this Release within seven (7) calendar days after he signs it.  McIntosh further acknowledges that, to be effective, his revocation must be in writing and returned to Edward J. Hardin, c/o Smith, Gambrell & Russell, LLP, 1105 W. Peachtree St. NE, Suite 1000, Atlanta, Georgia 30309.  McIntosh further acknowledges that, if by mail, the revocation must be: (i) postmarked within the 7-day period; (ii) properly addressed; (iii) postage prepaid; and (iv) sent by certified mail, return receipt requested.  McIntosh further agrees that if he exercises his right to

-3-


revoke, in addition to providing the required written notice within the 7-day revocation period, he or his counsel will provide additional notice of such revocation by calling Edward J. Hardin at (404) 815-3553 within the 7-day revocation period and advising him of such revocation decision by telephone or through voicemail.

McIntosh acknowledges and agrees that in the event he revokes his release of any ADEA claims as set forth in this Release, McIntosh shall not be entitled to, and the Company shall have no obligation to pay, the Final Compensation Payment.

For the avoidance of doubt, the Parties acknowledge and agree that, following McIntosh’s execution of this Release, he may not and shall not revoke any terms or provisions of the Letter Agreement or the release of any claims set forth in this Release, except for the release of any ADEA claims, which may only be revoked in accordance with Section 3b. of this Release.

4.COVENANT NOT TO SUE

Except as to those claims identified in Paragraphs 2c. and 2d. of this Release, McIntosh agrees and covenants not to institute any action, administrative proceeding, charge, complaint, grievance, appeal, or suit against any Releasee with any state, federal, or local court or agency or other tribunal or forum for any Compensation Claim arising from events occurring prior to the execution of this Release.

5.

REMEDIES FOR BREACH

In the event of a breach of any material term of this Release, the non-breaching party shall have available to it all remedies and damages under law.

6.

MISCELLANEOUS

a.The Parties acknowledge, understand, and agree that this Release may not be modified or canceled in any manner, except as otherwise provided herein or in writing signed by both Parties.

c.No provision of this Release is inferred or shall be interpreted or applied so as to preclude any party to this Release from complying with any federal, state, or local law, rule, or regulation.

d.Each provision of this Release shall be considered separable, distinct and severable from the other and remaining provisions, and any breach, invalidity or unenforceability of any provision shall not impair the operation, validity or enforceability of those provisions that are valid, and to the extent allowed by law, such invalid or otherwise unenforceable provision may be modified by a court of competent jurisdiction so as to render it enforceable.

e.The Parties acknowledge, understand, and agree that this Release shall be interpreted, enforced, and governed by and under the laws of the State of Florida except that the

-4-


preservation of the Company’s Indemnification Obligations shall be interpreted, enforced, and governed by Delaware law.

MCINTOSH HAS READ AND CONSIDERED THE TERMS AND CONDITIONS CONTAINED IN THIS RELEASE.  MCINTOSH FULLY UNDERSTANDS THAT HIS RIGHT TO RECEIVE THE BENEFITS DESCRIBED HEREIN IS SUBJECT TO THE TERMS AND CONDITIONS SET FORTH IN THIS RELEASE OF CLAIMS, AND THAT HE WOULD NOT RECEIVE SUCH BENEFITS BUT FOR HIS EXECUTION OF THIS RELEASE AND THE LETTER AGREEMENT.  MCINTOSH ALSO FULLY UNDERSTANDS THAT BY EXECUTION OF THIS RELEASE, HE WILL BE WAIVING HIS RIGHTS UNDER FEDERAL, STATE, AND LOCAL LAW TO BRING ANY CLAIMS THAT HE HAS OR MIGHT HAVE AGAINST ANY ONE OR MORE RELEASEES (EXCEPT AS OTHERWISE PROVIDED HEREIN). MCINTOSH ACKNOWLEDGES, UNDERSTANDS, AND AGREES THAT HE HAS BEEN AFFORDED REASONABLE TIME TO CONSIDER THIS RELEASE, THAT HE HAS BEEN ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTING THIS RELEASE, AND THAT HE HAS ALSO HAD AN OPPORTUNITY TO DISCUSS THIS RELEASE WITH HIS ACCOUNTANT AND TAX ADVISOR.

The Parties knowingly and voluntarily execute this Release as of the date set forth below.

ACCEPTED AND AGREED BY: Dennis McIntosh

Signature:

/s/Dennis McIntosh

Date:

2/2/2022

ACCEPTED AND AGREED BY: Alfi, Inc.

Printed Name:

Peter Bordes

Title:

Interim CEO

Signature:

/s/ Peter Bordes

Date:

February 3, 2022

-5-


Exhibit 10.25

Alfi, Inc. – Standard Form

Award Number: No. [ ]

ALFI, INC.

2018 STOCK INCENTIVE PLAN

STOCK OPTION AWARD AGREEMENT

1.Grant of Option.  Alfi, Inc., a Delaware corporation (the “Company”), hereby grants to ​ ​​ ​ (the “Grantee”) an option (the “Option”) to purchase the Total Number of Shares of Common Stock subject to the Option (the “Shares”), at the Exercise Price per Share (the “Exercise Price”) subject to the terms and provisions of this Stock Option Award Agreement (this “Option Agreement”) and the Alfi, Inc. 2018 Stock Incentive Plan (the “Plan”), which are incorporated herein by reference.  Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.

Award Number:

No. [ ]

Date of Award:

Type of Option:

Incentive Stock Option (“ISO”)

Non-Qualified Stock Option (“NQSO”)

Vesting Commencement Date:

Exercise Price per Share:

Total Number of Shares Subject

to the Option (the “Shares”):

Total Exercise Price:

Expiration Date:

(Date of Award + 10 years)

Post-Termination Exercise Period:

90 Days

If the Option is an ISO (as designated above), the Option is intended to qualify as an ISO as defined in Section 422 of the Internal Revenue Code (the “Code”).  However, notwithstanding such designation, the Option will qualify as an ISO only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded.

2.Vesting.

(a)Subject to the Grantee’s Continuous Service and other limitations set forth in this Option Agreement and the Plan, the Option may be exercised, in whole or in part, in accordance with the following vesting schedule, ​ ​​ ​​ ​​ ​​ ​​ ​:


Alfi, Inc. – Standard Form

Award Number: No. []

Rate

    

Options

Date

Period

2


Alfi, Inc. – Standard Form

(b)During any authorized leave of absence, the vesting of the Option shall be suspended after the leave of absence exceeds a period of Ninety (90) days.  Vesting of the Option shall resume upon the Grantee’s termination of the leave of absence and return to service to the Company or a Related Entity.  The Vesting Schedule of the Option shall be extended by the length of the suspension.

(c)In the event of termination of the Grantee’s Continuous Service when Cause exists (as determined in the discretion of the Administrator), the Grantee’s right to exercise the Option shall terminate concurrently with the termination of the Grantee’s Continuous Service, except as otherwise determined by the Administrator.

3.Exercise of Option.

(a)Right to Exercise.  The Option shall be exercisable during its term in accordance with the Vesting Schedule set forth in Section 2.  The Option shall be subject to the provisions of Section 11 of the Plan relating to the exercisability or termination of the Option in the event of a Corporate Transaction or Change in Control.  The Grantee shall be subject to reasonable limitations on the number of requested exercises during any monthly or weekly period as determined by the Administrator.

(b)Method of Exercise.  The Option shall be exercisable only by delivery of a written exercise notice (a form of which is attached as Exhibit A) (the “Exercise Notice”) or by such other procedure as specified from time to time by the Administrator.  The Exercise Notice shall state the election to exercise the Option, the whole number of Shares in respect of which the Option is being exercised, and such other provisions as may be required by the Administrator.  The Exercise Notice shall be delivered in person, by certified mail, or by such other method (including electronic transmission) as determined from time to time by the Administrator to the Company accompanied by payment of the Exercise Price.  The Option shall be deemed to be exercised upon receipt by the Company of such Election Notice accompanied by the Exercise Price, which, to the extent selected, shall be deemed to be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 5(d) below.

(c)Taxes.  No Shares will be delivered to the Grantee or other person pursuant to the exercise of the Option until the Grantee or other person has made arrangements acceptable to the Administrator for the satisfaction of applicable tax and other withholding obligations, including, without limitation, such other tax obligations of the Grantee incident to the receipt of Shares.  Upon exercise of the Option, the Company or the Grantee’s employer may offset or withhold (from any amount owed by the Company or the Grantee’s employer to the Grantee) or collect from the Grantee or other person an amount sufficient to satisfy such withholding obligations.  Furthermore, in the event of any determination that the Company has failed to withhold a sum sufficient to pay all withholding taxes due in connection with the Option, the Grantee agrees to pay to the Company the amount of such deficiency in cash within five (5) days after receiving a written demand from the Company to do so, whether or not the Grantee is an employee of the Company at that time.

3


Alfi, Inc. – Standard Form

4.Grantee’s Representations.  The Grantee understands that neither the Option nor the Shares exercisable pursuant to the Option have been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any United States securities laws.  In the event the Shares purchasable pursuant to the exercise of the Option have not been registered under the Securities Act, at the time the Option is exercised, the Grantee shall, if requested by the Company, concurrently with the exercise of all or any portion of the Option, deliver to the Company his or her Investment Representation Statement in the form attached hereto as Exhibit B.

5.Method of Payment.  Payment of the Exercise Price shall be made by any of the following, or a combination thereof, at the election of the Grantee; provided, however, that such exercise method does not then violate any Applicable Law; and, provided further, that the portion of the Exercise Price equal to the par value of the Shares must be paid in cash or other legal consideration permitted by the Delaware General Corporation Law:

(a)cash;

(b)check;

(c)if the exercise occurs on or after the Registration Date, surrender of Shares held for the requisite period, if any, necessary to avoid a charge to the Company’s earnings for financial reporting purposes, or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require which have a Fair Market Value on the date of surrender or attestation equal to the aggregate Exercise Price of the Shares as to which the Option is being exercised; or

(d)if the exercise occurs on or after the Registration Date, payment through- a broker-dealer sale and remittance procedure pursuant to which the Grantee (i) shall provide written instructions to a Company-designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (ii) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction.

6.Restrictions on Exercise.  The Option may not be exercised if the issuance of the Shares subject to the Option upon such exercise would constitute a violation of any Applicable Laws.  In addition, the Option may not be exercised until such time as the Plan has been approved by the stockholders of the Company.  If the exercise of the Option within the applicable time periods set forth in Section 7, 8 and 9 of this Option Agreement is prevented by the provisions of this Section 6, then the Option shall remain exercisable until thirty (30) days after the corresponding limitation or restriction on exercisability lapses (regardless as to whether or not the Company has notified the Grantee), but in any event no later than the Expiration Date set forth in Section 1.

7.Termination or Change of Continuous Service.  In the event the Grantee’s Continuous Service terminates, other than with the existence of Cause, the Grantee may, but only during the Post-Termination Exercise Period, exercise the portion of the Option that was vested at the date of such termination (the “Termination Date”).  The Post-Termination Exercise Period

4


Alfi, Inc. – Standard Form

shall commence on the Termination Date.  In the event of termination of the Grantee’s Continuous Service with the existence of Cause, the Grantee’s right to exercise the Option shall, except as otherwise determined by the Administrator, terminate concurrently with the termination of the Grantee’s Continuous Service (also the “Termination Date”).  In no event, however, shall the Option be exercised later than the Expiration Date set forth in Section 1.  In the event of the Grantee’s change in status from Employee, Director or Consultant to any other status of Employee, Director or Consultant, the Option shall remain in effect and the Option shall continue to vest in accordance with the Vesting Schedule set forth in Section 2 consistent with any minimum vesting requirements set forth in the Plan; provided, however, that, with respect to any ISO that shall remain in effect after a change in status from Employee to Director or Consultant, such ISO shall cease to be treated as an ISO and shall be treated as a NQSO on the day three (3) months and one (1) day following such change in status.  Except as provided in Sections 8 and 9 below, to the extent that the Option was unvested on the Termination Date, or if the Grantee does not exercise the vested portion of the Option within the Post-Termination Exercise Period, the Option shall terminate.

8.Disability of Grantee.  In the event the Grantee’s Continuous Service terminates as a result of his or her Disability, the Grantee may, but only within twelve (12) months commencing on the Termination Date (but in no event later than the Expiration Date), exercise the portion of the Option that was vested on the Termination Date; provided, however, that, if such Disability is not a “disability” as such term is defined in Section 22(e)(3) of the Code and the Option is an ISO, then such ISO shall cease to be treated as an ISO and shall be treated as a NQSO on the day three (3) months and one (1) day following the Termination Date.  To the extent that the Option was unvested on the Termination Date, or if the Grantee does not exercise the vested portion of the Option within the time specified herein, the Option shall terminate.  Section 22(e)(3) of the Code provides that an individual is permanently and totally disabled if he or she is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than twelve (12) months.

9.Death of Grantee.  In the event of the termination of the Grantee’s Continuous Service as a result of his or her death, or in the event of the Grantee’s death during the Post-Termination Exercise Period or during the twelve (12) month period following the Grantee’s termination of Continuous Service as a result of his or her Disability, the person who acquired the right to exercise the Option pursuant to Section 10 may exercise the portion of the Option that was vested at the date of termination within twelve (12) months commencing on the date of death (but in no event later than the Expiration Date).  To the extent that the Option was unvested on the date of death, or if the vested portion of the Option is not exercised within the time specified herein, the Option shall terminate.

10.Transferability of Option.  The Option, if an ISO, may not be transferred in any manner other than by will or by the laws of descent and distribution and may be exercised during the lifetime of the Grantee only by the Grantee.  The Option, if a NQSO, shall be transferable (i) to a revocable trust, by will, by the laws of descent and distribution or as otherwise permitted by Rule 701, or (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the Administrator by gift or pursuant to a domestic relations order to the Grantee’s Family Members.

5


Alfi, Inc. – Standard Form

Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee’s Option in the event of the Grantee’s death on a beneficiary designation form provided by the Administrator.  Following the death of the Grantee, the Option, to the extent provided in Section 9, may be exercised (a) by the person or persons designated under the deceased Grantee’s beneficiary designation or (b) in the absence of an effectively designated beneficiary, by the Grantee’s legal representative or by any person empowered to do so under the deceased Grantee’s will or under the then Applicable Laws of descent and distribution.  The terms of the Option shall be binding upon the executors, administrators, heirs, successors and transferees of the Grantee.

11.Term of Option.  The Option must be exercised no later than the Expiration Date set forth in Section 1 or such earlier date as otherwise provided herein.  After the Expiration Date or such earlier date, the Option shall be of no further force or effect and may not be exercised.

12.Company’s Right of First Refusal.

(a)Transfer Notice.  Neither the Grantee nor a transferee (either being sometimes referred to herein as the “Holder”) shall sell, hypothecate, encumber or otherwise transfer any Shares or any right or interest therein without first complying with the provisions of this Section 12 or obtaining the prior written consent of the Company.  In the event the Holder desires to accept a bona fide third-party offer for any or all of the Shares, the Holder shall provide the Company with written notice (the “Transfer Notice”) of:

(i)The Holder’s intention to transfer;

(ii)The name of the proposed transferee;

(iii)The number of Shares to be transferred; and

(iv)The proposed transfer price or value and terms thereof.

If the Holder proposes to transfer any Shares to more than one transferee, the Holder shall provide a separate Transfer Notice for the proposed transfer to each transferee.  The Transfer Notice shall be signed by both the Holder and the proposed transferee and must constitute a binding commitment of the Holder and the proposed transferee for the transfer of the Shares to the proposed transferee subject to the terms and conditions of this Option Agreement.

(b)Bona Fide Transfer.  If the Company determines that the information provided by the Holder in the Transfer Notice is insufficient to establish the bona fide nature of a proposed voluntary transfer, the Company shall give the Holder written notice of the Holder’s failure to comply with the procedure described in this Section 12, and the Holder shall have no right to transfer the Shares without first complying with the procedure described in this Section 12.  The Holder shall not be permitted to transfer the Shares if the proposed transfer is not bona fide.

(c)First Refusal Exercise Notice.  The Company shall have the right to purchase (the “Right of First Refusal”) all but not less than all, of the Shares which are described in the Transfer Notice (the “Offered Shares”) at any time within thirty (30) days after receipt of the Transfer Notice (the “Option Period”); provided, however, that, if the Offered Shares are not

6


Alfi, Inc. – Standard Form

Mature Shares (as defined below), then the Option Period shall be extended by the number of days necessary for the Offered Shares to become Mature Shares.  The Offered Shares shall be repurchased at (i) the per share price or value and in accordance with the terms stated in the Transfer Notice (subject to Section 12(d) below) or (ii) the Fair Market Value of the Shares on the date on which the purchase is to be effected if no consideration is paid pursuant to the terms stated in the Transfer Notice, which Right of First Refusal shall be exercised by written notice (the “First Refusal Exercise Notice”) to the Holder.  During the Option Period or the forty five (45) day period specified in Section 12(f) below, the Company may exercise its Repurchase Right (as set forth in Section 13 below) in lieu of or in addition to its Right of First Refusal if the Repurchase Right is or becomes exercisable during the Option Period or such forty five (45) day period.  “Mature Shares” shall mean the Shares that have been held by the Holder (and any successor Holder) for a period of more than six (6) months.

(d)Payment Terms.  The Company shall consummate the purchase of the Offered Shares on the terms set forth in the Transfer Notice within sixty (60) days after delivery of the First Refusal Exercise Notice; provided, however, that, in the event the Transfer Notice provides for the payment for the Offered Shares other than in cash, the Company and/or its assigns shall have the right to pay for the Offered Shares by the discounted cash equivalent of the consideration described in the Transfer Notice as reasonably determined by the Administrator.  Upon payment for the Offered Shares to the Holder or into escrow for the benefit of the Holder, the Company or its assigns shall become the legal and beneficial owner of the Offered Shares and all rights and interest therein or related thereto, and the Company shall have the right to transfer the Offered Shares to its own name or its assigns without further action by the Holder.

(e)Assignment.  Whenever the Company shall have the right to purchase Shares under this Right of First Refusal, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations, to exercise all or a part of the Company’s Right of First Refusal.

(f)Non-Exercise.  If the Company and/or its assigns do not collectively elect to exercise the Right of First Refusal within the Option Period or such earlier time if the Company and/or its assigns notifies the Holder that it will not exercise the Right of First Refusal, then the Holder may transfer the Shares upon the terms and conditions stated in the Transfer Notice, provided that:

(i)The transfer is made within forty-five (45) days of the earlier of (A) the date the Company and/or its assigns notify the Holder that the Right of First Refusal will not be exercised or (B) the expiration of the Option Period; and

(ii)The transferee agrees in writing that such Shares shall be held subject to the provisions of this Option Agreement.

The Company shall have the right to demand further assurances from the Holder and the transferee (in a form satisfactory to the Company) that the transfer of the Offered Shares was actually carried out on the terms and conditions described in the Transfer Notice.  No Offered Shares shall be

7


Alfi, Inc. – Standard Form

transferred on the books of the Company until the Company has received such assurances, if so demanded, and has approved the proposed transfer as bona fide.

(g)Expiration of Transfer Period.  Following such forty-five (45) day period, no transfer of the Offered Shares and no change in the terms of the transfer as stated in the Transfer Notice (including the name of the proposed transferee) shall be permitted without a new written Transfer Notice prepared and submitted in accordance with the requirements of this Right of First Refusal.

(h)Termination of Right of First Refusal.  The provisions of this Right of First Refusal shall terminate as to all Shares upon the Registration Date.

(i)Additional Shares or Substituted Securities.  In the event of any transaction described in Sections 10 or 11 of the Plan, any new, substituted or additional securities or other property which is by reason of any such transaction distributed with respect to the Shares shall be immediately subject to the Right of First Refusal, but only to the extent the Shares are at the time covered by such right.

13.Company’s Repurchase Right.

(a)Grant of Repurchase Right.  The Company is hereby granted the right (the “Repurchase Right”), exercisable at any time (i) during the ninety (90) day period following the Termination Date, or (ii) during the ninety (90) day period following an exercise of the Option that occurs after the Termination Date, to repurchase all or any portion of the Shares (in each case, the “Share Repurchase Period”).

(b)Exercise of the Repurchase Right.  The Repurchase Right shall be exercisable by written notice delivered to each Holder of the Shares prior to the expiration of the Share Repurchase Period.  The notice shall indicate the number of Shares to be repurchased and the date on which the repurchase is to be effected, such date to be not later than the last day of the Share Repurchase Period.  On the date on which the repurchase is to be effected, the Company and/or its assigns shall pay to the Holder in cash or cash equivalents (including the cancellation of any purchase-money indebtedness) an amount equal to the Fair Market Value (as of the Termination Date) of the Shares which are to be repurchased from the Holder.  Upon such payment or deposit into escrow for the benefit of the Holder, the Company and/or its assigns shall become the legal and beneficial owner of the Shares being repurchased and all rights and interest thereon or related thereto, and the Company shall have the right to transfer to its own name or its assigns the number of Shares being repurchased, without further action by the Holder.

(c)Assignment.  Whenever the Company shall have the right to purchase Shares under the Repurchase Right, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations, to exercise all or a part of the Company’s Repurchase Right.

(d)Termination of the Repurchase Right.  The Repurchase Right shall terminate with respect to any Shares for which it is not timely exercised.  In addition, the Repurchase Right shall terminate and cease to be exercisable with respect to all Shares upon the Registration Date.

8


Alfi, Inc. – Standard Form

(e)Additional Shares or Substituted Securities.  In the event of any transaction described in Section 10 or 11 of the Plan, any new, substituted or additional securities or other property which is by reason of any such transaction distributed with respect to the Shares shall be immediately subject to the Repurchase Right, but only to the extent the Shares are at the time covered by such right.

14.Stop-Transfer Notices.  In order to ensure compliance with the restrictions on transfer set forth in this Option Agreement or the Plan, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

15.Refusal to Transfer.  The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Option Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

16.Tax Consequences.

(a)The Grantee may incur tax liability as a result of the Grantee’s purchase or disposition of the Shares.  THE GRANTEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.

(b)Notwithstanding the Company’s good faith determination of the Fair Market Value of the Company’s Common Stock for purposes of determining the Exercise Price Per Share of the Option as set forth in Section 1, the taxing authorities may assert that the Fair Market Value of the Common Stock on the Date of Award was greater than the Exercise Price Per Share.  If the Option is designated as an ISO in Section 1, the Option may fail to qualify as an ISO if the Exercise Price Per Share of the Option is less than the Fair Market Value of the Common Stock on the Date of Award.  In addition, under Section 409A of the Code, if the Exercise Price Per Share of the Option is less than the Fair Market Value of the Common Stock on the Date of Award, the Option may be treated as a form of deferred compensation and the Grantee may be subject to an acceleration of income recognition, an additional twenty percent (20%) tax, plus interest and possible penalties.  The Company makes no representation that the Option will comply with Section 409A of the Code and makes no undertaking to prevent Section 409A of the Code from applying to the Option or to mitigate its effects on any deferrals or payments made in respect of the Option.  The Grantee is encouraged to consult a tax adviser regarding the potential impact of Section 409A of the Code.

17.Lock-Up Agreement.

(a)Agreement.  The Grantee, if requested by the Company and the lead underwriter of any public offering of the Common Stock (the “Lead Underwriter”), hereby irrevocably agrees not to sell, contract to sell, grant any option to purchase, transfer the economic risk of ownership in, make any short sale of, pledge or otherwise transfer or dispose of any interest in any Common Stock or any securities convertible into or exchangeable or exercisable for or any other rights to purchase or acquire Common Stock (except Common Stock included in such public

9


Alfi, Inc. – Standard Form

offering or acquired on the public market after such offering) during the one hundred and eighty (180) day period following the effective date of a registration statement of the Company filed under the Securities Act (or by another regulatory agency and/or exchange approved by the Board), or such shorter or longer period of time as the Lead Underwriter shall specify.  The Grantee further agrees to sign such documents as may be requested by the Lead Underwriter to effect the foregoing and agrees that the Company may impose stop-transfer instructions with respect to such Common Stock subject to the lock-up period until the end of such period.  The Company and the Grantee acknowledge that each Lead Underwriter of a public offering of the Company’s stock, during the period of such offering and for the lock-up period thereafter, is an intended beneficiary of this Section 17.

(b)No Amendment Without Consent of Underwriter.  During the period from identification of a Lead Underwriter in connection with any public offering of the Company’s Common Stock until the earlier of (i) the expiration of the lock-up period specified in Section 17(a) in connection with such offering or (ii) the abandonment of such offering by the Company and the Lead Underwriter, the provisions of this Section 17 may not be amended or waived except with the consent of the Lead Underwriter.

18.Entire Agreement: Governing Law.  This Option Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.  Nothing in this Option Agreement or the Plan (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties.  This Option Agreement and the Plan are to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties.  Should any provision of this Option Agreement or the Plan be determined to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable.

19.Construction.  The captions used in this Option Agreement are inserted for convenience and shall not be deemed a part of the Option for construction or interpretation.  Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular.  Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

20.Administration and Interpretation.  Any question or dispute regarding the administration or interpretation of this Option Agreement or the Plan shall be submitted by the Grantee or by the Company to the Administrator.  The resolution of such question or dispute by the Administrator shall be final and binding on all persons.

21.Venue.  The Company, the Grantee, and the Grantee’s assignees pursuant to Section 10 (the “Parties”) agree that any suit, action, or proceeding arising out of or relating to  this Option Agreement or the Plan shall be brought in the United States District Court for the

10


Alfi, Inc. – Standard Form

Southern District of Florida (or should such court lack jurisdiction to hear such action, suit or proceeding, in a Florida state court in the County of Miami-Dade) and that the Parties shall submit to the jurisdiction of such court.  The Parties irrevocably waive, to the fullest extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought in such court.  If any one or more provisions of this Section 21 shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.

22.Notices.  Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed to the other party at its address as shown in these instruments, or to such other address as such party may designate in writing from time to time to the other party.

23.Confidentiality.  To the extent required by Applicable Law, the Company shall provide to the Grantee, during the period the Option is outstanding, copies of financial statements of the Company at least annually.  The Grantee understands and agrees that such financial statements are confidential and shall not be disclosed by the Grantee, to any entity or person, for any reason, at any time, without the prior written consent of the Company, unless required by law.  If disclosure of such financial statements is required by law, whether through subpoena, request for production, deposition, or otherwise, the Grantee promptly shall provide written notice to Company, including copies of the subpoena, request for production, deposition, or otherwise, within five (5) business days of their receipt by the Grantee and prior to any disclosure so as to provide Company an opportunity to move to quash or otherwise to oppose the disclosure.  Notwithstanding the foregoing, the Grantee may disclose the terms of such financial statements to his or her spouse or domestic partner, and for legitimate business reasons, to legal, financial, and tax advisors.

Signatures on Following Page

11


Alfi, Inc. – Standard Form

IN WITNESS WHEREOF, the Company and the Grantee have executed this Option Agreement and agree that the Option is to be governed by the terms and conditions of this Option Agreement and the Plan.

Alfi, Inc.,
a Delaware corporation

By:

THE GRANTEE ACKNOWLEDGES AND AGREES THAT THE SHARES SUBJECT TO THE OPTION SHALL VEST, IF AT ALL, ONLY DURING THE PERIOD OF THE GRANTEE’S CONTINUOUS SERVICE (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THE OPTION OR ACQUIRING SHARES HEREUNDER).  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS OPTION AGREEMENT OR THE PLAN SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO FUTURE AWARDS OR CONTINUATION OF THE GRANTEE’S CONTINUOUS SERVICE, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE’S RIGHT OR THE RIGHT OF THE COMPANY OR RELATED ENTITY TO WHICH THE GRANTEE PROVIDES SERVICES TO TERMINATE THE GRANTEE’S CONTINUOUS SERVICE, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT NOTICE.  THE GRANTEE ACKNOWLEDGES THAT, UNLESS THE GRANTEE HAS A WRITTEN EMPLOYMENT AGREEMENT WITH THE COMPANY TO THE CONTRARY, THE GRANTEE’S STATUS IS AT WILL.

The Grantee acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and hereby accepts the Option subject to all of the terms and provisions of this Option Agreement and the Plan.  The Grantee has reviewed this Option Agreement and the Plan, in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement and fully understands all provisions of this Option Agreement and the Plan including, but not limited to, the provisions of Section 12 of this Option Agreement providing a right of first refusal in favor of the Company upon certain changes in record ownership, the provisions of Section 13 of this Option Agreement providing a repurchase option in favor of the Company upon certain repurchase events.  The Grantee hereby agrees that all questions of interpretation and administration relating to this Option Agreement and the Plan shall be resolved by the Administrator in accordance with Section 20 of this Option Agreement.  The Grantee further agrees to the venue selection in accordance with Section 211 of this Option Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address.

Dated:

Signed:

, Grantee

12


EXHIBIT A

ALFI, INC.

2018 STOCK INCENTIVE PLAN

EXERCISE NOTICE

Alfi, Inc.

Attention: Secretary

429 Lenox Avenue, Suite 547

Miami Beach, Florida 33139

1.Effective as of today, ______________, 20__, the undersigned (the “Grantee”) hereby elects to exercise the Grantee’s option to purchase ___________ shares of the Common Stock (the “Shares”) of Alfi, Inc., a Delaware corporation (the “Company”), under and pursuant to the Alfi, Inc. 2018 Stock Incentive Plan (the “Plan”) and the Stock Option Award Agreement dated _______ (the “Option Agreement”).  Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Exercise Notice.

2.Representations of the Grantee.  The Grantee acknowledges that the Grantee has received, read and understood the Option Agreement and the Plan and agrees to abide by and be bound by their terms and conditions.

3.Rights as Stockholder.  Until the stock certificate evidencing such Shares is issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Shares, notwithstanding the exercise of the Option.  The Company shall issue (or cause to be issued) such stock certificate promptly after the Option is exercised.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 10 of the Plan.

The Grantee shall enjoy rights as a stockholder until such time as the Grantee disposes of the Shares or the Company and/or its assignee(s) exercises the Right of First Refusal or the Repurchase Right.  Upon such exercise, the Grantee shall have no further rights as a holder of the Shares so purchased except the right to receive payment for the Shares so purchased in accordance with the provisions of the Option Agreement, and the Grantee shall forthwith cause the certificate(s) evidencing the Shares so purchased to be surrendered to the Company for transfer or cancellation.

4.Delivery of Payment.  The Grantee herewith delivers to the Company the full Exercise Price for the Shares, which, to the extent selected, shall be deemed to be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 5(d) of the Option Agreement.

5.Tax Consultation.  The Grantee understands that the Grantee may suffer adverse tax consequences as a result of the Grantee’s purchase or disposition of the Shares.  The Grantee

1


represents that the Grantee has consulted with any tax consultants the Grantee deems advisable in connection with the purchase or disposition of the Shares and that the Grantee is not relying on the Company for any tax advice.

6.Taxes.  The Grantee agrees to satisfy all applicable federal, state and local income and employment tax withholding obligations and herewith delivers to the Company the full amount of such obligations or has made arrangements acceptable to the Company to satisfy such obligations.  In the case of an ISO, the Grantee also agrees, as partial consideration for the designation of the Option as an ISO, to notify the Company in writing within thirty (30) days of any disposition of any shares acquired by exercise of the Option if such disposition occurs within two (2) years from the Date of Award or within one (1) year from the date the Shares were transferred to the Grantee.  If the Company is required to satisfy any federal, state or local income or employment tax withholding obligations as a result of such an early disposition, the Grantee agrees to satisfy the amount of such withholding in a manner that the Administrator prescribes.

7.Restrictive Legends.  The Grantee understands and agrees that the Company shall cause the legends set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL AND A REPURCHASE RIGHT HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE OPTION AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.  SUCH TRANSFER RESTRICTIONS, RIGHT OF FIRST REFUSAL AND REPURCHASE RIGHT ARE BINDING ON TRANSFEREES OF THESE SHARES.

8.Successors and Assigns.  The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this agreement shall inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon the Grantee and his or her heirs, executors, administrators, successors and assigns.

9.Construction.  The captions used in this Exercise Notice are inserted for convenience and shall not be deemed a part of this agreement for construction or interpretation.

2


Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular.  Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

10.Administration and Interpretation.  The Grantee hereby agrees that any question or dispute regarding the administration or interpretation of this Exercise Notice shall be submitted by the Grantee or by the Company to the Administrator.  The resolution of such question or dispute by the Administrator shall be final and binding on all persons.

11.Governing Law; Severability.  This Exercise Notice is to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties.  Should any provision of this Exercise Notice be determined by a court of law to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable.

12.Notices.  Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed to the other party at its address as shown below beneath its signature, or to such other address as such party may designate in writing from time to time to the other party.

13.Further Instruments.  The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry out the purposes and intent of this agreement.

<Remainder of page intentionally left blank.>

3


14.Entire Agreement.  The Option Agreement and the Plan are incorporated herein by reference and together with this Exercise Notice constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.  Nothing in the Option Agreement, the Plan, and this Exercise Notice (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties.

Submitted by:

Accepted by:

GRANTEE:

ALFI, INC.

By:

By:

(Signature)

Title:

Address:

Address:

429 Lenox Avenue, Suite 547

Miami Beach, Florida  33139

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Exercise Notice.>

4


EXHIBIT B

ALFI, INC.

2018 STOCK INCENTIVE PLAN

INVESTMENT REPRESENTATION STATEMENT

GRANTEE:

COMPANY:

Alfi, Inc.

SECURITY:

COMMON STOCK

AMOUNT

$

DATE:

In connection with the purchase of the above listed Securities, the undersigned Grantee represents to the Company the following:

(a)Grantee is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities.  Grantee is acquiring these Securities for investment for Grantee’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).

(b)Grantee acknowledges and understands that the Securities constitute “restricted securities” under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon among other things, the bona fide nature of Grantee’s investment intent as expressed herein.  Grantee further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available.  Grantee further acknowledges and understands that the Company is under no obligation to register the Securities.  Grantee understands that the certificate evidencing the Securities will be imprinted with a legend which prohibits the transfer of the Securities unless they are registered or such registration is not required in the opinion of counsel satisfactory to the Company.

(c)Grantee is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.  Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Option to the Grantee, the exercise will be exempt from registration under the Securities Act.  In the event the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold, subject to the satisfaction of certain of the conditions specified by Rule 144, including:  (1) the resale being made through a broker in an

1


unsolicited “broker’s transaction” or in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934); and, in the case of an affiliate, (2) the availability of certain public information about the Company, (3) the amount of Securities being sold during any three month period not exceeding the limitations specified in Rule 144(e), and (4) the timely filing of a Form 144, if applicable.

In the event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule 144, which requires the resale to occur not less than one year after the later of the date the Securities were sold by the Company or the date the Securities were sold by an affiliate of the Company, within the meaning of Rule 144; and, in the case of acquisition of the Securities by an affiliate, or by a non-affiliate who subsequently holds the Securities less than two (2) years, the satisfaction of the conditions set forth in sections (1), (2), (3) and (4) of the paragraph immediately above.

(d)Grantee further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk.  Grantee understands that no assurances can be given that any such other registration exemption will be available in such event.

(e)Grantee represents that Grantee is a resident of the state of ____________________.

Signature of Grantee:

Date:

                     , 20     

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Investment Representation Statement.>

2


EXHIBIT C

ALFI, INC.

2018 STOCK INCENTIVE PLAN

ADVANCE NOTICE OF INTENT TO EXERCISE

To be delivered (i) in person, (ii) by certified mail, return receipt requested or (iii) by overnight delivery service.

Alfi, Inc.

Attention: Chief Financial Officer

429 Lenox Avenue, Suite 547

Miami Beach, Florida 33139

(a)Effective as of today, ____________, 20__, I, ​ ​​ ​​ ​​ ​, hereby advise Alfi, Inc. (the “Company”) of my intent to exercise my option to purchase ___________ shares of the Common Stock (the “Shares”) of the Company under and pursuant to the Company’s 2018 Stock Incentive Plan (the “Plan”) and the Stock Option Award Agreement dated _______ (the “Option Agreement”).

(b)I plan to exercise the above Shares no later than ________________, 20__, which date is no less than thirty (30) days from the date of receipt by the Company of this Advance Notice of Intent to Exercise.

(c)Entire Agreement.  The Notice of Stock Option Grant, the Plan and the Option Agreement are incorporated herein by reference and together with this Advance Notice of Intent to Exercise constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.

Submitted by:

GRANTEE:

Name:

Signature:

Address:

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Advance Notice of Intent to Exercise.>

1


Exhibit 10.26

Award Number:

No. 11

ALFI, INC.

2018 STOCK INCENTIVE PLAN

STOCK OPTION AWARD AGREEMENT

1.Grant of Option.  Alfi, Inc., a Delaware corporation (the “Company”), hereby grants to Ron Spears (the “Grantee”) an option (the “Option”) to purchase the Total Number of Shares of Common Stock subject to the Option (the “Shares”), at the Exercise Price per Share (the “Exercise Price”) subject to the terms and provisions of this Stock Option Award Agreement (this “Option Agreement”) and the Alfi, Inc. 2018 Stock Incentive Plan (the “Plan”), which are incorporated herein by reference.  Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.

Award Number:

No. 11

Date of Award:

3/15/2021

Type of Option:

  Incentive Stock Option (“ISO”)

  Non-Qualified Stock Option (“NQSO”)

Vesting Commencement Date:

3/15/2021

Exercise Price per Share:

$   2.00

Total Number of Shares Subject

to the Option (the “Shares”):

63,001

Total Exercise Price:

$ 126,002.00

Expiration Date:

(Date of Award + 10 years)

3/15/2031

Post-Termination Exercise Period:

90 Days

If the Option is an ISO (as designated above), the Option is intended to qualify as an ISO as defined in Section 422 of the Internal Revenue Code (the “Code”).  However, notwithstanding such designation, the Option will qualify as an ISO only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded.

2.Vesting.

(a)Subject to the Grantee’s Continuous Service and other limitations set forth in this Option Agreement and the Plan, the Option may be exercised, in whole or in part, in accordance with the following vesting schedule, 25% earned after the first 12 months and 2.0836% earned per month for the following 36 months as noted:


Alfi, Inc. – Standard Form

Graphic

2


Alfi, Inc. – Standard Form

(b)During any authorized leave of absence, the vesting of the Option shall be suspended after the leave of absence exceeds a period of Ninety (90) days.  Vesting of the Option shall resume upon the Grantee’s termination of the leave of absence and return to service to the Company or a Related Entity.  The Vesting Schedule of the Option shall be extended by the length of the suspension.

(c)In the event of termination of the Grantee’s Continuous Service when Cause exists (as determined in the discretion of the Administrator), the Grantee’s right to exercise the Option shall terminate concurrently with the termination of the Grantee’s Continuous Service, except as otherwise determined by the Administrator.

3.Exercise of Option.

(a)Right to Exercise.  The Option shall be exercisable during its term in accordance with the Vesting Schedule set forth in Section 2.  The Option shall be subject to the provisions of Section 11 of the Plan relating to the exercisability or termination of the Option in the event of a Corporate Transaction or Change in Control.  The Grantee shall be subject to reasonable limitations on the number of requested exercises during any monthly or weekly period as determined by the Administrator.

(b)Method of Exercise.  The Option shall be exercisable only by delivery of a written exercise notice (a form of which is attached as Exhibit A) (the “Exercise Notice”) or by such other procedure as specified from time to time by the Administrator.  The Exercise Notice shall state the election to exercise the Option, the whole number of Shares in respect of which the Option is being exercised, and such other provisions as may be required by the Administrator.  The Exercise Notice shall be delivered in person, by certified mail, or by such other method (including electronic transmission) as determined from time to time by the Administrator to the Company accompanied by payment of the Exercise Price.  The Option shall be deemed to be exercised upon receipt by the Company of such Election Notice accompanied by the Exercise Price, which, to the extent selected, shall be deemed to be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 5(d) below.

(c)Taxes.  No Shares will be delivered to the Grantee or other person pursuant to the exercise of the Option until the Grantee or other person has made arrangements acceptable to the Administrator for the satisfaction of applicable tax and other withholding obligations, including, without limitation, such other tax obligations of the Grantee incident to the receipt of Shares.  Upon exercise of the Option, the Company or the Grantee’s employer may offset or withhold (from any amount owed by the Company or the Grantee’s employer to the Grantee) or collect from the Grantee or other person an amount sufficient to satisfy such withholding obligations.  Furthermore, in the event of any determination that the Company has failed to withhold a sum sufficient to pay all withholding taxes due in connection with the Option, the Grantee agrees to pay to the Company the amount of such deficiency in cash within five (5) days after receiving a written demand from the Company to do so, whether or not the Grantee is an employee of the Company at that time.

3


Alfi, Inc. – Standard Form

4.Grantee’s Representations.  The Grantee understands that neither the Option nor the Shares exercisable pursuant to the Option have been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any United States securities laws.  In the event the Shares purchasable pursuant to the exercise of the Option have not been registered under the Securities Act, at the time the Option is exercised, the Grantee shall, if requested by the Company, concurrently with the exercise of all or any portion of the Option, deliver to the Company his or her Investment Representation Statement in the form attached hereto as Exhibit B.

5.Method of Payment.  Payment of the Exercise Price shall be made by any of the following, or a combination thereof, at the election of the Grantee; provided, however, that such exercise method does not then violate any Applicable Law; and, provided further, that the portion of the Exercise Price equal to the par value of the Shares must be paid in cash or other legal consideration permitted by the Delaware General Corporation Law:

(a)cash;

(b)check;

(c)if the exercise occurs on or after the Registration Date, surrender of Shares held for the requisite period, if any, necessary to avoid a charge to the Company’s earnings for financial reporting purposes, or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require which have a Fair Market Value on the date of surrender or attestation equal to the aggregate Exercise Price of the Shares as to which the Option is being exercised; or

(d)if the exercise occurs on or after the Registration Date, payment through- a broker-dealer sale and remittance procedure pursuant to which the Grantee (i) shall provide written instructions to a Company-designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (ii) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction.

6.Restrictions on Exercise.  The Option may not be exercised if the issuance of the Shares subject to the Option upon such exercise would constitute a violation of any Applicable Laws.  In addition, the Option may not be exercised until such time as the Plan has been approved by the stockholders of the Company.  If the exercise of the Option within the applicable time periods set forth in Section 7, 8 and 9 of this Option Agreement is prevented by the provisions of this Section 6, then the Option shall remain exercisable until thirty (30) days after the corresponding limitation or restriction on exercisability lapses (regardless as to whether or not the Company has notified the Grantee), but in any event no later than the Expiration Date set forth in Section 1.

7.Termination or Change of Continuous Service.  In the event the Grantee’s Continuous Service terminates, other than with the existence of Cause, the Grantee may, but only during the Post-Termination Exercise Period, exercise the portion of the Option that was vested at the date of such termination (the “Termination Date”).  The Post-Termination Exercise Period

4


Alfi, Inc. – Standard Form

shall commence on the Termination Date.  In the event of termination of the Grantee’s Continuous Service with the existence of Cause, the Grantee’s right to exercise the Option shall, except as otherwise determined by the Administrator, terminate concurrently with the termination of the Grantee’s Continuous Service (also the “Termination Date”).  In no event, however, shall the Option be exercised later than the Expiration Date set forth in Section 1.  In the event of the Grantee’s change in status from Employee, Director or Consultant to any other status of Employee, Director or Consultant, the Option shall remain in effect and the Option shall continue to vest in accordance with the Vesting Schedule set forth in Section 2 consistent with any minimum vesting requirements set forth in the Plan; provided, however, that, with respect to any ISO that shall remain in effect after a change in status from Employee to Director or Consultant, such ISO shall cease to be treated as an ISO and shall be treated as a NQSO on the day three (3) months and one (1) day following such change in status.  Except as provided in Sections 8 and 9 below, to the extent that the Option was unvested on the Termination Date, or if the Grantee does not exercise the vested portion of the Option within the Post-Termination Exercise Period, the Option shall terminate.

8.Disability of Grantee.  In the event the Grantee’s Continuous Service terminates as a result of his or her Disability, the Grantee may, but only within twelve (12) months commencing on the Termination Date (but in no event later than the Expiration Date), exercise the portion of the Option that was vested on the Termination Date; provided, however, that, if such Disability is not a “disability” as such term is defined in Section 22(e)(3) of the Code and the Option is an ISO, then such ISO shall cease to be treated as an ISO and shall be treated as a NQSO on the day three (3) months and one (1) day following the Termination Date.  To the extent that the Option was unvested on the Termination Date, or if the Grantee does not exercise the vested portion of the Option within the time specified herein, the Option shall terminate.  Section 22(e)(3) of the Code provides that an individual is permanently and totally disabled if he or she is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than twelve (12) months.

9.Death of Grantee.  In the event of the termination of the Grantee’s Continuous Service as a result of his or her death, or in the event of the Grantee’s death during the Post-Termination Exercise Period or during the twelve (12) month period following the Grantee’s termination of Continuous Service as a result of his or her Disability, the person who acquired the right to exercise the Option pursuant to Section 10 may exercise the portion of the Option that was vested at the date of termination within twelve (12) months commencing on the date of death (but in no event later than the Expiration Date).  To the extent that the Option was unvested on the date of death, or if the vested portion of the Option is not exercised within the time specified herein, the Option shall terminate.

10.Transferability of Option.  The Option, if an ISO, may not be transferred in any manner other than by will or by the laws of descent and distribution and may be exercised during the lifetime of the Grantee only by the Grantee.  The Option, if a NQSO, shall be transferable (i) to a revocable trust, by will, by the laws of descent and distribution or as otherwise permitted by Rule 701, or (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the Administrator by gift or pursuant to a domestic relations order to the Grantee’s Family Members.

5


Alfi, Inc. – Standard Form

Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee’s Option in the event of the Grantee’s death on a beneficiary designation form provided by the Administrator.  Following the death of the Grantee, the Option, to the extent provided in Section 9, may be exercised (a) by the person or persons designated under the deceased Grantee’s beneficiary designation or (b) in the absence of an effectively designated beneficiary, by the Grantee’s legal representative or by any person empowered to do so under the deceased Grantee’s will or under the then Applicable Laws of descent and distribution.  The terms of the Option shall be binding upon the executors, administrators, heirs, successors and transferees of the Grantee.

11.Term of Option.  The Option must be exercised no later than the Expiration Date set forth in Section 1 or such earlier date as otherwise provided herein.  After the Expiration Date or such earlier date, the Option shall be of no further force or effect and may not be exercised.

12.Company’s Right of First Refusal.

(a)Transfer Notice.  Neither the Grantee nor a transferee (either being sometimes referred to herein as the “Holder”) shall sell, hypothecate, encumber or otherwise transfer any Shares or any right or interest therein without first complying with the provisions of this Section 12 or obtaining the prior written consent of the Company.  In the event the Holder desires to accept a bona fide third-party offer for any or all of the Shares, the Holder shall provide the Company with written notice (the “Transfer Notice”) of:

(i)The Holder’s intention to transfer;

(ii)The name of the proposed transferee;

(iii)The number of Shares to be transferred; and

(iv)The proposed transfer price or value and terms thereof.

If the Holder proposes to transfer any Shares to more than one transferee, the Holder shall provide a separate Transfer Notice for the proposed transfer to each transferee.  The Transfer Notice shall be signed by both the Holder and the proposed transferee and must constitute a binding commitment of the Holder and the proposed transferee for the transfer of the Shares to the proposed transferee subject to the terms and conditions of this Option Agreement.

(b)Bona Fide Transfer.  If the Company determines that the information provided by the Holder in the Transfer Notice is insufficient to establish the bona fide nature of a proposed voluntary transfer, the Company shall give the Holder written notice of the Holder’s failure to comply with the procedure described in this Section 12, and the Holder shall have no right to transfer the Shares without first complying with the procedure described in this Section 12.  The Holder shall not be permitted to transfer the Shares if the proposed transfer is not bona fide.

(c)First Refusal Exercise Notice.  The Company shall have the right to purchase (the “Right of First Refusal”) all but not less than all, of the Shares which are described in the Transfer Notice (the “Offered Shares”) at any time within thirty (30) days after receipt of the Transfer Notice (the “Option Period”); provided, however, that, if the Offered Shares are not

6


Alfi, Inc. – Standard Form

Mature Shares (as defined below), then the Option Period shall be extended by the number of days necessary for the Offered Shares to become Mature Shares.  The Offered Shares shall be repurchased at (i) the per share price or value and in accordance with the terms stated in the Transfer Notice (subject to Section 12(d) below) or (ii) the Fair Market Value of the Shares on the date on which the purchase is to be effected if no consideration is paid pursuant to the terms stated in the Transfer Notice, which Right of First Refusal shall be exercised by written notice (the “First Refusal Exercise Notice”) to the Holder.  During the Option Period or the forty five (45) day period specified in Section 12(f) below, the Company may exercise its Repurchase Right (as set forth in Section 13 below) in lieu of or in addition to its Right of First Refusal if the Repurchase Right is or becomes exercisable during the Option Period or such forty five (45) day period.  “Mature Shares” shall mean the Shares that have been held by the Holder (and any successor Holder) for a period of more than six (6) months.

(d)Payment Terms.  The Company shall consummate the purchase of the Offered Shares on the terms set forth in the Transfer Notice within sixty (60) days after delivery of the First Refusal Exercise Notice; provided, however, that, in the event the Transfer Notice provides for the payment for the Offered Shares other than in cash, the Company and/or its assigns shall have the right to pay for the Offered Shares by the discounted cash equivalent of the consideration described in the Transfer Notice as reasonably determined by the Administrator.  Upon payment for the Offered Shares to the Holder or into escrow for the benefit of the Holder, the Company or its assigns shall become the legal and beneficial owner of the Offered Shares and all rights and interest therein or related thereto, and the Company shall have the right to transfer the Offered Shares to its own name or its assigns without further action by the Holder.

(e)Assignment.  Whenever the Company shall have the right to purchase Shares under this Right of First Refusal, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations, to exercise all or a part of the Company’s Right of First Refusal.

(f)Non-Exercise.  If the Company and/or its assigns do not collectively elect to exercise the Right of First Refusal within the Option Period or such earlier time if the Company and/or its assigns notifies the Holder that it will not exercise the Right of First Refusal, then the Holder may transfer the Shares upon the terms and conditions stated in the Transfer Notice, provided that:

(i)The transfer is made within forty-five (45) days of the earlier of (A) the date the Company and/or its assigns notify the Holder that the Right of First Refusal will not be exercised or (B) the expiration of the Option Period; and

(ii)The transferee agrees in writing that such Shares shall be held subject to the provisions of this Option Agreement.

The Company shall have the right to demand further assurances from the Holder and the transferee (in a form satisfactory to the Company) that the transfer of the Offered Shares was actually carried out on the terms and conditions described in the Transfer Notice.  No Offered Shares shall be

7


Alfi, Inc. – Standard Form

transferred on the books of the Company until the Company has received such assurances, if so demanded, and has approved the proposed transfer as bona fide.

(g)Expiration of Transfer Period.  Following such forty-five (45) day period, no transfer of the Offered Shares and no change in the terms of the transfer as stated in the Transfer Notice (including the name of the proposed transferee) shall be permitted without a new written Transfer Notice prepared and submitted in accordance with the requirements of this Right of First Refusal.

(h)Termination of Right of First Refusal.  The provisions of this Right of First Refusal shall terminate as to all Shares upon the Registration Date.

(i)Additional Shares or Substituted Securities.  In the event of any transaction described in Sections 10 or 11 of the Plan, any new, substituted or additional securities or other property which is by reason of any such transaction distributed with respect to the Shares shall be immediately subject to the Right of First Refusal, but only to the extent the Shares are at the time covered by such right.

13.Company’s Repurchase Right.

(a)Grant of Repurchase Right.  The Company is hereby granted the right (the “Repurchase Right”), exercisable at any time (i) during the ninety (90) day period following the Termination Date, or (ii) during the ninety (90) day period following an exercise of the Option that occurs after the Termination Date, to repurchase all or any portion of the Shares (in each case, the “Share Repurchase Period”).

(b)Exercise of the Repurchase Right.  The Repurchase Right shall be exercisable by written notice delivered to each Holder of the Shares prior to the expiration of the Share Repurchase Period.  The notice shall indicate the number of Shares to be repurchased and the date on which the repurchase is to be effected, such date to be not later than the last day of the Share Repurchase Period.  On the date on which the repurchase is to be effected, the Company and/or its assigns shall pay to the Holder in cash or cash equivalents (including the cancellation of any purchase-money indebtedness) an amount equal to the Fair Market Value (as of the Termination Date) of the Shares which are to be repurchased from the Holder.  Upon such payment or deposit into escrow for the benefit of the Holder, the Company and/or its assigns shall become the legal and beneficial owner of the Shares being repurchased and all rights and interest thereon or related thereto, and the Company shall have the right to transfer to its own name or its assigns the number of Shares being repurchased, without further action by the Holder.

(c)Assignment.  Whenever the Company shall have the right to purchase Shares under the Repurchase Right, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations, to exercise all or a part of the Company’s Repurchase Right.

(d)Termination of the Repurchase Right.  The Repurchase Right shall terminate with respect to any Shares for which it is not timely exercised.  In addition, the Repurchase Right shall terminate and cease to be exercisable with respect to all Shares upon the Registration Date.

8


Alfi, Inc. – Standard Form

(e)Additional Shares or Substituted Securities.  In the event of any transaction described in Section 10 or 11 of the Plan, any new, substituted or additional securities or other property which is by reason of any such transaction distributed with respect to the Shares shall be immediately subject to the Repurchase Right, but only to the extent the Shares are at the time covered by such right.

14.Stop-Transfer Notices.  In order to ensure compliance with the restrictions on transfer set forth in this Option Agreement or the Plan, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

15.Refusal to Transfer.  The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Option Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

16.Tax Consequences.

(a)The Grantee may incur tax liability as a result of the Grantee’s purchase or disposition of the Shares.  THE GRANTEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.

(b)Notwithstanding the Company’s good faith determination of the Fair Market Value of the Company’s Common Stock for purposes of determining the Exercise Price Per Share of the Option as set forth in Section 1, the taxing authorities may assert that the Fair Market Value of the Common Stock on the Date of Award was greater than the Exercise Price Per Share.  If the Option is designated as an ISO in Section 1, the Option may fail to qualify as an ISO if the Exercise Price Per Share of the Option is less than the Fair Market Value of the Common Stock on the Date of Award.  In addition, under Section 409A of the Code, if the Exercise Price Per Share of the Option is less than the Fair Market Value of the Common Stock on the Date of Award, the Option may be treated as a form of deferred compensation and the Grantee may be subject to an acceleration of income recognition, an additional twenty percent (20%) tax, plus interest and possible penalties.  The Company makes no representation that the Option will comply with Section 409A of the Code and makes no undertaking to prevent Section 409A of the Code from applying to the Option or to mitigate its effects on any deferrals or payments made in respect of the Option.  The Grantee is encouraged to consult a tax adviser regarding the potential impact of Section 409A of the Code.

17.Lock-Up Agreement.

(a)Agreement.  The Grantee, if requested by the Company and the lead underwriter of any public offering of the Common Stock (the “Lead Underwriter”), hereby irrevocably agrees not to sell, contract to sell, grant any option to purchase, transfer the economic risk of ownership in, make any short sale of, pledge or otherwise transfer or dispose of any interest in any Common Stock or any securities convertible into or exchangeable or exercisable for or any other rights to purchase or acquire Common Stock (except Common Stock included in such public

9


Alfi, Inc. – Standard Form

offering or acquired on the public market after such offering) during the one hundred and eighty (180) day period following the effective date of a registration statement of the Company filed under the Securities Act (or by another regulatory agency and/or exchange approved by the Board), or such shorter or longer period of time as the Lead Underwriter shall specify.  The Grantee further agrees to sign such documents as may be requested by the Lead Underwriter to effect the foregoing and agrees that the Company may impose stop-transfer instructions with respect to such Common Stock subject to the lock-up period until the end of such period.  The Company and the Grantee acknowledge that each Lead Underwriter of a public offering of the Company’s stock, during the period of such offering and for the lock-up period thereafter, is an intended beneficiary of this Section 17.

(b)No Amendment Without Consent of Underwriter.  During the period from identification of a Lead Underwriter in connection with any public offering of the Company’s Common Stock until the earlier of (i) the expiration of the lock-up period specified in Section 17(a) in connection with such offering or (ii) the abandonment of such offering by the Company and the Lead Underwriter, the provisions of this Section 17 may not be amended or waived except with the consent of the Lead Underwriter.

18.Entire Agreement: Governing Law.  This Option Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.  Nothing in this Option Agreement or the Plan (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties.  This Option Agreement and the Plan are to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties.  Should any provision of this Option Agreement or the Plan be determined to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable.

19.Construction.  The captions used in this Option Agreement are inserted for convenience and shall not be deemed a part of the Option for construction or interpretation.  Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular.  Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

20.Administration and Interpretation.  Any question or dispute regarding the administration or interpretation of this Option Agreement or the Plan shall be submitted by the Grantee or by the Company to the Administrator.  The resolution of such question or dispute by the Administrator shall be final and binding on all persons.

21.Venue.  The Company, the Grantee, and the Grantee’s assignees pursuant to Section 10 (the “Parties”) agree that any suit, action, or proceeding arising out of or relating to  this Option Agreement or the Plan shall be brought in the United States District Court for the

10


Alfi, Inc. – Standard Form

Southern District of Florida (or should such court lack jurisdiction to hear such action, suit or proceeding, in a Florida state court in the County of Miami-Dade) and that the Parties shall submit to the jurisdiction of such court.  The Parties irrevocably waive, to the fullest extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought in such court.  If any one or more provisions of this Section 21 shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.

22.Notices.  Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed to the other party at its address as shown in these instruments, or to such other address as such party may designate in writing from time to time to the other party.

23.Confidentiality.  To the extent required by Applicable Law, the Company shall provide to the Grantee, during the period the Option is outstanding, copies of financial statements of the Company at least annually.  The Grantee understands and agrees that such financial statements are confidential and shall not be disclosed by the Grantee, to any entity or person, for any reason, at any time, without the prior written consent of the Company, unless required by law.  If disclosure of such financial statements is required by law, whether through subpoena, request for production, deposition, or otherwise, the Grantee promptly shall provide written notice to Company, including copies of the subpoena, request for production, deposition, or otherwise, within five (5) business days of their receipt by the Grantee and prior to any disclosure so as to provide Company an opportunity to move to quash or otherwise to oppose the disclosure.  Notwithstanding the foregoing, the Grantee may disclose the terms of such financial statements to his or her spouse or domestic partner, and for legitimate business reasons, to legal, financial, and tax advisors.

Signatures on Following Page

11


Alfi, Inc. – Standard Form

IN WITNESS WHEREOF, the Company and the Grantee have executed this Option Agreement and agree that the Option is to be governed by the terms and conditions of this Option Agreement and the Plan.

Alfi, Inc.,
a Delaware corporation

By:

/s/Paul Antonio Pereira

Paul Antonio Pereira

Chief Executive Officer

THE GRANTEE ACKNOWLEDGES AND AGREES THAT THE SHARES SUBJECT TO THE OPTION SHALL VEST, IF AT ALL, ONLY DURING THE PERIOD OF THE GRANTEE’S CONTINUOUS SERVICE (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THE OPTION OR ACQUIRING SHARES HEREUNDER).  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS OPTION AGREEMENT OR THE PLAN SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO FUTURE AWARDS OR CONTINUATION OF THE GRANTEE’S CONTINUOUS SERVICE, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE’S RIGHT OR THE RIGHT OF THE COMPANY OR RELATED ENTITY TO WHICH THE GRANTEE PROVIDES SERVICES TO TERMINATE THE GRANTEE’S CONTINUOUS SERVICE, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT NOTICE.  THE GRANTEE ACKNOWLEDGES THAT, UNLESS THE GRANTEE HAS A WRITTEN EMPLOYMENT AGREEMENT WITH THE COMPANY TO THE CONTRARY, THE GRANTEE’S STATUS IS AT WILL.

The Grantee acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and hereby accepts the Option subject to all of the terms and provisions of this Option Agreement and the Plan.  The Grantee has reviewed this Option Agreement and the Plan, in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement and fully understands all provisions of this Option Agreement and the Plan including, but not limited to, the provisions of Section 12 of this Option Agreement providing a right of first refusal in favor of the Company upon certain changes in record ownership, the provisions of Section 13 of this Option Agreement providing a repurchase option in favor of the Company upon certain repurchase events.  The Grantee hereby agrees that all questions of interpretation and administration relating to this Option Agreement and the Plan shall be resolved by the Administrator in accordance with Section 20 of this Option Agreement.  The Grantee further agrees to the venue selection in accordance with Section 211 of this Option Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address.

Dated:

10/4/2021

Signed:

/s/Ron Spears

Ron Spears, Grantee

12


EXHIBIT A

ALFI, INC.

2018 STOCK INCENTIVE PLAN

EXERCISE NOTICE

Alfi, Inc.

Attention: Secretary

429 Lenox Avenue, Suite 547

Miami Beach, Florida 33139

1.Effective as of today, ______________, 20__, the undersigned (the “Grantee”) hereby elects to exercise the Grantee’s option to purchase ___________ shares of the Common Stock (the “Shares”) of Alfi, Inc., a Delaware corporation (the “Company”), under and pursuant to the Alfi, Inc. 2018 Stock Incentive Plan (the “Plan”) and the Stock Option Award Agreement dated _______ (the “Option Agreement”).  Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Exercise Notice.

2.Representations of the Grantee.  The Grantee acknowledges that the Grantee has received, read and understood the Option Agreement and the Plan and agrees to abide by and be bound by their terms and conditions.

3.Rights as Stockholder.  Until the stock certificate evidencing such Shares is issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Shares, notwithstanding the exercise of the Option.  The Company shall issue (or cause to be issued) such stock certificate promptly after the Option is exercised.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 10 of the Plan.

The Grantee shall enjoy rights as a stockholder until such time as the Grantee disposes of the Shares or the Company and/or its assignee(s) exercises the Right of First Refusal or the Repurchase Right.  Upon such exercise, the Grantee shall have no further rights as a holder of the Shares so purchased except the right to receive payment for the Shares so purchased in accordance with the provisions of the Option Agreement, and the Grantee shall forthwith cause the certificate(s) evidencing the Shares so purchased to be surrendered to the Company for transfer or cancellation.

4.Delivery of Payment.  The Grantee herewith delivers to the Company the full Exercise Price for the Shares, which, to the extent selected, shall be deemed to be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 5(d) of the Option Agreement.

5.Tax Consultation.  The Grantee understands that the Grantee may suffer adverse tax consequences as a result of the Grantee’s purchase or disposition of the Shares.  The Grantee

1


represents that the Grantee has consulted with any tax consultants the Grantee deems advisable in connection with the purchase or disposition of the Shares and that the Grantee is not relying on the Company for any tax advice.

6.Taxes.  The Grantee agrees to satisfy all applicable federal, state and local income and employment tax withholding obligations and herewith delivers to the Company the full amount of such obligations or has made arrangements acceptable to the Company to satisfy such obligations.  In the case of an ISO, the Grantee also agrees, as partial consideration for the designation of the Option as an ISO, to notify the Company in writing within thirty (30) days of any disposition of any shares acquired by exercise of the Option if such disposition occurs within two (2) years from the Date of Award or within one (1) year from the date the Shares were transferred to the Grantee.  If the Company is required to satisfy any federal, state or local income or employment tax withholding obligations as a result of such an early disposition, the Grantee agrees to satisfy the amount of such withholding in a manner that the Administrator prescribes.

7.Restrictive Legends.  The Grantee understands and agrees that the Company shall cause the legends set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL AND A REPURCHASE RIGHT HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE OPTION AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.  SUCH TRANSFER RESTRICTIONS, RIGHT OF FIRST REFUSAL AND REPURCHASE RIGHT ARE BINDING ON TRANSFEREES OF THESE SHARES.

8.Successors and Assigns.  The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this agreement shall inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon the Grantee and his or her heirs, executors, administrators, successors and assigns.

9.Construction.  The captions used in this Exercise Notice are inserted for convenience and shall not be deemed a part of this agreement for construction or interpretation.

2


Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular.  Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

10.Administration and Interpretation.  The Grantee hereby agrees that any question or dispute regarding the administration or interpretation of this Exercise Notice shall be submitted by the Grantee or by the Company to the Administrator.  The resolution of such question or dispute by the Administrator shall be final and binding on all persons.

11.Governing Law; Severability.  This Exercise Notice is to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties.  Should any provision of this Exercise Notice be determined by a court of law to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable.

12.Notices.  Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed to the other party at its address as shown below beneath its signature, or to such other address as such party may designate in writing from time to time to the other party.

13.Further Instruments.  The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry out the purposes and intent of this agreement.

<Remainder of page intentionally left blank.>

3


14.Entire Agreement.  The Option Agreement and the Plan are incorporated herein by reference and together with this Exercise Notice constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.  Nothing in the Option Agreement, the Plan, and this Exercise Notice (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties.

Submitted by:

    

Accepted by:

GRANTEE: Ron Spears

ALFI, INC.

By:

By:

(Signature)

Title:

Address:

Address:

429 Lenox Avenue, Suite 547

Miami Beach, Florida 33139

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Exercise Notice.>

4


EXHIBIT B

ALFI, INC.

2018 STOCK INCENTIVE PLAN

INVESTMENT REPRESENTATION STATEMENT

GRANTEE:

Ron Spears

COMPANY:

Alfi, Inc.

SECURITY:

COMMON STOCK

AMOUNT

$

DATE:

In connection with the purchase of the above listed Securities, the undersigned Grantee represents to the Company the following:

(a)Grantee is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities.  Grantee is acquiring these Securities for investment for Grantee’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).

(b)Grantee acknowledges and understands that the Securities constitute “restricted securities” under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon among other things, the bona fide nature of Grantee’s investment intent as expressed herein.  Grantee further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available.  Grantee further acknowledges and understands that the Company is under no obligation to register the Securities.  Grantee understands that the certificate evidencing the Securities will be imprinted with a legend which prohibits the transfer of the Securities unless they are registered or such registration is not required in the opinion of counsel satisfactory to the Company.

(c)Grantee is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.  Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Option to the Grantee, the exercise will be exempt from registration under the Securities Act.  In the event the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold, subject to the satisfaction of certain of the conditions specified by Rule 144, including:  (1) the resale being made through a broker in an

1


unsolicited “broker’s transaction” or in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934); and, in the case of an affiliate, (2) the availability of certain public information about the Company, (3) the amount of Securities being sold during any three month period not exceeding the limitations specified in Rule 144(e), and (4) the timely filing of a Form 144, if applicable.

In the event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule 144, which requires the resale to occur not less than one year after the later of the date the Securities were sold by the Company or the date the Securities were sold by an affiliate of the Company, within the meaning of Rule 144; and, in the case of acquisition of the Securities by an affiliate, or by a non-affiliate who subsequently holds the Securities less than two (2) years, the satisfaction of the conditions set forth in sections (1), (2), (3) and (4) of the paragraph immediately above.

(d)Grantee further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk.  Grantee understands that no assurances can be given that any such other registration exemption will be available in such event.

(e)Grantee represents that Grantee is a resident of the state of ___________________.

Signature of Grantee: Ron Spears

Date:

, 20

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Investment Representation Statement.>

2


EXHIBIT C

ALFI, INC.

2018 STOCK INCENTIVE PLAN

ADVANCE NOTICE OF INTENT TO EXERCISE

To be delivered (i) in person, (ii) by certified mail, return receipt requested or (iii) by overnight delivery service.

Alfi, Inc.

Attention: Chief Financial Officer

429 Lenox Avenue, Suite 547

Miami Beach, Florida 33139

(a)Effective as of today,                     , 20      , I, Ron Spears, hereby advise Alfi, Inc. (the “Company”) of my intent to exercise my option to purchase ___________ shares of the Common Stock (the “Shares”) of the Company under and pursuant to the Company’s 2018 Stock Incentive Plan (the “Plan”) and the Stock Option Award Agreement dated _______ (the “Option Agreement”).

(b)I plan to exercise the above Shares no later than                          , 20     , which date is no less than thirty (30) days from the date of receipt by the Company of this Advance Notice of Intent to Exercise.

(c)Entire Agreement.  The Notice of Stock Option Grant, the Plan and the Option Agreement are incorporated herein by reference and together with this Advance Notice of Intent to Exercise constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Grantee with respect to the subject matter hereof, and may not be modified adversely to the Grantee’s interest except by means of a writing signed by the Company and the Grantee.

Submitted by:

GRANTEE:

Name:

Charles Pereira

Signature:

Address:

<Signature page to Alfi, Inc. 2018 Stock Incentive Plan – Advance Notice of Intent to Exercise.>

1


Exhibit 10.27

PROMISSORY NOTE

$250,000

Miami, Florida

August 8, 2019

FOR VALUE RECEIVED, the undersigned borrower (the “Borrower”) promises to pay to Lee Aerospace, Inc., a Kansas corporation (the “Lender”), at its principal office the principal sum of Two Hundred Fifty Thousand Dollars ($250,000), together with interest on the outstanding principal amount at the rate of Five Percent (5.0%) per annum (computed on the basis of actual calendar days elapsed and a year of three hundred sixty-five (365) days), or, if less, at the highest rate of interest then permitted under applicable law. Interest shall commence with the date hereof and shall continue to accrue on the outstanding principal until paid in accordance with the provisions hereof. If any interest is determined to be in excess of the then legal maximum rate, then that portion of each interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the obligations evidenced by this Promissory Note (this “Note”).

1.Maturity. Unless sooner paid in accordance with the terms hereof, the entire unpaid principal amount and all unpaid accrued interest of this Note shall become fully due and payable on the earlier of (i) the one (1) year anniversary of the date hereof, or (ii) the acceleration of the maturity of this Note pursuant to Section 2.

2.Events of Acceleration.

(a)The entire unpaid principal amount of this Note and all then accrued and unpaid interest of this Note shall become fully due and payable upon the earliest of:
(i)the closing of aggregate proceeds of at least One Million Dollars ($1,000,000) in new equity financing by the Borrower;
(ii)immediately prior to the first filing by the Borrower of a registration statement under the Securities Act of 1933, as amended;
(iii)the filing of a petition by or against the Borrower under any provision of the Bankruptcy Reform Act (Title 11 of the United States Code), as amended or recodified from time to time, or under any other law relating to bankruptcy, insolvency, reorganization or other relief for debtors;
(iv)the appointment of a receiver, trustee, custodian or liquidator of or for any part of these assets or property of the Borrower;
(v)immediately prior to the closing of an acquisition of the Borrower, whether by merger or the purchase of all of its outstanding stock or all (or substantially all) of its assets, by an unrelated third party;


(vi)the execution by the Lender of a general assignment for the benefit of creditors; or
(vii)the occurrence of an event of default under either of the Stock Pledge Agreements (as defined below).

3.Form of Payment; Prepayment. All payments of principal and interest on this Note shall be made without offset or deduction in lawful tender of the United States to the Lender. All payments on this Note shall be applied first to the payment of accrued and unpaid interest, and thereafter to the payment of principal. Prepayment of the principal balance of this Note, together with all accrued and unpaid interest, may be made in whole or in part at any time without penalty.

4.Security. The Borrower’s obligations under this Note shall be secured by a first-priority security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Lender’s Common Stock held and owned of record, respectively, by each of Paul Antonio Pereira and John M. Cook II (collectively, the “Shares”). The Shares shall be pledged pursuant to the Stock Pledge Agreements of even date herewith (in the form attached hereto as Exhibit A, collectively, the “Stock Pledge Agreements”), by and between, respectively, (i) the Borrower and Paul Antonio Pereira, and (ii) the Borrower and John M. Cook II, all terms of which are incorporated herein by this reference.

5.Default. For purposes of this Note, the failure of the Borrower to pay when due the principal balance and accrued interest under this Note shall constitute an “Event of Default.” If an Event of Default occurs, all indebtedness under this Note shall become immediately due and payable without any action on the part of the Lender, and the Borrower shall immediately pay to the Lender all such amounts.

6.Collection and Attorneys’ Fees. If any action is instituted to collect any indebtedness under this Note, then the Borrower promises to pay all reasonable costs and expenses, including reasonable attorneys’ fees, incurred by the Lender in connection with such action.

7.Assignment. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Notwithstanding the foregoing, neither the Lender nor the Borrower may assign, pledge or otherwise transfer this Note without the prior written consent of the other party.

8.Governing Law. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of law thereof.

9.Conflicting Agreements. In the event of any inconsistencies between the terms of this Note and the terms of any other document related to the loan evidenced by this Note, the terms of this Note shall prevail.


10.Amendment. Any term of this Note may be amended and the observance of any term of this Note may be waived only with the written consent of the Lender and the Borrower.

[Signature Page Follows.]


IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

BORROWER

LECTREFY, INC.

By: /s/ Paul Antonio Pereira

Name: Paul Antonio Pereira

Title: Chief Executive Officer

Acknowledged and Agreed:

LENDER

LEE AEROSPACE, INC.

By:/s/ James Lee

Name: James Lee

Title: Chief Executive Officer


EXHIBIT A

STOCK PLEDGE AGREEMENT

THIS STOCK PLEDGE AGREEMENT (this “Pledge Agreement”) is made by [Paul Antonio Pereira / John M. Cook II] (“Pledgor”), in favor of Lee Aerospace, Inc., a Kansas corporation (“Pledgee”), with its principal place of business at 9323 E. 34th St. N., Wichita, Kansas 67226.

WHEREAS, Lectrefy, Inc., a Delaware corporation (the “Borrower”), has concurrently herewith executed that certain Promissory Note, dated August 8 (the “Note”), in favor of Pledgee in the amount of Two Hundred Fifty Thousand Dollars ($250,000); and

WHEREAS, Pledgee is willing to accept the Note from Borrower, but only upon the condition, among others, that Pledgor shall have executed and delivered to Pledgee this Pledge Agreement.

NOW, THEREFORE, in consideration of the foregoing recitals and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound, Pledgor hereby agrees as follows:

1.As security for the full and prompt payment when due (whether by stated maturity or otherwise) of all indebtedness of the Borrower to Pledgee created under the Note, Pledgor hereby pledges to Pledgee, and grants to Pledgee, a security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock, which are held and owned of record by Pledgor (the “Pledged Shares”), and all dividends, cash, instruments and other proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the Pledged Shares (the “Pledged Collateral”). Pledgor represents and warrants that, except as provided for herein, the Pledged Shares have not been, and will not be, pledged or used as collateral for any other purpose.
2.At any time a default exists under the Note, Pledgee in its name or in the name of its nominee or of Pledgor may: (i) collect by legal proceedings or otherwise all dividends (except cash dividends), interest, principal payments and other sums now or hereafter payable upon or on account of the Pledged Collateral; (ii) enter into any extension, reorganization, deposit, merger or consolidation agreement, or any agreement relating to or affecting the Pledged Collateral, and in connection therewith may deposit or surrender control of the Pledged Collateral thereunder, accept other property in exchange for the Pledged Collateral and do and perform such acts and things as it may deem proper, and any money or property received in exchange for the Pledged Collateral shall be applied to the indebtedness or thereafter held by it pursuant to the provisions hereof; and (iii) insure, process and preserve the Pledged Collateral.


3.At the option of Pledgee, and without necessity of demand or notice, all or any part of the indebtedness of the Borrower under the Note shall immediately become due and payable irrespective of any agreed maturity, upon the happening of any of the following events: (i) material failure to keep or perform any of the terms or provisions of this Pledge Agreement; (ii) the Borrower’s failure to pay any installment of principal or interest on the Note when due; (iii) the levy of any attachment, execution or other process against the Pledged Collateral; or (iv) the insolvency, commission of an act of bankruptcy, general assignment for the benefit of creditors, filing of any petition in bankruptcy or for relief under the provisions of Title 11 of the United States Code of, by, or against Pledgor or the Borrower.
4.In the event of the nonpayment of any indebtedness when due under the Note, or upon the happening of any of the events specified in the last preceding section, Pledgee may apply, set off, collect or sell the Pledged Collateral in one or more sales, or take such steps as may be necessary to take ownership of the Pledged Shares or liquidate and reduce the Pledged Shares to cash in the hands of Pledgee in whole or in part.
5.The proceeds of the sale of any of the Pledged Collateral and all sums received or collected by Pledgee from or on account of the Pledged Collateral shall be applied by Pledgee to the payment of the indebtedness under the Note or any part thereof. The Borrower then shall pay any remaining balance of the Note to Pledgor; provided, however, that, if such disposition is at private sale, then the purchase price of the Pledged Collateral shall be mutually agreed to by Pledgee and Pledgor or, if the parties cannot agree upon a purchase price, then at a purchase price established by an independent appraiser knowledgeable of the value of the Pledged Collateral, mutually selected by Pledgor and the Pledgee, with the appraisal to be rendered within thirty (30) days of the appointment of the appraiser.
6.If any provision of this Pledge Agreement is held to be unenforceable for any reason, then it shall be adjusted, if possible, rather than voided in order to achieve the intent of the parties to the extent possible.
7.This Pledge Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware as applied to contracts made and performed entirely within the State of Delaware by residents of such State.

[Signature page follows.]


IN WITNESS WHEREOF, this Pledge Agreement has been executed by the Pledgor on August 8, 2019.

PLEDGOR:

By:

[Paul Antonio Pereira / John M. Cook II]

Acknowledged and Agreed:

LEE AEROSPACE, INC.

By:

Name: James Lee

Title: Chief Executive Officer

LECREFY, INC.

By:

Name: [Paul Antonio Pereira / John M. Cook II]

Title: [Chief Executive Officer / Chief Financial Officer]


Exhibit 10.28

FIRST AMENDED AND RESTATED PROMISSORY NOTE

$100,000

Miami, Florida

September 20, 2019

FOR VALUE RECEIVED, the undersigned borrower (the “Borrower”) promises to pay to Lee Aerospace, Inc., a Kansas corporation (the “Lender”), at its principal office the principal sum of One Hundred Thousand Dollars ($100,000), together with interest on the outstanding principal amount at the rate of Five Percent (5.0%) per annum (computed on the basis of actual calendar days elapsed and a year of three hundred sixty-five (365) days), or, if less, at the highest rate of interest then permitted under applicable law. Interest shall commence with the date hereof and shall continue to accrue on the outstanding principal until paid in accordance with the provisions hereof. If any interest is determined to be in excess of the then legal maximum rate, then that portion of each interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the obligations evidenced by this First Amended and Restated Promissory Note (this “Note”). This Note replaces and supersedes the prior Promissory Note, dated September 20, 2019, issued by the Borrower to the Lender for the same principal sum as set forth above, which prior Promissory Note shall terminate and have no further legal force or effect.

1.Maturity. Unless sooner paid in accordance with the terms hereof, the entire unpaid principal amount and all unpaid accrued interest of this Note shall become fully due and payable on the earlier of (i) the one (1) year anniversary of the date hereof, or (ii) the acceleration of the maturity of this Note pursuant to Section 2.

2.Events of Acceleration. The entire unpaid principal amount of this Note and all then accrued and unpaid interest of this Note shall become fully due and payable upon the earliest of:

(i)the closing of aggregate proceeds of at least One Million Dollars ($1,000,000) in new equity financing by the Borrower;
(ii)immediately prior to the first filing by the Borrower of a registration statement under the Securities Act of 1933, as amended;
(iii)the filing of a petition by or against the Borrower under any provision of the Bankruptcy Reform Act (Title 11 of the United States Code), as amended or recodified from time to time, or under any other law relating to bankruptcy, insolvency, reorganization or other relief for debtors;
(iv)the appointment of a receiver, trustee, custodian or liquidator of or for any part of these assets or property of the Borrower;


(v)immediately prior to the closing of an acquisition of the Borrower, whether by merger or the purchase of all of its outstanding stock or all (or substantially all) of its assets, by an unrelated third party;
(vi)the execution by the Borrower of a general assignment for the benefit of creditors; or
(vii)the occurrence of an event of default under either of the Stock Pledge Agreements (as defined below).

3.Form of Payment; Prepayment. All payments of principal and interest on this Note shall be made without offset or deduction in lawful tender of the United States to the Lender. All payments on this Note shall be applied first to the payment of accrued and unpaid interest, and thereafter to the payment of principal. Prepayment of the principal balance of this Note, together with all accrued and unpaid interest, may be made in whole or in part at any time without penalty.

4.Security. The Borrower’s obligations under this Note shall be secured by a first-priority security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock held and owned of record, respectively, by each of Paul Antonio Pereira and John M. Cook II (collectively, the “Shares”). The Shares shall be pledged pursuant to the First Amended and Restated Stock Pledge Agreements of even date herewith (in the form attached hereto as Exhibit A, collectively, the “Stock Pledge Agreements”), by and between, respectively, (i) the Lender and Paul Antonio Pereira, and (ii) the Lender and John M. Cook II, all terms of which are incorporated herein by this reference.

5.Default. For purposes of this Note, the failure of the Borrower to pay when due the principal balance and accrued interest under this Note shall constitute an “Event of Default.” If an Event of Default occurs, all indebtedness under this Note shall become immediately due and payable without any action on the part of the Lender, and the Borrower shall immediately pay to the Lender all such amounts.

6.Collection and Attorneys’ Fees. If any action is instituted to collect any indebtedness under this Note, then the Borrower promises to pay all reasonable costs and expenses, including reasonable attorneys’ fees, incurred by the Lender in connection with such action.

7.Assignment. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Notwithstanding the foregoing, neither the Lender nor the Borrower may assign, pledge or otherwise transfer this Note without the prior written consent of the other party.

8.overning Law. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of law thereof.


9.Conflicting Agreements. In the event of any inconsistencies between the terms of this Note and the terms of any other document related to the loan evidenced by this Note, the terms of this Note shall prevail.

10.Amendment. Any term of this Note may be amended and the observance of any term of this Note may be waived only with the written consent of the Lender and the Borrower.

[Signature page follows.]


IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

BORROWER

LECTREFY INC.

By: /s/ Paul Antonio Pereira

Name: Paul Antonio Pereira

Title: Chief Executive Officer

Acknowledged and Agreed:

LENDER

LEE AEROSPACE, INC.

By: /s/ James Lee

Name: James Lee

Title: Chief Executive Officer


EXHIBIT A

FIRST AMENDED AND RESTATED STOCK PLEDGE AGREEMENT

THIS FIRST AMENDED AND RESTATED STOCK PLEDGE AGREEMENT (this “Pledge Agreement”) is made by [Paul Antonio Pereira / John M. Cook II] (“Pledgor”), in favor of Lee Aerospace, Inc., a Kansas corporation (“Pledgee”), with its principal place of business at 9323 E. 34th St. N., Wichita, Kansas 67226.

WHEREAS, Lectrefy Inc., a Delaware corporation (the “Borrower”): (i) executed previously that certain Promissory Note, dated August 8, 2019, in favor of Pledgee in the amount of Two Hundred Fifty Thousand Dollars ($250,000) (the “First Note”); and (ii) has executed concurrently herewith that certain Promissory Note, dated September 20, 2019, in favor of Pledgee in the amount of One Hundred Thousand Dollars ($100,000) (the “Second Note” and, together with the First Note, the “Note”); and

WHEREAS, Pledgee is willing to accept the Note from Borrower, but only upon the condition, among others, that Pledgor shall have executed and delivered to Pledgee this Pledge Agreement.

NOW, THEREFORE, in consideration of the foregoing recitals and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound, Pledgor hereby agrees as follows:

1.As security for the full and prompt payment when due (whether by stated maturity or otherwise) of all indebtedness of the Borrower to Pledgee created under the Note, Pledgor hereby pledges to Pledgee, and grants to Pledgee, a security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock, which are held and owned of record by Pledgor (the “Pledged Shares”), and all dividends, cash, instruments and other proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the Pledged Shares (the “Pledged Collateral”). Pledgor represents and warrants that, except as provided for herein, the Pledged Shares have not been, and will not be, pledged or used as collateral for any other purpose.
2.At any time a default exists under the Note, Pledgee in its name or in the name of its nominee or of Pledgor may: (i) collect by legal proceedings or otherwise all dividends (except cash dividends), interest, principal payments and other sums now or hereafter payable upon or on account of the Pledged Collateral; (ii) enter into any extension, reorganization, deposit, merger or consolidation agreement, or any agreement relating to or affecting the Pledged Collateral, and in connection therewith may deposit or surrender control of the Pledged Collateral thereunder, accept other property in exchange for the Pledged Collateral and do and perform such acts and things as it may deem proper, and any money or property received in exchange for the Pledged Collateral shall be applied


to the indebtedness or thereafter held by it pursuant to the provisions hereof; and (iii) insure, process and preserve the Pledged Collateral.

3.At the option of Pledgee, and without necessity of demand or notice, all or any part of the indebtedness of the Borrower under the Note shall immediately become due and payable irrespective of any agreed maturity, upon the happening of any of the following events: (i) material failure to keep or perform any of the terms or provisions of this Pledge Agreement; (ii) the Borrower’s failure to pay any installment of principal or interest on the Note when due; (iii) the levy of any attachment, execution or other process against the Pledged Collateral; or (iv) the insolvency, commission of an act of bankruptcy, general assignment for the benefit of creditors, filing of any petition in bankruptcy or for relief under the provisions of Title 11 of the United States Code of, by, or against Pledgor or the Borrower.
4.In the event of the nonpayment of any indebtedness when due under the Note, or upon the happening of any of the events specified in the last preceding section, Pledgee may apply, set off, collect or sell the Pledged Collateral in one or more sales, or take such steps as may be necessary to take ownership of the Pledged Shares or liquidate and reduce the Pledged Shares to cash in the hands of Pledgee in whole or in part.
5.The proceeds of the sale of any of the Pledged Collateral and all sums received or collected by Pledgee from or on account of the Pledged Collateral shall be applied by Pledgee to the payment of the indebtedness under the Note or any part thereof. The Borrower then shall pay any remaining balance of the Note to Pledgor; provided, however, that, if such disposition is at private sale, then the purchase price of the Pledged Collateral shall be mutually agreed to by Pledgee and Pledgor or, if the parties cannot agree upon a purchase price, then at a purchase price established by an independent appraiser knowledgeable of the value of the Pledged Collateral, mutually selected by Pledgor and the Pledgee, with the appraisal to be rendered within thirty (30) days of the appointment of the appraiser.
6.This Pledge Agreement and the other documents referred to herein constitute the entire agreement between the parties with respect to the subject matter hereof and thereof and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein or therein. Without limiting the foregoing, this Pledge Agreement supersedes, and replaces in its entirety, the Stock Pledge Agreement, dated August 8, 2019, between the parties.
7.If any provision of this Pledge Agreement is held to be unenforceable for any reason, then it shall be adjusted, if possible, rather than voided in order to achieve the intent of the parties to the extent possible.
8.This Pledge Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware as applied to contracts made and performed entirely within the State of Delaware by residents of such State.

[Signature page follows.]


IN WITNESS WHEREOF, this Pledge Agreement has been executed and delivered by the Pledgor effective as of September 20, 2019.

PLEDGOR:

By:

[Paul Antonio Pereira / John M. Cook II]

Acknowledged and Agreed:

LEE AEROSPACE, INC.

By:                                

Name: James Lee

Title: Chief Executive Officer

LECTREFY INC.

By:                                

Name: [Paul Antonio Pereira / John M. Cook II]

Title: [Chief Executive Officer / Chief Financial Officer]


Exhibit 10.29

PROMISSORY NOTE

$75,000

Miami, Florida

October 25, 2019

FOR VALUE RECEIVED, the undersigned borrower (the “Borrower”) promises to pay to Lee Aerospace, Inc., a Kansas corporation (the “Lender”), at its principal office the principal sum of Seventy-Five Thousand Dollars ($75,000), together with interest on the outstanding principal amount at the rate of Five Percent (5.0%) per annum (computed on the basis of actual calendar days elapsed and a year of three hundred sixty-five (365) days), or, if less, at the highest rate of interest then permitted under applicable law. Interest shall commence with the date hereof and shall continue to accrue on the outstanding principal until paid in accordance with the provisions hereof. If any interest is determined to be in excess of the then legal maximum rate, then that portion of each interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the obligations evidenced by this Promissory Note (this “Note”).

1.Maturity. Unless sooner paid in accordance with the terms hereof, the entire unpaid principal amount and all unpaid accrued interest of this Note shall become fully due and payable on the earlier of (i) the one (1) year anniversary of the date hereof, or (ii) the acceleration of the maturity of this Note pursuant to Section 2.

2.Events of Acceleration.

(a)The entire unpaid principal amount of this Note and all then accrued and unpaid interest of this Note shall become fully due and payable upon the earliest of:
(i)the closing of aggregate proceeds of at least One Million Dollars ($1,000,000) in new equity financing by the Borrower;
(ii)immediately prior to the first filing by the Borrower of a registration statement under the Securities Act of 1933, as amended;
(iii)the filing of a petition by or against the Borrower under any provision of the Bankruptcy Reform Act (Title 11 of the United States Code), as amended or recodified from time to time, or under any other law relating to bankruptcy, insolvency, reorganization or other relief for debtors;
(iv)the appointment of a receiver, trustee, custodian or liquidator of or for any part of these assets or property of the Borrower;
(v)immediately prior to the closing of an acquisition of the Borrower, whether by merger or the purchase of all of its outstanding stock or all (or substantially all) of its assets, by an unrelated third party;

1


(vi)the execution by the Lender of a general assignment for the benefit of creditors; or
(vii)the occurrence of an event of default under either of the Stock Pledge Agreements (as defined below).

3.Form of Payment; Prepayment. All payments of principal and interest on this Note shall be made without offset or deduction in lawful tender of the United States to the Lender. All payments on this Note shall be applied first to the payment of accrued and unpaid interest, and thereafter to the payment of principal. Prepayment of the principal balance of this Note, together with all accrued and unpaid interest, may be made in whole or in part at any time without penalty.

4.Security. The Borrower’s obligations under this Note shall be secured by a first-priority security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Lender’s Common Stock held and owned of record, respectively, by each of Paul Antonio Pereira and John M. Cook II (collectively, the “Shares”). The Shares shall be pledged pursuant to the Second Amended and Restated Stock Pledge Agreements of even date herewith (in the form attached hereto as Exhibit A, collectively, the “Stock Pledge  Agreements”), by and between, respectively, (i) the Borrower and Paul Antonio Pereira, and (ii) the Borrower and John M. Cook II, all terms of which are incorporated herein by this reference.

5.Default. For purposes of this Note, the failure of the Borrower to pay when due the principal balance and accrued interest under this Note shall constitute an “Event of Default.” If an Event of Default occurs, all indebtedness under this Note shall become immediately due and payable without any action on the part of the Lender, and the Borrower shall immediately pay to the Lender all such amounts.

6.Collection and Attorneys’ Fees. If any action is instituted to collect any indebtedness under this Note, then the Borrower promises to pay all reasonable costs and expenses, including reasonable attorneys’ fees, incurred by the Lender in connection with such action.

7.Assignment. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Notwithstanding the foregoing, neither the Lender nor the Borrower may assign, pledge or otherwise transfer this Note without the prior written consent of the other party.

8.Governing Law. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of law thereof.

9.Conflicting Agreements. In the event of any inconsistencies between the terms of this Note and the terms of any other document related to the loan evidenced by this Note, the terms of this Note shall prevail.

2


10.Amendment. Any term of this Note may be amended and the observance of any term of this Note may be waived only with the written consent of the Lender and the Borrower.

[Signature page follows.]

3


IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

BORROWER

LECTREFY, INC.

By:/s/ Paul Antonio Pereira

Name: Paul Antonio Pereira

Title: Chief Executive Officer

Acknowledged and Agreed:

LENDER

LEE AEROSPACE, INC.

By:/s/ James Lee

Name: James Lee

Title: Chief Executive Officer

4


EXHIBIT A

SECOND AMENDED AND RESTATED STOCK PLEDGE AGREEMENT

THIS SECOND AMENDED AND RESTATED STOCK PLEDGE AGREEMENT (this “Pledge Agreement”) is made by [Paul Antonio Pereira / John M. Cook II] (“Pledgor”), in favor of Lee Aerospace, Inc., a Kansas corporation (“Pledgee”), with its principal place of business at 9323 E. 34th St. N., Wichita, Kansas 67226.

WHEREAS, Lectrefy, Inc., a Delaware corporation (the “Borrower”): (i) executed previously that certain Promissory Note, dated August 8, 2019, in favor of Pledgee in the amount of Two Hundred Fifty Thousand Dollars ($250,000) (the “First Note”); (ii) executed previously that certain Promissory Note, dated September 20, 2019, in favor of Pledgee in the amount of One Hundred Thousand Dollars ($100,000) (the “Second Note”); and (iii) has executed concurrently herewith that certain Promissory Note, dated October 25, 2019, in favor of Pledgee in the amount of Seventy-Five Thousand Dollars ($75,000) (the “Third Note” and, together with the First Note and the Second Note, the “Note”); and

WHEREAS, Pledgee is willing to accept the Note from Borrower, but only upon the condition, among others, that Pledgor shall have executed and delivered to Pledgee this Pledge Agreement.

NOW, THEREFORE, in consideration of the foregoing recitals and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound, Pledgor hereby agrees as follows:

1.As security for the full and prompt payment when due (whether by stated maturity or otherwise) of all indebtedness of the Borrower to Pledgee created under the Note, Pledgor hereby pledges to Pledgee, and grants to Pledgee, a security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock, which are held and owned of record by Pledgor (the “Pledged Shares”), and all dividends, cash, instruments and other proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the Pledged Shares (the “Pledged Collateral”). Pledgor represents and warrants that, except as provided for herein, the Pledged Shares have not been, and will not be, pledged or used as collateral for any other purpose.
2.At any time a default exists under the Note, Pledgee in its name or in the name of its nominee or of Pledgor may: (i) collect by legal proceedings or otherwise all dividends (except cash dividends), interest, principal payments and other sums now or hereafter payable upon or on account of the Pledged Collateral; (ii) enter into any extension, reorganization, deposit, merger or consolidation agreement, or any agreement relating to or affecting the Pledged Collateral, and in connection therewith may deposit or surrender control of the Pledged Collateral thereunder, accept other property in exchange for the Pledged Collateral and do and perform such acts and things as it may deem proper, and any money or property received in exchange for the Pledged Collateral shall be applied

5


to the indebtedness or thereafter held by it pursuant to the provisions hereof; and (iii) insure, process and preserve the Pledged Collateral.

3.At the option of Pledgee, and without necessity of demand or notice, all or any part of the indebtedness of the Borrower under the Note shall immediately become due and payable irrespective of any agreed maturity, upon the happening of any of the following events: (i) material failure to keep or perform any of the terms or provisions of this Pledge Agreement; (ii) the Borrower’s failure to pay any installment of principal or interest on the Note when due; (iii) the levy of any attachment, execution or other process against the Pledged Collateral; or (iv) the insolvency, commission of an act of bankruptcy, general assignment for the benefit of creditors, filing of any petition in bankruptcy or for relief under the provisions of Title 11 of the United States Code of, by, or against Pledgor or the Borrower.
4.In the event of the nonpayment of any indebtedness when due under the Note, or upon the happening of any of the events specified in the last preceding section, Pledgee may apply, set off, collect or sell the Pledged Collateral in one or more sales, or take such steps as may be necessary to take ownership of the Pledged Shares or liquidate and reduce the Pledged Shares to cash in the hands of Pledgee in whole or in part.
5.The proceeds of the sale of any of the Pledged Collateral and all sums received or collected by Pledgee from or on account of the Pledged Collateral shall be applied by Pledgee to the payment of the indebtedness under the Note or any part thereof. The Borrower then shall pay any remaining balance of the Note to Pledgor; provided, however, that, if such disposition is at private sale, then the purchase price of the Pledged Collateral shall be mutually agreed to by Pledgee and Pledgor or, if the parties cannot agree upon a purchase price, then at a purchase price established by an independent appraiser knowledgeable of the value of the Pledged Collateral, mutually selected by Pledgor and the Pledgee, with the appraisal to be rendered within thirty (30) days of the appointment of the appraiser.
6.This Pledge Agreement and the other documents referred to herein constitute the entire agreement between the parties with respect to the subject matter hereof and thereof and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein or therein. Without limiting the foregoing, this Pledge Agreement supersedes, and replaces in its entirety, the Stock Pledge Agreement, dated August 8, 2019, between the parties.
7.If any provision of this Pledge Agreement is held to be unenforceable for any reason, then it shall be adjusted, if possible, rather than voided in order to achieve the intent of the parties to the extent possible.
8.This Pledge Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware as applied to contracts made and performed entirely within the State of Delaware by residents of such State.

[Signature page follows.]

6


IN WITNESS WHEREOF, this Pledge Agreement has been executed and delivered by the Pledgor effective as of October 25, 2019.

PLEDGOR:

By:[Paul Antonio Pereira / John M. Cook II]

Acknowledged and Agreed:

LEE AEROSPACE, INC.

By:

Name: James Lee

Title: Chief Executive Officer

LECREFY, INC.

By:

Name: [Paul Antonio Pereira / John M. Cook II]

Title: [Chief Executive Officer / Chief Financial Officer]

7


Exhibit 10.30

PROMISSORY NOTE

$72,091

Miami, Florida

November 12, 2019

FOR VALUE RECEIVED, the undersigned borrower (the “Borrower”) promises to pay to Lee Aerospace, Inc., a Kansas corporation (the “Lender”), at its principal office the principal sum of Seventy-Two Thousand Ninety-One Dollars ($72,091), together with interest on the outstanding principal amount at the rate of Five Percent (5.0%) per annum (computed on the basis of actual calendar days elapsed and a year of three hundred sixty-five (365) days), or, if less, at the highest rate of interest then permitted under applicable law. Interest shall commence with the date hereof and shall continue to accrue on the outstanding principal until paid in accordance with the provisions hereof. If any interest is determined to be in excess of the then legal maximum rate, then that portion of each interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the obligations evidenced by this Promissory Note (this “Note”).

1.Maturity. Unless sooner paid in accordance with the terms hereof, the entire unpaid principal amount and all unpaid accrued interest of this Note shall become fully due and payable on the earlier of (i) the one (1) year anniversary of the date hereof, or (ii) the acceleration of the maturity of this Note pursuant to Section 2.
2.Events of Acceleration. The entire unpaid principal amount of this Note and all then accrued and unpaid interest of this Note shall become fully due and payable upon the earliest of:
(i)the closing of aggregate proceeds of at least One Million Dollars ($1,000,000) in new equity financing by the Borrower;
(ii)immediately prior to the first filing by the Borrower of a registration statement under the Securities Act of 1933, as amended;
(iii)the filing of a petition by or against the Borrower under any provision of the Bankruptcy Reform Act (Title 11 of the United States Code), as amended or recodified from time to time, or under any other law relating to bankruptcy, insolvency, reorganization or other relief for debtors;
(iv)the appointment of a receiver, trustee, custodian or liquidator of or for any part of these assets or property of the Borrower;
(v)immediately prior to the closing of an acquisition of the Borrower, whether by merger or the purchase of all of its outstanding stock or all (or substantially all) of its assets, by an unrelated third party;


(vi)the execution by the Borrower of a general assignment for the benefit of creditors; or
(vii)the occurrence of an event of default under either of the Stock Pledge Agreements (as defined below).
3.Form of Payment; Prepayment. All payments of principal and interest on this Note shall be made without offset or deduction in lawful tender of the United States to the Lender. All payments on this Note shall be applied first to the payment of accrued and unpaid interest, and thereafter to the payment of principal. Prepayment of the principal balance of this Note, together with all accrued and unpaid interest, may be made in whole or in part at any time without penalty.
4.Security. The Borrower’s obligations under this Note shall be secured by a first-priority security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock held and owned of record, respectively, by each of Paul Antonio Pereira and John M. Cook II (collectively, the “Shares”). The Shares shall be pledged pursuant to the Third Amended and Restated Stock Pledge Agreements of even date herewith (in the form attached hereto as Exhibit A, collectively, the “Stock Pledge Agreements”), by and between, respectively, (i) the Lender and Paul Antonio Pereira, and (ii) the Lender and John M. Cook II, all terms of which are incorporated herein by this reference.
5.Default. For purposes of this Note, the failure of the Borrower to pay when due the principal balance and accrued interest under this Note shall constitute an “Event of Default.” If an Event of Default occurs, all indebtedness under this Note shall become immediately due and payable without any action on the part of the Lender, and the Borrower shall immediately pay to the Lender all such amounts.
6.Collection and Attorneys’ Fees. If any action is instituted to collect any indebtedness under this Note, then the Borrower promises to pay all reasonable costs and expenses, including reasonable attorneys’ fees, incurred by the Lender in connection with such action.
7.Assignment. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Notwithstanding the foregoing, neither the Lender nor the Borrower may assign, pledge or otherwise transfer this Note without the prior written consent of the other party.
8.Governing Law. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of law thereof.
9.Conflicting Agreements. In the event of any inconsistencies between the terms of this Note and the terms of any other document related to the loan evidenced by this Note, the terms of this Note shall prevail.

2


10.Amendment. Any term of this Note may be amended and the observance of any term of this Note may be waived only with the written consent of the Lender and the Borrower.

[Signature page follows.]

3


IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

BORROWER

LECTREFY INC.

By:

/s/ Paul Antonio Pereira

Name:

Paul Antonio Pereira

Title:

Chief Executive Officer

Acknowledged and Agreed:

LENDER

LEE AEROSPACE, INC.

By:

/s/ James Lee

Name:

James Lee

Title:

Chief Executive Officer

4


Exhibit 10.31

PROMISSORY NOTE

$100,000

Miami, Florida

November 26, 2019

FOR VALUE RECEIVED, the undersigned borrower (the “Borrower”) promises to pay to Lee Aerospace, Inc., a Kansas corporation (the “Lender”), at its principal office the principal sum of One Hundred Thousand Dollars ($100,000), together with interest on the outstanding principal amount at the rate of Five Percent (5.0%) per annum (computed on the basis of actual calendar days elapsed and a year of three hundred sixty-five (365) days), or, if less, at the highest rate of interest then permitted under applicable law. Interest shall commence with the date hereof and shall continue to accrue on the outstanding principal until paid in accordance with the provisions hereof. If any interest is determined to be in excess of the then legal maximum rate, then that portion of each interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the obligations evidenced by this Promissory Note (this “Note”).

1.Maturity. Unless sooner paid in accordance with the terms hereof, the entire unpaid principal amount and all unpaid accrued interest of this Note shall become fully due and payable on the earlier of (i) the one (1) year anniversary of the date hereof, or (ii) the acceleration of the maturity of this Note pursuant to Section 2.
2.Events of Acceleration. The entire unpaid principal amount of this Note and all then accrued and unpaid interest of this Note shall become fully due and payable upon the earliest of:
(i)the closing of aggregate proceeds of at least One Million Dollars ($1,000,000) in new equity financing by the Borrower;
(ii)mmediately prior to the first filing by the Borrower of a registration statement under the Securities Act of 1933, as amended;
(iii)the filing of a petition by or against the Borrower under any provision of the Bankruptcy Reform Act (Title 11 of the United States Code), as amended or recodified from time to time, or under any other law relating to bankruptcy, insolvency, reorganization or other relief for debtors;
(iv)the appointment of a receiver, trustee, custodian or liquidator of or for any part of these assets or property of the Borrower;
(v)immediately prior to the closing of an acquisition of the Borrower, whether by merger or the purchase of all of its outstanding stock or all (or substantially all) of its assets, by an unrelated third party;


(vi)the execution by the Borrower of a general assignment for the benefit of creditors; or
(vii)the occurrence of an event of default under either of the Stock Pledge Agreements (as defined below).
3.Form of Payment; Prepayment. All payments of principal and interest on this Note shall be made without offset or deduction in lawful tender of the United States to the Lender. All payments on this Note shall be applied first to the payment of accrued and unpaid interest, and thereafter to the payment of principal. Prepayment of the principal balance of this Note, together with all accrued and unpaid interest, may be made in whole or in part at any time without penalty.
4.Security. The Borrower’s obligations under this Note shall be secured by a first-priority security interest in Fifty-Six Thousand Two Hundred Fifty (56,250) shares of the Borrower’s Common Stock held and owned of record, respectively, by each of Paul Antonio Pereira and John M. Cook II (collectively, the “Shares”). The Shares shall be pledged pursuant to the Third Amended and Restated Stock Pledge Agreements of even date herewith (in the form attached hereto as Exhibit A, collectively, the “Stock Pledge Agreements”), by and between, respectively, (i) the Lender and Paul Antonio Pereira, and (ii) the Lender and John M. Cook II, all terms of which are incorporated herein by this reference.
5.Default. For purposes of this Note, the failure of the Borrower to pay when due the principal balance and accrued interest under this Note shall constitute an “Event of Default.” If an Event of Default occurs, all indebtedness under this Note shall become immediately due and payable without any action on the part of the Lender, and the Borrower shall immediately pay to the Lender all such amounts.
6.Collection and Attorneys’ Fees. If any action is instituted to collect any indebtedness under this Note, then the Borrower promises to pay all reasonable costs and expenses, including reasonable attorneys’ fees, incurred by the Lender in connection with such action.
7.Assignment. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Notwithstanding the foregoing, neither the Lender nor the Borrower may assign, pledge or otherwise transfer this Note without the prior written consent of the other party.
8.Governing Law. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of law thereof.
9.Conflicting Agreements. In the event of any inconsistencies between the terms of this Note and the terms of any other document related to the loan evidenced by this Note, the terms of this Note shall prevail.

2


10.Amendment. Any term of this Note may be amended and the observance of any term of this Note may be waived only with the written consent of the Lender and the Borrower.

[Signature page follows.]

3


IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

BORROWER

LECTREFY INC.

By:

/s/ Paul Antonio Pereira

Name:

Paul Antonio Pereira

Title:

Chief Executive Officer

Acknowledged and Agreed:

LENDER

LEE AEROSPACE, INC.

By:

/s/ James Lee

Name:

James Lee

Title:

Chief Executive Officer

4


Exhibit 21.1

Subsidiaries of Alfi, Inc.

Name of Subsidiary

Jurisdiction of Incorporation

ALFI (N.I.) LTD

Northern Ireland


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Alfi, Inc.

Miami, Florida

We hereby consent to the incorporation by reference in Registration Statement Number 333-255921 on Form S-8 of Alfi, Inc., of our report dated May 16, 2022 on the consolidated financial statements of Alfi, Inc., appearing in this Annual Report on Form 10-K as of and for the year ended December 31, 2021.

/s/Frazier & Deeter, LLC

Tampa, Florida

May 16, 2022


Exhibit 31.1

Certification of Principal Executive Officer
pursuant to
Exchange Act Rules 13a-14(a) and 15d-14(a),
as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002

I, Peter Bordes, certify that:

1.I have reviewed this annual report on Form 10-K of Alfi, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 16, 2022

    

/s/ Peter Bordes

Peter Bordes

Interim Chief Executive Officer

(principal executive officer)


Exhibit 31.2

Certification of Principal Financial Officer
pursuant to
Exchange Act Rules 13a-14(a) and 15d-14(a),
as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002

I, Louis Almerini, certify that:

1.I have reviewed this annual report on Form 10-K of Alfi, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 16, 2022

    

/s/ Louis Almerini

Louis Almerini

Interim Chief Financial Officer

(principal financial and accounting officer)


Exhibit 32.1

Certifications of Principal Executive Officer and Principal Financial Officer
pursuant to
18 U.S.C. Section 1350,
as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Peter Bordes, Interim Chief Executive Officer (principal executive officer) of Alfi, Inc. (the “Company”), and Louis Almerini, Interim Chief Financial Officer (principal financial and accounting officer) of the Company, each hereby certifies that, to the best of his knowledge:

1)

The Company’s Annual Report on Form 10-K for the years ended December 31, 2021, 2020 and 2019, to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 16, 2022

/s/ Peter Bordes

Peter Bordes

Interim Chief Executive Officer

(principal executive officer)

/s/ Louis Almerini

Louis Almerini

Interim Chief Financial Officer

(principal financial and accounting officer)

The foregoing certifications are being furnished pursuant to 18 U.S.C. Section 1350. They are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.